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Abstract 
In the work compiled in this thesis, different methodologies have been 
developed based on Michael initiated cascade reactions in order to obtain 
enantioenriched interesting products, employing chiral amines as stereoinductors 
elements, under iminium ion activation. 
In this sense, firstly we studied the versatility of 4-alkenyl-5H-1,2,3-
oxathiazol-2,2-dioxides as multifunctional reagents in cascade processes. On the 
one hand, it has been demonstrated their ability as Michael donor/acceptor in 
Michael/Michael cascade reactions, using enals as initial acceptors, under 
iminium/enamine manifold. In addition, by transforming the obtained 
cycloadducts it has been possible to achieve the 1,2-aminoalcohol moiety, as well 
as to synthesize bicycle[3.1.0]hexanes, due to the ability of the sulfonate as 
leaving group. On the other hand, 4-alkenyl-5H-1,2,3-oxathiazol-2,2-dioxides have 
been used in the formation of this type of complex bicyclic structures through 
Michael/Michael/transannular nucleophilic substitution/imine hydrolysis cascade 
sequence. 
Secondly, several pyrrolidine derivatives have been synthesized in a 
stereocontrol way through one-pot Michael/intramolecular condensation/reduction 
sequence between aminomalonates and α,β-unsaturated ketones, employing chiral 
primary amines as catalysts. Moreover, they have been satisfactorily transformed 
into the corresponding proline derivatives, by the base-promoted intramolecular 
C→N acyl transfer reaction, followed by deprotection of the resulting carbamate. 
Finally, as part of a short stay in the Prof. M. Christmann group at Free 
University of Berlin, I could take part in a project related to the synthesis of (+)-
Greek tobacco lactone, completing the synthesis in 7 steps and with an overall 
yield of 7%. 
Resumen 
En el presente trabajo de investigación se han desarrollado diversas 
metodologías basadas en reacciones en cascada iniciadas por adiciones de 
Michael, con el fin de obtener productos enantioenriquecidos de interés, 
empleando aminas quirales como elementos estereoinductores de la reacción, bajo 
activación via ion iminio. 
En este sentido, en primer lugar se ha estudiado la versatilidad sintética de 
los 2,2-dióxidos de 4-alquenil-5H-1,2,3-oxatiazol como reactivos multifuncionales 
en procesos en cascada. Por un lado, se ha demostrado su capacidad como 
dadores/aceptores de Michael en reacciones en cascada Michael/Michael, 
empleando enales como aceptores iniciales combinando los modos de activación 
iminio y enamina. Adicionalmente, mediante la transformación de los cicloaductos 
obtenidos ha sido posible la obtención de la agrupación 1,2-amino alcohol, así 
como la síntesis de compuestos bicíclicos complejos, haciendo uso de la habilidad 
de la unidad sulfonato como grupo saliente. Por otro lado, los 2,2-dióxidos de 4-
alquenil-5H-1,2,3-oxatiazol se han empleado en la formación de dichas estructuras 
bicíclicas mediante un proceso en cascada Michael/Michael/sustitución nucleófila 
transanular/hidrólisis de imina. 
En segundo lugar, se han sintetizado derivados de pirrolidina de manera 
esterecontrolada mediante un proceso one-pot Michael/condensación 
intramolecular/reducción entre aminomalonatos y cetonas α,β-insaturadas, 
empleando aminas primarias como catalizadores. Además, han sido eficazmente 
transformados en los correspondientes derivados de prolina, mediante 
transposición intramolecular C→N de acilo seguido de desprotección del 
carbamato resultante. 
Finalmente, y como parte de una estancia corta llevada a cabo en el grupo 
del Prof. M. Christmann en la Universidad Libre de Berlín, pude tomar parte en el 
proyecto dirigido a la síntesis del producto natural (+)-Greek tobacco lactone, 
pudiéndose completar su síntesis en un total de 7 pasos con un rendimiento global 
del 7%. 
Laburpena 
Doktorego tesi honetan, kaskada erreakzioetan oinarritutako metodologia 
desberdinak aztertu dira, kaskadaren hasarazle gisa Michael adizio bidezko 
erreakzioa oinarritzat hartuz. Erreakzioaren elementu estereoinduzitzaile bezala 
amina kiralak erabili dira eta iminio bidezko aktibazioaren bitartez, interesdun 
produktu enantioaberastuak prestatu dira. 
Lehenik eta behin, kaskada prozesuetarako erreaktibo multifuntzional gisa, 
4-alkenil-5H-1,2,3-oxatiazol-2,2-dioxidoak erabili dira beraien aldakortasun 
sintetikoa ikasteko helburuarekin. Alde batetik, beraien Michael emaile/hartzaile 
gaitasuna frogatu da Michael/Michael bidezko kaskada erreakzioetan, hasierako 
hartzaile bezala enalak erabiliz eta iminio eta enamina bidezko aktibazioak 
konbinatuz. Gainera, lortutako produktuen transformazioen bidez, 1,2-
aminoalkohol taldea lortzea posible izan da, baita konposatu bizikliko konplexuak 
ere, sulfonatoaren talde ateragarri izaerari esker. Bestalde, 4-alkenil-5H-1,2,3-
oxatiazol-2,2-dioxidoak, egitura bizikliko hauen eraketan erabili dira 
Michael/Michael/ordezkapen nukleozale transanular/imina hidrolisi kaskada 
prozesu-sekuentziaren bitartez. 
Bestalde, pirrolidina eratorri sintetikoak modu estereokontrolatuan prestatu 
dira, one-pot bidezko Michael/kondentsazio intramolekular/erredukzio 
prosezuaren bitartez, aminomalonatoak eta zetona α,β-asegabetuak erabiliz, eta 
amina primariodun katalizatzaileez baliatuz. Gainera, hauek modu eraginkor 
batean transformatu dira prolina deribatuetan, azilo taldearen C→N transposizio 
intramolekular eta ondorengo karbamatoaren desbabespenari esker. 
Azkenik, Berlineko Freie Unibertsitateko Prof. M. Christmann-en taldean  
buruturiko egonaldi laburrean, (+)-Greek tobacco lactone produktu naturalaren 
sintesian parte hartzeko aukera izanda, sintesi totala %7ko etekin globalarekin eta 
7 pausutan osatzea posible izan zen. 
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1. ORGANOCATALYSIS 
Asymmetric organocatalysis is a synthetic methodology complementary to 
metal catalysis1 and enzymatic transformations2 that in the last years has been 
widely studied in the field of asymmetric synthesis. This method consists on the 
increase of the rate of several chemical reactions influenced by substoichiometric 
amounts of a small chiral organic compound, which does not contain a metal atom 
in its structure.3 
The advent of organocatalysis at the end of 1990’s brought the perspective 
of an additional mode of catalysis with notable advantages. Usually the reactions 
can be performed under aerobic conditions with wet solvents, due to the stability 
of the intermediates participating in the catalytic cycle towards these conditions. 
Moreover, organocatalysts are, in general, commercially available, 
environmentally friendly and cheaper than most of the metal-based catalysts. 
Therefore, it is possible to save cost, time and energy, simplifying the 
experimental procedure and reducing chemical waste. For these reasons, 
organocatalysis is considered a highly powerful tool for the synthesis of 
enantioenriched compounds, having increased notably the number of publications 
                                                     
1 Metal catalysis: a) Transition Metals for Organic Synthesis, 2nd ed. (Eds.: Beller, M.; Bolm, C.), 
Wiley-VCH, Weinheim, 2004; b) Transition Metal Reagents and Catalysts (Ed.: Tsuji, J.), John 
Wiley and Sons, Chichester, 2000; c) Application of Transition Metal Catalysts in Organic 
Synthesis (Eds.: Brandsma, L.; Vasilevsky, S. F.; Verkruijsse, H. D.), Springer, Heidelberg, 1999. 
2 Enzyme catalysis: a) Enzyme Catalysis in Organic Chemistry, 3rd ed. (Eds.: Drauz, K.; Gröger, H.; 
May, O.), Wiley-VCH, Weinheim, 2012; b) Tao, J.; Zhao, L.; Ran, N. Org. Process Res. Dev. 
2007, 11, 259; c) Benkovic, S. J.; Hammes-Schiffer, S. Science 2003, 301, 1196; d) Bruice, T. C. 
Acc. Chem. Res. 2002, 35, 139; e) Enzymes in Synthetic Organic Chemistry, 1st ed. (Eds.: Wong, C. 
H.; Whitesides, G. M.), Tetrahedron Organic Chemistry Series, Vol. 12, Oxford, 1994. 
3 a) MacMillan, D. W. C. Nature 2008, 455, 304; b) List, B.; Yang, J. W. Science 2006, 313, 1584; 
c) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138; d) Dalko, P. I.; Moisan, L. 
Angew. Chem. Int. Ed. 2001, 40, 3726. 
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in the past decade.4 In spite of these advantages, this field still presents several 
limitations. On the one hand, the typical organocatalytic reactions require for long 
reaction times and high catalyst loadings, presenting low turnover numbers. On 
the other hand, these factors might limit the potential uses of organocatalysis for 
industrial applications. However organocatalysts can be used in larger quantities 
than metal-based ones for the same price, avoiding the presence of metal traces, 
which is a crucial aspect to consider with respect to applications in medicinal 
chemistry,5 in order to prepare compounds for in vitro bioassays. In addition, the 
application of organocatalysis in the total synthesis of target molecules has 
increased significantly in recent years.6 Despite all these advances there are still 
synthetic problems that can only be dealt with the use of metal and/or enzymatic 
catalysts, being the development of new asymmetric organocatalytic 
methodologies still a necessity nowadays. 
Although the development of organocatalysis is recent, the first well 
established enantioselective reaction on a prochiral substrate in the absence of an 
enzyme, and using a chiral organic compound as a stereoinductor in a 
substoichiometric amount, can be attributed to Bredig and Fiske in 1913. They 
reported the synthesis of mandelonitrile from the addition of HCN to 
                                                     
4 For selected reviews on organocatalysis, see: a) Jacobsen, E. N.; MacMillan, D. W. C. Proc. Natl. 
Acad. Sci. USA 2010, 107, 20618; b) Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 38, 
2178; c) Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem. Int. Ed. 2008, 47, 
6138; d) Dondoni, A.; Massi, A. Angew. Chem. Int. Ed. 2008, 47, 4638; e) Pellissier, H. 
Tetrahedron 2007, 63, 9267; f) Gaunt, M. J.; Johansson, C. C. C.; McNally, A.; Vo N. T. Drug 
Discovery Today 2006, 12, 8. 
5 For selected reviews on organocatalysis applied to medicinal chemistry, see: a) Alemán, J.; Cabrera, 
S. Chem. Soc. Rev. 2013, 42, 774; b) Jaroch, S.; Weinmann, H.; Zeitler, K. ChemMedChem 2007, 
2, 1261. 
6 Organocatalysis in total synthesis: a) Sun, B.-F. Tetrahedron Lett. 2015, 56, 2133; b) Abbasov, M. 
E.; Romo, D. Nat. Prod. Rep. 2014, 31, 1318; c) Organocatalysis in Total Synthesis (Ed.: Dalko, 
P. I.), Wiley-VCH, Weinheim, 2013; d) Asymmetric Organocatalysis in Natural Product Synthesis 
(Ed.: Waser, M.), Springer, Wien, 2012; e) Marqués-López, E.; Herrera, R. P.; Christmann, M. 
Nat.Prod. Rep. 2010, 27, 1138. 
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benzaldehyde, using quinine or quinidine as chiral catalyst (Scheme 1.1).7 The 
resulting enantiomeric excess of the obtained cyanohydrins was very poor, 
(around 8% ee). However this work is considered the basis of future investigations 
in the field. 
 
Scheme 1.1 
In 1928, Wolfgang Langebeck reported that low molecular weight organic 
molecules, such as simple amino acids, can be used to explain and mimic the 
catalytic activity and selectivity of enzymes. Subsequently, he introduced for the 
first time the term “organic catalysis” to define the reactions promoted by organic 
molecules.8 In 1949, he also published a book entitled “Organic Catalysts and 
Their Relations with Enzymes”,9 considered as the first one in the field of 
organocatalysis. 
Pracejus and co-workers, in 1960, published probably the first 
organocatalytic reaction with a significant level of enantioselectivity, consisting 
on the addition of methanol to methylphenylketene, and employing O-
                                                     
7 Bredig, G.; Fiske, P. S. Biochem. Z. 1913, 46, 7. 
8 a) Langebeck, W. Angew. Chem. 1928, 41, 740; b) Langebeck, W. Angew. Chem. 1932, 45, 97. 
9 Langebeck, W. Die Organiche Katalysatoren und ihre Beziehungen zu den Fermenten, Springer-
Verlag, Berlin, 1949. 
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acetylquinine as catalyst. They obtained 74% ee in the final product, which was 
determined through polarimetry (Scheme 1.2).10 
 
Scheme 1.2 
An important progress regarding the enantioselectivity of these reactions 
took place in 1971, independently by two industry research groups at Hoffmann-
La Roche11 and Schering-Plough.12 The reaction, currently known as the Hajos-
Parrish-Eder-Sauer-Wiechert reaction, consisted on the use of the natural amino 
acid L-proline as catalyst in an intramolecular aldol reaction, providing 
enantioenriched synthetic useful intermediates for the preparation of several 
bioactive products, such as steroids and terpenes (Scheme 1.3). 
                                                     
10  Pracejus, H. Justus Liebig Ann. Chem. 1960, 634, 9. 
11 a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615; b) Hajos, Z. G.; Parrish, D. R. 
Asymmetric Synthesis of Optically Active Polycyclic Organic Compounds. German Patent DE 
2102623, 1971. 
12 a) Eder, U.; Sauer, G.; Wiechert, R. Optically Active 1,5-Indanone and 1,6-Naphthalenedione. 
German Patent DE 2014757, 1971; b) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem. Int. Ed. 
Engl. 1971, 10, 496. 
Introduction  9 
 
 
Scheme 1.3 
Other significant landmarks in the development of asymmetric 
organocatalysis appeared from 1980 to the late 90’s such as, for example, the 
enantioselective alkylation of enolates employing quaternary ammonium salts 
derivated from cinchona alkaloids as catalysts, based on the concept of phase-
transfer catalysis.13 Another relevant milestone is the use of chiral Brønsted acids 
(cyclic dipeptides or thioureas) by Inoue14 or Jacobsen15 for the asymmetric 
hydrocyanation of aldehydes and imines respectively. 
Surprisingly, in spite of the synthetic interest of this methodology, the field 
of organocatalysis as we know it nowadays was not well recognized by scientists 
until the 21st century, when two papers about the potential activity of 
aminocatalysis were reported in 2000. On the one hand, Barbas III and List 
published their well-known enantioselective intermolecular aldol reaction 
                                                     
13 a) Corey, E. J.; Xu, F.; Noe, M. C. J. Am. Chem. Soc. 1997, 119, 12414; b) O’Donnell, M. J.; 
Bennett, W. D.; Wu, S. J. Am. Chem. Soc. 1989, 111, 2353; c) Conn, R. S. E.; Lovell, A. V.; 
Karady, S.; Weinstock, L. M. J. Org. Chem. 1986, 51, 4710; d) Dolling, U.-H.; Davis, P.; 
Grabowski, E. J. J. J. Am. Chem. Soc. 1984, 106, 446. 
14  Oku, J.; Inoue, S. J. Chem. Soc. Chem. Commun. 1981, 229. 
15 a) Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10012; b) Sigman, M. S.; Jacobsen, 
E. N. J. Am. Chem. Soc. 1998, 120, 4901. 
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catalized by L-proline (Scheme 1.4),16 as the culmination of an intensive research 
that started with the use of aldolase antibodies as catalysts for the aldol reaction.17 
With the evidence of enamine intermediate formation in the enzymatic reaction of 
class I aldolases, they tried to explain the mechanism, developing the 
intermolecular aldol reaction, using the simple aminoacid L-proline in order to 
mimic the behaviour of the active site of the enzyme. They demonstrated that this 
aminoacid was able to catalyze the synthesis of aldols, in high yields and 
enantioselectivities, through the reaction between acetone and different aldehydes 
via enamine intermediates formed by condensation of the secondary amine with 
the ketone, this species acting as a nucleophile. 
 
Scheme 1.4 
The results obtained by Barbas III and List opened the opportunity to apply 
this mechanistic manifold to the synthesis of α-functionalized ketones and 
aldehydes, where the enamine intermediate reacts as a potential nucleophile with a 
variety of electrophiles.18 
                                                     
16 List, B.; Lerner, R. A.; Barbas III, C. F. J. Am. Chem. Soc. 2000, 122, 2395. 
17 For a full account, see: Barbas III, C. F. Angew. Chem. Int. Ed. 2008, 47, 42. 
18 For some general reviews on enamine catalysis, see: a) Desmarchelier, A.; Coeffard, V.; Moreau, 
X.; Greck, C. Tetrahedron 2014, 70, 2491; b) Kano, T.; Maruoka, K. Chem. Sci. 2013, 4, 907; c) 
Rios, R.; Moyano, A. Catalytic Asymmetric Conjugate Reactions (Ed.: Córdova, A.), Wiley-VCH, 
Weinheim, 2010, d) Kano, T.; Maruoka, K. Chem. Commun. 2008, 5465; e) Sulzer-Mossé, S.; 
Alexakis, A. Chem. Commun. 2007, 3123; f) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. 
Chem. Rev. 2007, 107, 5471. 
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On the other hand, in the same year, MacMillan developed the first highly 
enantioselective organocatalytic Diels-Alder reaction catalyzed by a chiral 
imidazolidinone-based salt, introducing iminium activation as a new concept 
(Scheme 1.5).19 After the formation of the iminium salt intermediate through 
condensation between the secondary amine and the α,β-unsaturated carbonyl 
compound, the LUMO energy of the dienophile decreases, favouring the orbital 
overlap in the Diels-Alder reaction. After this work, this type of catalysts and 
other secondary amines have demonstrated to be a powerful tool in asymmetric 
synthesis under this activation manifold.20 
 
Scheme 1.5 
After these initial steps, the field has experienced an impressive 
development with the appearance of new organocatalytic activation mechanisms 
and their application in multiple organic reactions of special relevance in 
synthesis. In this sense, a positive aspect that is very often highlighted with respect 
to the usefulness of organocatalytic methodologies is associated to the metal-free 
                                                     
19 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243. 
20 For some general reviews on iminium activation, see: a) Bartoli, G.; Melchiorre, P. Synlett 2008, 
1759; b) Erkkilä, A.; Majander, I.; Pihko, P. M. Chem. Rev. 2007, 107, 5416; c) Lelais, G.; 
MacMillan, D. W. C. Aldrichim. Acta 2006, 39, 79. 
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approach that these procedures imply. Moreover, several experimental protocols 
have been implemented in the last years in order to make organocatalysis a more 
sustainable alternative21 like, for example, through the use of friendlier reaction 
conditions, such as water22 or ionic liquids23 as solvents. Other alternatives rely on 
the design of more selective and recoverable catalysts, like supported catalysts in 
continuous-flow processes,24 the reduction of catalyst loadings (up to less than 5-
10 mol%),25 the development of cascade and/or multicomponent reactions26 or by 
means of the application of more energy-efficient activation techniques like 
microwave, ultrasound and ball milling, thus reducing the reaction time by 
increasing reactivity.27 For all of these reasons, organocatalysis is nowadays a 
field of recognized interest, being still necessary to continue with the search of 
new and more efficient catalysts and their application in methodologies directed 
towards the preparation of enantioenriched compounds. 
Without doubt, the most important point for the success of this methodology 
was the identification of the different generic activation modes, asymmetric 
induction and reactivity behind the participation of each organocatalysts across the 
                                                     
21 For general review, see: Hernández, J. G.; Juaristi, E. Chem. Commun. 2012, 48, 5396. 
22 a) Giacalone, F.; Gruttadauria, M. Comprehensive Enantioselective Organocatalysis: Catalysts, 
Reactions, and Applications (Ed.: Dalko, P. I.), Wiley-VCH, Weinheim, 2013; b) Mase, N.; 
Barbas III, C. F. Org. Biomol. Chem. 2010, 8, 4043; c) Raj, M.; Singh, V. K. Chem. Commun. 
2009, 6687; d) Gruttadauria, M.; Giacalone, F.; Noto, R. Adv. Synth. Catal. 2009, 351, 33. 
23 a) Luo, S.; Zhang, L.; Cheng, J.-P. Chem. Asian J. 2009, 4, 1184; b) Domínguez de María, P. 
Angew. Chem. Int. Ed. 2008, 47, 6960. 
24 a) Atodiresei, I.; Vila, C.; Rueping, M. ACS Catal. 2015, 5, 1972; b) Rodríguez-Escrich, C.; 
Pericàs, M. A. Eur. J. Org. Chem. 2015, 1173; c) Finelli, F. G.; Miranda, L. S. M.; de Souza, R. 
O. M. A. Chem. Commun. 2015, 51, 3708. 
25 For a selected review, see: Giacalone, F.; Gruttadauria, M.; Agrigento, P; Noto, R. Chem. Soc. 
Rev. 2012, 41, 2406. 
26 a) de Graaff, C.; Ruijter, E.; Orru, R. V. A. Chem. Soc. Rev. 2012, 41, 3969; b) Guillena, G.; 
Ramón, D. J.; Yus, M. Tetrahedron: Asymmetry 2007, 18, 693. 
27 a) Kranjc, K.; Kočevar, M. Curr. Org. Chem. 2013, 17, 457; b) Bruckmann, A.; Krebs, A.; Bolm, 
C. Green Chem. 2008, 10, 1131. 
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corresponding catalytic cycle. The main utility of these models relies on the fact 
that they are easy to apply as a template in new transformations. A general way to 
classify organocatalytic activation manifolds is related to the type of interaction 
between the catalyst and the substrate during the reaction. In this sense, there are 
two possibilities: a) processes including the formation of covalent adducts 
(covalent catalysis), and b) those based on non-covalent interactions, such as ion 
pairs or hydrogen bonds (non-covalent catalysis). Figure 1.1 shows the different 
activation modes and some representative examples of organic catalysts employed 
in each one. 
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Figure 1.1 
Covalent organocatalysis consists on the formation of a covalently bonded 
intermediate between the catalyst and the substrate through a reversible reaction, 
followed by the desired formation of new bond(s), to finish with the cleavage of 
the covalently bonded catalyst-product intermediate, in order to obtain the product 
and recover the catalyst ready to participate in another catalytic cycle. This 
activation is among the most widely used and thoroughly studied type of 
organocatalysis to date. As an advantage, the chiral inductor provides, in general, 
Introduction  15 
 
a good stereocontrol, due to the strong nature of the catalyst-substrate interaction. 
On the other hand, for the same reason the turnover number might be negatively 
affect, being necessary higher catalyst loadings and also longer reaction times to 
achieve good conversion. In covalent catalysis, the most studied activation is 
aminocatalysis, which consists on the use of primary or secondary amines as 
catalysts that are able to activate carbonyl compounds through the formation of 
reactive azomethine species by condensation. In this context, the most commonly 
used are enamine18 and iminium ion20 methodologies, although there are other 
variants, such as dienamine,28 trienamine,29 tetraenamine30 and vinilogous 
iminium,31 and the radical iminium ion, known as SOMO catalysis.32 N-
heterocyclic carbenes are other important class of covalent catalysis, which 
activate the carbonyl substrate by the formation of a nucleophilic intermediate, 
known as Breslow intermediate, which is able to react with an electrophilic 
species. The most interesting and important property of these last catalysts is their 
                                                     
28 For a review in dienamine catalysis, see: a) Fraile, A.; Alemán, J. Synlett 2015, 26, 1940; b) 
Christmann, M. Asymmetric Synthesis II: More Methods and Applications (Eds.: Christmann, M.; 
Bräse, S.), Wiley-VCH, Weinheim, 2012; c) Ramachary, D. B.; Reddy, Y. V. Eur. J. Org. Chem. 
2012, 865; for pioneering work, see d) Bertelsen, S.; Marigo, M.; Brandes, S.; Dinér P.; 
Jørgensen, K. A. J. Am. Chem. Soc. 2006, 128, 12973. 
29 For a review in trienamine catalysis, see: a) Reboredo, S.; Parra, A.; Alemán, J. Asym. Catal. 
2013, 1, 24; b) Kumar, I.; Ramaraju, P.; Mir, N. A. Org. Biomol. Chem. 2013, 11, 709; c) Arceo, 
E.; Melchiorre, P. Angew. Chem. Int. Ed. 2012, 51, 5290; for pioneering work, see: d) Jia, Z.-J.; 
Jiang, H.; Li, J.-L.; Gschwend, B.; Li, Q.-Z.; Yin, X.; Grouleff, J.; Chen, Y.-C.; Jørgensen, K. A. 
J. Am. Chem. Soc. 2011, 133, 5053. 
30 For examples on tetraenamine catalysis, see: a) Zhou, Q.-Q.; Xiao, Y.-C.; Yuan, X.; Chen, Y.-C. 
Asian J. Org. Chem. 2014, 3, 545; b) Stiller, J.; Poulsen, P. H.; Cruz, D. C.; Dourado, J.; Davis, 
R. L.; Jørgensen, K. A. Chem. Sci. 2014, 5, 2052. 
31  For a selected review, see: Lear, M. J.; Hayashi, Y. ChemCatChem 2013, 5, 3499. 
32 For selected examples on SOMO catalysis, see: a) Jui, N. T.; Garber, J. A. O.; Finelli, F. G.; 
MacMillan, D. W. C. J. Am. Chem. Soc. 2012, 134, 11400; b) Rendler, S.; MacMillan, D. W. C. 
J. Am. Chem. Soc. 2010, 132, 5027; c) Graham, T. H.; Jones, C. M.; Jui, N. T.; MacMillan, D. W. 
C. J. Am. Chem. Soc. 2008, 130, 16494; d) Jang, H.-Y.; Hong, J.-B.; MacMillan, D. W. C. J. Am. 
Chem. Soc. 2007, 129, 7004; e) Beeson, T. D.; Mastracchio, A.; Hong, J.-B.; Ashton, K.; 
MacMillan, D. W. C. Science 2007, 316, 582; f) Bertelsen. S.; Nielsen, M.; Jørgensen, K. A. 
Angew. Chem. Int. Ed. 2007, 46, 7356. 
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capacity to invert the reactivity of aldehydes, from being typically electrophilic to 
act as nucleophiles, through an umpolung process.33 
On the other hand, the non-covalent organocatalysis is based on weaker 
interactions between the catalyst and the substrate, being this property an 
advantage, comparing to covalent catalysis, due to the lower requirement of 
catalyst loading and reaction times. However, this can lead to a poorer control of 
the stereoselectivity of the reaction, owing to the higher degree of conformational 
freedom. In this category, the most studied approach is the one in which the 
catalyst activates the substrate by the formation of multiple hydrogen bonds.34 
This kind of catalysts presents different functional groups in their structure that 
contain acidic protons that are able to activate the substrate by coordination with 
heteroatoms present in the molecule, decreasing the electron density at that point 
and, as a consequence, improving the reactivity. Moreover, the spatial 
arrangement around the reaction site can be tuned, in order to control the 
stereochemical outcome. Within this group, chiral phosphoric or sulfonic acids,35 
                                                     
33 For selected reviews about the N-heterocyclic carbenes, see: a) Flanigan, D. M.; Romanov-
Michailidis, F.; White, N. A.; Rovis, T. Chem. Rev. 2015, 115, 9307; b) Dwivedi, S.; Gupta, S.; 
Das, S. Curr. Organocatal. 2014, 1, 13; c) Bugaut, X.; Glorius, F. Chem. Soc. Rev. 2012, 41, 
3511; d) Enders, D.; Niemeier, O.; Henseler, A. Chem. Rev. 2007, 107, 5606; d) Marion, N.; 
Díez-González, S.; Nolan, S. P. Angew. Chem. Int. Ed. 2007, 46, 2988; e) Enders, D.; Balensiefer, 
T. Acc. Chem. Res. 2004, 37, 534. 
34  For some general reviews on catalysis by hydrogen bonds formation, see: a) Hydrogen Bonding in 
Organic Synthesis (Ed.: Pihko, P. M.), Wiley-VCH, Weinheim, 2009; b) Yu, X.; Wang, W. 
Chem. Asian J. 2008, 3, 516; c) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713; d) 
Taylor, M. S.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520; e) Schreiner, P. R. Chem. 
Soc. Rev. 2003, 32, 289. 
35 For recent reviews on phosphoric or sulfonic acids as donors, see: a) Akiyama, T.; Mori, K. Chem. 
Rev. 2015, 115, 9277; b) Mori, K.; Takahiko, A. Comprehensive Enantioselective 
Organocatalysis (Ed.: Dalko, P. I.), Wiley-VCH, Weinheim, 2013; c) Rueping, M.; Kuenkel, A.; 
Atodiresei, I. Chem. Soc. Rev. 2011, 40, 4539; d) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 
2011, 44, 1156; e) Terada, M. Synthesis 2010, 12, 1929. 
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(thio)ureas,36 guanidines,37 squaramides,38 etc. can be found. Another type of non-
covalent catalysis is the ion-pairing catalysis39 that consists on the interation 
between the substrate and the catalyst by the formation of chiral ion pairs. Phase-
transfer catalysis (PTC)40 is one of the most studied cases, in which typically 
chiral cation-directed catalysts, such as quaternary ammonium or phosphonium 
salts, have been used in reactions between two substances located in different 
immiscible phases. The general advantages of this method are its simple 
experimental procedure, mild reaction conditions and the non-toxicity of reagents. 
Finally, chiral Brønsted base catalysis41 is also based on electrostatic interactions, 
activating pro-nucleophiles by deprotonation. 
Finally, it is also important to mention that, within these different activation 
methodologies, the mechanism of the reaction and the subsequent catalytic 
intermediates have to be clearly identified in order to gain further insights that can 
assist the development process of a given organocatalytic reaction, with the 
purpose of clarifying anomalous outcomes and/or identifying novel reactivity 
patterns.42 
                                                     
36 For a selected reviews on (thio)ureas as catalysts, see: a) Held, F. E.; Tsogoeva, S. B. Catal. Sci. 
Technol. 2016, 6, 645; b) Fang, X.; Wang, C.-J. Chem. Commun. 2015, 51, 1185; c) Takemoto, Y. 
Chem. Pharm. Bull. 2010, 58, 593; d) Connon, S. Synlett 2009, 354; e) Zhang, Z.; Schreiner, P. 
R. Chem. Soc. Rev. 2009, 38, 1187. 
37  For a recent review on guanidines as catalysts, see: Selig, P. Synthesis 2013, 45, 703. 
38 For specific reviews on squaramides as catalysts, see: a) Chauhan, P.; Mahajan, S.; Kaya, U.; 
Hack, D.; Enders, D. Adv. Synth. Catal. 2015, 357, 253; b) Alemán, J.; Parra, A.; Jiang, H.; 
Jørgensen, K. A. Chem. Eur. J. 2011, 17, 6890. 
39  For a general review, see: Brak, K.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2013, 52, 534. 
40 For recent reviews on chiral phase-transfer catalysis, see: a) Kaneko, S.; Kumatabara, Y.; 
Shirakawa, S. Org. Biomol. Chem. 2016, accepted; b) Shirakawa, S.; Maruoka, K. Angew. Chem. 
Int. Ed. 2013, 52, 4312; c) Jew, S.; Park, H. Chem. Commun. 2009, 7090; d) Ooi, T.; Maruoka, K. 
Angew. Chem. Int. Ed. 2007, 46, 4222. 
41 For a selected review on chiral Brønsted base catalysis, see: Palomo, C.; Oiarbide, M.; López, R. 
Chem. Soc. Rev. 2009, 38, 632 
42  For a selected review, see: Holland, M. C.; Gilmour, R. Angew. Chem. Int. Ed. 2015, 54, 3862. 
18 Chapter 1 
 
Introduction  19 
 
2. PRECEDENTS OF THE GROUP 
Historically, our research group has been very active in the development of 
new methodologies in the field of asymmetric synthesis and their application to 
the synthesis of target molecules, such as chiral building blocks, drugs and natural 
products. Initially, the methodological tool to achieve the required stereocontrol 
was the chiral auxiliary strategy, using satisfactorily the β-aminoalcohol (S,S)-(+)-
pseudoephedrine in conventional enolate chemistry43 and diverse conjugate 
addition reactions.44 
In the last years, the group moved its interest to organocatalysis, being 
especially active in using aminocatalysis. The first work reported by the group was 
based on the enamine activation, and consisted in a Michael reaction between 
aldehydes and β-nitroacrolein dimethyl acetal,45 using prolinol derivatives as 
catalysts and obtaining very promising results. This investigation was completed 
with the transformation of obtained Michael adducts through a simple and 
effective protocol for the synthesis of highly functionalized enantioenriched 
pyrrolidines (Scheme 1.6).46 
                                                     
43  Latest aldol reaction: a) Ocejo, M.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E. J. Org. Chem. 
2011, 76, 460; latest Mannich reaction: b) Iza, A.; Vicario, J. L.; Carrillo, L.; Badía, D. Synthesis 
2006, 4065; latest electrophilic amination reaction: c) Vicario, J. L.; Badía, D.; Carrillo, L.; 
Anakabe, E. Tetrahedron: Asymmetry 2002, 13, 745; azidirine ring opening reaction: d) Vicario, 
J. L.; Badía, D.; Carrillo, L. J. Org. Chem. 2001, 66, 5801. 
44  Conjugated additions: a) Ocejo, M.; Carrillo, L.; Badía, D.; Vicario, J. L.; Fernández, N.; Reyes, 
E. J. Org. Chem. 2009, 74, 4404; b) Reyes, E.; Vicario, J. L.; Carrillo, L.; Badía, D.; Uria, U.; Iza, 
A. J. Org. Chem. 2006, 71, 7763; aza-Michael reactions: c) Etxebarria, J.; Vicario, J. L.; Badía, 
D.; Carrillo, L.; Ruiz, N. J. Org. Chem. 2005, 70, 8790; d) Etxebarria, J.; Vicario, J. L.; Badía, D.; 
Carrillo, L. J. Org. Chem. 2004, 69, 2588; 1,4-addition/α-alkylation tandem reaction: e) Reyes, 
E.; Vicario, J. L.; Carrillo, L.; Badía, D.; Iza, A.; Uria, U. Org. Lett. 2006, 8, 2535. 
45  Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L. Org. Lett. 2006, 8, 6135. 
46  Ruiz, N.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; Uria, U. Chem. Eur. J. 2008, 14, 9357. 
20 Chapter 1 
 
 
Scheme 1.6 
Simultaneously, the iminium ion catalysis has also been widely studied and 
successfully employed in the group. Initially, the aza-Michael reaction was 
performed using α,β-unsaturated aldehydes as Michael acceptors and several 
nitrogen heterocycles as pro-nucleophiles, obtaining the best results employing the 
MacMillan’s catalyst47 or O-trimethylsilyl diarylprolinol48 according to the 
different substitution patterns of heterocycle (Scheme 1.7). Due to the ability of 
tetrazol moiety to undergo chemical transformations, several high interest 
compounds were prepared, like chiral ureas and formamidines. 
                                                     
47 Uria, U.; Vicario, J. L.; Badía, D.; Carrillo, L. Chem. Commun. 2007, 2509. 
48 Uria, U.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L. Org. Lett. 2011, 13, 336. 
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Scheme 1.7 
Continuing with Michael-type reactions with α,β-unsaturated aldehydes 
under iminium activation, the group has developed two different protocols 
employing acyl anion equivalents in umpolung transformations. In the first 
example N-nitromethylphthalimide was used as hydroxymoyl anion equivalent 
obtaining very good results. The obtained products can be easily transformed to 
the corresponding chiral oximes that could be subsequently derived to aldehydes 
through a simple process, without racemization.49 Additionally, in another 
example, hydrazones have been employed as masked glyoxyl anion equivalents in 
the enantioselective conjugate addition to α,β-unsaturated aldehydes. After 
                                                     
49 Alonso, B.; Reyes, E.; Carrillo, L.; Vicario, J. L.; Badía, D. Chem. Eur. J. 2011, 17, 6048. 
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oxidation/[1,3]-H shift procedure the subsequent γ-hydrazono carboxylic acids 
could be obtained (Scheme 1.8).50 
 
Scheme 1.8 
The iminium activation concept has also been efficiently used in cascade 
reactions initiated by conjugated addition that are subsequently followed by 
hemiaminalization (shown on Scheme 1.9). On the one hand, aza-
Michael/hemiaminal formation process between enals and N,N’-disubstituted 
hydrazides was developed to achieve polysubstituted enantioenriched pirazolidine 
type heterocycles.51 On the other hand, Michael/hemiaminal formation cascade 
                                                     
50 Fernández, M.; Uria, U.; Vicario, J. L.; Reyes, E.; Carrillo, L. J. Am. Chem. Soc. 2012, 134, 
11872. 
51  Fernández, M.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L. Adv. Synth. Catal. 2012, 354, 371. 
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reaction between α,β-unsaturated aldehydes and aminoacetophenone was 
developed, in which the obtained adducts were converted into γ-lactams in good 
yields after oxidation.52 
 
Scheme 1.9 
This type of activation was also used in the development of the first 
example of a formal (3+2) cycloaddition reaction between α,β-unsaturated 
aldehydes and azomethine ylides, the latest being generated in situ from 
aminomalonate imines. This reaction provided access to densely functionalized 
                                                     
52 Talavera, G.; Reyes, E.; Vicario, J. L.; Carrillo, L.; Uria, U. Adv. Synth. Catal. 2013, 355, 653. 
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pyrrolidines in good yields and excellent stereocontrol (see Scheme 1.10).53 It 
should be pointed out that computational calculations were also performed in 
order to get some insight on the mechanism of the reaction. DFT calculations 
revealed that the reaction consisted on a Michael/Mannich cascade reaction and 
not on a concerted [3+2] cycloaddition, therefore combining iminium and enamine 
activation in a typical Michael initiated cascade reaction.54 This revealed us the 
ability of cascade reactions to the preparation of complex molecules, by 
combination of different activation modes of the aminocatalysis. Moreover, a 
multicomponent procedure was developed for this reaction, starting directly from 
diethyl aminomalonate and aromatic aldehydes, instead of preformed imine, and 
using also α,β-unsaturated aldehydes as Michael acceptors.55 Alternatively, 
isoquinolinium and phthalizinium methylides have also been employed, as stable 
azomethine ylides, in the same type of reaction, using MacMillan-type catalyst 
(Scheme 1.10).56 
                                                     
53  a) Ugarriza, I.; Uria, U.; Reyes, E.; Carrillo, L.; Vicario, J. L. Asymmetric Catal. 2015, 2, 26; b) 
Reboredo, S.; Vicario, J. L.; Badía, D.; Carrillo, L.; Reyes, E. Adv. Synth. Catal. 2011, 353, 3307; 
c) Vicario, J. L.; Reboredo, S.; Badía, D.; Carrillo, L. Angew. Chem. Int. Ed. 2007, 46, 5168. 
54  Reboredo, S.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; de Cózar, A.; Cossío, F. P. Chem. 
Eur. J. 2012, 18, 7179. 
55  Reboredo, S.; Vicario, J. L.; Carrillo, L.; Reyes, E.; Uria, U. Synthesis 2013, 45, 2669. 
56  Fernández, N.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E. Chem. Commun. 2011, 47, 12313. 
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Scheme 1.10 
In connection with this topic, our group has developed several cascade 
processes applying the iminium/enamine manifold, in a satisfactory way (see 
Scheme 1.11). One example is the ciclopropanation of enals through iminium ion-
assisted Michael addition of bromomalonates to enals, followed by intramolecular 
α-alkylation of the resulting enamine intermediate, using water as solvent.57 The 
same activation strategy was applied in the synthesis of dihydropyridazines 
through an aza-Michael/aldol condensation domino reaction.58 Finally, the 
                                                     
57  a) Martínez, J. I.; Reyes, E.; Uria, U.; Carrillo, L.; Vicario, J. L. ChemCatChem 2013, 5, 2240; b) 
Uria, U.; Vicario, J. L.; Badía, D.; Carrillo, L.; Reyes, E.; Pesquera, A. Synthesis 2010, 701. 
58  Fernández, M.; Vicario, J. L.; Reyes, E.; Carrillo, L.; Badía, D. Chem. Commun. 2012, 48, 2092. 
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enantioselective synthesis of polysubstituted furofuranes was described as a result 
of a complex oxa-Michael/aldol/hemiacetalization cascade process by reaction of 
dihydroxyacetone with different enals. In this reaction two new C-O bonds and a 
C-C bond were formed, with the generation of four stereogenic centers.59 
 
Scheme 1.11 
                                                     
59 Reyes, E.; Talavera, G.; Vicario, J. L.; Badía, D.; Carrillo, L. Angew. Chem. Int. Ed. 2009, 48, 
5701. 
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Recently, our group has developed a straightforward access to 
enantioenriched pyrroloquinoline derivatives through a one-pot process consisting 
of cyclopropane ring opening/aza-Michael/aldol condensation cascade reaction 
followed by a one-pot acid-promoted lactamization. In this reaction, different 
aminobenzaldehydes reacted with conveniently functionalized 
cyclopropaneacetaldehydes (Scheme 1.12),60 being the latter activated by a chiral 
secondary amine that generates a donor-acceptor cyclopropane, which has the 
potential to undergo a ring opening process, leading to the formation of an 
electrophilic α,β-unsaturated iminium ion that is able to participate in the 
iminium/enamine cascade sequence. 
 
Scheme 1.12 
On the other hand, the group has also satisfactorily surveyed the possibility 
of combining enamine catalysis with the principle of vinylogy, making use of the 
formation of intermediates like dienamines and trienamines in cycloaddition 
chemistry. In this sense, dienamine catalysis has been used in a formal [2+2] 
cycloaddition between α-hydroxymethylnitrostyrene and enolizable α,β-
                                                     
60  Sánchez-Díez, E.; Vesga, D. L.; Reyes, E.; Uria, U.; Carrillo, L.; Vicario, J. L. Org. Lett. 2016, 
18, 1270. 
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unsaturated aldehydes, followed by an intramolecular hemiacetalization process to 
afford polysubstituted cyclobutanes in good yields and excellent stereocontrol 
(shown on Scheme 1.13).61 In a different approach dienamine catalysis has been 
used in the formation of enantioenriched tetrahydro-1H-isochromanes through a 
Diels-Alder/β-elimination process, starting from the same type of aldehydes and 
using racemic 5-acyloxydihydropyranones as dienophiles.62 To finish with this 
type of catalysis, recently the group has developed an enantioselective [5+2] 
cycloaddition reaction with oxidopyrylium ylides generated in situ from 
substituted acetoxypyranones in the presence of a Brønsted base, to obtain 8-
oxabicyclo[3.2.1]octane derivatives in very good yields and excellent 
enantioselectivities (Scheme 1.13).63 
                                                     
61  Talavera, G.; Reyes, E.; Vicario, J. L.; Carrillo, L. Angew. Chem. Int. Ed. 2012, 51, 4104. 
62  Orue, A.; Reyes, E.; Vicario, J. L.; Carrillo, L.; Uria, U. Org. Lett. 2012, 14, 3740. 
63 a) Roca-López, D.; Uria, U.; Reyes, E.; Carrillo, L.; Jørgensen, K. A.; Vicario, J. L.; Merino, P. 
Chem. Eur. J. 2016, 22, 884; b) Orue, A.; Uria, U.; Reyes, E.; Carrillo, L.; Vicario, J. L. Angew. 
Chem. Int. Ed. 2015, 54, 1. 
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Scheme 1.13 
The trienamine activation manifold has been successfully applied in the 
Diels-Alder reaction between unconjugated 2,5-dienals and nitrostyrenes to obtain 
densely functionalized cyclohexenes in excellent yields and stereoselectivities. 
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The related fully conjugated α,β,γ,δ-unsaturated aldehydes failed as diene 
precursors in the same reaction, translating into a better ability of the 
unconjugated enals to condense with the amine catalyst, leading to the same 
vinylogous trienamine intermediate (Scheme 1.14).64 
 
Scheme 1.14 
Apart from aminocatalysis, the group has explored other organocatalytic 
activation methodologies, such as hydrogen-bonding catalysis and more recently 
N-heterocyclic carbene catalysis. Thus, the group has developed an 
enantioselective and diastereodivergent procedure to the synthesis of 
polysubstituted cyclohexanes through Michael/Henry cascade reaction employing 
hydrogen-bond activation, by reaction between nitroalkenes and α-nitro-δ-oxo 
esters. It has been demonstrated that two similar bifunctional squaramides 
containing a chiral 1,2-diamine backbone with the same absolute configuration 
lead to the diastereodivergent formation of the corresponding products (see 
Scheme 1.15).65 Moreover, this procedure has been satisfactorily extended to a 
diastereodivergent intermolecular Michael reaction of nitroalkenes as Michael 
                                                     
64 Prieto, L.; Talavera, G.; Uria, U.; Reyes, E.; Vicario, J. L.; Carrillo, L. Chem. Eur. J. 2014, 20, 
2145. 
65  Martínez, J. I.; Villar, L.; Uria, U.; Carrillo, L.; Reyes, E.; Vicario, J. L. Adv. Synth. Catal. 2014, 
356, 3627. 
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acceptors and nitroacetates as donors towards the obtention of enantioenriched 
2,4-dinitro esters.66 
 
Scheme 1.15 
Finally, the group has applied the N-heterocyclic carbene catalysis to the 
enantioselective synthesis of tertiary propargylic alcohols through cross-benzoin 
                                                     
66  Martínez, J. I.; Uria, U.; Muñiz, M.; Reyes, E.; Carrillo, L.; Vicario, J. L. Beilstein J. Org. Chem. 
2015, 11, 2577. 
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reaction between aldehydes and ynones, obtaining good yields and 
enantioselectivities (Scheme 1.16).67 
 
Scheme 1.16 
                                                     
67 Sánchez-Díez, E.; Fernández, M.; Uria, U.; Reyes, E.; Carrillo, L.; Vicario, J. L. Chem. Eur. J. 
2015, 21, 8384. 
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3. GENERAL OBJETIVES 
The present work has been carried out in line with the research field of the 
group. Accordingly, it is focused on the development of new asymmetric 
methodologies, employing the organocatalysis as a main tool, specifically, the 
aminocatalysis applied to the search of new cascade reactions to the obtention of 
high functionalized carbo- and heterocycles, initiated by conjugated addition. In 
this sense, this research work will be divided into two different parts, including a 
chapter detailing the work performed in the context of a short stay in Free 
University of Berlin under the supervision of Prof. M. Christmann. 
The first general objective will be developed the potential activity of 4-
alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides as a Michael donor/acceptors in 
aminocatalytic cascade reactions with enals, using the iminium/enamine manifold. 
As it is shown in Figure 1.2, this type of substrates presents a pronucleophilic 
carbon at the 5-position that can participate as Michael donor in conjugate 
additions, moreover, it can act as electrophile due to the high ability of sulfonate 
as leaving group. Additionally, this class of α,β-unsaturated cyclic sulfamidate 
imines have the potential to participate as Michael acceptor, being this class of 
substrate excellent precursors for cascade reactions. 
 
Figure 1.2 
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With this in mind, we will first develop the aminocatalyzed 
Michael/Michael cascade reaction employing α,β-unsaturated aldehydes as the 
initial Michael acceptors, via iminium activation, using as nucleophile this type of 
cyclic sulfamidate imines, followed by a second Michael addition of the 
subsequent enamine to the α,β-unsaturated sulfamidate imine, to the obtention of 
chiral polycyclic structures (Scheme 1.17). Moreover, due to the presence of 
several functionalities, such as the sulfonate group, we envisioned many 
possibilities for performing different chemical manipulations on the structure. 
 
Scheme 1.17 
The second general objective will be design a new methodology for the 
organocatalytic synthesis of proline derivatives. In this sense, we will first develop 
a Michael-initiated cascade reaction between aminomalonates as donors, and 
enones as acceptors, under the iminium ion activation, followed by intramolecular 
condensation of the primary amine with the ketone. The reduction of the resulting 
imine would provide the corresponding chiral pyrrolidines (Scheme 1.18). If the 
reaction proceeds in a satisfactory way, the obtained pyrrolidines can be 
transformed into the corresponding N-protected prolines through a known 
intramolecular C→N acyl rearrangement. 
Introduction  35 
 
 
Scheme 1.18 
Finally, a short chapter about the work carried out in the group of Prof. M. 
Christmann in Free University of Berlin during my stay there. This proyect 
consisted on the total synthesis of the natural product (+)-Greek tobacco lactone, 
starting from the commercially available nerol (Scheme 1.19). 
 
Scheme 1.19 
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1. INTRODUCTION: ORGANOCATALYTIC CASCADE 
REACTIONS INITIATED BY CONJUGATE ADDITION 
Before starting to describe the different aspects related to cascade reactions, 
it is important to define several general concepts about this area. Sequential 
transformations or one-pot processes involve multiple transformations followed by 
a single workup step. In 1993, Tietze divided the one-pot reactions into two 
groups, domino and consecutive reactions. He defined a domino, cascade or 
tandem process as involving “two or more consecutive reactions in which 
subsequent reactions result as a consequence of the functionality formed by bond 
formation or fragmentation in the previous step”, which take place under the same 
reaction conditions, without adding additional reagents and/or catalysts; and a 
consecutive reaction, being the only different with the cascade reactions that the 
addition of one or more catalysts or reagents is required after the first 
transformation, without purifications, to obtain the final product.1 In 2001, Faber 
added, referring to cascade and domino processes, that “both individual reactions 
belong tightly together and are rather difficult to perform in a stepwise or 
independent fashion. As a consequence, the intermediate between both steps is 
likely to be unstable and often eludes isolation and characterization”. In contrast, 
he defined tandem processes as two-step reactions that can be carried out 
separately, in a consecutive fashion.2 Few years later, others classified cascade or 
domino reactions with strict conditions.3 Fogg and dos Santos added to the 
definition of domino (cascade) reaction that multiple transformations, which 
                                                     
1 a) Tietze, L. F. Chem Rev. 1996, 96, 115; b) Tietze, L. F.; Beifuss, U. Angew. Chem. Int. Ed. 1993, 
32, 131. 
2 Mayer, S. F.; Kroutil, W.; Faber, K. Chem. Soc. Rev. 2001, 30, 332. 
3 a) Chapman, C. J.; Frost, C. G. Synthesis 2007, 1; b) Fogg, D. E.; dos Santos, E. N. Coord. Chem. 
Rev. 2004, 248, 2365. 
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involve this kind of reactions, should take place through a single catalytic 
mechanism. On the other hand, they described the tandem process as a sequential 
transformation, but in this case, via two or more mechanistically distinct catalytic 
processes. More recently, Jørgensen and co-workers have developed a 
classification and nomenclatural method that is able to describe asymmetric 
catalytic one-pot reactions, based on the relative position of the 
enantiodifferentiating step, the total number of manual operations and the number 
of all bonds formed.4 In spite of this, and as Nicolau has pointed out,5 there are 
several authors that often used indifferently the terms domino, cascade and 
tandem. For this reason, the several organocatalytic cascade processes described in 
the literature will be covered in the following lines without distinction between 
these descriptors. 
Cascade reactions constitute a powerful tool in synthetic chemistry due to 
their ability to achieve the formation of complex molecules in a single step. These 
transformations present several positive features, such as atom economy and less 
operational time, avoiding protection/deprotection steps and the isolation of 
intermediates, and therefore reducing the generation of waste. Specifically, as it 
has been mentioned in the previous chapter, organocatalytic cascade reactions are 
aligned with several of the principles of green chemistry. This type of reactions, 
with the suitable catalyst, can be highly regio- and stereoselective, with the 
consequent obtention of enantioenriched compounds. Taking this into account, the 
different activation manifolds of organocatalysis can be combined, this serving as 
an excellent platform to develop new cascade routes to the synthesis of chiral 
compounds, as it can be seen by the large number of publications.6 
                                                     
4 Albrecht, Ł.; Jiang, H.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2011, 50, 8492. 
5 Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew. Chem. Int. Ed. 2006, 45, 7134. 
6 For some reviews on organocatalytic cascade reactions, see: a) Vetica, F.; de Figueiredo, R. M.; 
Orsini, M.; Tofani, D.; Gasperi, T. Synthesis 2015, 47, 2139; b) Volla, C. M. R.; Atodiresei, I.; 
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Among the several possibilities, the conjugate addition reaction is one of the 
most powerful tools to promote cascade processes due to the formation of a 
nucleophilic intermediate, after the initial nucleophilic attack to an electron 
deficient olefin, such as unsaturated carbonyl compounds, which can react with an 
electrophile both intramolecularly and intermolecularly (Scheme 2.1). 
 
Scheme 2.1 
Within the field of organocatalysis, the use of chiral amines as catalysts 
(aminocatalysis) for asymmetric cascade reactions, particularly when they are 
initiated by a conjugate addition, has been one of the most studied activation 
manifolds in this particular context. The ability of this kind of catalysts to activate 
carbonyl compounds and to provide high stereoselectivity to the process, 
especially through the combination of enamine and iminium ion activation (see 
Scheme 2.2), is probably the reason for the wide use of this methodology in 
cascade reactions. 
                                                                                                                                      
Rueping, M. Chem. Rev. 2014, 114, 2390; c) Pellissier, H. Chem. Rev. 2013, 113, 442; d) 
Pellissier, H. Adv. Synth. Catal. 2012, 354, 237; e) Enders, D.; Grondal, C.; Hüttl, M. R. M. 
Angew. Chem. Int. Ed. 2007, 46, 1570; for specific reviews on aminocatalytic cascade reaction, 
see: f) Song, A.; Wang, W. Catalytic Cascade Reactions (Eds.: Xu, P.-F.; Wang, W.), John Wiley 
& Sons, p. 1-52, New Jersey, 2014; g) Yu, X.; Wang, W. Org. Biomol. Chem. 2008, 6, 2037. 
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Scheme 2.2 
As it can be observed in the previous scheme, the enamine activation 
consists on the formation of an enamine intermediate, through the initial 
condensation of a primary or secondary amine with the corresponding enolizable 
aldehyde or ketone. After condensation a chiral iminium salt is formed, increasing 
the acidity of the proton in α-position. This results in the formation of an enamine, 
being the latter a more active nucleophile than the starting aldehyde or ketone, and 
that therefore can react with an electrophile, such as a Michael acceptor. Finally, 
the adduct presents an iminium ion moiety that needs to be hydrolyzed, in order to 
recover the catalyst and to obtain the product. On the other hand, iminium 
catalysis consists on the formation of an iminium ion, through the condensation of 
the amine catalyst and an α,β-unsaturated aldehyde or ketone, which leads to a 
decrease in the energy of the LUMO with respect to the starting substrate. Thus, 
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this species has an enhanced electrophilicity and can be attacked by different 
nucleophiles through conjugate addition. After the nucleophilic attack, an enamine 
intermediate is formed, which has the potential to react with an electrophile in an 
intra- or intermolecular fashion, depending on the functionality of the substrate or 
on the addition of an external electrophile. Consequently, the iminium salt is 
formed, obtaining the product after the corresponding release of the catalyst, 
through a hydrolysis process. In summary, the combination of both activation 
methods allows the development of cascade processes under the iminium/enamine 
manifold. It should be pointed out that in some cases, the catalyst is hydrolyzed 
before a second or another step in cascade process, resulting in a reaction of the 
Michael adduct that depends on its functionalities to react intramolecularly or with 
external reactive, controlling the stereochemical outcome by the substrate 
chirality. 
It is important to mention that the catalysts, in addition to participate by 
promoting the reaction through the activation of the substrates, they also 
incorporate a chiral element within their structure that is able to differentiate both 
diastereotopic faces of the activated intermediate. In this sense, there are two ways 
for exerting this stereodiscrimination; by steric control or by introducing a 
stereodirecting element. Typically, the catalyst presents a bulky group that blocks 
one of the stereotopic faces of the intermediate. The second possibility consists on 
the introduction of a convenient substituent, such as a hydrogen bond donor, able 
to direct the nucleophilic attack through its face, via secondary interactions. 
Another aspect to be considered is that the catalyst has to exert an efficient control 
regarding the geometry of the catalytically generated azomethine intermediate 
(iminium ion or enamine), because the presence of mixtures of Z/E isomers on the 
iminium ion or of syn/anti conformers on the enamine intermediate, combined 
with an efficient stereochemical bias of their respective prostereogenic faces still 
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will lead to the formation of mixture of enantiomers. In general, when catalysts 
with stereodirecting elements are used, this is not a problem, because this type of 
substituents determines the configuration of the reactive intermediate. However, in 
the case of catalysts that exert their stereochemical influence through steric bias, 
need to be large enough both to exert good π-facial discrimination and also to 
determine the geometry of the intermediate (see Scheme 2.3). In the case of 
cascade processes initiated by conjugate addition via enamine activation, in 
general, after the 1,4-addition of the enamine to a Michael acceptor, the formed 
iminium ion is hydrolyzed and the acyclic intermediate subsequently reacts 
without the participation of amine catalyst and under substrate control. The case of 
iminium ion activation is completely different because after the conjugate addition 
to the activated Michael acceptor, the catalyst remains bounded with the generated 
enamine, being able to carry out the following step under its control. 
 
Scheme 2.3 
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It should be pointed out that, both chiral primary and secondary amines can 
be used as catalysts when applying these two activation manifolds and this 
depends on the type of substrate. In general, aldehydes condense fast with 
secondary amines, which means that chiral pyrrolidines, derived from commercial 
enantiopure proline are typically used as catalysts. However, secondary amines 
condense very slowly with ketones due to the lower electrophility of the carbonyl 
group and the higher steric crowding of the generated intermediate compared with 
the corresponding aldehydes. Moreover, the control of the geometry is more 
difficult in case of ketones due to the fact that the generated iminium ion has 
substituents with similar size attached to the azomethine carbon that can lead to a 
mixture of stereoisomers. For these reasons, it has been demonstrated that chiral 
primary amines have the ability to activate ketones efficiently,7 being the 
condensation between both reagents more favoured in terms of reactivity and 
sterical requirements. Moreover, this would also permit a more effective geometry 
control on the Z/E stereochemistry of the double bond (Figure 2.1). 
 
Figure 2.1 
                                                     
7 For some reviews on the use of primary amines as catalysts, see: a) Duan, J.; Li, P. Catal. Sci. 
Technol. 2014, 4, 311; b) Melchiorre, P. Angew. Chem. Int. Ed. 2012, 51, 9748; c) Xu, L.-W.; Luo, 
J.; Lu, Y. Chem. Commun. 2009, 1807; d) Chen, Y.-C. Synlett 2008, 1919; e) Bartoli, G.; 
Melchiorre, P. Synlett 2008, 1759. 
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Apart from the use of aminocatalysis in cascade reactions initiated by 
conjugate addition, there are other ways to activate the Michael acceptors and/or 
donors. One of these methodologies is the use of the hydrogen bond catalysis,8 
which consist on the activation of the substrate by the formation of a network of 
hydrogen bonds that increment the reactivity of the Michael acceptor, modulating 
the chiral space in the Michael addition. Due to the weak interactions between the 
substrate and catalyst, after the conjugate addition step, sometimes the subsequent 
step is controlled by the substrate. Finally, other activation manifolds, such as N-
heterocyclic carbenes and phase-transfer catalysts, have been less studied in this 
field. 
In conclusion, the capacity of the different activation methods of 
organocatalysis to developed cascade reactions, specifically initiated by conjugate 
addition, has been demonstrated in the last years. According to the objectives of 
this thesis, we will present in the following sections some selected examples 
illustrating different cascade reactions initiated by Michael-type reactions focused 
on Michael/Michael cascade reactions for the construction of complex carbocyclic 
scaffolds. 
1.1. Michael/Michael cascade reactions 
Organocatalytic Michael/Michael cascade methodology has been 
successfully used for the straightforward access to enantioenriched polysubstituted 
(poly)cyclic compounds. Taking into account the different organocatalytic 
activation modes shown previously, and the ability to combine most of them, the 
                                                     
8 For specific reviews on hydrogen-bond mediated cascade reactions, see: a) Chauhan, P.; Mahajan, 
S.; Kaya, U.; Hack, D.; Enders, D. Adv. Synth. Catal. 2015, 357, 253; b) Jiang, J.; Gong, L.-Z. 
Catalytic Cascade Reactions (Eds.: Xu, P.-F.; Wang, W.), John Wiley & Sons, p. 53-122, New 
Jersey, 2014; c) Lv, F.; Liu, S.; Hu, W. Asian J. Org. Chem. 2013, 2, 824. 
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Michael/Michael cascade reactions will be classified depending on the 
mechanistic manifold operating in the process. For this type of methodology, the 
presence of two unsaturated systems with different reactivities is generally 
necessary. These engage in a cascade reaction started by the initial conjugate 
addition to one of the Michael acceptors followed by an intramolecular reaction 
between the nucleophilic intermediate generated in this initial step and the second 
Michael acceptor. For obvious reasons, it should be noted that these two Michael 
acceptor systems do not have to interfere with each other, and therefore one 
system has to be more reactive than the other in the first conjugate addition and 
the second should be reactive enough to undergo the second Michael reaction. 
1.1.1. Michael/Michael cascade processes initiated by conjugate addition 
under enamine activation 
In general, for an intramolecular double Michael cascade reaction initiated 
by conjugate addition under enamine activation, a conveniently functionalized 
substrate is required that incorporates an enolizable aldehyde or ketone together 
with the Michael acceptor. This general approach is followed by Hong an co-
workers that used as a Michael donor/acceptor 7-oxohep-2-enoates and diverse 
nitroalkenes as Michael acceptors, employing diphenylprolinol derivative as 
catalyst and obtaining tetrasubstituted cyclohexanes with excellent estereocontrol 
(Scheme 2.4).9 The reaction consists on enamine formation between the aldehyde 
and the catalyst, followed by Michael addition to the nitroalkene. It should be 
noted that this is not a real cascade reaction, because the first Michael adduct 
needs the addition of an external base to promote the second 1,4-addition, not 
participating the catalyst in this step. Moreover, when the (E)-7-oxohep-2-enoate 
                                                     
9 Hong, B.-C.; Nimje, R. Y.; Wu, M.-F.; Sadani, A. A. Eur. J. Org. Chem. 2008, 1449. 
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was used, a mixture of diastereoisomers was observed. Nevertheless, with the Z-
diastereoisomer the product was obtained as a single diastereoisomer. 
 
Scheme 2.4 
Recently, Zhao and co-workers have developed a highly diastereodivergent 
synthesis of tetrasubstituted six member rings, employing the same type of 
substrates that in the previous case.10 The control of the diastereoselectivity was 
achieved through controlling the stereochemistry of each single step of the cascade 
reaction using pseudodiastereoisomeric modularly designed organocatalysts self-
assembled between proline and thioureas, the latter derived from cinchona 
alkaloids. By the combination of both enantiomers of proline and the 
pseudoenantiomers of cinchona derived thioureas, pseudodiastereoisomeric 
catalysts were formed, achieving the desired diastereodivergence (Scheme 2.5). 
                                                     
10 Rana, N. K.; Huang, H.; Zhao, C.-G. Angew. Chem. Int. Ed. 2014, 53, 7619. 
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Scheme 2.5 
In this sense, it was possible to obtain selectively four possible 1,2-syn 
stereoisomers, by combining appropriately the catalysts, being the first step 
controlled through enamine catalysis and the second step through non-covalent 
interactions exerted by the bifunctional tertiary amine/thiourea. After the 
formation of 1,2-syn stereoisomers, the corresponding 1,2-anti stereoisomers 
could be prepared heating the reaction, thus allowing the selective synthesis of 
eight possible stereoisomers of these tetrasubstituted enantioenriched cyclohexane 
derivatives. This type of reaction has also been extended to 6-oxohex-2-enoates, to 
the obtention of the corresponding five member rings in a Michael/Michael 
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cascade process, using in this case trans-perhydroindolic acid as efficient 
catalyst.11  
Other approaches to Michael/Michael cascade reactions have been 
developed using α,β-unsaturated aldehydes as the first Michael acceptor and 7-
oxooct-5-enals12 as the Michael donor/acceptor, employing O-TMS 
diphenylprolinol as catalyst. In this case, firstly an intermolecular Michael 
addition takes place between both activated 7-oxooct-5-enal and α,β-unsaturated 
aldehyde, followed by an intramolecular Michael addition of the generated 
enamine to the α,β-unsaturated ketone. After the double Michael cascade reaction, 
by the addition of TsOH, aldol condensation occurs in one-pot fashion. This 
transformation was successfully applied towards the synthesis of (+)-galbulin, 
employing racemic (E)-3-methyl-7-oxooct-5-enal as the first Michael donor, 
yielding the key intermediate with total diastereocontrol (Scheme 2.6).13 A kinetic 
resolution of the racemic compound was observed because one of both 
enantiomers was not able to react due to steric reasons. 
                                                     
11  An, Q.; Shen, J.; Butt, N.; Liu, D.; Liu, Y.; Zhang, W. Synthesis 2013, 45, 1612. 
12 a) Hong, B.-C.; Nimje, R. Y.; Liao, J.-H. Org. Biomol. Chem. 2009, 7, 3095; for a related 
example, see: b) Hong, B.-C.; Sadani, A. A.; Nimje, R. Y.; Dange, N. S.; Lee, G.-H. Synthesis 
2011, 1887. 
13 Hong, B.-C.; Hsu, C.-S.; Lee, G.-H. Chem. Commun. 2012, 48, 2385. 
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Scheme 2.6 
In 2009, Melchiorre and co-workers studied the possibility of using ketones 
as Michael donors in Michael/Michael cascade reactions using chiral primary 
amine catalysis. As it has already been mentioned before, primary amines activate 
ketones more effectively than the respective secondary amines owing to the 
formation of a less sterically crowded enamine and with a more efficient control of 
its geometry. In this sense, simple chiral primary amines derived from natural 
cinchona alkaloids were evaluated as catalysts in the reaction of acyclic enones 
with different Michael acceptors, such as nitrostyrenes (Scheme 2.7).14 
Cyclohexanones were obtained with up to four stereocenters, in high yields and 
                                                     
14 Wu, L.-Y.; Bencivenni, G.; Mancinelli, M.; Mazzanti, A.; Bartoli, G.; Melchiorre, P. Angew. 
Chem. Int. Ed. 2009, 48, 7196. 
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excellent stereocontrol, using 9-epi-9-amino-9-deoxyhydroquinine and 2-
fluorobenzoic acid as the catalytic system. 
 
Scheme 2.7 
The mechanism of this reaction consists on the activation of the α,β-
unsaturated ketone, generating an enamine that undergoes Michael addition with 
the electron-poor alkene. The iminium ion formed can react intramolecularly 
through a second Michael addition to obtain the corresponding cycloadducts in a 
formal [4+2] cycloaddition. The reaction was extended to other Michael 
acceptors, such as α-cyanocinnamates or N-protected maleimides. 
Melchiorre and co-workers also applied this general reaction scheme to 
synthesize spirocyclic oxindoles in very good yields and enantioselectivities (see 
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Scheme 2.8).15 Unprotected oxindole derivatives were employed as the initial 
Michael acceptors and several α,β-unsaturated ketones as the precursors of 
catalytically generated nucleophilic dienamine intermediates formed after 
condensation with the catalyst. Later on, the same group also applied this 
approach towards the efficient obtention of spirocyclic benzofuranone 
cyclohexanones starting from benzofuranone derivatives and different enones, 
using the same catalytic system.16 Recently, Wang et al. have developed an 
efficient synthesis of spiropyrazolone derivatives by reaction between unsaturated 
ketones and unsaturated pyrazolones, applying analogous approach with a quinine-
based catalyst and using benzoic acid as cocatalyst.17 
 
Scheme 2.8 
A similar approach for the preparation of spirooxindole derivatives was 
developed by Wang and co-workers, through the reaction between several α,β-
                                                     
15 Bencivenni, G.; Wu, L.-Y.; Mazzanti, A.; Giannichi, B.; Pesciaioli, F.; Song, M.-P.; Melchiorre, 
P. Angew. Chem. Int. Ed. 2009, 48, 7200. 
16  Cassani, C.; Tian, X.; Escudero-Adán, E. C.; Melchiorre, P. Chem. Commun. 2011, 47, 233. 
17  Liang, J.; Chen, Q.; Liu, L.; Jiang, X.; Wang, R. Org. Biomol. Chem. 2013, 11, 1441. 
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unsaturated ketones and isatylidene malononitrile derivatives via double Michael 
cascade reaction (see Scheme 2.9),18 observing a difference in regioselectivity in 
the formation of spiro[cyclohexane-1,3’-indoline]-2’,3-dione, compared with the 
system used by Melchiorre, due to stronger electron-withdrawing character of the 
two cyano groups. Excellent results were obtained regarding the yield and the 
stereocontrol of the reaction, requiring the matched combination of a cinchona-
based chiral primary amine and a (R)-BINOL-based phosphoric acid as chiral 
counteranion. 
 
Scheme 2.9 
In related work, Xu and co-workers employed enones and different types of 
nitrostyrenes, having an enoate in the ortho position, in a Michael/Michael 
cascade reaction catalyzed by primary amines.19 After the double Michael 
reaction, a base was added to the reaction vessel in order to generate a 
nucleophilic nitronate and this initiated an intramolecular Michael/aldol cascade 
                                                     
18 a) Lan, Y.-B.; Zhao, H.; Liu, Z.-M.; Liu, G.-G.; Tao, J.-C.; Wang, X.-W. Org. Lett. 2011, 13, 
4866; for another example using N-protected isatylidene malononitrile, see: b) Huang, H.; Bihani, 
M.; Zhao, J. C.-G. Org. Biomol. Chem. 2016, 14, 1755. 
19  Yu, D.-F.; Wang, Y.; Xu, P.-F. Adv. Synth. Catal. 2011, 353, 2960. 
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reaction resulting in the formation of tetracyclic ring system incorporating both a 
chroman and bicycle[2.2.2]octane structural moieties (Scheme 2.10). 
 
Scheme 2.10 
In 2012, Chen and co-workers developed a stereodivergent formal [4+2] 
cycloaddition using in this case cyclic β-susbstituted enones and polyconjugated 
malononitriles as the initial Michael acceptors. A concerted cycloaddition pathway 
was initially proposed but, after isolation of several Michael adducts that were 
identified as intermediates of the reaction, a double Michael cascade reaction was 
proposed as a more realistic pathway. The endo and exo diastereoisomers could be 
selectively prepared by varying the nature of primary amine catalyst and the 
cocatalyst. In particular, the presence of a hydroxyl group in the quinoline moiety 
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of the quinine-based catalyst favours the formation of the exo diastereisomer 
through hydrogen bond interactions. On the other hand, avoiding the presence of 
non-covalent interactions the endo diastereoisomer is mainly formed (Scheme 
2.11).20 
 
Scheme 2.11 
                                                     
20 Feng, X.; Zhou, Z.; Zhou, R.; Zhou, Q.-Q.; Dong, L.; Chen, Y.-C. J. Am. Chem. Soc. 2012, 134, 
19942. 
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An interesting work in this field was reported by Li and co-workers,21 in 
which the possibility of using cyclic ketones as double Michael donors and 2-
nitroallyl acetates as double Michael acceptors in a Michael/elimination/Michael 
cascade reaction was surveyed. In this case, a bifunctional pyrrolidine/thiourea 
catalyst was used as the initial activating agent of the pronucleophile (Scheme 
2.12). 
 
Scheme 2.12 
It is noteworthy that the additional hydrogen bond donor functionality of the 
catalyst was found to be crucial in the reaction outcome, presumably being this 
                                                     
21  Cao, C.-L.; Zhou, Y.-Y.; Zhou, J.; Sun, X.-L.; Tang, Y.; Li, Y.-X.; Li, G.-Y.; Sun, J. Chem. Eur. 
J. 2009, 15, 11384. 
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involved in the activation of the nitroolefin through the two Michael-type reaction 
steps. 
1.1.2. Michael/Michael cascade processes initiated by conjugate addition 
under iminium ion activation 
There are several examples in which the initial activation consists on the 
formation of an iminium ion starting from an unsaturated aldehyde or ketone that 
plays as the Michael acceptor in the first conjugate addition step and subsequently 
as the Michael donor, via enamine formation, in the second conjugate addition. 
This involves the use of a functionalized substrate containing C-H acidic moiety 
able to play the role of Michael donor as the starting nucleophilic reagent that 
initiates the cascade reaction, together with an activated double bond with the 
ability to react intramolecularly with the enamine generated after the first 
conjugate addition. In this sense, the first aminocatalytic asymmetric double 
Michael cascade reaction initiated by iminium ion formation and following the 
iminium/enamine manifold, was developed by Wang and co-workers for the 
synthesis of highly functionalized cyclopentanes (see Scheme 2.13).22 Different 
α,β-unsaturated aldehydes were used as the initial Michael acceptors and malonic 
ester reagents containing an α,β-unsaturated ester moiety as bifunctional 
compounds. Under the optimal conditions, several enantioenriched cyclopentanes 
were prepared, using diphenylprolinol trimethylsilyl ether as the best catalyst. 
                                                     
22 Zu, L.; Li, H.; Xie, H.; Wang, J.; Jiang, W.; Tang, Y.; Wang, W. Angew. Chem. Int. Ed. 2007, 46, 
3732. 
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Scheme 2.13 
Córdova and co-workers, developed a nitro-Michael/Michael cascade 
reaction following a similar approach, but employing δ-nitro-α,β-unsaturated 
esters as bifunctional reagents, leading to cyclopentanes with four contiguous 
stereogenic centers in excellent yields and enantioselectivities.23 In this case, a 
basic additive was necessary to increment the yield and selectivity, being DABCO 
the best one. By contrast, acid additives reduced the stereocontrol of the reaction. 
Few years later, Ma et al.,24 reported the enantioselective synthesis of 
cyclopentanones through double Michael addition, using β-keto esters bearing a 
highly electron-deficient olefin as bifunctional compounds (Scheme 2.14). A 
rather low catalyst loading (2-5 mol%) was enough for the completion of the 
                                                     
23 Zhao, G.-L.; Ibrahem, I.; Dziedzic, P.; Sun, J.; Bonneau, C.; Córdova, A. Chem. Eur. J. 2008, 14, 
10007. 
24  Ma, A.; Ma, D. Org. Lett. 2010, 12, 3634. 
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reaction, obtaining very good results with a wide range of substituted α,β-
unsaturated aldehydes, including α,β- and β,β-disubstituted enals, therefore 
increasing the interest of the methodology. 
 
Scheme 2.14 
Recently, Sheng and co-workers have applied this methodology to the 
efficient obtention of tetrahydrothiopyrans25 and spirotetrahydrothiopyrans26 
employing ketothioeter enones as new bifunctional substrates, and enals as 
activated Michael acceptors (Scheme 2.15). It is an alternative methodology to the 
formation of sulfur-containing cyclic compounds. It should be noted that one of 
the spirooxindole derivatives (R1 = 4-BrC6H4; R2 = 2-Br; R3 = Me) was a potent 
inhibitor of p53-MDM2 protein-protein interaction, showing also good antitumor 
activity, which reinforces the importance of the methodology. 
                                                     
25 Wang, S.; Zhang, Y.; Dong, G.; Wu, S.; Fang, K.; Li, Z.; Miao, Z.; Yao, J.; Li, H.; Li, J.; Zhang, 
W.; Wang, W.; Sheng, C. Org. Lett. 2014, 16, 692. 
26  Wang, S.; Jiang, Y.; Wu, S.; Dong, G.; Miao, Z.; Zhang, W.; Sheng, C. Org. Lett. 2016, 18, 1028. 
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Scheme 2.15 
In a different context, there are several reports, in which γ,δ-unsaturated β-
ketoesters (Nazarov reagents) have been surveyed as bifunctional compounds in 
combination with α,β-unsaturated aldehydes, in Michael/Michael cascade 
reactions, using secondary amines as catalysts. In 2008, Jørgensen and co-workers 
employed unsubstituted Nazarov reagents in the double Michael addition but, 
surprisingly, an unexpected Michael/Morita-Baylis-Hillman cascade reaction was 
observed.27 However, in an independent work, Gong et al. had already developed 
a novel organocatalytic formal [3+3] cycloaddition reaction using β-aryl 
                                                     
27 Cabrera, S.; Alemán, J.; Bolze, P.; Bertelsen, S.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2008, 
47, 121. 
64 Chapter 2 
 
substituted Nazarov reagents that involved an initial Michael reaction under 
iminium catalysis.28 With this in mind, Brenner and co-workers successfully 
developed a Michael/Michael cascade reaction, employing Nazarov reagents, in 
which the olefin was incorporated into a carbocycle.29 Under the optimal 
conditions, with O-TMS diphenylprolinol as catalyst and trifluoroethanol as 
solvent, several α,β-unsaturated aldehydes were reacted, leading to the 
corresponding fused bicycles in excellent enantioselectivities (Scheme 2.16). 
 
Scheme 2.16 
The proposed mechanism involves the initial activation of the enal by 
condensation with the secondary amine, forming the iminium ion intermediate 
                                                     
28 Zhu, M.-K.; Wei, Q.; Gong, L.-Z. Adv. Synth. Catal. 2008, 350, 1281. 
29 McGarraugh, P. G.; Brenner, S. E. Org. Lett. 2009, 11, 5654. 
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with enhanced electrophilicity that undergoes the first Michael addition through 
nucleophilic attack of the activated methylene group of the Nazarov reagent. The 
generated enamine intermediate subsequently reacts through a second 1,4-addition 
to the C-C double bond of the Nazarov reagent and finally, the catalyst is released 
and the product is obtained. The formation of three diastereoisomers was 
observed, one as a minor byproduct, and the others as a result of the epimerization 
of the α-position of the aldehyde. Few years later, the same group extended the 
optimized conditions to both alkyl- and aryl-substituted unsaturated β-ketoesters, 
obtaining the corresponding cyclohexenes in good yields and excellent 
enantioselectivities.30 Surprinsingly, in contrast to the work of Gong and co-
workers,28 the double Michael addition proceeded well with β-aryl substituted 
Nazarov reagents, most likely due to the effect of the solvent assuming that with 
protic solvents employed by Brenner, the second Michael acceptor was activated 
by hydrogen bonding. 
In 2011, Hong and co-workers developed a nitro-Michael/Michael cascade 
reaction between several α,β-unsaturated aldehydes and different bifunctional 
reagents (shown on Scheme 2.17).31 These last were prepared in around 60% ee 
first by Michael addition of carbethoxymethylenetriphenylphosphorane to 
nitroalkenes using a chiral thiourea as catalyst and next Wittig reaction with ethyl 
glyoxylate or formaldehyde. These products were subjected to Michael/Michael 
cascade reaction with enals towards the synthesis of enantioenriched 
pentasubstituted cyclopentane and cyclohexanecarbaldehydes. With the racemic 
mixture of the bifunctional reagent very low diastereomeric ratios were observed, 
being the diastereoselectivity controlled by the substrate. 
                                                     
30 McGarraugh, P. G.; Jones, J. H.; Brenner-Moyer, S. E. J. Org. Chem. 2011, 76, 6309. 
31 Hong, B.-C.; Nimje, R. Y.; Lin, C.-W.; Liao, J.-H. Org. Lett. 2011, 13, 1278. 
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Scheme 2.17 
As it has been mentioned before, in general the Michael/Michael cascade 
reactions with enals activated through the iminium/enamine manifold typically 
involve substrates having both a pro-nucleophile and a Michael acceptor. 
Nevertheless, there are several examples, in which dienones that presents two 
Michael acceptors on the same molecule, are activated by iminium ion formation, 
using chiral primary amines as efficient catalysts. Relatedly, Yan and co-workers 
developed the synthesis of cyclohexanone derivatives in good yields and 
stereoselectivities, by double conjugate addition of malononitrile, to dienones, 
using 9-epi-9-amino-9-deoxyquinine as catalyst and trifluoroacetic acid (TFA) as 
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cocatalyst (Scheme 2.18).32 The reaction worked well with aryl substituents in β-
position of the dienone, but failed with β-alkyl substituents. 
 
Scheme 2.18 
This type of dienones was also used in double Michael cascade reaction 
with N-protected 3-unsubstituted oxindoles. Under the optimal conditions, using 
9-epi-9-amino-9-deoxycinchonine as catalyst and (S)-BINOL-phosphoric acid as 
cocatalyst, several spirocyclic oxindoles were prepared in very good yields and 
excellent stereocontrol.33 The protecting group on the nitrogen of oxindole was 
found to be necessary for the success of the reaction (see Scheme 2.19). Wang and 
co-workers were able to develop the same type of reaction using commercially 
available N-unprotected 3-unsubstituted oxindole and derivatives with the 
employment of cinchona-based primary amine and chiral amino acid derivative as 
                                                     
32 a) Li, X.-M.; Wang, B.; Zhang, J.-M.; Yan, M. Org. Lett. 2011, 13, 374; for a similar example 
using non-covalent bonded catalysis, see: b) de Fusco, C.; Lattanzi, A. Eur. J. Org. Chem. 2011, 
3728. 
33 Wang, L.-L.; Peng, L.; Bai, J.-F.; Jia, L.-N.; Luo, X.-Y.; Huang, Q.-C.; Xu, X.-Y.; Wang, L.-X. 
Chem. Commun. 2011, 47, 5593. 
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catalytic system.34 They also developed satisfactorily this [5+1] Michael/Michael 
cascade reaction with N-phenyl protected pyrazolones as dinucleophiles. More 
recently, Veselý and co-workers have extended the methodology towards the 
obtention of sulfur-containing spirocyclic scaffolds, starting from the dione system 
and different sulfur-containing dinucleophiles, such as benzothiophenone and N-
phenylrhodanine, obtaining moderate to good yields and stereoselectivities.35 
 
Scheme 2.19 
From a different point of view, there are also several examples regarding 
vinylogous versions of the Michael/Michael cascade sequence based on iminium 
ion catalysis. One example is the one developed by Chen et al.,36 who used 
substituted alkylidenemalononitriles as vinylogous pronucleophiles in the double 
Michael cascade reaction (see Scheme 2.20). A plausible mechanism of the 
                                                     
34 Wu, B.; Chen, J.; Li, M.-Q.; Zhang, J.-X.; Xu, X.-P.; Ji, S.-J.; Wang, X.-W. Eur. J. Org. Chem. 
2012, 1318. 
35  Géant, P.-Y.; Urban, M.; Remeš, M.; Císařová, I.; Veselý, J. Eur. J. Org. Chem. 2013, 7979. 
36  a) Kang, T.-R.; Xie, J.-W.; Du, W.; Feng, X.; Chen, Y.-C. Org. Biomol. Chem. 2008, 6, 2673; for 
a pioneering work on asymmetric vinylogous Michael addition, see: b) Xie, J.-W.; Chen, W.; Li, 
R.; Zeng, M.; Du, W.; Yue, L.; Chen, Y.-C.; Wu, Y.; Zhu, J.; Deng, J.-G. Angew. Chem. Int. Ed. 
2007, 46, 389. 
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reaction consists on the 1,4-addition of the deprotonated γ-position of the 
alkylidenemalononitrile to the iminium ion derived from the enone by 
condensation with 9-epi-9-amino-9-deoxyquinine. Then, the second Michael 
addition occurs through the reaction between the nucleophilic enamine, generated 
after the first Michael addition, and the α,α-dicyanoalkene. It is also possible that 
this last Michael reaction could proceed without catalyst activation, only with the 
assistance of an external base. In addition, a desymmetrization process occurred, 
when 4-substituted cyclohexylidenemalononitriles were employed. Under the 
optimal conditions, a variety of bicyclic compounds were prepared in very good 
yields and stereoselectivities, as single diastereoisomers. 
 
Scheme 2.20 
Recently, Zanardi and co-workers have developed a similar reaction but 
employing enals instead of enones, and allylidene malononitriles as remotely 
enolizable nucleophiles.37 The reaction proceeded in a similar way compared to 
                                                     
37  Brindani, N.; Rassu, G.; Dell’amico, L.; Zambrano, V.; Pinna, L.; Curti, C.; Sartori, A.; Battistini, 
L.; Casiraghi, G.; Pelosi, G.; Greco, D.; Zanardi, F. Angew. Chem. Int. Ed. 2015, 54, 7386. 
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the previous example, but after the vinylogous double Michael addition, a retro-
Michael reaction occurs, releasing the malononitrile unit. In this case, L-prolinol 
TMS-ether and triethylamine were used as the catalytic system, affording 
polycyclic carbaldehydes in good yields and excellent diastereo- and 
enantioselectivities (Scheme 2.21). 
 
Scheme 2.21 
Finally, a pioneering example of a Michael/Michael/retro-Michael cascade 
reaction proceeding through initial iminium ion formation, reported by Barbas III 
and co-workers should also be presented,38 which consists on the enantioselective 
synthesis of 5,6-dihydroindolizines, by the reaction between α,β-unsaturated 
aldehydes, as acceptor/donor substrates, and N-protected dialkyl 2-((1H-pyrrol-2-
yl)methylene) malonates as donor/acceptor compounds, in which the α-position of 
a pyrrole enolate would act as an electron-donor intermediate. Excellent results 
were obtained related to the yield and the stereocontrol (Scheme 2.22). 
                                                     
38 Jiang, X.; Tan, B.; Barbas III, C. F. Angew. Chem. Int. Ed. 2013, 52, 9261. 
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Scheme 2.22 
1.1.3. Michael/Michael cascade processes activated by H-bond catalysis 
Hydrogen bond catalysis has been satisfactorily applied to the development 
of asymmetric double Michael cascade reactions, activating the substrates by the 
formation of networks of hydrogen bonds between catalyst and substrates, and 
being able to modulate the chiral space around the reaction point. The fact that 
catalyst-substrate interactions are weak in nature entails the possibility that, once 
the initial conjugate addition step that initiates the cascade process has taken 
place, the catalyst might not be involved in the second step, this one proceeding 
exclusively through substrate control. In some other examples, this is not the case 
and the catalyst remains bonded to all the reaction intermediates that participate in 
the cascade reaction therefore exerting its stereochemical influence across the 
whole process. 
One illustrative example of Michael/Michael cascade reactions under this 
type of activation manifold is the reported by Zhong and co-workers showing the 
synthesis of enantioenriched polysubstituted cyclopentanes.39 Several nitroalkenes 
were employed as the initial Michael acceptors and 5-acetylhex-2-enedioate 
                                                     
39 Tan, B.; Shi, Z.; Chua, P. J.; Zhong, G. Org. Lett. 2008, 10, 3425. 
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derivatives as the functionalized donor, using a cinchona-based primary amine as 
hydrogen bonding catalyst (shown on Scheme 2.23). Later, a similar unsaturated 
ester with an enolizable malonate was employed together with a selected 
nitroolefin in the construction of the tetracyclic core of lycorine-type alkaloids.40  
 
Scheme 2.23 
In 2012, Cobb and co-workers reported the application of bifunctional 
thiourea derivatives to the enantioselective Michael/Michael cascade reaction of 
several nitroalkenes to 6-nitrohex-2-enoates, towards the synthesis of 
tetrasubstituted cyclohexanes in good yields and excellent stereocontrol (Scheme 
2.24).41 
                                                     
40  Wang, Y.; Luo, Y.-C.; Zhang, H.-B.; Xu, P.-F. Org. Biomol. Chem. 2012, 10, 8211. 
41 a) Rajkumar, S.; Shankland, K.; Brown, G. D.; Cobb, A. J. A. Chem. Sci. 2012, 3, 584; for a 
pioneering work, see: b) Nodes, W. J.; Nutt, D. R.; Chippindale, A. M.; Cobb, A. J. A. J. Am. 
Chem. Soc. 2009, 131, 16016. 
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Scheme 2.24 
This methodology has also been applied to the preparation of spirocyclic 
compounds, as shown across a large number of publications. In general, all these 
approaches make use of methyleneindolinones or related compounds as the initial 
Michael acceptors, in combination with a suitable functionalized pronucleophile 
incorporating the second Michael acceptor moiety. As representative example, 
Scheme 2.25 shows the synthesis of spirooxindole derivatives with four adjacent 
stereocenters including two contiguous quaternary stereogenic centers, in high 
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yields and moderate to excellent stereoselectivities, employing 6-nitrohex-2-en-1-
ones as the initial donor and quinidine-derived thiourea as catalyst.42 
 
Scheme 2.25 
On the other hand, there is another example, in which oxindoles, 
incorporating a substituent that contained an activated double bond in 3-position, 
were used as the initial Michael donors, and in this case making use of the higher 
reactivity of nitroolefins as the initial acceptors. Spirocyclopentaneoxindoles were 
obtained in excellent yields, diastereo- and enantioselectivities, under the optimal 
conditions, employing a bifunctional thiourea catalyst bearing central and axial 
chiral elements, developed by the same group (Scheme 2.26).43 
                                                     
42  a) Abbaraju, S.; Ramireddy, N.; Rana, N. K.; Arman, H.; Zhao, J. C.-G. Adv. Synth. Catal. 2015, 
357, 2633; for related examples, see: b) Zhou, M.-Q.; Zuo, J.; Cui, B.-D.; Zhao, J.-Q.; You, Y.; 
Bai, M.; Chen, Y.-Z.; Zhang, X.-M.; Yuan, W.-C. Tetrahedron 2014, 70, 5787; c) Wei, Q.; Gong, 
L.-Z. Org. Lett. 2010, 12, 1008. 
43 a) Li, Y.-M.; Li, X.; Peng, F.-Z.; Li, Z.-Q.; Wu, S.-T.; Sun, Z.-W.; Zhang, H.-B.; Shao, Z.-H. Org. 
Lett. 2011, 13, 6200; for a related example, see: b) Sun, W.; Hong, L.; Zhu, G.; Wang, Z.; Wei, 
X.; Ni, J.; Wang, R. Org. Lett. 2014, 16, 544. 
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Scheme 2.26 
In a different point of view, Gu and co-workers employed nitromethane as 
double nucleophile and chalcone derivatives as double Michael acceptors, with the 
obtention of polysubstituted chromans in high yields and enantioselectivities, 
using the hydroquinine-based thiourea as catalyst (see Scheme 2.27).44 In contrast, 
by the use of o-divinylbenzenes, as double Michael acceptors, instead of previous 
chalcones, Wang et al. have been able to control the regioselectivity after the first 
Michael addition of nitromethane, towards the product obtained by the 
nucleophilic attack of the resulting enolate. Under the optimal conditions, aryl 
substituents were well tolerated, obtaining enantioenriched trisubstituted indanes 
as single diastereoisomers (see Scheme 2.27).45 
                                                     
44 Jia, Z.-X.; Luo, Y.-C.; Cheng, X.-N.; Xu, P.-F.; Gu, Y.-C. J. Org. Chem. 2013, 78, 6488. 
45 Li, N.; Liu, G.-G.; Chen, J.; Pan, F.-F.; Wu, B.; Wang, X.-W. Eur. J. Org. Chem. 2014, 2677. 
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Scheme 2.27 
Finally, the use of indolin-3-one derivatives in Michael/Michael cascade 
reactions catalyzed by cinchona-based bifunctional thiourea has been recently 
reported. This reaction involves the initial Michael reaction of the starting material 
through the C-2 carbon of the indole moiety with nitroalkenes under catalyst 
activation, which is followed by the intramolecular Michael reaction. This 
methodology shows up as an excellent approach to enantioenriched N-fused 
piperidinoindolines furnishing good yields, moderate diastereoselectivities and 
excellent enantioselectivities (Scheme 2.28).46 
                                                     
46 Zhao, Y.-L.; Wang, Y.; Cao, J.; Liang, Y.-M.; Xu, P.-F. Org. Lett. 2014, 16, 2438. 
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Scheme 2.28 
In summary, across these introductory pages it has been clearly stablished 
the important progress made in the development of catalytic enantioselective 
Michael/Michael cascade reactions through the application of different 
organocatalytic activation manifolds. Moreover, the usefulness of this type of 
reactions has been fully demonstrated through the synthesis of substituted cyclic 
compounds with different degrees of complexity. However, and in spite of all the 
publications in this field, the development of new asymmetric double Michael 
cascade reactions towards the novel synthesis of enantioenriched carbo- and 
heterocyclic rings with different functionalities still remains necessary, due to the 
importance of this type of molecules as building blocks towards the preparation of 
interesting target compounds. 
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2. SPECIFIC OBJECTIVES AND WORK PLAN 
Taking into account the revised literature, and despite the large number of 
examples reported that involve organocatalytic enantioselective Michael/Michael 
cascade reactions, we considered that the development of new polyfunctional 
reagents that can participate as Michael donor-acceptor compounds able to react 
intermolecularly with a second Michael acceptor under organocatalytic conditions 
is still a field of great interest. In particular, with a focus on the development of 
new reagents that incorporate additional reactive motifs that could be used as the 
starting point for the synthesis of more complex molecules. 
In this sense, we have focused our attention in alkenyl sulfamidate imines 
such as the general structure depicted in Figure 2.2, as suitable polyfunctional 
reagents to develop a Michael/Michael cascade process. During the last decade, 
cyclic sulfamidate imines, in particular, five-membered ring heterocycles, such as 
5H-1,2,3-oxathiazole 2,2-dioxides, have received much attention due to their 
versatility as reagents in organic synthesis. 
 
Figure 2.2 
A remarkable feature of this particular type of reagents is the presence of an 
imine moiety activated by the electron-withdrawing sulfonyl group, whose 
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reactivity has been widely studied in 1,2-additions47 and hydrogenations.48 
Moreover, in most of these works the obtained cyclic sulfamidates have been used 
as building blocks towards the synthesis of a wide variety of compounds, taking 
advantage of the presence of the sulfonate as good leaving group. In particular, 
and related to the use of this type of compounds in the field of organocatalysis, 
there is one example, in which the imine acts as a heterodienophile in an 
enantioselective [4+2] cycloaddition.49 In this work, He and co-workers employed 
six-membered cyclic sulfamidate imines as heterodienophiles and in situ generated 
dienes via enamine activation of enones, therefore using a chiral primary amine as 
catalyst (Scheme 2.29). Several disubstituted piperidin-4-ones were obtained in 
good yields with high stereocontrol. 
                                                     
47 a) Kong, J.; McLaughlin, M.; Belyk, K.; Mondschein, R. Org. Lett. 2015, 17, 5520; b) Chen, Y.-
J.; Chen, Y.-H.; Feng, C.-G.; Lin, G.-Q. Org. Lett. 2014, 16, 3400; c) Nishimura, T.; Ebe, Y.; 
Fujimoto, H.; Hayashi, T. Chem. Commun. 2013, 49, 5504; d) Luo, Y.; Hepburn, H. B.; 
Chotsaeng, N.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 8309; e) Chang, S.; Lee, E. E. 
Synthesis 2010, 2361; f) Zhu, B.-H.; Zheng, J.-C.; Yu, C.-B.; Sun, X.-L.; Zhou, Y.-G.; Shen, Q.; 
Tang, Y. Org. Lett. 2010, 12, 504. 
48 a) Seo, Y. J.; Kim, J.; Lee, H.-K. J. Org. Chem. 2015, 80, 8887; b) Kim, J.; Seo, Y. J.; Kang, S.; 
Han, J.; Lee, H.-K. Chem. Commun. 2014, 50, 13706; c) Lee, H.-K.; Kang, S.; Choi, E. B. J. Org. 
Chem. 2012, 77, 5454; d) Han, J.; Kang, S.; Lee, H.-K. Chem. Commun. 2011, 47, 4004; e) Lee, 
S. A.; Kwak, S. H.; Lee, K.-I. Chem. Commun. 2011, 47, 2372; f) Kang, S.; Han, J.; Lee, E. S.; 
Choi, E. B.; Lee, H.-K. Org. Lett. 2010, 12, 4184; g) Wang, Y.-Q.; Yu, C.-B.; Wang, D.-W.; 
Wang, X.-B.; Zhou, Y.-G. Org. Lett. 2008, 10, 2071. 
49 Liu, Y.; Kang, T.-R.; Liu, Q.-Z.; Chen, L.-M.; Wang, Y.-C.; Liu, J.; Xie, Y.-M.; Yang, J.-L.; He, 
L. Org. Lett. 2013, 15, 6090. 
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Scheme 2.29 
In contrast, there are few examples in the literature describing the potential 
reactivity of the pronucleophilic point located at the 5-position of this type of 
sulfamidate imines (see Figure 2.2). In one recent example, Samanta and co-
workers have developed a Michael/aldol/hemiacetalization sequence carried out in 
a one-pot manner, in which the use of 4-aryl-5H-1,2,3-oxathiazole 2,2-dioxides as 
double nucleophiles is described, employing α,β-unsaturated aldehydes and 
formaldehyde as electrophiles. Several spiro-sulfamidate imine fused δ-lactone 
derivatives were obtained, after in situ oxidation of the corresponding lactols, in 
good yields, with moderate to good diastereoselectivities but with poor 
enantiocontrol in general (Scheme 2.30),50 although it should be noted that in one 
single case an excellent enantioselectivity with moderate diastereoselectivity was 
achieved, using O-TMS diphenyl prolinol as catalyst at 4 ºC. 
                                                     
50 a) Majee, D.; Biswas, S.; Mobin, S. M.; Samanta, S. Tetrahedron Lett. 2014, 55, 4553; for a 
related example, see: b) Majee, D.; Srivastava, A.; Mobin, S. M.; Samanta, S. RSC Advances 
2013, 3, 11502. 
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Scheme 2.30 
Taking into account that this type of five-membered cyclic sulfamidate 
imines are relatively unexplored in the chemical literature related to their use as 
reagents under organocatalytic conditions and knowing the potential activity of 
this moiety, we initially proposed the use of 4-alkenyl-5H-1,2,3-oxathiazole 2,2-
dioxides as suitable reagents in organocatalytic Michael/Michael cascade 
reactions with enals under iminium activation of the latter. Particularly, the 
presence of acidic protons at the 5-position together with the α,β-unsaturation of 
the sulfamidate imine would favour the formation of an enamine tautomer that can 
be consider as a potential nucleophile in an initial intermolecular Michael reaction 
with an activated α,β-unsaturated aldehyde via iminium ion formation with a 
chiral secondary amine as catalyst, followed by a second 1,4-addition of the 
generated enamine to the alkenyl sulfamidate imine, resulting in the formation of a 
polysubstituted cyclohexene after the release of the catalyst through a hydrolysis 
process (Scheme 2.31). 
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Scheme 2.31 
On the other hand, as shown in the Figure 2.2, the presence of a reactive 
azomethine functionality and a sulfonate group anticipates many different 
possibilities for carrying out further chemical manipulations on the structure of the 
enantioenriched adducts obtained initially. For this reason, we established as the 
second objective of the present work, the study of the synthetic versatility of the 
oxathiazole 2,2-dioxide moiety, in order to obtain molecules of higher complexity. 
With the objectives in mind, the following work plan was proposed: 
1. Synthesis of the starting materials. Initially, the corresponding 4-
alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides with different type of substituents in 
both α- and β-position of the alkene have to be prepared using simple and 
straightforward methodologies. 
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2. Viability of the Michael/Michael cascade reaction. Having prepared 
the desired α,β-unsaturated cyclic sulfamidate imines, the viability of the 
Michael/Michael cascade reaction will be surveyed using 4-(cyclohex-1-en-1-yl)-
5H-1,2,3-oxathiazole 2,2-dioxide and (E)-crotonaldehyde as model substrates, and 
a variety of chiral secondary amines as catalysts. 
3. Optimization of the reaction conditions. Once the feasibility of the 
process is demonstrated, different reaction parameters, such as catalyst, additive, 
solvent and temperature will be optimized, in order to obtain the corresponding 
decaline derivative in high yield and stereocontrol (Scheme 2.32). 
 
Scheme 2.32 
4. Scope of the reaction. Having stablished the best reaction conditions, 
several cyclic alkenyl sulfamidate imines and different substituted enals will be 
tested, in order to obtain a series of chiral cyclohexenes and decaline derivatives 
(Scheme 2.33). Through these experiments, the scope and limitations of the 
methodology will be stablished. 
 
Scheme 2.33 
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5. Transformation of the cycloadducts. Several transformations will be 
explored in order to check the potential applications of the prepared compounds 
containing the sulfamidate moiety as chiral building blocks. 
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3. RESULTS AND DISCUSSION 
Considering all the examples found in the literature about the 
organocatalytic Michael/Michael cascade reactions, and having proposed the 
different objectives and work plan, we will present and discuss the results 
achieved on this part of the research work. 
3.1. Organocatalytic Michael/Michael cascade reaction 
3.1.1. Synthesis of the starting materials 
A stated previously, we started with the synthesis of non commercially 
available 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides. In this sense, the desired 
five-membered cyclic sulfamidate imines were prepared through a two step route, 
starting from the corresponding alkenyl methyl ketones 1. These are commercially 
available or can be easily prepared through literature procedures.51 The synthesis 
started with the α-hydroxylation of these starting ketones 1 under acidic conditions 
using [bis(trifluoroacetoxy)iodo]benzene (PIFA) as the stoichiometric oxidant, 
following a known procedure.52 With α-hydroxy ketones 2 in hands, the synthesis 
continued with the formation of the cyclic sulfamidate imines 3 through 
sulfonylation of the primary alcohol with sulfamoyl chloride in DMA as solvent, 
followed by acid-catalyzed intramolecular condensation.48c Sulfamoyl chloride 
has to be prepared from commercially available chlorosulfonyl isocyanate by 
reaction with formic acid. Thus, a series of α,β-unsaturated sulfamidate imines 
were prepared in moderate overall yields, including several examples that 
                                                     
51 a) de Paula, B. R. S.; Zampieri, D. S.; Rodrigues, J. A. R.; Moran, P. J. S. Tetrahedron: 
Asymmetry 2013, 24, 973; b) Austin, W. F.; Zhang, Y.; Danheiser, R. L. Org. Lett. 2005, 7, 3905. 
52  Moriarty, R. M.; Berglund, B. A.; Penmasta, R. Tetrahedron Lett. 1992, 33, 6065. 
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incorporated both aliphatic and aromatic substituents at the terminal carbon atom 
of the alkenyl substituent (Table 2.1). 
 
Table 2.1: Synthesis of 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides 3. 
 
Entry R1 R2 3 Yield 2 (%) Yield 3 (%) 
1 -(CH2)4- 3a 46 77 
2 -(CH2)3- 3b - 7a 
3 Me Me 3c 28 56 
4 Me Et 3d 24 69 
5 Me Ph 3e 40 66 
a The yield of product 3b was calculated over the two reactions, without isolating the 
corresponding α-hydroxy ketone. 
It should be pointed out that after selective n.O.e. NMR experiments 
conducted on cyclic sulfamidate imines 3c and 3e, we concluded that the acyclic 
alkenes presented E-configuration, as confirmed by the existence of a strong 
n.O.e. between H1 and the protons of the CH2, and no n.O.e. between the protons 
of the CH2 and the protons of the methyl group (Figure 2.3). 
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Figure 2.3 
3.1.2. Viability of the Michael/Michael cascade reaction 
Once the desired α,β-unsaturated cyclic sulfamidate imines 3 have been 
synthesized, we started the study of the proyected organocatalytic 
Michael/Michael cascade process, evaluating the viability of the reaction. In this 
sense, the reaction between 4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3a and (E)-crotonaldehyde 4a was used as a representative model system 
at room temperature, in the presence of chiral secondary amine 5a as catalyst 
using CHCl3 as solvent. Amine 5a has been recognized as a privileged chiral 
organocatalyst to activate enals under iminium/enamine manifold in cascade 
processes.53 The reaction did not lead to any product when it was carried out 
under these conditions and similarly, no product formation was observed when 
benzoic acid was incorporated as cocatalyst which is known to favour the 
formation of iminium ions. Satisfactorily, when a Brønsted base such as DABCO 
(20 mol%) was used as cocatalyst, the decaline derivative 6a was isolated, as a 
result of a final enamine/imine tautomerization step, in 55% yield and as a single 
diastereoisomer, as determined by 1H-NMR analysis of the non-purified reaction 
                                                     
53 a) Meninno, S.; Lattanzi, A. Chem. Commun. 2013, 49, 3821; b) Jensen, K. L.; Dickmeiss, G.; 
Jiang, H.; Albrecht, L.; Jørgensen, K. A. Acc. Chem. Res. 2012, 45, 248; c) Xu, L.-W.; Li, L.; Shi, 
Z.-H. Adv. Synth. Catal. 2010, 352, 243; d) Mielgo, A.; Palomo, C. Chem. Asian J. 2008, 3, 922; 
e) Palomo, C.; Mielgo, A. Angew. Chem. Int. Ed. 2006, 45, 7876. 
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mixture, and obtaining full conversion of the cyclic sulfamidate imine 3a after 24 
hours at room temperature (Scheme 2.34). It should be pointed out that the 
reaction did not take place without the presence of the catalyst 5a, when DABCO 
was used as the only catalytic system. 
 
Scheme 2.34 
The incorporation of a Brønsted base as additive was found to be 
completely necessary for the success of the reaction, presumably because it 
contributes to the formation of a nucleophilic species through deprotonation of 
substrate 3a that next undergoes the Michael/Michael cascade reaction. At this 
point, and with the objective to determine the enantiomeric excess of 6a, a racemic 
standard was required, which was easily prepared by carrying out the reaction in 
the presence of an equimolar mixture of the (R) and (S) enantiomers of the catalyst 
5a, under the reaction conditions shown on Scheme 2.34. The obtained racemic 
cycloadduct (±)-6a was subjected to HPLC analysis on a chiral stationary phase, 
achieving the separation of the enantiomers with a Chiralpak IA chiral column and 
a mixture of 90:10 n-hexane/i-PrOH as eluent, in a 1.0 mL/min flow. When the 
chiral cycloadduct 6a, obtained through the (S)-5a catalyzed reaction, was 
subjected to HPLC analysis using these conditions, an excellent 92% ee was 
observed. The obtained chromatograms are depicted in Figure 2.4. 
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Figure 2.4 
Moreover, cycloadduct 6a was isolated as a yellow solid that could be 
recrystallized, obtaining suitable crystals for performing X-ray analysis and 
therefore being able to determine at this point the absolute stereostructure of the 
adduct obtained in the Michael/Michael cascade process. The structure of 6a, 
depicted in Figure 2.5, showed a 3aS,4R,5S,5aR,9aR configuration, which also 
entails the preferential formation of the decaline framework in a trans 
configuration. 
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Figure 2.5 
3.1.3. Optimization of the reaction conditions 
Having demonstrated the ability of the prepared sulfamidate imine 3a to act 
as Michael donor-acceptor in the projected double Michael cascade reaction with 
enals under iminium activation and after the excellent result obtained in the 
experiment shown on Scheme 2.34 regarding the stereoselectivity, we proceeded 
to study the reaction conditions, in order to specifically improve the yield of the 
reaction without affecting the stereocontrol. Initially, we surveyed a series of 
secondary amine catalysts (20 mol%), using DABCO (20 mol%) as cocatalyst in 
CHCl3 at room temperature (Table 2.2). 
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Table 2.2: Screening of reaction conditions: Secondary amine catalyst.a 
 
 
a The reaction was performed in 0.15 mL of CHCl3 and 0.15 mmol scale of 3a, using 
1.5 equiv. of 4a. b Isolated product yield after flash column chromatography. c 
Diastereomeric ratios determined by 1H-NMR analysis of non purified reaction 
mixtures. d Enantiomeric excesses determined by HPLC analysis on chiral stationary 
phase of the compound 6a. e The reaction was carried out for 48 hours. f No reaction. g 
Not determined. 
After analyzing these results, it can be observed that changing the nature of 
the O-substituent of the diphenyl prolinol archetypical catalyst to the bulkier 
triphenylsilyl group or the smaller methyl group (catalysts 5b and 5c) led to 
similar results compared with the initial catalyst 5a, observing a slower reaction in 
the case of catalyst 5b. On the other hand, when a catalyst with higher steric 
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hindrance (catalyst 5d) was employed, the formation of the product was not 
observed, and the same happened when catalysts with stereo-directing groups were 
used, such as the simple diphenylprolinol 5e. The use of its derivative 5f resulted 
in a very low conversion. Finally, catalyst 5g maintained the activity but the 
stereochemical control was significantly poorer, concluding that the secondary 
amine 5a initially used in our first experiment was the best catalyst for the 
reaction. It should be noted that in all cases only one diastereoisomer was 
observed. 
Because of the relevance of the Brønsted base in the reaction, we continued 
with the screening of other possible bases as cocatalysts, trying both with organic 
and inorganic Brønsted bases. As it can be observed in Table 2.3, the use of other 
organic bases (entries 2-5) did not improve the result obtained with DABCO 
(entry 1). On the other hand, no product was detected when an inorganic base such 
as Na2CO3 (entry 6) was used. 
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Table 2.3: Screening of reaction conditions: Brønsted base additive.a 
 
Entry Additive Yield (%)b drc ee (%)d 
1 DABCO 55 >20:1 92 
2 DBU 24 >20:1 90 
3 Et3N 34 >20:1 91 
4 DMAP 45 >20:1 91 
5 Pyridine n.d.e n.d.e n.d.e 
6 Na2CO3 n.r.f n.d.e n.d.e 
a The reaction was performed in 0.15 mL of CHCl3 and 0.15 mmol scale of 3a, using 1.5 
equiv. of 4a. b Isolated product yield after flash column chromatography. c Diastereomeric 
ratios determined by 1H-NMR analysis of non purified reaction mixtures. d Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 6a. e 
Not determined. f No reaction. 
Having demonstrated that DABCO was the best additive for the reaction, 
we proceeded to carry out the cascade process using different solvents in order to 
study the influence of this parameter in the reaction (Table 2.4). The use of other 
halogenated solvents, such as CH2Cl2 and 1,2-dichloroethane, did not provide 
better results than the obtained with CHCl3 (entries 2-3 vs. entry 1). When other 
solvents with different polarities and properties were used (entries 4-7), the yield 
of the reaction was adversely affected, even though the stereoselectivity was not 
harmed. 
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Table 2.4: Screening of reaction conditions: Solvent.a 
 
Entry Solvent Yield (%)b ee (%)c 
1 CHCl3 55 92 
2 CH2Cl2 49 94 
3 DCE 51 92 
4 THF 33 93 
5 Et2O 20 93 
6 i-PrOH 16 96 
7 Toluene 30 92 
a The reaction was performed in 0.15 mL of solvent and 0.15 mmol scale of 3a, using 1.5 
equiv. of 4a. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 6a. 
With the previous results in hands, we next considered to evaluate the effect 
of the temperature (Table 2.5). In this sense, we initially tried with a higher 
temperature, observing that the reaction performed poorly, isolating cycloadduct 
6a in a lower yield (entry 2). On the other hand, at lower temperatures the reaction 
was found to be cleaner, obtaining a 60% yield and 96% ee at -30 ºC, although 
requiring for a longer reaction time (entry 4). When the reaction was carried out at 
an even lower temperature (-50 ºC), only trace amounts of product 6a were 
detected by 1H-NMR analysis of the crude reaction mixture after 48 hours (entry 
5). Taking -30 ºC as the best temperature, we next decided to change the dilution 
of the reaction. From these experiments, we concluded that reducing the 
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concentration to the half, the yield was slightly increased (entry 6). Moreover, 
when the reaction was carried out under an inert atmosphere and using dry CHCl3 
as solvent, we were able to isolate the decaline derivative 6a in 66% yield (entry 
7). 
 
Table 2.5: Screening of reaction conditions: Temperature.a 
 
Entry T (ºC) Yield (%)b drc ee (%)d 
1 r.t. 55 >20:1 92 
2 50 45 >20:1 90 
3 4 56 >20:1 92 
4e -30 60 >20:1 96 
5e -50 <5 n.d.f n.d.f 
6e,g -30 62 >20:1 95 
7e,g,h -30 66 >20:1 96 
a The reaction was performed in 0.15 mL of CHCl3 and 0.15 mmol scale of 3a, using 1.5 
equiv. of 4a. b Isolated product yield after flash column chromatography. c Diastereomeric 
ratios determined by 1H-NMR analysis of non purified reaction mixtures. d Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 6a. e 
The reaction was carried out for 48 hours. f Not determined. g The reaction was performed 
in 0.30 mL of CHCl3 and 0.15 mmol scale of 3a. h Dry CHCl3 was used under inert 
atmosphere. 
Taking into account all the results obtained after the evaluation of the 
different reaction parameters, we concluded that the best conditions for the 
Michael/Michael cascade reaction between 4-(cyclohex-1-en-1-yl)-5H-1,2,3-
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oxathiazole 2,2-dioxide 3a and (E)-crotonaldehyde 4a were those shown in the 
entry 7 of the Table 2.5, that involved a 20 mol% of 5a as catalyst with 20 mol% 
of DABCO as cocatalyst in dry CHCl3 under inert atmosphere at -30 ºC for 48 
hours (Scheme 2.35). 
 
Scheme 2.35 
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3.1.4 Scope of the reaction 
Having established the optimal reaction conditions, we proceeded to 
investigate the performance of other α,β-unsaturated aldehydes and cyclic 
sulfamidate imines containing different substitution patterns, in order to study the 
scope and limitations of the reaction. Continuing with the previously used imine 
3a, the reaction was tested using enals with different β-alkyl substituents. As it can 
be appreciated in the Table 2.6, using the (E)-hex-2-enal 4c under the optimized 
conditions, good results were obtained but requiring long reaction times, 
comparing with the result achieved with the less bulkier (E)-crotonaldehyde 4a 
(entry 2 vs. entry 1). In order to improve the reaction rate, the reaction was carried 
out increasing the amount of aldehyde 4c, without obtaining any improvement 
(entry 3). At this point, we decided to carry out the reaction at room temperature, 
observing very good results regarding the rate, the yield and the stereoselectivity 
of the process using 2 equiv. of the corresponding aldehyde (entry 5). 
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Table 2.6: Evaluation of the bulkier (E)-hex-2-enal 4c in the reaction with the imine 3a.a 
 
Entry R (4) 3a:4 (equiv.) T (ºC) Time (h) Yield (%)b ee (%)c 
1 Me (4a) 1:1.5 -30 48 66 96 
2 n-Pr (4c) 1:1.5 -30 192 67 97 
3 n-Pr (4c) 1:2 -30 192 73 97 
4 n-Pr (4c) 1:1.5 r.t. 72 67 94 
5 n-Pr (4c) 1:2 r.t. 60 71 96 
a The reaction was performed in 0.30 mL of dry CHCl3 and 0.15 mmol scale of 3a. b 
Isolated product yield after flash column chromatography. c Enantiomeric excesses 
determined by HPLC analysis on chiral stationary phase of the compound 6. 
With the conditions shown in the entry 5 of the Table 2.6, other β-alkyl 
substituted enals 4 were tested, using the sulfamidate imine 3a. As it can be seen 
in Table 2.7, the reaction proceeded in a satisfactory way in all of the cases, 
obtaining a series of decaline derivatives 6a-g with five contiguous stereocenters, 
in good yields, excellent enantioselectivities and as single diastereoisomers. It 
should be pointed out that the size of the β-alkyl chain did not considerably affect 
the yield nor the stereoselectivity of the reaction, and the inclusion of β-ramified 
alkyl chains was also well tolerated (entries 2-7). Finally, we studied the 
possibility to carry out the reaction on larger scale, observing similar yield and 
enantioselectivity when 0.5 g of 3a was used in the reaction with enal 4c as a 
model substrate (entry 3 vs. entry 8). 
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Table 2.7: Scope of the reaction using sulfamidate imine 3a and β-alkyl substituted enals.a 
 
Entry R (4) 6 Time (h) Yield (%)b ee (%)c 
1d Me (4a) 6a 48 66 96 
2 Et (4b) 6b 60 66 95 
3 n-Pr (4c) 6c 60 71 96 
4 n-Bu (4d) 6d 72 67 95 
5 i-Bu (4e) 6e 60 65 97 
6 n-C5H11 (4f) 6f 72 61 95 
7 n-C6H13 (4g) 6g 72 57 95 
8e n-Pr (4c) 6c 60 67 95 
a The reaction was performed in 0.30 mL of dry CHCl3 and 0.15 mmol scale of 3a, using 2 
equiv. of 4. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 6. d The 
reaction was carried out at -30 ºC using 1.5 equiv. of 4a. e Reaction performed on a 0.5 g 
scale of 3a. 
On the other hand, we also evaluated the use of functionalized α,β-
unsaturated δ-aminoaldehyde 4h as the initial Michael acceptor, to demonstrate 
the functional group compatibility of the developed methodology. Under the 
optimal conditions shown in the entry 5 of the Table 2.6, the Michael/Michael 
cascade reaction was followed by the intramolecular attack of the protected amine 
to the formyl group, affording the corresponding hemiaminal 6h in good yield and 
excellent enantioselectivity (Scheme 2.36). Moreover, after the formation of six 
stereogenic centers, only one diastereoisomer was detected by 1H-NMR analysis, 
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forming only the anomer, with a large preference for the axial orientation, 
confirmed by n.O.e. experiments. 
 
Scheme 2.36 
At this point, and continuing with the use of the cyclic sulfamidate imine 
3a, we decided to extend the reaction to different β-aryl substituted α,β-
unsaturated aldehydes, observing the formation of considerable secondary 
products, that disfavoured the obtention of the desired product, which we were 
unable to purify. For this reason, we decided to reduce in situ both the formyl and 
the azomethine moieties after the Michael/Michael cascade operation, in order to 
be capable of purifying the corresponding decaline. In this sense, using (E)-
cinnamaldehyde 4i as a representative enal, we isolated the cyclic sulfamidate 6i, 
after extensive reduction with NaBH4 in MeOH at 0 ºC, in high enantioselectivity 
and as a single diastereoisomer, but in poor yield (Scheme 2.37). 
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Scheme 2.37 
In order to improve these results, we tested the reaction at lower 
temperature with the aim of minimizing the formation of byproducts, only 
observing poorer yield. 
We next surveyed the performance of the sulfamidate imine 3b, with the 
purpose of obtaining octahydro-1H-indene derivatives. After several experiments, 
both with β-alkyl and β-aryl substituted enals, only a complex mixture of 
compounds was observed, not detecting any characteristic signal of a possible 
cyclization product by 1H-NMR analysis (Scheme 2.38). 
 
Scheme 2.38 
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On the other hand, we continued with the scope of the reaction using the 
more conformationally flexible sulfamidate imine 3c. Interestingly, in this case the 
reaction took place satisfactorily with a variety of β-aryl substituted α,β-
unsaturated aldehydes under the optimized conditions shown in the entry 7 of the 
Table 2.5, carrying out the reaction at low temperature. As shown in Table 2.8, the 
resulting polysubstituted cyclohexanes 7a-k were obtained in very good yields and 
excellent enantioselectivities using (E)-cinnamaldehyde 4i (entry 1) and other β-
aryl substituted enals, both with electron-donating (entry 2 and entries 4-6) and 
electron-withdrawing (entries 7-8 and 10-12) substituents at the aryl ring. In 
contrast, no reaction was detected with enals incorporating ortho-substituted aryl 
substituents (entries 3 and 9), observing only a complex mixture of products. 
Unfortunately, the same reaction with (E)-crotonaldehyde 4a yielded the 
cyclohexane 7k in poor yield, albeit with excellent stereocontrol (entry 13). With 
β-alkyl substituted enals containing longer alkyl chains, very low conversions 
were observed, not being able to improve these results using higher temperatures. 
In all cases only one diastereoisomer was detected, but it should be noted that in 
some of these cases (entries 2 and 10) it was necessary to leave the reaction at 
room temperature during four hours after full conversion, to achieve total 
diastereocontrol towards the formation of thermodynamically more stable product. 
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Table 2.8: Scope of the reaction using sulfamidate imine 3c and different enals.a 
 
Entry R (4) 7 Time (h) Yield (%)b ee (%)c 
1 Ph (4i) 7a 60 66 98 
2d 4-MeC6H4 (4j) 7b 60 59 >99 
3 2-MeOC6H4 (4k) - 48 n.r.e n.d.f 
4 4-MeOC6H4 (4l) 7c 48 65 >99 
5 4-AcO-3-MeOC6H3 (4m) 7d 48 72 >99 
6 3,5-(MeO)2C6H3 (4n) 7e 60 71 99 
7 4-ClC6H4 (4o) 7f 60 65 98 
8 4-BrC6H4 (4p) 7g 60 67 96 
9 2-NO2C6H4 (4q) - 48 n.r.e n.d.f 
10d 4-NO2C6H4 (4r) 7h 60 73 96 
11 4-CNC6H4 (4s) 7i 48 73 98 
12 4-CF3C6H4 (4t) 7j 60 67 98 
13 Me (4a) 7k 48 36 91 
a The reaction was performed in 0.30 mL of dry CHCl3 and 0.15 mmol scale of 3c, using 
1.5 equiv. of 4. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 7. d Full 
diastereocontrol was achieved leaving stirring the reaction during four hours at room 
temperature after full conversion. e No reaction. f Not determined. 
With these results in hand, we next decided to extend the reaction to other 
related α,β-unsaturated sulfamidate imines, such as 3d incorporating longer alkyl 
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chains at the β-position, and also surveyed the possibility to use substrate 3e that 
incorporates a phenyl group at this position (Table 2.9). With sulfamidate imine 
3d similar results of those obtained before with sulfamidate imine 3c were 
observed, achieving good yields and excellent stereoselectivities (entries 1-5). It 
should be highlighted that in some of these cases the presence of a minor 
diastereisomer was detected by 1H-NMR analysis, even after stirring the reaction 
at room temperature after full conversion in order to facilitate the interconversion 
of minor diastereoisomer into the thermodynamically favoured one. We were 
unable to isolate this minor one but it is likely to be the diastereoisomer with the 
substituents derived from the alkenyl moiety of the starting sulfamidate imine in 
cis position, due to the equilibrium existing between the last formed enamine and 
the finally obtained imine in the course of the reaction. In the case of sulfamidate 
imine 3e, the reactions took place with poorer yields, but excellent results were 
obtained concerning the stereoselectivity (entries 6, 8 and 9). The observed low 
yields can be attributed to the lower electrophilicity of the α,β-unsaturated 
sulfamidate imine 3e, due to the extended conjugation of the unsaturated system 
with the aromatic ring. In fact, when enals incorporating electron-rich β-aryl 
substituents were tested, we did not observe the formation of the corresponding 
products (entry 7). 
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Table 2.9: Scope of the reaction using sulfamidate imines 3d and 3e, and different enals.a 
 
Entry R1 (3) R2 (4) 7 Yield (%)b drc ee (%)d 
1 Et (3d) Ph (4i) 7l 57 >20:1 96 
2 Et (3d) 4-MeOC6H4 (4l) 7m 66 10:1 99 
3 Et (3d) 3,5-(MeO)2C6H3 (4n) 7n 61 8:1 99 
4 Et (3d) 4-BrC6H4 (4p) 7o 62 8:1 97 
5 Et (3d) 4-NO2C6H4 (4r) 7p 50 13:1 94 
6e,f Ph (3e) Ph (4i) 7q 30 >20:1 99 
7f Ph (3e) 4-MeOC6H4 (4l) - n.r.g n.d.h n.d.h 
8f Ph (3e) 4-BrC6H4 (4p) 7r 26 >20:1 >99 
9f Ph (3e) 4-NO2C6H4 (4r) 7s 35 >20:1 98 
a The reaction was performed in 0.30 mL of dry CHCl3 and 0.15 mmol scale of 3d, using 
1.5 equiv. of 4. b Isolated product yield after flash column chromatography. c 
Diastereomeric ratios determined by 1H-NMR analysis of non purified reaction mixtures. d 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 7. e The reaction carried out for 84 hours. f The reaction was performed in 0.40 
mL of dry CHCl3 and 0.20 mmol scale of 3e, using 2 equiv. of 4. g No reaction. h Not 
determined. 
It is noteworthy that during all these experiments, and in particular when 
sulfamidate imines incorporating an acyclic alkene 3c-e in combination with β-
aryl substituted enals were used, the formation of an additional byproduct in small 
amounts was observed. In the reaction between sulfamidate imine 3c and (E)-
cinnamaldehyde 4i, we were able to isolate and characterize this product (8a) in 
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<10% yield, corresponding to a possible Michael/Michael cascade reaction, 
followed by a transannular nucleophilic substitution/imine hydrolysis sequence 
(Figure 2.6). This compound was isolated as a single diastereoisomer. This 
interesting finding prompted us to study in detail this new reactivity that constitute 
an efficient approach to the synthesis of bicycle[3.1.0]hexane scaffolds. This 
chemistry will be described later on within this chapter. 
 
Figure 2.6 
Continuing with the cycloaddition reaction, we had previously confirmed 
the absolute configuration of the decaline derivative 6a by X-ray analysis, also 
demonstrating the formation of the trans-decaline framework, which is more 
stable than the corresponding cis stereoisomer. The fact that a possible 
equilibration between cis/trans isomers could take place in some cases did not 
allow to extend this configuration to the cyclohexanes 7 based on mechanistic 
analogy. However, we were able to confirm that the cyclohexane 7a had all the 
substituents in the same orientation than the decaline derivative 6a, through single 
crystal X-ray analysis (see Figure 2.7), showing a 4R,5R,6S,7S,7aS absolute 
configuration, which could be extended to the cycloadducts 6 and 7 by analogy 
with full reliability. 
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Figure 2.7 
A plausible mechanism for this transformation is proposed in Scheme 2.39. 
Taking into account the absolute configuration of the obtained cycloadducts, we 
propose a stepwise mechanism that consists on an aminocatalytic Michael/Michael 
cascade reaction under iminium/enamine manifold. Initially, the iminium ion is 
formed by condensation between the aldehyde and the aminocatalyst, decreasing 
the energy of its LUMO, which is followed by the Michael addition of the active 
nucleophile, generated from the activation of the sulfamidate imine by DABCO, to 
the iminium ion through its less hindered Re face. After the first Michael reaction, 
in which the first two stereogenic centers are generated, the (E)-enamine 
intermediate is formed, which is able to undergo a second Michael addition to the 
α,β-unsaturated sulfamidate imine through its less hindered face, forming two new 
stereocenters in anti-relative arrangement. Finally, the catalyst is released by 
hydrolysis, followed by imine/enamine tautomerization towards the obtention of 
the final adduct 6 and 7. It should be noted that in this equilibrium a new 
stereogenic center is generated, being presumably controlled by thermodynamic 
issues, leading to the most stable diastereoisomer with all substituents in 
equatorial positions. 
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Scheme 2.39 
3.1.5 Transformation of the cycloadducts 
Having stablished a good protocol for the Michael/Michael cascade 
reaction, which allows the synthesis of a wide variety of enantioenriched 
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polysubstituted cyclohexanes and decaline derivatives, we proceeded to exploit 
the reactivity of the sulfamidate imine scaffold. 
Initially, using the cycloadduct 6a as a model substrate, we decided to 
obtain the corresponding sulfamidate by the reduction of the imine group. The 
treatment with the conditions previously used in the Scheme 2.37, i.e. NaBH4 in 
MeOH at 0 ºC, afforded the corresponding sulfamidate 9 and also reducing the 
formyl group, in excellent yield, as a single diastereoisomer and keeping the 
enantiopurity of the starting material (Scheme 2.40). 
 
Scheme 2.40 
The cyclic sulfamidates are synthetically interesting compounds due to their 
applicability to the preparation of different products with heteroatomic functional 
groups, through regiospecific ring-opening reactions with several nucleophiles.54 
One of the most useful transformations is the synthesis of β-amino alcohols, which 
are a common moiety found in natural and synthetic products. Chiral 1,2-amino 
alcohols can be used as building blocks for the preparation of a wide range of 
                                                     
54  For some reviews on the reactivity of cyclic sulfamidates, see: a) Megía-Fernández, A.; Morales-
Sanfrutos, J.; Hernández-Mateo, F.; Santoyo-González, F. Curr. Org. Chem. 2011, 15, 401; b) 
Bower, J. F.; Rujirawanich, J.; Gallagher, T. Org. Biomol. Chem. 2010, 8, 1505; c) Meléndez, R. 
E.; Lubell, W. D. Tetrahedron 2003, 59, 2581. 
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biologically active natural and unnatural compounds or as chiral auxiliaries, 
catalyst or ligands.55 For this reason, we decided to prepare the vicinal amino 
alcohol from the corresponding cyclic sulfamidate, following a well-known 
procedure.48c Thus, the reduction of the sulfamidate 9 with LiAlH4, followed by 
hydrolytic treatment, afforded the β-amino alcohol 10 with retention of 
stereochemistry at C-3a and C-9b in good yield and without any epimerization of 
the stereocenters initially generated during the cascade process (Scheme 2.41). 
The cis-relation between the amino and hydroxy group was confirmed by NMR 
experiments, due to the presence of n.O.e. between H1 and H2, and the absence of 
n.O.e. between H1 and H3, and between H1 and H4a. 
 
Scheme 2.41 
                                                     
55  For some reviews, see: a) Weng, C.; Zhang, H.; Xiong, X.; Lu, X.; Zhou, Y. Asian J. Chem. 2014, 
26, 3761; b) Karjalainen, O. K.; Koskinen, A. M. P. Org. Biomol. Chem. 2012, 10, 4311; c) Della 
Sala, G.; Russo, A.; Lattanzi, A. Curr. Org. Chem. 2011, 15, 2147; d) de Parrodi, C. A.; Juaristi, 
E. Synlett 2006, 2699; e) Lee, H.-S.; Kang, S. H. Synlett, 2004, 1673; f) Bergmeier, S. C. 
Tetrahedron, 2000, 56, 2561; g) Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835. 
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3.2. Transannular SN2 reaction: Synthesis of bicycle[3.1.0]hexanes 
After finishing with the previous Michael/Michael cascade reaction we 
decided to go back to the minor side product 8a obtained in the reaction between 
the sulfamidate imine 3c and (E)-cinnamaldehyde 4i under the conditions shown 
in the entry 1 of the Table 2.8. This type of polycyclic structures containing a 
fused cyclopropane moiety is widespreadly found in many natural products.56 
Furthermore, these congested molecules are useful synthetic intermediates in the 
synthesis of complex compounds57 due to their rigid structure and high π 
character. Moreover, the formation of this product would demonstrate the 
applicability of the studied sulfamidate imines 3. In view of the potential interest 
of this reaction we decided to survey the possibility of carrying out a one-pot or 
cascade sequence involving the initial double Michael cascade reaction followed 
by a transannular SN2-type reaction that closes the bicyclic system. In this sense, 
we initially tried to carry out the transannular nucleophilic substitution/imine 
hydrolysis sequence using the Michael/Michael cycloadduct 7a and different 
bases, such as DABCO, at different temperatures. In all cases the reaction did not 
take place, observing the decomposition of the substrate under the hardest 
conditions. At this point, we decided to use an achiral primary amine, such as 
benzhydrylamine, in order to favour the imine formation by condensation with the 
hindered aldehyde. The reaction failed, when catalytic amount (20 mol%) of 
benzhydrylamine was used, observing the formation of the corresponding imine 
when equimolecular amount of the primary amine was employed at room 
temperature. After trying at different temperatures, we found that using the 
                                                     
56  For a selected review, see: Chen, D. Y.-K.; Pouwer, R. H.; Richard, J.-A. Chem. Soc. Rev. 2012, 
41, 4631. 
57  For some reviews, see: a) Cavitt, M. A.; Phun, L. H.; France, S. Chem. Soc. Rev. 2014, 43, 804; b) 
Tang, P.; Qin, Y. Synthesis, 2012, 44, 2969. 
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enantioenriched Michael/Michael adduct 7a with 1 equiv. of benzhydrylamine in 
DCE at 75 ºC after 17 hours, bicyclic compound 11a was isolated in 80% yield as 
a mixture of two diastereoisomers in a 6.3:1 ratio, after hydrolysis of the resulting 
imines with HCl 1 M at 75 ºC (Scheme 2.42). Interestingly, none of the isolated 
diastereoisomers of 11a were the previously found diastereoisomer 8a. 
 
Scheme 2.42 
After n.O.e. experiments performed on both diastereisomers of 11a, we 
concluded that the major product was the 2,3-cis diastereoisomer and the minor 
was the 2,3-trans one (Figure 2.8). In both diastereoisomers, the presence of n.O.e. 
was observed between the proton of the aldehyde and the protons of the aromatic 
ring, and no n.O.e. between the proton of the aldehyde and H6, showing that the 
aldehyde, the phenyl group and H5 were in the same side. In the case of the major 
diastereoisomer, significant n.O.e. was appreciated between H6 and H3, and 
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between H6 and H2, indicating a cis configuration of the substituents at C-2 and C-
3 (cis-11a). In the minor diastereoisomer, the presence of n.O.e. was observed 
between H6 and the protons of the methyl group at C-3, and between H6 and H2, 
indicating a trans configuration of the substituents at C-2 and C-3 (trans-11a). 
 
Figure 2.8 
It should be noted that the enantiopurity of the major diastereoisomer cis-
11a was verified by HPLC analysis, obtaining 99% ee. The separation conditions 
were achieved using a racemic standard, prepared from racemic 7a, consisting on 
the use of the Chiralpak AS-H chiral column and a mixture of 90:10 n-hexane/i-
PrOH as eluent, in a 1.0 mL/min flow.  
Regarding the mechanism for this reaction a plausible proposal is shown on 
the Scheme 2.42, in which first an imine is proposed to be formed by condensation 
between the primary amine and the aldehyde, followed by the consequent enamine 
formation, which would be able to attack intramolecularly to the sulfonate group 
through an anti nucleophilic substitution, forming the bicycle[3.1.0]hexane 
scaffold, after hydrolysis of the corresponding imines. Due to the presence of an 
acidic proton at C-3 position, this stereocenter can epimerize to form the most 
stable diastereoisomer isolated in our case. 
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With the best conditions in our hands (shown in Scheme 2.42), we 
proceeded to extend the reaction to other Michael/Michael cycloadducts 7. As 
shown in the Table 2.10, when double Michael products with methyl group at R1 
and different substituents in the aromatic ring at R2 (entries 1-10) were tested, 
good results were obtained regarding the yield and diastereoselectivity, in most 
cases, observing the decomposition of the starting material only for compounds 7c 
and 7e (entries 3 and 5). On the other hand, when cycloadducts incorporated bulky 
groups at R1, such as ethyl or phenyl group, the reaction performed poorly, 
observing a complex mixture of products (entries 11-12), only being able to purify 
the bicyclic compound 11i in moderate yield and diastereocontrol (entry 13). In 
general, when cycloadducts with strong electron-withdrawing groups in the 
aromatic ring at R2 were used, slower reactions were observed and consequently 
the products were isolated in moderated yield, due to the decomposition of the 
starting material (entries 8, 9 and 13). Finally, we tried to carry out the reaction 
with alkyl substitutents at R2 of the cycloadduct, such as 6a and 7k, only 
observing the condensation product with the primary amine. 
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Table 2.10: Transannular nucleophilic substitution/imine hydrolysis sequence of various 
Michael/Michael cycloadducts 7. 
 
Entry R1, R2 (7) 11 Time (h) 
Yield 
(%)a 
cis:transb 
1 Me, Ph (7a) 11a 17 80 6.3:1 
2 Me, 4-MeC6H4 (7b) 11b 17 77 6.7:1 
3 Me, 4-MeOC6H4 (7c) - 17 n.d.c n.d.c 
4 Me, 4-AcO-3-MeOC6H3 (7d) 11c 17 71 6.7:1 
5 Me, 3,5-(MeO)2C6H3 (7e) - 17 n.d.c n.d.c 
6 Me, 4-ClC6H4 (7f) 11d 17 71 6.1:1 
7 Me, 4-BrC6H4 (7g) 11e 17 72 5.9:1 
8 Me, 4-NO2C6H4 (7h) 11f 36 51 6.3:1 
9 Me, 4-CNC6H4 (7i) 11g 36 58 6.3:1 
10 Me, 4-CF3C6H4 (7j) 11h 17 75 6.3:1 
11 Et, Ph (7l) - 17 n.d.c n.d.c 
12 Ph, Ph (7q) - 17 n.d.c n.d.c 
13 Ph, 4-NO2C6H4 (7s) 11i 36 57 3:1 
a Combined yield of both diastereoisomers after flash column chromatography. b 
Diastereomeric ratios determined by 1H-NMR analysis of non purified reaction mixtures. c 
Not determined. 
Luckily, the compound 11e was isolated as a yellow solid that could be 
recrystallized, determining the absolute configuration by single crystal X-ray 
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analysis, and confirming the configuration previously proposed based on NMR 
experiments (shown in Figure 2.8). The crystal structure of 11e is depicted in 
Figure 2.9 showing an 1S,2R,3S,5S,6R absolute configuration. The remaining 
compounds 11 were assigned by mechanistic analogy. 
 
Figure 2.9 
Having demonstrated the ability of the Michael/Michael cascade products to 
undergo the transannular nucleophilic substitution/imine hydrolysis sequence, and 
knowing that after the double Michael cascade reaction the resulting iminium ion 
intermediate can tautomerize to form the corresponding enamine, we next decided 
to try the Michael/Michael/transannular SN2/imine hydrolysis cascade sequence. 
In this sense, and based on the previously formation of the bicyclic compound 8a, 
we started the study of this reaction using sulfamidate imine 3c and (E)-
cinnamaldehyde 4i as a model substrates, testing first the reaction at different 
temperatures in the presence of 20 mol% of (S)-α,α-diphenylprolinol trimethylsilyl 
ether 5a and 20 mol% of DABCO as cocatalyst in 1,2-dichloroethane (DCE) 
instead of CHCl3, due to its higher boiling point. We observed that at higher 
temperatures the formation of the bicycle[3.1.0]hexane derivative 8a was 
favoured, disfavouring the formation of the Michael/Michael product 7a. After 
several experiments, we found that at reflux of DCE, the cycloadduct 7a was not 
formed, isolating the bicyclic compound 8a in 39% yield and as a single 
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diastereoisomer, as determined by 1H-NMR analysis of the non-purified reaction 
mixture, obtaining full conversion after 24 hours (Scheme 2.43). 
 
Scheme 2.43 
At this stage, we decided to determine the enantiomeric excess of the 
obtained compound 8a, in order to evaluate the success of the reaction regarding 
the stereoselectivity. For this reason, we first proceeded to prepare a racemic 
standard carrying out the reaction in the presence of an equimolecular mixture of 
(R) and (S) enantiomers of the catalyst 5a. Both enantiomers of (±)-8a were 
separated by HPLC using a Chiralpak AS-H chiral column and a mixture of 90:10 
n-hexane/i-PrOH as eluent, in a 1.0 mL/min flow. Under these conditions, the 
chiral cycloadduct 8a was subjected to HPLC analysis, observing an excellent 
enantiomeric excess of 95% (Figure 2.10). 
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Figure 2.10 
We next proceeded to optimize the reaction in order to improve the low 
yield previously obtained. In this sense, we initially tested the influence of the 
temperature, the amount of the Brønsted base additive and the ratio between the 
reagents, using the previous model system, in order to find better reaction 
conditions for the preparation of the bicyclic compound 8a (Table 2.11). When the 
amount of DABCO was increased, reflux conditions were not neccesary to obtain 
compound 8a without the formation of 7a, being able to carry out the reaction at 
75 ºC. As it can be observed in entry 3, using 3 equiv. of DABCO led to 
cycloadduct 8a in higher yield (53%) after 12 hours, keeping excellent 
stereoselectivity. These results were not improved using more excess of enal 
(entry 5). Next, we decided to reduce the temperature maintaining the amount of 
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additive (entries 6-7), observing lower yields due to the competitive formation of 
cycloadduct 7a. Following the reaction by 1H-NMR, using the conditions shown in 
the entry 3, we could observe that the starting material 3c was consumed very fast, 
forming a complex mixture of products, with several signals in the typical range of 
aldehydes. Stirring the reaction for 12 hours, all the signal evolved to single one 
showing that a mixture of stereoisomeric intermediates was formed that slowly 
converted into one single product that after purification showed to be 8a. The 
same reaction without aldehyde 4i resulted in a fast decomposition of the 
sulfamidate imine 3c. From these experiments we can conclude that the moderate 
yield observed initially could be due to the instability of the imine 3c or of the 
intermediates formed during the reaction. For this reason, in order to increase the 
yield, we performed the reaction in two different ways: (1) By adding the substrate 
3c portionwise during 1 hour (entry 8) and (2) with excess of the cyclic 
sulfamidate imine 3c (entry 9), not observing better results regarding the yield of 
the reaction in any of the cases. 
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Table 2.11: Screening of reaction conditions: Temperature and proportion of additive and 
reagents.a 
 
Entry 3c:4i (equiv.) DABCO (equiv.) T (ºC) Yield (%)b ee (%)c 
1 1:1.5 0.2 reflux 39 95 
2 1:1.5 1 75 40 95 
3 1:1.5 3 75 53 94 
4 1:1.5 5 75 51 94 
5 1:3 3 75 53 93 
6 1:1.5 3 50 43 95 
7 1:1.5 3 r.t. 30 96 
8d 1:1.5 3 75 43 95 
9e 1.5:1 3 75 34 n.d.f 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 3c. b Isolated 
product yield after flash column chromatography. c Enantiomeric excesses determined by 
HPLC analysis on chiral stationary phase of the compound 8a. d Portionwise addition of 3c 
during one hour. e The reaction was performed in 0.15 mmol scale of 4i. f Not determined. 
From these experiments, we concluded that carrying out the reaction at 75 
ºC, and using a large amount of the Brønsted base (3 equiv.) were the best 
conditions to promote the reaction. At this point, we also decided to evaluate the 
effect of other Brønsted bases in the reaction, in order to favour the formation of 
the bicyclic compound 8a (Table 2.12). In all cases poorer results were observed 
regarding the yield comparing with the obtained with DABCO (entries 2-6 vs. 
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entry 1), not observing any reactivity with DBU and TMP, as hindered bases 
(entries 2 and 6). 
 
Table 2.12: Screening of reaction conditions: Additive.a 
 
Entry Additive Time (h) Yield (%)b drc ee (%)d 
1 DABCO 12 53 >20:1 94 
2 DBU 12 n.r.e n.d.f n.d.f 
3 Et3N 36 29 >20:1 94 
4 DIPEA 36 23 >20:1 96 
5 DMAP 36 23 >20:1 94 
6 TMP 12 n.r.e n.d.f n.d.f 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 3c, using 1.5 
equiv. of 4i. b Isolated product yield after flash column chromatography. c Diastereomeric 
ratios determined by 1H-NMR analysis of non purified reaction mixtures. d Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 8a. e No 
reaction. f Not determined. 
We next evaluated the influence of the solvent in the reaction (Table 2.13). 
Different polar aprotic solvents were tested, observing that 1,4-dioxane performed 
in similar terms as DCE (entry 2 vs. entry 1), while the use of more polar ones, 
such as MeCN and DMF (entries 3 and 4), affected negatively the yield of the 
reaction. We also tried with a polar protic solvent like i-PrOH (entry 5), in order to 
verify if its ability as hydrogen donor was beneficial for the reaction, not 
observing any improvement. Finally, the use of a less polar solvent, like toluene 
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(entry 6), did not translate into a better yield. We could also observe that in all 
solvents tested excellent stereocontrol was observed, obtaining the higher yield 
with DCE. 
 
Table 2.13: Screening of reaction conditions: Solvent.a 
 
Entry Solvent Yield (%)b ee (%)c 
1 DCE 53 94 
2 1,4-dioxane 48 92 
3 MeCN 35 94 
4 DMF 19 92 
5 i-PrOH 35 93 
6 Toluene 42 90 
a The reaction was performed in 0.30 mL of solvent and 0.15 mmol scale of 3c, using 1.5 
equiv. of 4i. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 8a. 
Having studied the different variables of the reaction, we concluded that the 
optimal conditions for the synthesis of bicycle[3.1.0]hexane derivative 8a by one-
pot reaction of the cyclic sulfamidate 3c and (E)-cinnamaldehyde 4i are the use of 
20 mol% of catalyst 5a and 3 equiv. of DABCO as additive in DCE at 75 ºC 
(Scheme 2.44). 
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Scheme 2.44 
With the best conditions in hands, we continued with the study of the scope 
of the reaction, trying first with different β-aryl substituted enals, using cyclic 
sulfamidate imine 3c as starting material (Table 2.14). 
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Table 2.14: Scope of the reaction using sulfamidate imine 3c and β-aryl substituted enals.a 
 
Entry R (4) 8 Yield (%)b ee (%)c 
1 Ph (4i) 8a 53 94 
2 4-MeC6H4 (4j) 8b 55 93 
3 2-MeOC6H4 (4k) 8c 39 90 
4 4-MeOC6H4 (4l) 8d 43 94 
5 4-AcO-3-MeOC6H3 (4m) 8e 51 94 
6 3,5-(MeO)2C6H3 (4n) 8f 42 92 
7 4-ClC6H4 (4o) 8g 52 92 
8 4-BrC6H4 (4p) 8h 46 90 
9 2-NO2C6H4 (4q) 8i 47 92 
10 4-NO2C6H4 (4r) 8j 32 86 
11 4-CNC6H4 (4s) 8k 41 89 
12 4-CF3C6H4 (4t) 8l 54 90 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 3c, using 1.5 
equiv. of 4. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 8. 
As it can be observed in the Table 2.14, the reaction proceeded in moderate 
yields and very good to excellent enantioselectivities in all cases, both with 
electron-donor (entries 2-6) and electron-withdrawing substituents (entries 7-12) 
in the aromatic ring of a variety of β-aryl substituted enals, providing the 
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corresponding bicyclic compounds 8 as single diastereoisomers. In contrast to the 
Michael/Michael reaction, in this case the reaction took place with ortho-
substituted aromatic enals in modest yields (entries 3 and 9). Unfortunately, when 
(E)-crotonaldehyde or another β-alkyl substituted enal were examined, the 
decomposition of the starting reagents were observed. 
On the other hand, we extended the reaction to β-ethyl and β-phenyl 
substituted sulfamidate imines 3d and 3e, using aromatic enals with different 
substituents (Table 2.15). With imine 3d low to moderate yields were achieved, 
isolating the corresponding products in high enantiopurity and as a single 
diastereoisomers (entries 1-3). When substrate 3e was used, moderate yields were 
obtained (entries 4-7), observing a significant drop in the enantioselectivity when 
enals with electron-poor substituents on the aromatic ring at β-position were 
employed (entries 6-7). 
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Table 2.15: Scope of the reaction using sulfamidate imines 3d and 3e, and β-aryl 
substituted enals.a 
 
Entry R1 (3) R2 (4) 8 Yield (%)b ee (%)c 
1 Et (3d) Ph (4i) 8m 43 91 
2 Et (3d) 4-MeOC6H4 (4l) 8n 41 90 
3 Et (3d) 4-BrC6H4 (4p) 8o 30 86 
4 Ph (3e) Ph (4i) 8p 49 93 
5 Ph (3e) 4-AcO-3-MeOC6H3 (4m) 8q 51 90 
6 Ph (3e) 4-BrC6H4 (4p) 8r 42 75 
7 Ph (3e) 4-NO2C6H4 (4r) 8s 46 76 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 3, using 1.5 
equiv. of 4. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 8. 
At this stage, with the purpose of obtaining the tricycle compound derived 
from the sulfamidate imine 3a, we tried to carry out the reaction under the 
previous optimal conditions by reacting the imine 3a and (E)-cinnamaldehyde 4i 
(see entry 1, Table 2.16), observing the formation of the desired product 12a, 
together with the Michael/Michael product. We also observed by NMR the 
formation of an unknown product that could not be isolated. In order to avoid the 
formation of secondary products, we increased the amount of DABCO to 5 equiv., 
not detecting the formation of these byproducts, and isolating the corresponding 
tricycle 12a in low yield, but in excellent enantiopurity and as a single 
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diastereoisomer (entry 2). We also tried with excess of the sulfamidate imine 3a, 
keeping the high stereocontrol and increasing the yield with 1.5 equiv. of 3a (entry 
3). 
 
Table 2.16: Screening for the best reaction conditions using the sulfamidate imine 3a.a 
 
Entry 3a:4i (equiv.) DABCO (equiv.) Yield (%)b ee (%)c 
1 1:1.5 3 n.d.d n.d.d 
2 1:1.5 5 38 98 
3e 1.5:1 5 46 98 
4e 2:1 5 44 98 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 3a. b Isolated 
product yield after flash column chromatography. c Enantiomeric excesses determined by 
HPLC analysis on chiral stationary phase of the compound 12a. d Not determined. e The 
reaction was performed in 0.15 mmol scale of 4i. 
With the conditions shown in the entry 3 of the Table 2.16, we surveyed 
different β-aryl substituted enals using the substrate 3a (Table 2.17). The reaction 
proceeded in low to moderate yields and excellent stereocontrol regardless of the 
electronic nature of the aromatic ring (entries 2-3). In contrast, the reaction failed 
when β-alkyl substituted enals, such as (E)-crotonaldehyde or (E)-hex-2-enal, were 
used. 
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Table 2.17: Scope of the reaction using sulfamidate imine 3a and β-aryl substituted enals.a 
 
Entry R (4) 12 Yield (%)b ee (%)c 
1 Ph (4i) 12a 46 98 
2 4-MeOC6H4 (4l) 12b 34 96 
3 4-BrC6H4 (4p) 12c 38 96 
a The reaction was performed in 0.30 mL of DCE and 0.15 mmol scale of 4, using 1.5 
equiv. of 3a. b Isolated product yield after flash column chromatography. c Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 12. 
Finally, we were also able to determine the absolute configuration of the 
product 8e by single crystal X-ray analysis (Figure 2.11), showing a 
1S,2S,3S,5S,6R configuration at the five formed stereocenters. The stereostructure 
of all other compounds 8 and 12 was stablished based on mechanistic analogy. 
 
Figure 2.11 
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At this stage, we decided to prepare a new α,β-unsaturated sulfamidate 
imine without any substituent in α-position of the alkenyl moiety (Scheme 2.45). 
In this sense, α-hydroxy ketone 14 was firstly synthetized, in 34% yield, starting 
from commercially available (E)-4-phenylbut-3-en-2-one 13 following the 
previously used procedure.52 Finally, the desired sulfamidate imine 15 was 
prepared in 57% yield from the corresponding compound 14, through the 
previously employed methodology.48c 
 
Scheme 2.45 
Having prepared the compound 15, we initially tried to form the 
Michael/Michael cascade product, using the reaction conditions shown in the 
entry 1 of the Table 2.8, with (E)-cynnamaldehyde 4i, 20 mol% of catalyst 5a and 
DABCO, in dry CHCl3 at -30 ºC. After 2 days, low conversion was observed, but 
surprisingly, the bicyclic compound was found to be the major product, observing 
also the formation of the Michael/Michael cascade product. At room temperature, 
full conversion was achieved, isolating the bicycle 16a in 48% yield and as a 
single diastereoisomer in 99% ee (Scheme 2.46). The configuration of the 
stereocenters were confirmed by NMR experiments, matching with the 
configuration of bicycles 8 and tricycles 12, due to the presence of n.O.e. between 
H6 and the protons of the aromatic ring at C-2, and between the proton of the 
aldehyde and the protons of the phenyl group at C-6. 
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Scheme 2.46 
It should be pointed out that the double Michael product was only observed 
as minor product. Trying higher temperatures, better results were not achieved. 
We could satisfactorily extend the reaction to other enals with electron-donating 
groups in the aromatic ring (Scheme 2.47). 
 
Scheme 2.47 
In summary, different diastereoisomers of the bicycle[3.1.0]hexane 
derivative can be prepared through two different approaches, as it can be observed 
in Scheme 2.48. 
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Scheme 2.48 
In the transannular nucleophilic substitution/imine hydrolysis cascade 
reaction of double Michael cycloadducts 7, the configuration of obtained bicyclic 
compounds 11 match with the configuration of the starting reagent, only observing 
the epimerization of the stereocenter at the C-3 carbon, due to the presence of an 
acidic proton. However, in the Michael/Michael/transannular nucleophilic 
substitution/imine hydrolysis cascade sequence, the configuration of the 
stereocenter at the C-2 carbon is the opposite compared with the double Michael 
product 7. In this case, this position does not present an acidic proton, so the 
reaction has to take place through another mechanistic pathway compared with the 
previously developed Michael/Michael cascade reaction. In this sense, we propose 
the mechanism shown in Scheme 2.49 as the most plausible one. 
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Scheme 2.49 
Initially, after the iminium ion formation by condensation between the enal 
and the catalyst, the first Michael addition takes place between the activated 
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nucleophile and the iminium ion through its less hindered face, generating the 
corresponding enamine. Then, an intramolecular Michael addition takes place, 
towards the formation of the most stable intermediate I, which can evolve to the 
double Michael cycloadduct 7 after the hydrolysis of the catalyst. This 
intermediate is in equilibrium with the intermediate II, through a retro-Michael 
reaction. Depending on the reaction conditions and on the substituents of the 
sulfamidate imine 3, the formation of the intermediate II is favoured. This last one 
is able to evolve to the corresponding enamine, which can attack intramolecularly 
to the sulfonate group position through a transannular SN2-type reaction that after 
the hydrolysis of both imines, the catalyst is recovered and the desired 
cyclopropane is obtained. At this point, it should be highlighted that further 
experiments and computacional studies are needed, in order to confirm our 
mechanistic proposal. 
Having shown the usefulness of this methodology in the preparation of a set 
of interesting bicyclic and tricyclic compounds containing a fused cyclopropane 
moiety, we proceeded to evaluate the synthetic possibilities of these cycloadducts. 
In this way, we initially tried the selective reduction of the formyl group of 
compound 8a, using a mild reducing agent, such as sodium triacetoxyborohydride, 
observing low conversion and a mixture of mono- and direduced compounds. For 
this reason, we decided to reduce both carbonyl groups of compounds 8a and 8p 
as selected examples, employing sodium borohydride as a reducing agent, in 
MeOH at 0 ºC, isolating diols 17a and 17p in excellent yields and as single 
diastereoisomers, as checked by 1H-NMR analysis. It should be highlighted that 
the product 17p was recrystallized, determining the configuration of the generated 
new stereocenter by single crystal X-ray analysis (Scheme 2.50). 
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Scheme 2.50 
Next, we tried to carry out the reduction of the diastereoisomer 11a 
obtained by cyclization of adduct 7a, and using the same conditions than in the 
previous case, obtaining a 1:1 mixture of the two possible diastereoisomers. 
Fortunately, when L-selectride was used as a more sterically hindered reductant at 
low temperature, only one diastereoisomer was obtained (Scheme 2.51). The 
configuration of the generated stereocenter in the diol 18 was determined by 
NOESY experiments, observing n.O.e. between H2 and H6 and no n.O.e. between 
H2 and the protons of the methyl group, indicating that the hydroxy group was on 
the opposite site, comparing with the diol obtained from the other diastereoisomer 
8a. 
 
Scheme 2.51 
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4. CONCLUSIONS 
Considering all the results presented in this chapter, some conclusions are 
drawn: 
1. A novel aminocatalytic enantioselective Michael/Michael cascade reaction, 
promoted by DABCO and (S)-diphenylprolinol trimethylsilyl ether, has been 
developed using several 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides and enals 
following the iminium/enamine manifold, being able to prepare a series of chiral 
trans-decalines derivatives and polysubstituted cyclohexanes in good yields and 
excellent stereoselectivities. Furthermore, this reaction allows the use of enals and 
sulfamidate imines with both aliphatic and aromatic substituents in different 
positions. 
2. The 5H-1,2,3-oxathiazole 2,2-dioxide moiety could be employed as a 
masked β-amino alcohol, which can be prepared from the obtained double Michael 
products through a simple diastereoselective reduction/hydrolysis sequence. 
3. It can be accessed to bicycle[3.1.0]hexane scaffolds in very good yields and 
diastereoselectivities from the corresponding Michael/Michael cycloadducts 
through a transannular nucleophilic substitution/imine hydrolysis sequence, 
demonstrating the usefulness of the cyclic sulfamidate imine moiety 
4. Finally, the synthetic ability of the α,β-unsaturated cyclic sulfamidate 
imines have been demonstrated through an organocatalytic multiple cascade 
reaction, consisting on a Michael/Michael/transannular nucleophilic 
substitution/imine hydrolysis sequence, towards the synthesis of enantioenriched 
bicyclic and tricyclic compounds in moderate yields and obtaining a different 
138 Chapter 2 
 
diastereoisomer that in the previous case. It should be noted that different 
substitution patterns are admitted, with the limitation of β-alkyl substituted enals, 
with which no reaction was observed. 
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1. INTRODUCTION: ORGANOCATALYTIC ASYMMETRIC 
SYNTHESIS OF PYRROLIDINE DERIVATIVES 
Nitrogen-containing structural moieties are widely present in nature 
including, among others, chiral five-membered heterocycles. Specifically, the 
pyrrolidine framework and derivatives, like for example prolines, are part of many 
natural and synthetic compounds with interesting biological and pharmaceutical 
activities.1 Moreover, they can be employed as building blocks, ligands or 
organocatalysts.2 For these reasons, during the last decade, many strategies have 
been reported towards the asymmetric synthesis of stereodefined pyrrolidine 
derivatives. Among the various synthetic approaches, organocatalysis has been 
postulated as a powerful tool in this field during the last years.3 In this sense, 
within the different organocatalytic methodologies for the synthesis of chiral 
pyrrolidine derivatives, we will focus on three main strategies based on the type of 
disconnection, relying on the construction of the heterocyclic architecture through 
a ring closure process (Figure 3.1). 
                                                     
1 For selected reviews, see: a) Nair, V.; Suja, T. D. Tetrahedron 2007, 63, 12247; b) Hanessian, S. 
ChemMedChem 2006, 1, 1300; c) Pyne, S. G.; Tang, M.-Y. Curr. Org. Chem. 2005, 9, 1393; d) 
Liddell, J. R. Nat. Prod. Rep. 2002, 19, 773; e) Pearson, W. H. Studies in Natural Product 
Chemistry (Ed.: Atta-ur-Rahman), Elsevier, Vol. 1, p. 323, New York, 1998; f) Sardina, F. J.; 
Rapoport, H. Chem. Rev. 1996, 96, 1825. 
2 For selected reviews, see: a) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 
107, 5471; b) Erkkilä, A.; Majander, I.; Pihko, P. M. Chem. Rev. 2007, 107, 5416; c) Asymmetric 
Organocatalysis (Eds.: Berkessel, A.; Gröger, H.), Wiley-VCH, Weinheim, 2005; d) Seayad, J.; 
List, B. Org. Biomol. Chem. 2005, 3, 719; e) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 
43, 5138; f) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2001, 40, 3726; g) Fache, F.; Schulz, 
E.; Tommasino, M. L.; Lemaire, M. Chem. Rev. 2000, 100, 2159. 
3 For recent reviews, see: a) Randjelovic, J.; Simic, M.; Tasic, G.; Husinec, S.; Savic, V. Curr. Org. 
Chem. 2014, 18, 1073; b) Kumar, I. RSC Adv. 2014, 4, 16397; c) Han, M.-Y.; Jia, J.-Y.; Wang, W. 
Tetrahedron Lett. 2014, 55, 784; d) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 2011, 44, 1156. 
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Figure 3.1 
In this context, the most studied are those involving a double C-C bond 
disconnection, through a typical 1,3-dipolar cycloaddition, and a consecutive C-C 
and C-N bond disconnection or vice versa, in one-pot fashion. 
1.1. Double C-C bond disconnection strategy 
The construction of the pyrrolidine scaffold, following a double C-C bond 
disconnection strategy, has been widely investigated through the [3+2] 
cycloaddition with azomethine ylides as 1,3-dipoles (Scheme 3.1), as it can be 
appreciated in the large number of publications.4 Within the different activation 
modes of the organocatalysis, the 1,3-dipolar cycloadditions will be classified in 
two main groups, the aminocatalytic reactions and hydrogen bonding activated 
reactions. 
                                                     
4 For some reviews, see: a) Narayan, R.; Potowsky, M.; Jia, Z.-J.; Antonchick A. P.; Waldmann, H. 
Acc. Chem. Res. 2014, 47, 1296; b) Nájera, C.; Sansano, J. M. J. Organomet. Chem. 2014, 771, 78; 
c) Adrio, J.; Carretero, J. C. Chem. Commun. 2011, 47, 6784; d) Garner, P.; Kaniskan, H. U. Curr. 
Org. Synth. 2010, 7, 348; e) Nájera, C.; Sansano, J. M.; Yus, M. J. Braz. Chem. Soc. 2010, 21, 
377; f) Nájera, C.; Sansano, J. M. Top. Heterocycl. Chem. 2008, 12, 117; g) Nájera, C.; Sansano, J. 
M. Angew. Chem. Int. Ed. 2005, 44, 6272. 
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Scheme 3.1 
Within the aminocatalytic 1,3-dipolar cycloadditions, the first example was 
reported in 2007, by our group,5 employing diphenylprolinol as the optimal 
catalyst. Several chiral pyrrolidines were obtained in high yields and excellent 
stereocontrol, by reaction between in situ generated azomethine ylides, through a 
1,2-prototropy process of imines derived from aminomalonates, and α,β-
unsaturated aldehydes activated by iminium ion formation (see Scheme 3.2). After 
DFT calculations it was concluded that the reaction consisted on an initial Michael 
addition of the dipole to the preactivated enal, as the rate determining step, 
followed by intramolecular Mannich reaction of the subsequent enamine, thus 
discarding the concerted pathway.6 
                                                     
5 Vicario, J. L.; Reboredo, S.; Badía, D.; Carrillo, L. Angew. Chem. Int. Ed. 2007, 46, 5168. 
6 Reboredo, S.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.; de Cózar, A.; Cossío, F. P. Chem. 
Eur. J. 2012, 18, 7179. 
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Scheme 3.2 
The obtained adducts were satisfactorily transformed into N-containing 
bicyclic and tricyclic compounds,7 and the reaction was carried out in a 
multicomponent version, without the preformation of the imine.8 Additionally, the 
reaction was extended to the use of azomethine ylides with two different electron-
withdrawing groups, imino cyanoacetates, controlling the 2,5-diastereoselectivity 
through the formation of an intramolecular hydrogen bond between the protonated 
imine and the ethoxycarbonyl group. As a result, pyrrolidine derivatives were 
obtained with up to four stereogenic centers, including a quaternary one, in good 
yields and excellent stereoselectivities.9 Related with this topic, in the same year, 
                                                     
7 a) Iza, A.; Ugarriza, I.; Uria, U.; Reyes, E.; Carrillo, L.; Vicario, J. L. Tetrahedron 2013, 69, 8878; 
b) Iza, A.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E.; Martínez, J. I. Org. Biomol. Chem. 
2010, 8, 2238. 
8 Reboredo, S.; Vicario, J. L.; Carrillo, L.; Reyes, E.; Uria, U. Synthesis 2013, 45, 2669. 
9 Reboredo, S.; Vicario, J. L.; Badía, D.; Carrillo, L.; Reyes, E. Adv. Synth. Catal. 2011, 353, 3307. 
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Córdova and co-workers developed a diastereo- and enantioselective dynamic 
multicomponent transformation between enals, aldehydes and protected α-
cyanoglycine esters. The stereochemical outcome was successfully controlled by 
the cooperative combination of hydrogen bonds and iminium activation, using O-
protected diphenyl prolinol as catalyst and methyl oximinocyanoacetate as a 
hydrogen-bond-donating cocatalyst (Scheme 3.3).10 
 
Scheme 3.3 
It should be noted that our group also developed this reaction with acrolein 
as substrate providing C-3 unsubstituted pyrrolidines as single diastereoisomers, 
with good enantioselection, employing in this case L-proline as catalyst.11 
Moreover, 1,3-dipolar cycloaddition using stable azomethine ylides, such as 
isoquinolinium and phthalizinium methylides, was also studied obtaining 
                                                     
10 Lin, S.; Deiana, L.; Zhao, G.-L.; Sun, J.; Córdova, A. Angew. Chem. Int. Ed. 2011, 50, 7624. 
11 Ugarriza, I.; Uria, U.; Reyes, E.; Carrillo, L.; Vicario, J. L. Asymm. Catal. 2015, 2, 26. 
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polysubstituted chiral pyrroloisoquinolines and pyrrolophthalazines in high yields 
and good enantiocontrol (Scheme 3.4).12 
 
Scheme 3.4 
Recently, aminocatalysis has been applied in the asymmetric synthesis of 
CF3-containing spiro[pyrrolidin-3,2’-oxindoles], employing enals and 
unprecedented 1,3-dipoles, which were obtained by the condensation of 
trifluoroethylamine and isatins.13 Under the optimal conditions, with low catalyst 
loading, a serie of spirooxindoles, including unprotected spirooxindoles, were 
prepared in excellent yields, diastereo- and enantioselectivities (Scheme 3.5). 
                                                     
12  Fernández, N.; Carrillo, L.; Vicario, J. L.; Badía, D.; Reyes, E. Chem. Commun. 2011, 47, 12313. 
13 Ma, M.; Zhu, Y.; Sun, Q.; Li, X.; Su, J.; Zhao, L.; Zhao, Y.; Qiu, S.; Yan, W.; Wang, K.; Wang, 
R. Chem. Commun. 2015, 51, 8789. 
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Scheme 3.5 
In spite of the progress of aminocatalytic formal 1,3-dipolar cycloaddition, 
dipolarophiles are limited to enals. For this reason, a significant advance has been 
observed during the last years regarding the development of hydrogen bond 
catalysis in this reaction. In 2008, Gong and co-workers developed a Brønsted acid 
catalyzed, three-component, asymmetric 1,3-dipolar cycloaddition, by reaction 
between aldehydes, aminomalonates and several maleates as dipolarophiles, 
affording the corresponding pyrrolidines in high yields and excellent 
enantioselectivities (Scheme 3.6).14 With this work, the concept of the formation 
of chiral Brønsted acid bonded dipole able to participate in new asymmetric 1,3-
dipolar cycloaddition was established. 
                                                     
14 Chen, X.-H.; Zhang, W.-Q.; Gong, L.-Z. J. Am. Chem. Soc. 2008, 130, 5652. 
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Scheme 3.6 
One year later, Gong et al. extended successfully the three-component 1,3-
dipolar cycloaddition to methyleneindolinones as dipolarophiles, using the same 
type of dipoles and a phosphoric acid as catalyst, towards the synthesis of 
spiro[pyrrolidin-3,3’-oxindole] derivatives with an unusual regioselectivity and 
excellent stereoselectivities.15 Moreover, this type of architecture is presented in 
many biologically relevant molecules, increasing the interest of the proyect. In this 
case, relying on theoretical calculations, it can be concluded that both the 
methyleneindolinone and the azomethine ylide are hydrogen bonded with the 
chiral acid, providing the excellent stereocontrol and regioselectivity. The unusual 
                                                     
15 Chen, X.-H.; Wei, Q.; Luo, S.-W.; Xiao, H.; Gong, L.-Z. J. Am. Chem. Soc. 2009, 131, 13819. 
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observed regioselectivity is not directed by electronic effect but it is presumably 
controlled by the stabilization stemming from the favourable π-π stacking 
interaction between the conjugate esters and the oxindole ring. With these 
precedents, the [3+2] cycloaddition was satisfactorily extended by the same group 
employing the same type of azomethine ylides and changing the nature of 
dipolarophile, trying with quinone derivatives,16 methyl 2-(2-
nitrophenyl)acrylates,17 fumarates and vinyl ketones and esters.18 
In 2010, the first asymmetric intramolecular 1,3-dipolar cycloaddition was 
developed catalyzed by BINOL-derived phosphoric acid, by reaction between 
aldehydes that incorporated dipolarophile functionalities, and α-aryl amino esters. 
After the formation of the imine and the subsequent dipole, the intramolecular 
cycloaddition is occurred, obtaining the corresponding chromeno[4,3-
b]pyrrolidine derivatives with very good results (Scheme 3.7).19 
                                                     
16  Wang, C.; Chen, X.-H.; Zhou, S.-M.; Gong, L.-Z. Chem. Commun. 2010, 46, 1275. 
17  Cheng, M.-N.; Wang, H.; Gong, L.-Z. Org. Lett. 2011, 13, 2418. 
18 He, L.; Chen, X.-H.; Wang, D.-N.; Luo, S.-W.; Zhang, W.-Q.; Yu, J.; Ren, L.; Gong, L.-Z. J. Am. 
Chem. Soc. 2011, 133, 13504. 
19 a) Li, N.; Song, J.; Tu, X.-F.; Liu, B.; Chen, X.-H.; Gong, L.-Z. Org. Biomol. Chem. 2010, 8, 
2016; for a recent example of the synthesis of chromeno[4,3-b]pyrrolidine derivatives through a 
[3+2] cycloaddition/intramolecular transesterification sequence, see: b) Tian, L.; Xu, G.-Q.; Li, 
Y.-H.; Liang, Y.-M.; Xu, P.-F. Chem. Commun. 2014, 50, 2428. 
152 Chapter 3 
 
 
Scheme 3.7 
Azomethine ylides are usually generated from the corresponding aldehydes, 
and rarely ketones have been used as the precursors of this type of 1,3-dipoles. In 
this sense, the same group employed for the first time azomethine ylides derived 
from the condensation between unsymmetrical cyclic ketones, such as isatin 
derivatives, with aminomalonates towards the obtention of spiro[pyrrolidin-3,2’-
oxindoles], using maleates as dipolarophiles under chiral phosphoric acid catalysis 
(shown on Scheme 3.8).20 More recently, different azomethine ylides derived from 
isatin derivatives have also been successfully used with other dipolarophiles, such 
as nitroalkenes,21 maleimides22 and methyleneindolinones.23 With the last one, 
3,3’-pyrrolidinyldispirooxindoles containing two contiguous quaternary 
stereogenic centers were obtained in high yields and stereoselectivities. 
                                                     
20  Shi, F.; Tao, Z.-L.; Luo, S.-W.; Tu, S.-J.; Gong, L.-Z. Chem. Eur. J. 2012, 18, 6885. 
21 a) Sun, Q.; Li, X.; Su, J.; Zhao, L.; Ma, M.; Zhu, Y.; Zhao, Y.; Zhu, R.; Yan, W.; Wang, K.; 
Wang, R. Adv. Synth. Catal. 2015, 357, 3187; b) Tian, L.; Hu, X.-Q.; Li, Y.-H.; Xu, P.-F. Chem. 
Commun. 2013, 49, 7213. 
22 Zhao, H.-W.; Yang, Z.; Meng, W.; Tian, T.; Li, B.; Song, X.-Q.; Chen, X.-Q.; Pang, H.-L. Adv. 
Synth. Catal. 2015, 357, 2492. 
23  Dai, W.; Jiang, X.-L.; Wu, Q.; Shi, F.; Tu, S.-J. J. Org. Chem. 2015, 80, 5737. 
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Scheme 3.8 
On the other hand, Zhang and co-workers described the first asymmetric 
[3+2] cycloaddition of azomethine ylides with nitroalkenes, employing in this case 
a bifunctional thiourea as hydrogen-bonding catalyst. Under the optimal 
conditions, pyrrolidines were obtained with high diastereoselectivities but with 
low to moderate enantiocontrol (Scheme 3.9).24 
                                                     
24 Xue, M.-X.; Zhang, X.-M.; Gong, L.-Z. Synlett 2008, 691. 
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Scheme 3.9 
Isocyanoesters can also be used as 1,3-dipoles in the organocatalyzed [3+2] 
cycloaddition reactions conducing to pyrrolines as initially developed by Gong et 
al. using cinchona alkaloid-derived chiral base as catalyst to form 2,3-
dihydropyrroles with excellent results (Scheme 3.10).25 It should be noted that the 
hydroxy group present in the quinoline moiety of the catalyst acts as hydrogen-
bond donor increasing the stereoselectivity of the process. 
                                                     
25 Guo, C.; Xue, M.-X.; Zhu, M.-K.; Gong, L.-Z. Angew. Chem. Int. Ed. 2008, 47, 3414. 
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Scheme 3.10 
Latter, Wang and co-workers described the use of isocyanoesters with 
methyleneindolinones in a quinine-based bifunctional thiourea catalyzed [3+2] 
reaction, towards the obtention of 3,3’-pyrrolidinyl spirooxindoles in high 
enantiocontrol, after the corresponding reduction of the resulting imine (Scheme 
3.11).26 The diastereoselectivity could be controlled by simply changing the N-
protecting group. With a stereodirecting group at this position, the anti 
diastereoisomer was obtained as the mayor product, while the syn diastereiosomer 
appeared as the predominant product when a group without any directing element 
was used. A similar approach was developed by Yan and co-workers, employing 
the same type of isocyanoacetates, but in this case, isatylidene malononitrile 
derivatives were used as dipolarophiles, observing different regioselectivity than 
in the previous case, due to the high electron-attractor character of nitriles.27 
                                                     
26 Wang, L.-L.; Bai, J.-F.; Peng, L.; Qi, L.-W.; Jia, L.-N.; Guo, Y.-L.; Luo, X.-Y.; Xu, X.-Y.; Wang, 
L.-X. Chem. Commun. 2012, 48, 5175. 
27  Wei, W.-T.; Chen, C.-X.; Lu, R.-J.; Wang, J.-J.; Zhang, X.-J.; Yan, M. Org. Biomol. Chem. 2012, 
10, 5245. 
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Scheme 3.11 
Finally, there are also several examples, in which α-isothiocyanato imides 
are used as 1,3-dipoles in organocatalytic [3+2] cycloaddition. The groups of 
Wang and Barbas III, respectively, reported the asymmetric [3+2] reaction 
between this type of imides and methyleneindolinones, employing in both cases 
bifunctional organocatalysts.28 The work of Wang et al. is shown on Scheme 3.12, 
in which a series of 3,3’-thiopyrrolidonyl spirooxindoles were obtained in 
excellent yields, diastereo- and enantioselectivities. Moreover, these compounds 
were easily transformable into the corresponding 3,3’-pyrrolidinyl spirooxindoles, 
without any loss of stereoselectivity. Recently, similar reports have been published 
                                                     
28  a) Tan, B.; Zeng, X.; Leong, W. W. Y.; Shi, Z.; Barbas III, C. F.; Zhong, G. Chem. Eur. J. 2012, 
18, 63; b) Cao, Y.; Jiang, X.; Liu, L.; Shen, F.; Zhang, F.; Wang, R. Angew. Chem. Int. Ed. 2011, 
50, 9124. 
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employing 3-isothiocyanato oxindoles as dienophiles and different electron-poor 
olefins as dipolarophiles.29 
 
Scheme 3.12 
In 2013, Gong and co-workers, based on the enzyme-catalyzed 
transamination reactions occurring in nature, developed the first asymmetric 
biomimetic multi-component 1,3-dipolar cycloaddition of benzylamine derivatives 
and α-keto esters with several electron-deficient olefins (Scheme 3.13).30 The 
azomethine ylide was generated in situ, under phosphoric acid activation, from a 
1,3-proton shift reaction of the ketimine formed from the corresponding α-keto 
ester and amine. Under the optimal conditions, with bisphosphoric acid as catalyst, 
diverse polysubstituted pyrrolidines were obtained in high yields and 
stereoselectivities. 
                                                     
29 a) Kayal, S.; Mukherjee, S. Eur. J. Org. Chem. 2014, 6696; b) Wu, H.; Zhang, L.-L.; Tian, Z.-Q.; 
Huang, Y.-D.; Wang, Y.-M. Chem. Eur. J. 2013, 19, 1747; c) Liu, X.-L.; Han, W.-Y.; Zhang, X.-
M.; Yuan, W.-C. Org. Lett. 2013, 15, 1246. 
30  Guo, C.; Song, J.; Gong, L.-Z. Org. Lett. 2013, 15, 2676. 
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Scheme 3.13 
1.2. Consecutive C-N and C-C bond disconnection strategy 
Within the double disconnection strategies to achieve the pyrrolidine 
moiety, there are several organocatalytic examples based on the simultaneous C-N 
and C-C bond disconnection pathway. In general, this strategy involves an initial 
aza-Michael reaction with activated alkenes followed by the C-C bond formation 
through a ring closure process. In this sense, the first organocatalytic aza-
Michael/Michael cascade reaction towards the synthesis of chiral pyrrolidines was 
accomplished by Wang and co-workers,31 in the reaction between α,β-unsaturated 
aldehydes and N-protected 4-amino-2-butenoates. Aminocatalysis was used to 
activate the enal through the iminium/enamine manifold. In this case, the 
possibility of an undesired intramolecular lactamization was prevented with the 
trans geometry of the N-protected ethyl 4-amino-2-butenoate. As a result, several 
enantioenriched pyrrolidines were prepared in excellent yields using (S)-α,α-
diphenylprolinol trimethylsilyl ether as catalyst, and in the presence of 
stoichiometric amounts of sodium acetate as Brønsted base (Scheme 3.14). In 
                                                     
31 Li, H.; Zu, L.; Xie, H.; Wang, J.; Wang, W. Chem. Commun. 2008, 5636. 
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related reports, nitroalkenes activated by hydrogen bond catalysis have been 
used.32 
 
Scheme 3.14 
Following a different strategy, Cho and co-workers have developed an 
aminocatalytic aza-Michael/aldol cascade reaction towards the obtention of chiral 
polysubstituted pyrrolizines in good yields and excellent stereoselectivities. This 
approach involved the use of 2-acylpyrroles as pronucleophiles and enals or 
enones as Michael acceptors, reacting through the iminium/enamine manifold 
(Scheme 3.15).33 
                                                     
32 a) Zhao, B.-L.; Lin, Y.; Yan, H.-H.; Du, D.-M. Org. Biomol. Chem. 2015, 13, 11351; b) Noole, 
A.; Pehk, T.; Järving, I.; Lopp, M.; Kanger, T. Tetrahedron: Asymmetry 2012, 23, 188. 
33 a) Lee, H.-J.; Cho, C.-W. Eur. J. Org. Chem. 2014, 387; b) Lee, H.-J.; Cho, C.-W. J. Org. Chem. 
2013, 78, 3306; c) Bae, J.-Y.; Lee, H.-J.; Youn, S.-H.; Kwon, S.-H.; Cho, C.-W. Org. Lett. 2010, 
12, 4352. 
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Scheme 3.15 
Recently, using the same methodology, Enders and co-workers have 
developed an O-TMS diphenylprolinol catalyzed aza-Michael/aldol cascade 
reaction between α-ketoamides and enals, followed by Wittig reaction in a one-pot 
fashion. Based on the iminium/enamine sequence, a variety of substituted 
pyrrolidin-2-ones were prepared in good to excellent enantioselectivities and as 
single diastereoisomers (Scheme 3.16).34 
                                                     
34 Joie, C.; Deckers, K.; Enders, D. Synthesis 2014, 46, 799. 
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Scheme 3.16 
To finish with the approaches involving the consecutive C-N and C-C bond 
formation strategy, there is another interesting example, in which Moreau et al. 
were able to convert α,α-disubstituted aldehydes into 2,2-disubstituted-3-
pyrrolines through a primary amine-catalyzed α-amination/aza-Michael/aldol 
condensation proceeding in a one-pot sequence (see Scheme 3.17).35 In this 
process, the aldehyde underwent an initial α-amination with di-tert-
butylazodicarboxylate catalyzed by a primary amine and TFA as cocatalyst. Under 
these acidic conditions, the selective N-Boc cleavage occurred, followed by 
organocatalyzed aza-Michael/aldol condensation sequence with an acroleine that 
was added afterwards to the reaction mixture. 
                                                     
35 Desmarchelier, A.; Coeffard, V.; Moreau, X.; Greck, C. Chem. Eur. J. 2012, 18, 13222. 
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Scheme 3.17 
1.3. Consecutive C-C and C-N bond disconnection strategy 
The formation of pyrrolidine derivatives through the initial formation of a 
C-C bond followed by C-N bond formation has been less explored.3b In the last 
years, several organocatalytic examples have been reported, which can be 
classified as cascade processes initiated by Mannich-type reaction. Most of these 
cases are based on a formal [3+2] cycloaddition between 1,3-carbon dipole 
precursors with imines as dipolarophiles. In general, this approach has been less 
considered due to the difficulty to find a suitable way for the in situ generation of 
a suitable carbon-based 1,3-donor-acceptor system and the low reactivity of imines 
in nucleophilic additions, being necessary its activation, for example, by 
introducing a strong electron-withdrawing group on the nitrogen atom, in order to 
increase its electrophilicity. Apart from this, there are more organocatalytic 
examples within this disconnection strategy that consist on the use of double 
donor and double acceptor compounds towards the obtention of the pyrrolidine 
framework. 
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Scheme 3.18 shows the example of Jacobsen and co-workers, who 
developed the synthesis of chiral substituted 2-aryl-2,5-dihydropyrroles via 
phosphinothiourea catalyzed [3+2] cycloaddition between electron-poor allenes 
and N-diphenylphosphinoyl (DPP) imine. Under the optimal conditions, excellent 
enantioselectivities were obtained for a variety of (hetero)aryl imines.36 The 
reaction consisted on the initial attack of the phosphine catalyst to the allene, 
forming a stable carbanion that underwent addition to the imine. In this step the 
thiourea was proposed to remind bounded to the imine by coordination with the 
carbonyl group of the phosphinoyl moiety, thus controlling the stereoselectivity. 
Then, the amide moiety was proposed to react intramolecularly to the remaining 
vinylphosphonium salt that, after protonation and formation of 
hydroxyphosphorane followed by base-promoted elimination, delivered the 
corresponding 2,5-dihydropyrroles. 
 
Scheme 3.18 
                                                     
36 Fang, Y.-Q.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 5660. 
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Based on hydrogen bond catalysis, Enders and co-workers described in 
2010 the first Mannich/aza-Michael cascade reaction employing a chiral 
bifunctional thiourea as catalyst.37 The reaction between N-Boc-protected aryl 
aldimines and γ-malonate-substituted α,β-unsaturated esters afforded the desired 
trisubstituted pyrrolidines in good to excellent yields and enantioselectivities (see 
Scheme 3.19). Recently, the same group applied a similar methodology, consisting 
on a Mannich/N-deprotection/aza-Michael sequence, towards the synthesis of 3,3’-
pyrrolidinyl-dispirooxindoles, with two vicinal spiro-stereocenters, in good yields 
and excellent stereoselectivities by reacting N-Boc-protected isatin-derived 
ketimines and 3-substituted oxindole containing an α,β-unsaturated ester moiety, 
as donor-Michael acceptor.38 
 
Scheme 3.19 
Similarly, Huang and co-workers developed an aza-Henry/aza-Michael 
cascade reaction, employing N-tosyl-protected aldimines and 5-nitropent-2-enoates 
as donor-acceptor system, under bifunctional catalysis using a Cinchona alkaloid-
                                                     
37 Enders, D.; Göddertz, D. P.; Beceño, C.; Raabe, G. Adv. Synth. Catal. 2010, 352, 2863. 
38 Zhao, K.; Zhi, Y.; Puttreddy, R.; Rissanen, K.; Enders, D. Chem. Commun. 2016, 52, 2249. 
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derived carbamate organocatalyst.39 The reaction began with an organocatalytic 
reversible aza-Henry reaction, followed by dynamic kinetic resolution (DKR)-
driven aza-Michael cyclization, affording 2,3,5-trisubstituted pyrrolidines in good 
yields and high enantio- and diastereoselectivities (Scheme 3.20). 
 
Scheme 3.20 
There is another interesting example that also uses a hydrogen bonding 
catalyst, in which Schneider et al. developed a highly enantioselective vinylogous 
Mukaiyama-Mannich reaction followed by lactamization to the formation of γ-
lactams in one-pot fashion. Moreover, they transformed the obtained lactams into 
the corresponding pyrrolidines in very good yields (Scheme 3.21).40 
                                                     
39 Cheng, T.; Meng, S.; Huang, Y. Org. Lett. 2013, 15, 1958. 
40 Abels, F.; Lindemann, C.; Schneider, C. Chem. Eur. J. 2014, 20, 1964. 
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Scheme 3.21 
Based on aminocatalysis, Kumar and co-workers developed an asymmetric 
Mannich/cyclization cascade reaction catalized by L-proline for the obtention of 
2,3-disubstituted pyrrolidines in good yields and excellent stereoselectivities. The 
reaction consisted on the initial enamine activation of succinaldehyde, followed by 
Mannich reaction with N-PMP protected aldimines and hemiaminalization. This 
cascade process was followed by reductive amination and simultaneous aldehyde 
reduction, resulting in the formal [3+2] cycloaddition in a one-pot sequence 
(Scheme 3.22).41 
                                                     
41 Kumar, I.; Mir, N. A.; Gupta, V. K.; Rajnikant Chem. Commun. 2012, 48, 6975. 
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Scheme 3.22 
In 2013, De Paolis et al. reported another example based on enamine 
activation, consisting on a one-pot Mannich/Wittig olefination/hydroamination 
sequence for the synthesis of polysubstituted pyrrolidines with excellent results 
regarding the stereoselectivity.42 The reaction started with the Mannich reaction 
between N-heteroarylalkyne aldehyde and N-protected aldimine catalyzed by a 
chiral secondary amine, followed by the Wittig olefination of the aldehyde adduct, 
to finish with the 5-exo-dig hydroamination of the alkyne, promoted by Brønsted 
acid (Scheme 3.23). 
                                                     
42 Jean, A.; Blanchet, J.; Rouden, J.; Maddaluno, J.; De Paolis, M. Chem. Commun. 2013, 49, 1651. 
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Scheme 3.23 
On the other hand, there are several works related to the synthesis of 
pyrrolidine derivatives through different approaches that those cascades initiated 
by Mannich reactions. For example, in 2012, Córdova and co-workers developed 
the use of α-cyanoglycine esters in asymmetric Michael/hemiaminal cascade 
reaction towards the synthesis of 5-hydroxyproline derivatives.43 The reaction 
consists on an initial Michael addition to an enal catalyzed by O-TMS 
diphenylprolinol via iminium ion activation, followed by the releasing of the 
catalyst and intramolecular hemiaminal formation to afford the desired pyrrolidine 
derivatives in good yields and stereoselectivities (Scheme 3.24). 
                                                     
43 Breistein, P.; Johansson, J.; Ibrahem, I.; Lin, S.; Deiana, L.; Sun, J.; Córdova, A. Adv. Synth. 
Catal. 2012, 354, 1156. 
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Scheme 3.24 
There are other related aminocatalytic examples, in which 
Michael/hemiaminal cascade methodology is also efficiently used towards the 
obtention of the pyrrolidine moiety.44 For example, MacMillan and co-workers 
developed the enantioselective (3+2) cycloaddition between β-amino aldehydes 
and several olefins towards the synthesis of stereochemically complex N-protected 
pyrrolidines under SOMO-activation (see Scheme 3.25).45 Under the optimal 
conditions, using imidazolidinone catalyst and iron(III)trisphenanthroline as 
oxidant, high yields and good to excellent stereoselectivities were obtained. 
Regarding the mechanism, firstly the catalyst condenses with the β-amino 
aldehyde, forming the corresponding radical enamine, due to the presence of an 
                                                     
44 a) Scorzelli, F.; Di Mola, A.; Croce, G.; Palombi, L.; Massa, A. Tetrahedron Lett. 2015, 56, 2787; 
b) Talavera, G.; Reyes, E.; Vicario, J. L.; Carrillo, L.; Uria, U. Adv. Synth. Catal. 2013, 355, 653. 
45 Jui, N. T.; Garber, J. A. O.; Finelli, F. G.; MacMillan, D. W. C. J. Am. Chem. Soc. 2012, 134, 
11400. 
170 Chapter 3 
 
oxidant. Then, the generated three-π-electron radical cation attacks to the alkene 
furnishing a radical species that after oxidation a cationic intermediate is formed, 
which is vulnerable to the intramolecular nucleophilic addition of the amine. 
 
Scheme 3.25 
Maruoka et al. reported an example of this type of disconnection using the 
phase-transfer catalysis as a stereoinducting methodology.46 The asymmetric 
synthesis of α-substituted proline derivatives through a double alkylation process 
between α-substituted-α-amino acid derivatives and dihaloalkanes employing a 
chiral quaternary ammonium salt as catalyst was explored affording the final 
adducts with very good results (Scheme 3.26). 
                                                     
46 Kano, T.; Sakamoto, R.; Mii, H.; Wang, Y.-G.; Maruoka, K. Tetrahedron 2010, 66, 4900. 
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Scheme 3.26 
Recently, Rios and co-workers developed the asymmetric synthesis of α-
methylene-γ-lactams, employing a chiral Lewis base as a stereoinducting tool. The 
reaction between protected 2-aminomalonates and Morita-Baylis-Hillman 
carbonates afforded the corresponding lactams in good yields and moderate 
enantioselectivities, through the nucleophilic substitution of MBH carbonates by 
aminomalonate, followed by a favoured 5-exo-trig cyclization (Scheme 3.27).47 
                                                     
47 Companyó, X.; Geant, P.-Y.; Mazzanti, A.; Moyano, A.; Rios, R. Tetrahedron, 2014, 70, 75. 
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Scheme 3.27 
Based on the use of N-protected 2-aminomalonates as double donors, Romo 
et al. developed the synthesis of pyrrolidinones through chiral tertiary amine 
catalyzed Michael/proton transfer/lactamization cascade reaction employing α,β-
unsaturated acyl chlorides as substrates (Scheme 3.28). Furthermore, they 
satisfactorily transformed one of these lactams (R1 = H; R2 = 4-ClC6H4) into the 
corresponding pyrrolidine, which is a precursor for the melanocortin-4 receptor 
agonist.48 First, an activated α,β-unsaturated acylammonium species is formed, by 
reaction of the tertiary amine catalyst with the acyl chloride, followed by the 
Michael reaction of the aminomalonate. After the proton transfer, an 
intramolecular lactamization is occurred releasing the tertiary amine catalyst, and 
affording the corresponding lactams in good yields and excellent 
enantioselectivities. 
                                                     
48 Vellalath, S.; Van, K. N.; Romo, D. Angew. Chem. Int. Ed. 2013, 52, 13688. 
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Scheme 3.28 
It should be pointed out that concerning this pyrrolidine synthesis strategy, 
there are more examples using different organocatalytic activations, such as N-
heterocyclic carbene catalysis.49 In the latest example, Wang and co-workers, 
described the enantioselective synthesis of pyrrolidinone derivatives by reacting α-
amino ketones and α,β-unsaturated carboxylic acids. These last ones, after in situ 
formation of the corresponding anhydrides, can be activated by N-heterocyclic 
carbenes through the generation of α,β-unsaturated acyl azolium intermediates. 
The α-amino ketone is able to attack through Michael addition to the previously 
formed intermediate that after proton transfer, the nucleophilic amine is able to 
attack intramolecularly through a lactamization process, regenerating the catalyst 
and affording the final pyrrolidinones in good yields, moderate to good 
diastereoselectivities and excellent enantiocontrol (Scheme 3.29). 
                                                     
49 a) Chen, X.-Y.; Gao, Z.-H.; Song, C.-Y.; Zhang, C.-L.; Wang, Z.-X.; Ye, S. Angew. Chem. Int. 
Ed. 2014, 53, 11611; b) Zhang, B.; Feng, P.; Sun, L.-H.; Cui, Y.; Ye, S.; Jiao, N. Chem. Eur. J. 
2012, 18, 9198. 
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Scheme 3.29 
In summary, it could be highlighted the ability of the organocatalysis 
applied to the asymmetric synthesis of pyrrolidine derivatives, as it can be 
observed in the large number of presented publications, through the mentioned 
strategies. 
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2. SPECIFIC OBJECTIVES AND WORK PLAN 
From the presented literature review in the introduction of this chapter, we 
can conclude that there are plenty of organocatalytic examples regarding the 
synthesis of chiral pyrrolidine derivatives, owing to the great interest of the 
compounds containing the pyrrolidine framework. In spite of this, and as it has 
been observed, within the different disconnection pathways, the simultaneous C-C 
and C-N bond formation strategy, specifically employing double donor and double 
acceptor substrates, are less explored. 
Inspired by the work of Laronze and co-workers,50 in which the 
cyclocondensation reaction of conjugated ketones with diethyl aminomalonate in 
benzene or toluene under reflux was described, using stoichiometric amount of 
anhydrous zinc chloride as Lewis acid, yielding the 3,4-dihydro-2H-pyrroles as a 
racemic mixture (see Scheme 3.30), we envisioned that this reaction can be carried 
out applying the organocatalysis in order to obtain the products in a stereoselective 
manner. 
 
Scheme 3.30 
With this work in mind and taking into account the reviewed literature, we 
planned as a general objective the preparation of chiral polysubstituted proline 
derivatives. For this purpose, we initially proposed that an α,β-unsaturated ketone 
                                                     
50 Itoua, G. B.; Laronze, J.-Y. Synthesis 1987, 353. 
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could be activated via iminium ion formation being able to act as Michael acceptor 
with enhanced electrophilicity, able to react with a dialkyl aminomalonate 
undergoing a Michael addition product that after hydrolysis of the catalyst, the 
primary amine derived from the aminomalonate can condense intramolecularly 
with the resulting ketone, affording the corresponding 1-pyrroline. The reduction 
of the imine moiety would lead to the formation of the target pyrrolidines (see 
Scheme 3.31). Due to the use of an enone as Michael acceptor, we considered the 
employment of a chiral primary amine as catalyst, owing to its known ability to 
activate ketones,51 to render the initial conjugate addition enantioselective. 
 
Scheme 3.31 
Then, the obtained pyrrolidine 2,2-dicarboxylates should be transformed 
into the desired proline derivatives, in order to illustrate their potential 
applications as chiral building blocks, through the recently developed 
intramolecular base-promoted C→N acyl transfer reaction.52 This methodology 
has been satisfactorily employed in our group towards the obtention of N-
protected α-amino acids from N-substituted α-aminomalonates, obtaining very 
good yields in most of the cases (Scheme 3.32). Finally, the N-deprotection of the 
carbamate should allow us to obtain a variety of α-amino acids derivatives. 
                                                     
51 For selected reviews on the use of primary amines as catalysts, see: a) Duan, J.; Li, P. Catal. Sci. 
Technol. 2014, 4, 311; b) Melchiorre, P. Angew. Chem. Int. Ed. 2012, 51, 9748; c) Xu, L.-W.; 
Luo, J.; Lu, Y. Chem. Commun. 2009, 1807; d) Chen, Y.-C. Synlett 2008, 1919; e) Bartoli, G.; 
Melchiorre, P. Synlett 2008, 1759. 
52  Ugarriza, I.; Uria, U.; Carrillo, L.; Vicario, J. L.; Reyes, E. Chem. Eur. J. 2014, 20, 11650. 
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Scheme 3.32 
It should be noted that after the corresponding C→N acyl rearrangement a 
new stereogenic center would be formed, which needs to be controlled by the 
stereoinduction exerted by the substrate (Scheme 3.33). 
 
Scheme 3.33 
Based on the presented objectives, we proposed the following work plan: 
1. Study of the Michael/condensation/reduction process. Initially, we will 
study the possibility of the synthesis of pyrrolidine derivatives using the reaction 
between (E)-4-phenylbut-3-en-2-one and diethyl aminomalonate as model system, 
and in the presence of a chiral primary amine as catalyst. The obtained pyrroline 
will be reduced using standard conditions to afford the desired pyrrolidines. The 
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regioselectivity of the initial Michael reaction should be suitably controlled due to 
the ambident nature of the aminomalonate nucleophile. 
2. Optimization of the reaction conditions. Having demonstrated the 
success of the reaction, we will proceed to survey different experimental variables, 
such as solvent, additive, catalyst and temperature, using the same reaction model, 
in order to carry out the reaction with the optimal yield and stereocontrol (Scheme 
3.34). 
 
Scheme 3.34 
3. Scope of the reaction. With the best conditions in hands, we will 
evaluate various Michael acceptors, studying the effect of different substitution 
patterns on the reactivity and enantioselectivity of the reaction. Furthermore, 
different dialkyl aminomalonates will be tested (Scheme 3.35). 
 
Scheme 3.35 
4. Transformation of the adducts: Synthesis of proline derivatives. 
Finally, we will focus on the application of the intramolecular base-promoted 
C→N acyl transfer reaction into these pyrrolidine 2,2-dicarboxylates, with the 
purpose of obtaining N-protected proline ester derivatives. If the reaction takes 
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place efficiently, the corresponding carbamates will subsequently be deprotected 
in order to achieve the desired unprotected proline esters. 
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3. RESULTS AND DISCUSSION 
Once the different examples found in the literature about the topic have 
been reviewed and commented, and the specific objectives and work plan have 
been established, we will proceed with the presentation and the corresponding 
discussion of the most relevant results obtained on this part of our research. 
3.1. Study of the Michael/condensation/reduction process 
We started our study by evaluating the viability of the reaction. In this 
sense, the reaction between (E)-4-phenylbut-3-en-2-one 19a and diethyl 
aminomalonate 20a, was used as a representative model system in the presence of 
9-epi-9-amino-9-deoxycinchonidine 21a as primary amine catalyst derived from 
Cinchona alkaloids, in THF as solvent and at room temperature. In order to favour 
the formation of the iminium ion, p-toluenesulfonic acid was also added as a 
Brønsted acid cocatalyst in the same ratio than the catalyst. The reaction was 
followed by 1H-NMR, through the observation of several characteristic signals 
related to the formation of the expected cyclic imine, such as the singlet signal 
corresponding to the methyl group of the pyrroline at 2.24 ppm, and obtaining full 
chemical conversion after 180 hours. However, when we tried to purify the 
product by flash column chromatography, only decomposition was observed, due 
to the instability of the imine. For this reason, we proceeded to the reduction of the 
resulting pyrroline in a one-pot fashion, employing NaBH3CN in EtOH as solvent. 
Pyrrolidine 22a was obtained as a single diastereoisomer in excellent yield after 
purification by flash column chromatography (Scheme 3.36). The latter finding 
indicated that the stereogenic center generated after the initial Michael addition 
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step was able to exert an effective asymmetric induction on the reduction of the 
imine group. 
 
Scheme 3.36 
At this point, the relative configuration of the stereogenic centers formed in 
the one-pot process was determined through NOESY experiment. The presence of 
significant n.O.e. was observed between the protons of the aromatic ring and one 
of the two diastereotopic protons at C-4, exclusively, H4a, and between the protons 
of the methyl group and H4a. No n.O.e. was appreciated between H4b and the 
aromatic protons, and between H4b and the methyl protons. This indicated a cis 
relative configuration of substituents at C-3 and C-5 (Figure 3.2). 
 
Figure 3.2 
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For the determination of the enantiomeric excess of the cycloadduct 22a, 
the preparation of a racemic compound was necessary. Thus, the same reaction 
was performed in the presence of benzhydrylamine as non-chiral primary amine 
catalyst, obtaining, after reduction of the corresponding 3,4-dihydropyrrole, the 
racemic pyrrolidine (±)-22a, which was subjected to HPLC analysis on chiral 
stationary phase. The separation of both enantiomers was achieved employing a 
Chiralpak IA chiral column with a mixture of 98:2 n-hexane/i-PrOH as eluent, in a 
1.0 mL/min flow. With these conditions, we measured the enantiomeric excess of 
the adduct 22a obtained using catalyst 21a, observing that a 78% ee has been 
achieved. Both chromatograms are shown on Figure 3.3. With this result, we 
decided to check the enantiocontrol exerted by its quasienantiomer, 9-epi-9-amino-
9-deoxycinchonine, with which the opposite enantiomer was obtained in a 68% ee, 
lower than in the previous case. 
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Figure 3.3 
3.2. Optimization of the reaction conditions 
After the initial result obtained in the experiment shown on Scheme 3.36, 
we proceeded to evaluate different reaction conditions, in order to improve the 
outcome of the reaction. First, we evaluated the influence of solvents with 
different properties. The results are summarized in the Table 3.1. 
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Table 3.1: Screening of reaction conditions: Solvent.a 
 
Entry Solvent Yield (%)b ee (%)c 
1 THF 84 78 
2 Et2O 61 62 
3 CHCl3 78 76 
4 CH2Cl2 63 68 
5 EtOAc 80 78 
6 CH3CN 59 51 
7 DMF 63 8 
8 EtOH 88 20 
9 Toluene 67 65 
a The reaction was performed in 2 mL of solvent and 0.4 mmol scale of 19a, using 1.4 
equiv. of 20a. b Isolated product yield in two-step reaction after flash column 
chromatography. c Enantiomeric excesses determined by HPLC analysis on chiral stationary 
phase of the compound 22a. 
As shown in Table 3.1, the best results were obtained with THF, CHCl3 and 
EtOAc as solvents (entries 1, 3 and 5). The use of more polar solvents, such as 
CH3CN and DMF, resulted in a reduction of the enantiomeric excess (entries 6 
and 7), observing also low stereocontrol when a polar protic solvent was employed 
186 Chapter 3 
 
(entry 8). In the presence of a non polar solvent the stereochemical outcome was 
not improved (entry 9). 
In order to increase the enantioselectivity of the reaction, we decided to 
study the effect of the ratio between the amount of catalyst and the acidic additive 
(see Table 3.2), taking into account previous works of Melchiorre and co-
workers,53 in which the ability of the acid cocatalyst to modify the three-
dimensional structure of the catalyst, has been described. In particular, these 
reports indicate that the anion of the acidic additive assembles to both the iminium 
ion and the protonated tertiary amine of the activated intermediate, making it more 
rigid and therefore leading to a better stereocontrol in the reaction. The presence 
of multiple basic points at the structure of the catalyst also implies that the acid 
cocatalyst might be needed in excess with respect to the amount of cinchona 
alkaloid-based catalyst. 
                                                     
53 a) Moran, A.; Hamilton, A.; Bo, C.; Melchiorre, P. J. Am. Chem. Soc. 2013, 135, 9091; b) Tian, 
X.; Cassani, C.; Liu, Y.; Moran, A.; Urakawa, A.; Galzerano, P.; Arceo, E.; Melchiorre, P. J. Am. 
Chem. Soc. 2011, 133, 17934. 
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Table 3.2: Screening of reaction conditions: Amount of additive.a 
 
Entry TsOH (mol%) Time (h) Yield (%)b ee (%)c 
1 20 180 84 78 
2 30 72 82 81 
3 40 60 86 83 
4 60 48 84 83 
5d 40 48 85 80 
a The reaction was performed in 2 mL of THF and 0.4 mmol scale of 19a, using 1.4 equiv. 
of 20a. b Isolated product yield in two-step reaction after flash column chromatography. c 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 22a. d The reaction was carried out using 2.0 equiv. of 20a. 
From the experiments shown in the Table 3.2, it was concluded that 
increasing the amount of additive, the enantioselectivity and the rate of the 
reaction were improved, keeping an excellent yield (entries 1-4). It was found that 
the best result was obtained using double amount of acid than catalyst (entry 3), 
not observing any improvement in the reaction outcome with more amount of 
cocatalyst (entry 4). We also tried the reaction using double amount of 
aminomalonate 20a than enone 19a, not achieving better results (entry 5). 
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We next decided to evaluate different acidic additives, keeping the double 
amount of additive than catalyst, and carrying out the reaction in THF, CHCl3 and 
EtOAc, which were the solvents that performed better in the reaction (entries 1, 3 
and 5 in Table 3.1). From the results shown in Table 3.3, in the case of use THF as 
solvent (entries 1-6), it can be observed that employing CH3SO3H with similar pKa 
compared to TsOH, better results were observed regarding the rate and the 
enantioselectivity of the process (entry 2 vs. entry 1). However, reducing the 
acidity of the additive, the reaction outcome was proportionally getting worse 
(entries 3-6). The additives that showed better results, were also tested in CHCl3 
(entries 7-9), observing in this case the opposite reaction performance regarding 
the acidity, finding better results with TFA as additive, but requiring long reaction 
time (entry 9). Finally, EtOAc was tested as solvent (entries 10-12) using the same 
three additives, observing in this case worse yields while decreasing the acidity, 
obtaining the best results when TsOH was used (entry 10). Taking into account all 
the results, we concluded that the optimal conditions were the use of THF as 
solvent and CH3SO3H as cocatalyst (entry 2). 
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Table 3.3: Screening of reaction conditions: Brønsted acid additive.a 
 
Entry Solvent Additive pKab Time (h) Yield (%)c ee (%)d 
1 THF TsOH -2.8 60 86 83 
2 THF CH3SO3H -2.6 42 89 89 
3 THF TFA -0.2 72 92 82 
4 THF DPP 1.9 60 85 75 
5e THF 4-NO2C6H4CO2H 3.4 132 58 54 
6f THF PhCO2H 4.2 168 50 20 
7 CHCl3 TsOH -2.8 84 84 78 
8 CHCl3 CH3SO3H -2.6 156 80 83 
9 CHCl3 TFA -0.2 120 87 87 
10 EtOAc TsOH -2.8 84 90 85 
11 EtOAc CH3SO3H -2.6 204 81 80 
12 EtOAc TFA -0.2 84 72 85 
a The reaction was performed in 2 mL of solvent and 0.4 mmol scale of 19a, using 1.4 
equiv. of 20a. b pKa values measured in H2O. Perrin, D. D.; Serjeant, E. P.; Dempsey, B. 
pKa Predictions for Organic Acids and Bases, Chapman and Hall, London, 1981. c Isolated 
product yield in two-step reaction after flash column chromatography. d Enantiomeric 
excesses determined by HPLC analysis on chiral stationary phase of the compound 22a. e 
Conversion of 84% (calculated by 1H-NMR analysis of the non purified reaction mixture). f 
Conversion of 73% (calculated by 1H-NMR analysis of the non purified reaction mixture). 
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Additionally, we tried to improve the enantioselectivity using chiral 
Brønsted acid, in order to find the matching combination. When chiral aminoacids 
were employed, such as N-Boc-L-phenylalanine and its enantiomer, worse results 
were obtained regarding the yield and enantioselectivity (Scheme 3.37), while 
with higher acidity additives, like chiral phosphoric acids, low conversion or no 
reaction was observed. 
 
Scheme 3.37 
Concurrently, we studied a selection of some other primary amine catalysts, 
like several cinchona alkaloid-base derivatives (catalysts 21b-d in Table 3.4) and 
thiourea derivatives (catalysts 21e and 21f in Table 3.4), with the purpose of 
improving the enantiocontrol. 
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Table 3.4: Screening of reaction conditions: Primary amine catalyst.a 
 
 
a The reaction was performed in 2 mL of THF and 0.4 mmol scale of 19a, using 1.4 equiv. 
of 20a. b Isolated product yield in two-step reaction after flash column chromatography. c 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 22a. d The reaction was carried out without the presence of acid cocatalyst, 
obtaining 76% of conversion (calculated by 1H-NMR analysis of the non purified reaction 
mixture). 
The use of the primary amines derived from quinine and hydroxyquinine 
(21b and 21c) did not improve the previous results obtained by the catalyst 
derived from cinchonidine 21a. When 9-epi-9-amino-9-deoxy-6-
hydroxycinchonidine 21d was used as catalyst, the enantioselectivity remained 
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unchanged but the yield was slightly decreased. We also carried out the reaction 
with bifunctional primary amine/thiourea catalysts such as the Jacobsen thiourea 
derivative 21e and the Takemoto thiourea derivative 21f in absence of the acid 
cocatalyst, owing to the acidic nature of the thiourea moiety. In both cases, full 
conversion was not achieved and the opposite enantiomer was obtained as a major 
product, without any improvement in the enantioselectivity. To conclude, 9-epi-9-
amino-9-deoxycinchonidine was chosen as the best catalyst for the stereochemical 
outcome. 
Finally, we also proceeded to carry out the reaction at different 
temperatures, with the aim of observing the effect on the enantiocontrol (Table 
3.5). At higher temperature, the enantioselectivity was significantly decreased 
(entry 2), while at lower temperatures the rate of the reaction decreased, not 
achieving full conversion at -30 ºC after long reaction time (entries 3-4). In 
conclusion, performing the reaction at room temperature was the best option 
regarding the rate, the yield and the enantiopurity. 
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Table 3.5: Screening of reaction conditions: Temperature.a 
 
Entry T (ºC) Time (h) Yield (%)b ee (%)c 
1 r.t. 42 89 89 
2 50 24 83 76 
3 4 84 83 90 
4d -30 240 53 86 
a The reaction was performed in 2 mL of THF and 0.4 mmol scale of 19a, using 1.4 equiv. 
of 20a. b Isolated product yield in two-step reaction after flash column chromatography. c 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 22a. d Conversion of 76% (calculated by 1H-NMR analysis of the non purified 
reaction mixture). 
At this point, after taking into account a wide variety of optimization 
experiments, we established that the best conditions for the Michael/condensation 
cascade reaction between (E)-4-phenylbut-3-en-2-one 19a and diethyl 
aminomalonate 20a were the use of 20 mol% of 9-epi-9-amino-9-
deoxycinchonidine 21a as catalyst with 40 mol% of methanesulfonic acid as 
cocatalyst in THF at room temperature, followed by the diastereoselective 
reduction of the generated imine in one-pot fashion, employing NaBH3CN in 
EtOH at room temperature (Scheme 3.38). 
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Scheme 3.38 
3.3. Scope of the reaction 
After studying the reaction conditions and decided the optimal protocol, we 
proceeded to extend the methodology to the use of other α,β-unsaturated ketones 
containing different substitution patterns, in order to determine the scope and 
limitations of the cascade reaction. First, we studied the addition of diethyl 
aminomalonate 20a to different β-(hetero)aryl substituted enones 19a-n under the 
optimized conditions (Table 3.6). Excellent results were obtained both with β-aryl 
and heteroaryl-substituted α,β-unsaturated ketones, regardless of the electronic 
nature of the aryl substituent, leading to the desired pyrrolidines in high yields and 
enantioselectivities, and as single diastereoisomers after the reduction step. It can 
be observed that enones incorporating electron-donating groups at the aryl 
substituent required longer reaction times than enones with electron-withdrawing 
groups (entries 5, 9 and 12). The position of the substituent at the aryl group also 
had a reasonable influence on the reaction rate (entries 3-9). In the case of use 
heteroaryl substituted enones, higher yields and enantioselectivities were observed 
performing the reaction with TFA as cocatalyst in CHCl3 (entries 13-14 vs. 15-16). 
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Table 3.6: Scope of the reaction using a series of β-substituted enones.a 
 
Entry R (19) 22 Time (h) Yield (%)b ee (%)c 
1 Ph (19a) 22a 42 89 89 
2 4-MeC6H4 (19b) 22b 41 70 90 
3 2-MeOC6H4 (19c) 22c 119 67 89 
4 3-MeOC6H4 (19d) 22d 68 77 89 
5 4-MeOC6H4 (19e) 22e 41 79 89 
6 2,6-(MeO)2C6H4 (19f) 22f 97 63 77 
7 3,5-(MeO)2C6H4 (19g) 22g 29 67 87 
8 2-FC6H4 (19h) 22h 42 78 89 
9 4-FC6H4 (19i) 22i 26 74 89 
10 4-ClC6H4 (19j) 22j 27 78 89 
11 4-CF3C6H4 (19k) 22k 23 53 87 
12 4-NO2C6H4 (19l) 22l 20 70 86 
13 2-Furyl (19m) 22m 72 73 76 
14 2-Thienyl (19n) 22n 96 72 78 
15d 2-Furyl (19m) 22m 120 80 86 
16d 2-Thienyl (19n) 22n 120 81 87 
a The reaction was performed in 2 mL of solvent and 0.4 mmol scale of 19, using 1.4 equiv. 
of 20a. b Isolated product yield in two-step reaction after flash column chromatography. c 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 22. d Reaction carried out using TFA as an additive and CHCl3 as a solvent. 
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Once it was analyzed the effect of different aryl and heteroaryl substituents 
at β-position of the Michael acceptor, we decided to employ several 
aminomalonates and enones with different substituents at β and α’-position (Table 
3.7). A more sterically demanding ethyl group at the α’-position of the unsaturated 
ketone was also well tolerated (entry 1), decreasing the yield and the reaction rate, 
comparing with the less congested compound, however with α’-aryl-substituted 
enones, a class of substrates that are not generally suitable for iminium ion 
activation, the reaction did not work efficiently. For instance, with (E)-1-
phenylbut-2-en-1-one as Michael acceptor the reaction did not progress, observing 
a complex mixture of products, while the reaction with (E)-chalcone 19p 
furnished the intermediate pyrroline after the cascade reaction in low yield and 
moderate enantiocontrol (entry 2). This intermediate proved to be unreactive 
towards reduction under our optimal conditions, probably due to the conjugated 
character of the azomethine moiety, but fortunately, in this case we were able to 
isolate the pyrroline by flash column chromatography. It should be noted that, the 
reaction with alkyl substituents in α’ and β-position of the enone, such as (E)-pent-
3-en-2-one, resulted in a dirty reaction, not observing the desired 1-pyrroline. We 
also surveyed the (E)-3-methyl-4-phenylbut-3-en-2-one, with methyl group in α-
position, only recovering starting material, presumably because of the more 
overcrowded system. On the other hand, the reaction was carried out satisfactorily 
when dimethyl aminomalonate 20b was used (entries 3 and 4), obtaining the 
corresponding pyrrolidines in very good yields and enantioselectivities. 
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Table 3.7: Scope of the reaction using different aminomalonates and enones.a 
 
Entry R1, R2 (19) R3 (20) 22 
Time 
(h) 
Yield 
(%)b 
ee 
(%)c 
1 4-MeOC6H4, Et (19o) Et (20a) 22o 168 65 89 
2d Ph, Ph (19p) Et (20a) 22p 192 31 58 
3 Ph, Me (19a) Me (20b) 22q 41 91 90 
4 2,6-(MeO)2C6H4, Me (19f) Me (20b) 22r 72 67 80 
a The reaction was performed in 2 mL of solvent and 0.4 mmol scale of 19, using 1.4 equiv. 
of 20. b Isolated product yield in two-step reaction after flash column chromatography. c 
Enantiomeric excesses determined by HPLC analysis on chiral stationary phase of the 
compound 22. d The intermediate pyrroline was isolated. 
Fortunately, pyrrolidine 22r was isolated as a white solid that could be 
recrystallized, determining the absolute configuration by single crystal X-ray 
analysis, and confirming the cis configuration of substituents at C-3 and C-5. The 
crystal structure of 22r is depicted in Figure 3.4 showing a 3S,5S configuration at 
the two stereogenic centers generated during the one-pot process. This can be 
extended by mechanistic analogy to the other prepared pyrrolidines 22a-r. 
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Figure 3.4 
Regarding the mechanism of the reaction (see Scheme 3.39), we proposed, 
after all experimental studies, that the reaction consisted on a 
Michael/condensation cascade reaction by reacting enones and dialkyl 
aminomalonates using a primary amine as catalyst. First, the iminium ion 
intermediate is formed, with the E configuration, by condensation of the enone 
with the aminocatalyst, followed by the Michael addition of the aminomalonate to 
the less hindered Re face of the activated species. Owing to the relevance of the 
acidic additive on the stereochemical outcome, improving the enantioselectivity 
with double amount of acid than catalyst, we proposed, based on the results by 
Melchiorre and co-workers,53 that the anions of the acid cocatalyst are assembled 
to the activated intermediate, by formation of ion-pairs both with the iminium ion 
and the protonated tertiary amine, thus modulating the chiral space, and blocking 
in this case the Si stereotopic face. After the Michael addition, an enamine 
intermediate is formed, followed by the subsequent protonation towards the 
generation of the iminium ion. The hydrolysis of this intermediate regenerates the 
catalyst and provides the Michael adduct that is able to cyclize via intramolecular 
condensation of the primary amine with the resulting carbonyl group, obtaining 
the corresponding chiral pyrrolines. Finally, cis-3,5-disubstituted pyrrolidines are 
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obtained after the diastereoselective reduction of pyrrolines, under substrate 
control with the hydride reagent approaching from the less hindered face. 
 
Scheme 3.39 
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3.4. Transformation of the adducts: Synthesis of proline derivatives 
At this point, with the objective of synthesizing the corresponding chiral 
prolines from the already prepared enantioenriched pyrrolidine 2,2-dicarboxylates, 
we proceeded to apply the base-promoted intramolecular C→N acyl transfer 
reaction, previously developed in our group.52 The reaction consists on the initial 
deprotonation of the secondary amine through the use of an organolithium base, 
such as MeLi, followed by the nucleophilic attack of the subsequent anion to one 
of the two carboxylate groups, forming an azidirine-type compound that was 
previously confirmed in our group.52 The highly strained azidirine can evolve to 
the corresponding enolate through an irreversible ring-opening process, followed 
by protonation by the addition of water, forming the consequent carbamate 
(Scheme 3.40). 
 
Scheme 3.40 
In this sense, when compounds 22a-o and 22q-r were treated with one 
equivalent of methyllithium in dry THF at -78 ºC during 1 hour, the expected N-
protected proline ester derivatives were obtained after quenching the reaction 
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through dropwise addition of water at -78 ºC (Table 3.8). The rearrangement took 
place with high yields in all of the cases, with the exception of proline 23l, which 
was isolated with poor conversion (entry 12). Moreover, all proline ester 
derivatives were obtained with moderate to excellent diastereoselectivities with 
respect to the generation of a new stereogenic center at C-2. As it can be observed, 
with more congested compounds, such as pyrrolidines with ortho and meta 
substituents in the aromatic ring at C-3 (entries 3, 4 and 8), the 
diastereoselectivities were significantly better. It should be noted that when the 
rearrangement took place from 5-ethyl-substituted pyrrolidine 22o (entry 15), the 
diastereomeric ratio was improved (dr: 3:1 to dr: 6:1) when the reaction was 
quenched through dropwise addition of t-BuOH in dry THF at -78 ºC. 
Unfortunately, this procedure could not be extended to the other pyrrolidines. 
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Table 3.8: Synthesis of N-protected proline derivatives. 
 
Entry R1 R2 R3 23 Yield (%)a drb 
1 Ph Me Et 23a 84 7:1 
2 4-MeC6H4 Me Et 23b 80 10:1 
3 2-MeOC6H4 Me Et 23c 78 >20:1 
4 3-MeOC6H4 Me Et 23d 77 >20:1 
5 4-MeOC6H4 Me Et 23e 73 6:1 
6 2,6-(MeO)2C6H4 Me Et 23f 73 3:1 
7 3,5-(MeO)2C6H4 Me Et 23g 84 10:1 
8 2-FC6H4 Me Et 23h 85 17:1 
9 4-FC6H4 Me Et 23i 71 6:1 
10 4-ClC6H4 Me Et 23j 86 7:1 
11 4-CF3C6H4 Me Et 23k 80 5:1 
12c 4-NO2C6H4 Me Et 23l 60 7:1 
13 2-Furyl Me Et 23m 78 9:1 
14 2-Thienyl Me Et 23n 84 13:1 
15d 4-MeOC6H4 Et Et 23o 89 6:1 
16 Ph Me Me 23q 80 10:1 
17 2,6-(MeO)2C6H4 Me Me 23r 75 3:1 
a Isolated product yield of the mixture of diastereoisomers after flash column 
chromatography. b Diastereomeric ratios determined by 1H-NMR analysis of non purified 
reaction mixtures. c Calculated yield over a conversion of 40% (calculated by 1H-NMR 
analysis of the non purified reaction mixture). d Reaction quenched through dropwise 
addition of t-BuOH in dry THF at -78 ºC. 
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In order to confirm the configuration of the new stereogenic center formed 
at C-2, a NOESY experiment was performed on N-protected proline ester 23a (see 
Figure 3.5). The presence of significant n.O.e. was observed between H2 and the 
protons of the aromatic ring and the absence of n.O.e.was appreciated between H2 
and H3, indicating a 2,3-trans configuration of the major diastereoisomer. 
 
Figure 3.5 
Finally, we proceeded to perform the N-deprotection of some representative 
compounds in order to demonstrate the synthetic potential of this methodology to 
access to polysubstituted chiral proline ester derivatives. The deprotection could 
be carried out using TMSI in chloroform under reflux, followed by the addition of 
methanol to decompose the previously formed silyl carbamate.54 Under these 
conditions, the deprotection of ethyl and methyl carbamates 23a and 23q took 
place in high yields without epimerization of any of the stereogenic centers 
present in the molecule (Scheme 3.41). 
                                                     
54 Cheng, J.; Xu, L.; Stevens, E. D.; Trudell, M. L. J. Heterocyclic Chem. 2004, 41, 569. 
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Scheme 3.41 
Moreover, the spectroscopic data of the compound 24a matched to the 
reported same product,55 confirming the absolute stereochemistry proposed for all 
proline ester derivatives. 
                                                     
55 Halland, N.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 8331. 
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4. CONCLUSIONS 
Taking into account the results obtained in this chapter, several conclusions 
can be presented: 
1. An aminocatalytic one-pot Michael addition/intramolecular 
condensation/diastereoselective reduction sequence is presented as a novel 
methodology for the regioselective synthesis of polysubstituted chiral pyrrolidines 
in high yields and enantioselectivities, allowing the use of a wide variety of 
enones as Michael acceptors. 
2. The possibility of carrying out the reaction in a one-pot fashion, without the 
purification of the pyrroline intermediate, and the use of very simple and cheap 
starting materials, allows the preparation of the target molecules following a 
straightforward procedure. 
3. The resulting pyrrolidines can be transformed into the corresponding N-
protected proline esters in very good yields and diastereoselectivities, through a 
base-promoted intramolecular C→N acyl transfer reaction. In addition, the 
deprotection can be successfully performed following a well-known and easy 
procedure, affording the desired enantioenriched unprotected proline ester 
derivatives, demonstrating the usefulness of this methodology. 
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1. INTRODUCTION 
In 1993, Wahlberg et al. isolated thirteen lactones from an extract of sun-
cured leaves of Greek tobacco.1 Some of them were new natural products, 
including the (3aR, 5R, 7aR)-7a-methyl-5-(prop-1-en-2-yl)hexahydro-2H-furo[3,2-
b]pyran-2-one, known as (+)-Greek tobacco lactone (Figure 4.1). 
 
Figure 4.1 
During the last years, this natural product has attracted considerable 
attention due to its simple but interesting structure, being composed by a unique 
cis-fused tetrahydropyran-butyrolactone core. Although nowadays the biological 
activity is unknown, it should be pointed out that the cis-fused tetrahydropyran 
moiety is commonly found in many natural products.2 Since 2007, three total 
synthesis of (+)-Greek tobacco lactone have been reported, following different 
strategies, which will be summarized in the following lines. 
                                                     
1  Pettersson, T.; Eklund, A.-M.; Wahlberg, I. J. Agric. Food Chem. 1993, 41, 2097. 
2 For some examples, see: a) Suchaichit, N.; Kanokmedhakul, K.; Panthama, N.; Poopasit, K.; 
Moosophon, P.; Kanokmedhakul, S. Fitoterapia 2015, 103, 206; b) Lin, Y.-S.; Lin, J.-H.; Chang, 
C.-C.; Lee, S.-S. J. Nat. Prod. 2015, 78, 181; c) Hwang, B. S.; Yoon, E. Y.; Kim, H. S.; Yih, W.; 
Park, J. Y.; Jeong, H. J.; Rho, J.-R. Bioorg. Med. Chem. Lett. 2013, 23, 3023; d) Ono, M.; Takaki, 
Y.; Takatsuji, M.; Akiyama, K.; Okawa, M.; Kinjo, J.; Miyashita, H.; Yoshimitsu, H.; Nohara, T. 
Chem. Pharm. Bull. 2012, 60, 1083; e) Kito, K.; Ookura, R.; Yoshida, S.; Namikoshi, M.; Ooi, T.; 
Kusumi, T. Org. Lett. 2008, 10, 225; f) Wright, A. E.; Botelho, J. C.; Guzmán, E.; Harmody, D.; 
Linley, P.; McCarthy, P. J.; Pitts, T. P.; Pomponi, S. A.; Reed, J. K. J. Nat. Prod. 2007, 70, 412. 
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The first total synthesis was reported by Clark and co-workers in six steps 
with an overall yield of 22% of a racemic mixture (see Scheme 4.1).3 The 
synthesis started with the reaction of methacrolein with the Grignard reagent 
prepared in situ from the commercially available alkyl bromide, obtaining the 
allylic alcohol in excellent yield. The alkylation of the hydroxyl group with ethyl 
propiolate, followed by the acetal deprotection afforded the corresponding 
aldehyde. As key step, the aldehyde was treated with samarium(II) iodide in the 
presence of methanol to afford the tetrahydropyran core through an intramolecular 
reductive cyclization in good yield. Swern oxidation of the resulting alcohol 
furnished the corresponding ketone, which after 1,2-addition of methyllithium, 
followed by an intramolecular lactonization in one-pot fashion, afforded the 
natural product in a diastereoselective way, completing the six steps of the total 
synthesis. Through this synthesis the characterization of the (+)-Greek tobacco 
lactone was completed, allowing the correction of a misassigned carbonyl group in 
the original 13C-NMR spectrum reported by Wahlberg et al. Moreover, with this 
work the relative stereochemistry was confirmed by NMR spectroscopy. 
                                                     
3 Clark, J. S.; Hayes, S. T.; Blake, A. J.; Gobbi, L. Tetrahedron Lett. 2007, 48, 2501. 
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Scheme 4.1 
In 2012, Fall and co-workers developed another total synthesis of the 
natural product, requiring seven steps with an overall yield of 15%.4 As it is 
shown on Scheme 4.2, the commercially available ester can be transformed into 
the corresponding aldehyde in two steps. The addition of the in situ metalated 
vinyl bromide furnished an alcohol that was protected as t-butyldiphenylsilylether. 
The furan moiety was oxidized employing a singlet oxygen conditions previously 
employed by the same group, with the use of Rose bengal dye as photosensitizers,5 
obtaining a tertiary alcohol. Then, the angular methyl group was formed by the 
                                                     
4 Zuñiga, A.; Pazos, G.; Besada, P.; Fall, Y. Tetrahedron Lett. 2012, 53, 4293. 
5 Teijeira, M.; Suárez, P. L.; Gómez, G.; Terán, C.; Fall, Y. Tetrahedron Lett. 2005, 46, 5889. 
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addition of (i-PrO)3TiCH3 to the previously generated alcohol, and finally, the 
desired product was obtained by the intramolecular nucleophilic attack of the 
secondary alcohol to the unsaturated lactone, after deprotection of the hydroxyl 
group in one-pot fashion. 
 
Scheme 4.2 
It should be noted that until the last step, non-optically pure compounds 
were used for the different reactions, observing in the final cylization step the 
presence of only two diastereoisomers, but in very low diastereomeric ratio (dr: 
1.7:1), being the mayor product the Greek tobacco lactone as a racemic mixture. 
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Because of lack of stereocontrol, recently, Pihko and co-workers have 
developed a protecting-group-free enantioselective route to (+)-Greek tobacco 
lactone in six steps and an overall yield of 12% (see Scheme 4.3).6 Firstly, the 
silyloxyfuran derivative was easily prepared from the commercially available 5-
methylfuran-2(3H)-one. The formed product was used in an aminocatalytic 
Mukaiyama-Michael reaction, previously described by the same group,7 with 
acrolein, under the iminium ion activation, obtaining the corresponding aldehyde 
in an enantioenriched way (88% ee). Then, the last one was subjected to Wittig 
olefination conditions, affording an alkene, which after asymmetric Sharpless 
dihydroxylation was converted into the corresponding diol in excellent 
diastereoselectivity after recrystallization. An oxa-Michael reaction of the 
secondary alcohol to the α,β-unsaturated lactone using basic conditions was 
carried out in order to give the 6-exo-trig cyclization product. Finally, the 
synthesis was completed after the elimination of the tertiary alcohol towards the 
construction of the isopropenyl side chain. 
                                                     
6 Siitonen, J. H.; Pihko, P. M. Synlett 2014, 25, 1888. 
7 Kemppainen, E. K.; Sahoo, G.; Piisola, A.; Hamza, A.; Kótai, B.; Pápai, I.; Pihko, P. M. Chem. 
Eur. J. 2014, 20, 5983. 
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Scheme 4.3 
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2. OBJECTIVES AND PREVIOUS APPROACHES IN THE GROUP 
The total synthesis of terpenoids and terpene-like structures is considered a 
great challenge for the synthetic chemists. This type of compounds usually 
presents one oxidized carbon atoms that may favour the design of a retrosynthetic 
pathway, but, in general, the use of protecting groups and several changes in the 
oxidation state of multiple atoms are required. In this sense, with the purpose of 
minimizing the number of steps for a given target molecule, an alternative is 
proposed, consisting on the identification of terpene substructures in a compound 
of interest, in order to reduce the number of carbon-carbon bond formation in the 
synthetic route. The use of this strategy in total synthesis is one of the subjects of 
the M. Christmann research group at the Institute for Chemistry and Biochemistry 
– Organic Chemistry at the Free University of Berlin, where I incorporated in the 
context of a short stay, from January to April of 2015. Using this methodology, 
they have completed the first total synthesis of englerin A and derivatives starting 
from the commercially available nepetalactone, a bicyclic monoterpenoid.8 
Taking into account the different routes developed towards the synthesis of 
(+)-Greek tobacco lactone 25, and based on the previously mentioned approach, 
they initially proposed as objective the synthesis of this molecule in less steps, 
with only one carbon-carbon bond formation, two oxidations strategies and a 
functional group transformation. The initial retrosynthetic analysis, shown on 
Scheme 4.4, consisted on a disconnection of the tetrahydropyran moiety of the 
natural product and displacement of the double bond leading to the lactone 26 
                                                     
8 a) Radtke, L.; Willot, M.; Sun, H.; Ziegler, S.; Sauerland, S.; Strohmann, C.; Fröhlich, R.; 
Habenberger, P.; Waldmann, H.; Christmann, M. Angew. Chem. Int. Ed. 2011, 50, 3998; b) Willot, 
M.; Radtke, L.; Könning, D.; Fröhlich, R.; Gessner, V. H.; Strohmann, C.; Christmann, M. Angew. 
Chem. Int. Ed. 2009, 48, 9105. 
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bearing a hydroxyl group and a trisubstituted alkene, which are suitable 
functionalities for an oxidative cyclization catalyzed by palladium(II). The lactone 
can be obtained through a lactonization process from the corresponding alcohol 
and carboxylic acid, which can be prepared by hydrolyzing the corresponding 
nitrile 27. This one can be synthetized by nucleophilic ring-opening of the 
terminal epoxide 28, prepared through a diastereoselective epoxidation of the 
monosubstituted double bond of the commercially available (R)-(-)-linalool 29, 
naturally occurring terpene alcohol. 
 
Scheme 4.4 
First, the diastereoselective epoxidation of the terminal alkene of 29 using 
several strategies was surveyed in the group. In this case, it was not easy to predict 
the stereochemical outcome of the product, due to the stereocenter present on the 
substrate. For this reason, the reaction was initially performed under asymmetric 
Sharpless epoxidation conditions, using both enantiomers of the chiral ligand, and 
obtaining low yields and moderate to good diastereoselectivities. In order to 
improve the reaction outcome, vanadium catalyzed epoxidation conditions were 
used, observing poorer results regarding the diastereoselectivity. In summary, the 
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best results were achieved under Sharpless epoxidation conditions, obtaining the 
product in low yield and as inseparable mixture of diastereoisomers (Scheme 4.5). 
 
Scheme 4.5 
At this point, and with the purpose of obtaining the desired epoxide 28 as a 
single diastereoisomer, an alternative was suggested, consisting on four synthetic 
steps starting from the commercially available nerol 30, a structural isomer of 
linalool (Scheme 4.6), based on a previous work.9 
 
Scheme 4.6 
Taking into account the proposed alternative, the general objective of the 
present research work consisted on the total synthesis of the (+)-Greek tobacco 
lactone starting from nerol. 
                                                     
9 Hashimoto, M.; Yanagiya, M.; Shirahama, H. Chem. Lett. 1988, 645. 
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3. RESULTS AND DISCUSSION 
As it mentioned above, the stereoselective synthesis of the epoxide 28, can 
be carried out in four steps starting from the readily available nerol. The first step 
consisted on an enantioselective epoxidation of the allylic alcohol 30. For this 
purpose, we chose the procedure described by Sharpless,10 due to the expected 
regioselectivity, the availability of the reagents and high enantiomeric excesses 
observed in similar reactions. In this case, in order to achieve the correct 
enantiomer (2R,3S)-31, D-(-)-diethyl tartrate was used as chiral ligand, under 
conditions previously employed by the group in a satisfactory way, obtaining the 
desired epoxide 31 in very good yield and with moderate enantiocontrol (Scheme 
4.7). 
 
Scheme 4.7 
The obtained epoxide 31 is a constitutional isomer of the epoxide 28, 
having the opposite configuration at C-3 with respect to the required on the natural 
product. In order to achieve the desired epoxide, first the alcohol was protected as 
the sulfonate 32, thus becoming a good leaving group. In this sense, applying 
known conditions,11 the sulfonate ester 32 was isolated in 77% yield (see Scheme 
                                                     
10 Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974. 
11 Riou, M.; Barriault, L. J. Org. Chem. 2008, 73, 7436. 
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4.8). Then, we proceeded to the epoxide opening under acidic conditions in SN1 
like fashion, by attacking of water as a weak nucleophile, in order to obtain the 
diol compound 33, with inversion of configuration at C-3. The reaction was 
carried out using TsOH in MeCN and water, obtaining the diol 33 in good yield 
(shown on Scheme 4.8). At this point, we proceeded to the formation of the 
terminal epoxide using basic conditions, through an intramolecular nucleophilic 
substitution of the secondary hydroxyl group to the electrophilic carbon, 
displacing the tosylate unit. The reaction was performed using K2CO3 as a base in 
MeOH, at low temperature, in order to avoid the base-catalyzed Payne 
rearrangement,12 towards the obtention of the more substituted epoxide. In the 
conditions shown on Scheme 4.8, the desired epoxide 28 was obtained in very 
good yield, as a unique structural isomer. 
 
Scheme 4.8 
                                                     
12 Payne, G. B. J. Org. Chem. 1962, 27, 3819. 
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Then, with the aim of obtain the nitrile compound 27 through a 
regioselective ring opening, different cyanide sources were tested. The use of 
KCN as the nucleophilic agent, employing different metal salts, such as LiClO4, 
has been previously reported in the synthesis of 1,2-hydroxy nitriles from oxiranes 
in high yields.13 In our case, no reaction was observed, detecting a complex 
mixture of products when only KCN was used. Diethyl aluminium cyanide 
(Nagata’s reagent), also has been used in epoxide opening reactions, as a cyanide 
donor and a Lewis acid.14 When Et2AlCN 1 M was used in toluene at r.t., the 
reaction performed excellently, observing that the nucleophilic attack occurred on 
the less substituted carbon of the oxirane ring, obtaining the expected nitrile 27 in 
good yield (Scheme 4.9). 
 
Scheme 4.9 
We next proceeded to carry out the hydrolysis of the nitrile. Based on the 
work of Benedetti and co-workers,14b an aqueous solution of NaOH was used, in 
order to hydrolyze the nitrile group towards the formation of the corresponding 
carboxylate. Then, the solution was carefully acidified until reaching pH = 2, 
forming the desired (4R,5R)-lactone 26 in very good yield after 17 hours at room 
temperature (Scheme 4.10). In spite of working in mild acidic conditions, 
                                                     
13 Chini, M.; Crotti, P.; Favero, L.; Macchia, F. Tetrahedron Lett. 1991, 32, 4775. 
14 a) García Ruano, J. L.; Fernández-Ibáñez, M. A.; Martín Castro, A. M.; Rodríguez Ramos, J. H.; 
Rubio Flamarique, A. C. Tetrahedron: Asymmetry 2002, 13, 1321; b) Benedetti, F.; Berti, F.; 
Norbedo, S. Tetrahedron Lett. 1999, 40, 1041. 
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undesired elimination product 34 was observed, but in a very low yield. At this 
point, we were able to compare the obtained specific rotation value of the 
compound 26 with the reported data of the opposite enantiomer,15 concluding that 
we were preparing the correct diastereoisomer in an enantioenriched way. 
 
Scheme 4.10 
At this stage, we proceeded to continue with the study of the final step of 
the total synthesis of the Greek tobacco lactone, consisting on a palladium(II) 
catalyzed Wacker-type oxidative cyclization. It should be highlighted that the 
following experiments were performed using the lactone ent-26 prepared by the 
group, which has the opposite configuration compared with the natural product, 
                                                     
15 Viturro, C. I.; Maier, M. S.; Stortz, C. A.; de la Fuente, J. R. Tetrahedron: Asymmetry 2001, 12, 
991. 
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because the L-(+)-DET chiral ligand employed in the first step is more cost 
efficient than its enantiomer. 
We initially tested the reaction under the conditions developed by Stoltz and 
co-workers using catalytic amounts of Pd(OCOCF3)2, pyridine as ligand, Na2CO3 
as base and 3 Å molecular sieves in toluene under oxygen atmosphere,16 but no 
product formation was observed even at elevated temperature and after long 
reaction time (entry 1 of Table 4.1). When a stronger base, such as t-BuOK, was 
used, only the elimination product ent-34 was observed (entry 2). As an 
alternative, the conditions used by Zhang et al. for the synthesis of chiral chroman 
derivatives were also tested. These involved the use of catalytic amounts of 
Pd(OCOCF3)2, a chiral ligand and p-benzoquinone as oxidizing agent in MeOH at 
60 ºC.17 In our case, pyridine was used as ligand, not detecting the formation of 
the desired product (entry 3). The same negative result was observed by applying 
the conditions reported by Hosokawa and co-workers,18 which employed catalytic 
amounts of Pd(OAc)2 and Cu(OAc)2, this last one being required to reoxidize 
Pd(0), and O2 as stoichiometric oxidizing agent for copper (entry 4). At this point, 
typical Wacker oxidation conditions were also tested, detecting the consumption 
of the starting material, but observing the formation of product 35, as elucidated 
by NMR experiments, in 28% yield (entry 5). The structure of oxepane derivative 
35 was further confirmed by single crystal X-ray analysis (Figure 4.2), also 
allowing to establish the (4S,5S) configuration of the lactone ent-26. 
                                                     
16 Trend, R. M.; Ramtohul, Y. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 17778. 
17 Liu, Q.; Wen, K.; Zhang, Z.; Wu, Z.; Zhang, Y. J.; Zhang, W. Tetrahedron 2012, 68, 5209. 
18 Hosokawa, T.; Uno, T.; Inui, S.; Murahashi, S.-I. J. Am. Chem. Soc. 1981, 103, 2318. 
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Figure 4.2 
The formation of this compound was explained through a Lewis acid 
catalyzed nucleophilic addition of the hydroxyl group to the most substituted 
carbon of the double bond, followed by protonation to afford the oxepane 
derivative 35. 
 
Table 4.1: Palladium(II) catalyzed oxycyclization. 
 
Entry Pd(II) (equiv.) 
Ligand 
(equiv.) 
Additive 
(equiv.) 
Solvent T (ºC) 
Yield 
(%)a 
1 
Pd(OCOCF3)2 
(0.05) 
Py (0.2) Na2CO3 (2), O2 Toluene 80 n.r.b 
2c 
Pd(OCOCF3)2 
(0.05) 
Py (0.2) t-BuOK (2), O2 Toluene 80 n.d.d 
3 
Pd(OCOCF3)2 
(0.2) 
Py (0.2) BQ (4) MeOH 60 n.r.b 
4 Pd(OAc)2 (0.1) - 
Cu(OAc)2 (0.1), 
O2 
MeOH 35 n.r.b 
5 PdCl2 (0.2) - CuCl2 (3) MeOH r.t. 28e 
a Isolated product yield after flash column chromatography. b No reaction. c The elimination 
product ent-34 was observed. d Not determined. e Isolated yield of the compound 35. 
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As an alternative, we focused on carrying out this transformation through 
oxidative cyclizations by allylic C-H activation using the White catalyst as a 
palladium source. Based on the work of Belani and co-workers,19 we tested the 
oxidative cyclization using the White catalyst under different conditions, 
employing in all cases p-benzoquinone as oxidizing agent (Table 4.2). Initially, 10 
mol% of catalyst was used in the presence of a slight excess of acetic acid, in 
CH2Cl2 at 40 ºC, observing very low conversion towards the compound ent-25 and 
in moderate diastereoselectivity (entry 1). In order to improve the conversion, we 
increased the catalyst loading and changed the solvent to 1,4-dioxane, heating the 
mixture at 80 ºC, observing a slight increase in the conversion (entry 2). In both 
cases, the product ent-25 could not be properly purified. Additionally, we tested 
the reaction with a stoichiometric amount of the White catalyst, obtaining a 
complex mixture of products (entry 3). Taking into account previous reports,20 we 
decided to use a Lewis acid as cocatalyst, such as AgOTf, observing full 
conversion of the starting material towards the formation of the oxepane derivative 
35 in 61% yield (entry 4). 
                                                     
19 Ayyagari, N.; Belani, J. D. Synlett 2014, 25, 2350. 
20 Ammann, S. E.; Rice, G. T.; White, M. C. J. Am. Chem. Soc. 2014, 136, 10834. 
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Table 4.2: Evaluation of the White catalyst in the reaction. 
 
Entry 
Cat. 
(equiv.) 
Additive 
(equiv.) 
Solvent T (ºC) 
Conv. 
(%)a 
Yield 
(%)b 
drc 
1 0.1 AcOH (1.1) CH2Cl2 40 13 n.d.d 85:15 
2 0.2 AcOH (1.1) 1,4-Dioxane 80 28 n.d.d 84:16 
3 1 AcOH (1.1) 1,4-Dioxane 80 n.d.d n.d.d n.d.d 
4 0.1 AgOTf (0.1) 1,4-Dioxane 80 >95 61e - 
a Conversions determined by 1H-NMR analysis of non purified reaction mixtures. b Isolated 
product yield after flash column chromatography. c Diastereomeric ratios determined by 1H-
NMR analysis of non purified reaction mixtures. d Not determined. e Isolated yield of the 
compound 35. 
In similar studies, Semmelhack and co-workers had previously used 
stoichiometric amounts of Pd(OAc)2 in several solvents, of which DMSO showed 
highest conversion rates.21 The experiments carried out following this type of 
procedure are shown in the Table 4.3. First, we tested the reaction using 
stoichiometric amounts of Pd(OAc)2 in DMSO at r.t., but only recovering the 
starting material (entry 1). Raising the temperature of the reaction to 80 ºC and 
after 24 hours, low conversion was observed towards the formation of the product 
ent-25 and with poor diastereoselectivity. In this case, we could isolate the target 
compound in 19% yield (entry 2). It should be highlighted that in longer reaction 
times the conversion was not increased. With the purpose of improving the 
reaction outcome, we decided to use an inorganic base to favour the deprotonation 
                                                     
21 Semmelhack, M. F.; Kim, C. R.; Dobler, W.; Meier, M. Tetrahedron Lett. 1989, 30, 4925. 
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process, observing only traces of the product (entry 3). At this point, we proposed 
to change the palladium source in order to promote the product formation, 
performing the reaction in DMSO at 80 ºC (entries 4-6). With PdCl2 and 
Na2PdCl4, very low conversion was observed, in contrast, with a Pd(II) species 
containing more electron-withdrawing groups, such as Pd(OCOCF3)2, moderate 
conversion was observed, isolating the compound ent-25 in 30% yield as a 
mixture of diastereoisomers (dr: 81:19), and byproduct 36 in 21% yield (entry 6), 
as a result of the oxidative cyclization on the more substituted carbon of the 
double bond. The identity of this compound was unambiguously established by X-
ray analysis (Figure 4.3). 
 
Figure 4.3 
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Table 4.3: Study of several reaction conditions using stoichiometric amounts of Pd source. 
 
Entry Pd(II) source 
Additive 
(equiv.) 
T (ºC) 
Conv. 
(%)a 
(ent-25:36) 
Yield (%)b 
drc 
1 Pd(OAc)2 - r.t. n.r.d - - 
2 Pd(OAc)2 - 80 32 19:- 63:37 
3 Pd(OAc)2 Na2CO3 (2) 80 <5 n.d.e n.d.e 
4 PdCl2 - 80 <5 n.d.e n.d.e 
5 Na2PdCl4 - 80 <5 n.d.e n.d.e 
6 Pd(OCOCF3)2 - 80 54 30:21 81:19 
7f Pd(OCOCF3)2 - 80 >95 n.d.e 83:17 
8 Pd(OCOCF3)2 - 80 (MW) 59 40:14 85:15 
9 Pd(OCOCF3)2 - 100 (MW) 62 n.d.e 71:29 
a Conversions determined by 1H-NMR analysis of non purified reaction mixtures. b Isolated 
product yield of each compound after flash column chromatography. c Diastereomeric ratios 
determined by 1H-NMR analysis of non purified reaction mixtures. d No reaction. e Not 
determined. f Portionwise addition of the Pd source during 7.5 hours. 
It should be noted that in the previous cases no full conversion was 
achieved, even with stoichiometric amounts of palladium(II) species. For this 
reason, first we decided to add the palladium source portionwise, in order to 
achieve full conversion. After the portionwise addition during 7.5 hours the 
comsuption of the starting material was observed but a complex mixture of 
products were detected, including the desired product ent-25 (entry 7). Next, we 
proposed to try the microwave-assisted reaction, due to its known ability to 
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increase the rate and the yield of the reaction.22 In this sense, when we carried out 
the reaction at 80 ºC assisted by microwave irradiation during 8 hours, using 
stoichiometric amounts of Pd(OCOCF3)2, similar conversion was achieved but 
compound ent-25 was isolated in better yield (40%) albeit as a mixture of 
diastereoisomers (dr: 85:15), identifying again the formation of the 
tetrahydrooxepine derivative 36, which was isolated in 14% yield (entry 8). 
Finally, we tested the reaction at a higher temperature (entry 9), observing a 
sluggish reaction, being unable to isolate properly the target compound. 
At this stage, we decided to study the effect of the solvent in the reaction, 
using stoichiometric amounts of Pd(OCOCF3)2 and heating at 80 ºC, without the 
use of the microwave oven. When aprotic polar solvents were tested such as 
dioxane, DMF and DMPU, a complex mixture of products were obtained, 
detecting very low formation of the desired product. The same problem was 
observed with halogenated solvents, such as DCE, trifluorotoluene and 
chlorobenzene; with a protic one, like i-PrOH and with a less polar one, such as 
toluene. Surprisingly, in the case of use MeCN as solvent, full conversion was 
achieved, but isolating compound 36 as the major product, together with an 
isomer, as a result of the reinsertion of the palladium species followed by the 
corresponding β-hydrogen elimination, with an overall 40% yield (Scheme 4.11). 
As it can be observed, the structure of the new formed product 37 was also 
confirmed by X-ray analysis. 
                                                     
22 For a selected review, see: Kranjc, K.; Kočevar, M. Curr. Org. Chem. 2013, 17, 457. 
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Scheme 4.11 
Continuing with the objective of the natural product synthesis, we proposed 
to use an oxidizing agent in this reaction, keeping the use of stoichiometric 
amounts of the catalyst, in order to improve the conversion of the reaction. The 
conditions shown in the entry 6 of the Table 4.3 were selected to carry out the 
following experiments. When molecular oxygen was used as an oxidizing agent, 
full conversion was achieved after 6 hours, observing a mixture of three products, 
ent-25, 36 and 37, in a good overall yield, but isolating the enantiomer of the 
natural product 25 in poor yield (Scheme 4.12). 
 
Scheme 4.12 
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Having obtained full conversion, we reduced the amount of the catalyst to 
the half, observing full conversion after 24 hours, but not improving the formation 
of the compound ent-25. We also tried to perform the reaction at 50 ºC, observing 
again a similar ratio between the previous formed three products. Changing the 
oxidant to p-benzoquinone or Cu(OAc)2, only low conversions were reached. On 
the other hand, when AgOAc was used as an oxidant, full conversion was 
achieved after 7 hours, observing again a mixture of the previously obtained three 
products, but in this case the ent-25 was isolated as the major product in 36% 
yield and with moderate diastereoselectivity (Scheme 4.13), not improving the 
result obtained in the case of use the conditions shown in the entry 8 of the Table 
4.3. With these last conditions, we tested the reaction under microwave 
irradiation, observing very low conversion of the product ent-25. Additionally, 
different silver salts were tested, not improving the result obtained with the 
AgOAc. 
 
Scheme 4.13 
In summary, the use of molecular oxygen or silver salts as oxidizing agents, 
increased the reaction rate, but a mixture of tetrahydropyran and 
tetrahydrooxepine derivatives were observed, isolating the target compound ent-
25 in low yield. With the conditions shown in the entry 8 of the Table 4.3, we 
decided to carry out the reaction using the lactone 26, in order to prepare the (+)-
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Greek tobacco lactone 25, which was isolated in 41% yield with moderate 
diastereoselectivity, and also observing the formation of the product ent-36 in 
15% yield (Scheme 4.14). It should be pointed out that the mesured specific 
rotation value matched with the one reported in the literature.6 
 
Scheme 4.14 
On the other hand, it should be highlighted that the formation of unsaturated 
seven-membered rings through an oxidative cyclization is a less explored field.23 
Moreover, our formed tetrahydrooxepine derivative 36 can be regarded as a 
structural part of the natural product armatol A (Figure 4.4). The total synthesis of 
this natural product was described by Jamison and co-workers,24 constructing the 
terminal tetrahydrooxepine ring system from the corresponding hydrazone, 
through the Shapiro reaction, in only 6% yield. It should be noted that in our case 
we could be able to prepare this diastereoisomer through the methodology 
developed up to this moment, starting the synthesis from geraniol. 
                                                     
23 Wu, L.; Qiu, S.; Liu, G. Org. Lett. 2009, 11, 2707. 
24 Underwood, B. S.; Tanuwidjaja, J.; Ng, S.-S.; Jamison, T. F. Tetrahedron 2013, 69, 5205. 
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Figure 4.4 
For these reasons, we decided to carry out a parallel study directed to 
improve the reaction outcome towards the formation of unsaturated seven-
membered oxepane rings. As it can be appreciated in the Scheme 4.11, the 
reaction in MeCN only afforded the both isomers of the tetrahydrooxepine 
derivatives. With this in mind, we initially tested the reaction of ent-26 using 
molecular oxygen as oxidant, observing full conversion after 1.5 hours, and 
isolating the compound 36 in 52% yield and its isomer 37 in 18% yield, improving 
the previous obtained result (entry 2 vs. entry 1 of the Table 4.4). With this 
promising result, we decided to decrease the amount of the palladium species, in 
order to carry out the reaction in catalytic conditions. With 0.5 equiv. of 
Pd(OCOCF3)2 similar results were obtained regarding the yield and the reaction 
rate (entry 3), but with 0.2 equiv. very low conversion was detected (entry 4). 
Using 0.5 equiv. of the Pd source as optimal amount, we tried to reduce the 
temperature, not observing full conversion after 24 hours (entry 5). With the 
purpose of promoting the reaction we used pyridine as ligand, not observing the 
formation of the product (entry 6). 
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Table 4.4: Evaluation of the 7-endo-trig cyclization. 
 
Entry 
Pd(OCOCF3)2 
(equiv.) 
Oxidant T (ºC) 
Conv. 
(%)a 
(36:37) 
Yield (%)b 
(36:37)c 
1 1 - 80 >95 32:8 3.8:1 
2 1 O2 80 >95 52:18 3.6:1 
3 0.5 O2 80 >95 49:15 3.8:1 
4 0.2 O2 80 n.d.d n.d.d 2.8:1 
5 0.5 O2 50 60 n.d.d 3.8:1 
6e 0.5 O2 80 n.r.f - - 
a Conversions determined by 1H-NMR analysis of non purified reaction mixtures. b Isolated 
product yield of each compound after flash column chromatography. c Ratios determined by 
1H-NMR analysis of non purified reaction mixtures. d Not determined. e Pyridine (1 equiv.) 
was used as ligand. f No reaction. 
In summary, with 0.5 equiv. of Pd(OCOCF3)2 in MeCN at 80 ºC, we were 
able to prepare the tetrahydrooxepine derivatives in a good overall yield. 
However, the 7-endo-trig cyclization has to be more investigated, with the aim of 
obtaining the tetrahydrooxepine derivative in catalytic and totally regioselective 
way, being able to extend this methodology to other substrates. 
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4. CONCLUSIONS 
Taking into account the results presented throughout this chapter, some 
conclusions can be outlined: 
1. The total synthesis of the (+)-Greek tobacco lactone was completed, starting 
from nerol, in seven steps and with an overall yield of 7%. It should be noted that 
it is possible to prepare both enantiomers of the natural product and possibly, 
different diastereoisomers starting the total synthesis from geraniol with the E-
configuration in the alkene. In the final step, the oxidative cyclization, 
stoichiometric amounts of palladium source were needed, obtaining a moderate 
yield and diastereoselectivity of the natural product. For this reason, further 
studies are necessary in order to increase the overall yield of the process. 
2. Additionally, changing the reaction conditions, we selectivily prepared 7-
endo-trig cyclization adducts in good yield although as mixture of C=C bond 
regioisomers, using substoichiometric amounts of Pd species. Furthermore, the 
approach developed here can be applicable to the construction of 
tetrahydrooxepine moiety of more complex natural products, such as armatol A, 
which require further investigations. 
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1. CONCLUSIONS 
Throughout the present work it has been demonstrated that the cascade 
processes initiated by conjugate additions, under iminium ion activation, represent 
a powerful tool for the enantioselective synthesis of polysubstituted compounds 
with a high level of complexity, in a simple way. From all the obtained results, we 
could conclude the following: 
a) 4-Alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides in Michael/Michael 
cascade reactions: It has been demonstrated that this type of compounds are able 
to participate in different cascade reactions due to their functionality. Initially, a 
novel aminocatalytic Michael/Michael cascade reaction has been developed, 
employing these compounds with enals, under iminium/enamine manifold, using a 
chiral secondary amine as catalyst, towards the formation of cyclohexanes and 
decaline derivatives in good yields and excellent stereocontrol. The 5H-1,2,3-
oxathiazole 2,2-dioxide scaffold could be employed as a masked 1,2-amino 
alcohol that can be prepared from the previously obtained cycloadducts, which can 
also be transformed into the corresponding bicycle[3.1.0]hexane derivatives in 
very good yields, through a transannular SN2 reaction/imine hydrolysis sequence, 
demonstrating the versatility of the sulfamidate imine moiety. Moreover, it is 
possible to prepare a different diastereoisomer of the bicycle[3.1.0]hexanes in 
moderate yields and excellent stereoselectivities through an organocatalytic 
multiple cascade reaction, consisting on a Michael/Michael/transannular 
nucleophilic substitution/imine hydrolysis sequence between 4-alkenyl-5H-1,2,3-
oxathiazole 2,2-dioxides and enals. 
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b) Organocatalytic approach to chiral proline derivatives: An 
aminocatalytic one-pot Michael/intramolecular condensation/diastereoselective 
reduction sequence, between aminomalonates and enones, has been developed as a 
novel methodology towards the synthesis of enantioenriched polysubstituted 
pyrrolidines in high yields, under iminium ion activation. The obtained pyrrolidine 
2,2-dicarboxylates can be transformed into the corresponding N-protected proline 
derivatives in very good yields and diastereoselectivities, through a base-promoted 
intramolecular C→N acyl rearrangement, that after deprotection of the resulting 
carbamates, the desired unprotected proline esters are obtained in good yields, 
demonstrating the utility of this methodology. 
c) Total synthesis of (+)-Greek tobacco lactone: The total synthesis of 
this natural product has been completed in seven steps and with an overall yield of 
7%, starting from the commercially available nerol. Moreover, changing the 
reaction conditions of the last step, the oxidative cyclization, it was possible to 
obtain the 7-endo-trig cyclization product in good yield, but as a mixture of 
isomers, using substoichiometric amounts of Pd species. 
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1. GENERAL METHODS AND MATERIALS 
NMR: Monodimensional and/or bidimensional nuclear magnetic resonance 
proton and carbon spectra (1H-NMR and 13C-NMR) were acquired at 25 ºC on a 
Bruker AC-300 spectrometer (300 MHz for 1H and 75.5 MHz for 13C), Jeol ECX 
400 spectrometer (400 MHz for 1H and 100.7 MHz for 13C), Bruker AC-500 
spectrometer (500 MHz for 1H and 125.7 MHz for 13C) and a Bruker AVANCE III 
700 spectrometer (700 MHz for 1H and 176.2 MHz for 13C). Chemical shifts (δ) 
are reported in ppm relative to residual solvent signals (CHCl3, 7.26 ppm for 1H-
NMR, CDCl3, 77.0 ppm for 13C-NMR. MeOH, 4.87 ppm and 3.31 ppm for 1H-
NMR, CD3OD, 49.1 ppm for 13C-NMR. CH3COCH3, 2.05 ppm for 1H-NMR, 
CD3COCD3, 206.7 ppm and 29.9 ppm for 13C-NMR) and coupling constants (J) in 
hertz (Hz). The following abbreviations are used to indicate the multiplicity in 
NMR spectra: s, singlet; d, doublet; t, triplet; q, quartet; app d, apparent doublet; 
app t, apparent triplet; dd, doublet of doublets; ddd, doublet of doublets of 
doublets; dq, doublet of quartets; m, multiplet; bs, broad signal. 13C-NMR spectra 
were acquired on a broad band decoupled mode using DEPT experiments 
(Distortionless Enhancement by Polarization Transfer) for assigning different 
types of carbon environment. Selective n.O.e., NOESY, COSY, HSQC and 
HMBC experiments were acquired to confirm precise molecular conformation and 
to assist in deconvoluting complex multiplet signals.1 
IR: Infrared spectra (IR) were measured in a Jasco FT/IR 4100 in the 
interval between 4000 and 400 cm-1 with a 4 cm-1 resolution. Only characteristic 
bands are given in each case. 
                                                 
1 Kinss, M.; Sanders, J. K. M. J. Mag. Res. 1984, 56, 518. 
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MS: Mass spectra (MS) were recorded on an Agilent 7890A gas 
chromatograph coupled to an Agilent 5975C quadropole mass spectrometer under 
electronic impact ionization (EI) 70 eV. The obtained data is presented in mass 
units (m/z) and the values found in brackets belong to the relative intensities 
comparing to the base peak (100%). 
M.p.: Melting points were measured in a Stuart SMP30 apparatus in open 
capilliary tubes and are uncorrected. 
Polarimetry: Optical rotations were measured at 20 ºC on a Jasco P-2000 
polarimeter with a sodium lamp at 589 nm and a path length of 1 dm. Solvent and 
concentration (g/dL) are specified in each case. 
HRMS: High resolution mass spectrometry experiments were performed in 
an Acquity GC coupled to a TOF mass spectrometer (GCT Micromass) using 
chemical ionization (CI) or on an Acquity UPLC coupled to a QTOF mass 
spectrometer (SYNAPT G2 HDMS) using electrospray ionization (ESI) at the 
SGIker Unit of the University of the Basque Country (UPV/EHU). 
HPLC: High performance liquid chromatography on a chiral stationary 
phase experiments were performed in a Waters 2695 chromatograph coupled to a 
Waters 2998 photodiode array detector. Daicel Chiralpak AD-H, AS-H and IA, 
and Chiralcel OZ-3 columns (0.46 cm x 25 cm) were used; specific conditions are 
indicated for each case. 
X-Ray: X-ray data collections were performed in an Agilent Supernova 
diffractometer equipped with an Atlas CCD area detector, and a CuK micro-
focus source with multilayer optics (λ = 1.54184 Å, 250 µm FWHM beam size) at 
the SGIker Unit of the University of the Basque Country (UPV/EHU). The quality 
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of the crystals was checked under a polarizing microscope, and a suitable crystal 
or fragment was mounted on a Mitegen MicromountTM using Paratone-N inert oil 
and transferred to the diffractometer. Alternatively, an Oxford Diffraction 
Xcalibur 2 diffractometer equipped with a Sapphire 2 CCD area detector, and a 
MoKα sealed-tube source with graphite monochromator (λ = 0.71073 Å, 0.5 mm 
collimator) was used. The samples were kept at 100(1) K with a Oxford 
Cryosystems Cryostream 700 cooler. 
Miscellaneous: Reactions were monitored using analytical thin layer 
chromatography (TLC), in pre-coated aluminium-backed plates (Merck Kieselgel 
60 F254). These were visualized by ultraviolet irradiation or by immersion in 
phosphomolybdic acid or KMnO4-H2SO4 ethanolic solutions.2 For flash 
chromatography Merck 60, 230-400 mesh silica gel was used.3 
Anhydrous solvents were purified and dried with activated molecular sieves 
prior to use.4 For the removal of solvents under reduced pressure Büchi R-210 
rotary evaporators were used. 
For reactions carried out under inert conditions, the argon was previously 
dried through a column of P2O5 and a column of KOH and CaCl2. All the 
glassware was dried for 12 hours prior to utilizing in an oven at 140 ºC and 
allowed to cool under a dehumidified atmosphere.5 
Reactions at reduced temperatures were carried out using a Termo Haake 
EK90 refrigerator. 
                                                 
2 Stahl, E. Thin Layer Chromatography, Springer-Verlag, Berlin, 1969. 
3 Still, W. C.; Kann, H.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
4 Armarego, W. L. F.; Chai, C. L. L. Purification of Laboratory Chemicals, Elsevier, Oxford, 2003. 
5 Kramer, G. W.; Levy, A. B.; Midland, M. M. Organic Synthesis via Boranes, John Wiley  Sons, 
New York, 1975. 
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2. 4-ALKENYL-5H-1,2,3-OXATHIAZOLE 2,2-DIOXIDES IN 
MICHAEL/MICHAEL CASCADE REACTIONS 
2.1. Synthesis of α-hydroxy ketones 2a and 2c-e. 
General procedure: 
To a mixture of CH3CN/H2O (5:1 mL), trifluoroacetic acid (2.00 mmol) and 
the corresponding alkenyl methyl ketone 1 (1.00 mmol) were added. Then 
[bis(trifluoroacetoxy)iodo]benzene (2.00 mmol) was added and the reaction was 
stirred under reflux during the time specified in each case and then allowed to 
reach room temperature. The solvent was removed under vacuum and H2O (5 mL) 
was added. The mixture was extracted with CH2Cl2 (3 × 10 mL) and the combined 
organic layers were washed with a solution of saturated aqueous NaHCO3 (3 × 10 
mL). The organic phase was dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The crude was purified by flash column 
chromatography (FC) with the indicated eluent to obtain the corresponding α-
hydroxy ketone 2. 
1-(Cyclohex-1-en-1-yl)-2-hydroxyethanone (2a) 
Following the general procedure, 2a (256 mg, 1.83 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 5 hours, starting from 1-(cyclohex-1-en-1-
yl)ethanone 1a (0.51 mL, 4.00 mmol), trifluoroacetic acid (0.61 mL, 8.00 mmol) 
and [bis(trifluoroacetoxy)iodo]benzene (3.44 g, 8.00 mmol) in a mixture of 
CH3CN/H2O (20:4 mL) as solvent. 
254 Chapter 5 
 
Yield: 46%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.81-6.71 (m, 1H, CH2CH), 4.42 (s, 
2H, CH2OH), 3.42 (s, 1H, OH), 2.23-2.08 (m, 4H, CH2CH+CH2CCH), 1.63-1.44 
(m, 4H, CH2CH2CH2CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 198.7 (CO), 141.2 (CH2CH), 136.2 
(CH2CCH), 64.1 (CH2OH), 25.9 (CH2CH), 22.7 (CH2CCH), 21.5, 21.4 
(CH2CH2CH2CH2). 
IR (ATR) cm-1: 3458 (O-H st), 1664 (C=O st). 
MS (EI) m/z (relative abundance): 140 (2), 124 (1), 109 (100), 81 (63), 65 
(6), 53 (26). 
HRMS: Calculated for [C8H13O2]+: 141.0916 [M+H]+; found: 141.0918. 
(E)-1-Hydroxy-3-methylpent-3-en-2-one (2c) 
Following the general procedure, 2c (634 mg, 5.56 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 6:4) as a 
yellow oil after 4 hours, starting from 3-methylpent-3-en-2-one 1c 
(2.34 mL, 20.00 mmol), trifluoroacetic acid (3.06 mL, 40.00 mmol) and 
[bis(trifluoroacetoxy)iodo]benzene (17.73 g, 40.00 mmol) in a mixture of 
CH3CN/H2O (100:20 mL) as solvent. 
Yield: 28%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.71-6.61 (m, 1H, CH3CH), 4.51 (s, 
2H, CH2OH), 3.42 (s, 1H, OH), 1.90-1.84 (m, 3H, CH3CH), 1.84-1.80 (m, 3H, 
CH3C). 
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13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.2 (CO), 138.8 (CH3CH), 135.2 
(CH3C), 64.2 (CH2OH), 14.6 (CH3CH), 10.8 (CH3C). 
IR (ATR) cm-1: 3440 (O-H st), 1674 (C=O st). 
MS (EI) m/z (relative abundance): 114 (7), 97 (11), 83 (66), 69 (18), 59 
(34), 55 (100). 
HRMS: Calculated for [C6H11O2]+: 115.0759 [M+H]+; found: 115.0764. 
(E)-1-Hydroxy-3-methylhex-3-en-2-one (2d) 
Following the general procedure, 2d (311 mg, 2.42 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 2 hours, starting from (E)-3-methylhex-3-en-2-
one6 1d (1.14 g, 10.17 mmol), trifluoroacetic acid (1.56 mL, 20.34 mmol) and 
[bis(trifluoroacetoxy)iodo]benzene (9.02 g, 20.34 mmol) in a mixture of 
CH3CN/H2O (50:10 mL) as solvent. 
Yield: 24%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.59-6.51 (m, 1H, CH2CH), 4.54 (s, 
2H, CH2OH), 3.44 (s, 1H, OH), 2.35-2.22 (m, 2H, CH2CH), 1.86-1.82 (m, 3H, 
CH3C), 1.09 (t, J = 7.6 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.5 (CO), 145.5 (CH2CH), 133.6 
(CH3C), 64.2 (CH2OH), 22.2 (CH2CH), 12.8 (CH3CH2), 11.0 (CH3C). 
IR (ATR) cm-1: 3462 (O-H st), 1667 (C=O st). 
                                                 
6 Austin, W. F.; Zhang, Y.; Danheiser, R. L. Org. Lett. 2005, 7, 3905. 
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MS (EI) m/z (relative abundance): 128 (2), 111 (2), 97 (100), 79 (2), 69 
(62), 53 (13). 
HRMS: Calculated for [C7H13O2]+: 129.0916 [M+H]+; found: 129.0911. 
(E)-1-Hydroxy-3-methyl-4-phenylbut-3-en-2-one (2e) 
Following the general procedure, 2e (1.36 g, 7.70 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 1:1) as a 
yellow oil after 2 hours, starting from 3-methyl-4-phenylbut-3-en-
2-one7 1e (3.07 g, 19.17 mmol), trifluoroacetic acid (2.94 mL, 38.33 mmol) and 
[bis(trifluoroacetoxy)iodo]benzene (17.00 g, 38.33 mmol) in a mixture of 
CH3CN/H2O (95:19 mL) as solvent. 
Yield: 40%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.49-7.36 (m, 6H, Carom-H+Carom-
CH), 4.71 (s, 2H, CH2OH), 3.49 (s, 1H, OH), 2.19-2.13 (m, 3H, CH3C). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.0 (CO), 139.8 (Carom-CH), 
135.0 (Carom-C), 133.8 (CH3C), 129.9, 129.2, 128.6 (Carom-H), 64.7 (CH2OH), 13.0 
(CH3C). 
IR (ATR) cm-1: 3457 (O-H st), 1665 (C=O st). 
MS (EI) m/z (relative abundance): 176 (1), 145 (81), 117 (58), 115 (100), 
91 (37), 77 (11), 51 (13). 
HRMS: Calculated for [C11H12O2Na]+: 199.0735 [M+Na]+; found: 
199.0740. 
                                                 
7 de Paula, B. R. S.; Zampieri, D. S.; Rodrigues, J. A. R.; Moran, P. J. S. Tetrahedron: Asymmetry 
2013, 24, 973. 
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2.2. Synthesis of 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides 3a-e. 
General procedure: 
To a solution of the corresponding α-hydroxy ketone 2 (1.00 mmol) in dry 
DMA (2.5 mL) under inert atmosphere, sulfamoyl chloride (2.00 mmol), 
previously released from chlorosulfonyl isocyanate with formic acid following 
representative procedure,8 was added portionwise. After stirring at room 
temperature for 2 hours, the reaction mixture was diluted with EtOAc (10 mL) and 
washed with brine (3 × 10 mL). The organic layer was dried over anhydrous 
Na2SO4, filtered and the solvent was removed under reduced pressure. Then p-
toluenesulfonic acid (0.10 mmol) and toluene (2.5 mL) were added, and the 
reaction was stirred under reflux for 1 hour with a Dean-Stark receiver. The 
mixture was diluted with EtOAc (10 mL) and washed with a solution of saturated 
aqueous NaHCO3 (3 × 10 mL). The organic layer was dried over Na2SO4, filtered 
and concentrated in vacuo. The crude was purified by flash column 
chromatography (FC) with the indicated eluent to give the corresponding cyclic 
sulfamidate imine 3. 
4-(Cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide (3a) 
Following the general procedure, 3a (283 mg, 1.41 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 6:4 to 1:1) as a 
yellow solid, starting from α-hydroxy ketone 2a (256 mg, 1.83 
mmol) and sulfamoyl chloride (423 mg, 3.66 mmol) in dry DMA 
(5 mL), and then p-toluenesulfonic acid (35 mg, 0.18 mmol) using toluene (5 mL) 
as solvent. 
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Yield: 77%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.80-6.77 (m, 1H, CH2CH), 5.31 (s, 
2H, OCH2), 2.40-2.35 (m, 4H, CH2CH+CH2CCH), 1.81-1.61 (m, 4H, 
CH2CH2CH2CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 175.7 (CN), 146.8 (CH2CH), 131.3 
(CH2CCH), 74.0 (OCH2), 26.9 (CH2CH), 24.2 (CH2CCH), 21.3, 21.1 
(CH2CH2CH2CH2). 
IR (ATR) cm-1: 1632 (C=C st), 1570 (C=N st), 1354 (SO2 st as), 1186 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 151-153. 
MS (EI) m/z (relative abundance): 201 (87), 186 (13), 172 (5), 160 (1), 144 
(2), 136 (5), 120 (33), 106 (100), 92 (56), 79 (88), 66 (26), 52 (33). 
HRMS: Calculated for [C8H12NO3S]+: 202.0538 [M+H]+; found: 202.0525. 
(E)-4-(1-Methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide (3c) 
Following the general procedure, 3c (544 mg, 3.10 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 6:4) as a 
yellow solid, starting from α-hydroxy ketone 2c (634 mg, 5.56 
mmol) and sulfamoyl chloride (1.28 g, 11.12 mmol) in dry DMA 
(14 mL), and then p-toluenesulfonic acid (106 mg, 0.56 mmol) using toluene (14 
mL) as solvent. 
Yield: 56%. 
                                                                                                                            
8 Lee, H.-K.; Kang, S.; Choi, E. B. J. Org. Chem. 2012, 77, 5454. 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 6.59-6.52 (m, 1H, CH3CH), 5.32 (s, 
2H, OCH2), 2.01-1.99 (m, 6H, CH3CH+CH3C). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 176.6 (CN), 144.2 (CH3CH), 130.2 
(CH3C), 74.1 (OCH2), 15.6 (CH3CH), 12.5 (CH3C). 
IR (ATR) cm-1: 1638 (C=C st), 1561 (C=N st), 1351 (SO2 st as), 1181 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 122-124. 
MS (EI) m/z (relative abundance): 175 (39), 160 (1), 135 (1), 110 (4), 94 
(14), 81 (100), 75 (1), 66 (21), 54 (46). 
HRMS: Calculated for [C6H10NO3S]+: 176.0381 [M+H]+; found: 176.0376. 
(E)-4-(1-Methylbut-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide (3d) 
Following the general procedure, 3d (305 mg, 1.61 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 6:4) as an 
orange solid, starting from α-hydroxy ketone 2d (300 mg, 2.34 
mmol) and sulfamoyl chloride (541 mg, 4.68 mmol) in dry DMA 
(6 mL), and then p-toluenesulfonic acid (44 mg, 0.23 mmol) using toluene (6 mL) 
as solvent. 
Yield: 69%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.46-6.40 (m, 1H, CH2CH), 5.33 (s, 
2H, OCH2), 2.42-2.32 (m, 2H, CH2CH), 2.00 (s, 3H, CH3C), 1.10 (t, J = 7.6 Hz, 
3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 176.9 (CN), 150.8 (CH2CH), 128.7 
(CH3C), 74.2 (OCH2), 23.0 (CH2CH), 12.6, 12.6 (CH3C+CH3CH2). 
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IR (ATR) cm-1: 1631 (C=C st), 1563 (C=N st), 1346 (SO2 st as), 1190 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 56-58. 
MS (EI) m/z (relative abundance): 189 (15), 174 (16), 162 (1), 149 (3), 135 
(1), 124 (7), 110 (33), 94 (100), 80 (29), 68 (48), 53 (39). 
HRMS: Calculated for [C7H12NO3S]+: 190.0538 [M+H]+; found: 190.0523. 
(E)-4-(1-Phenylprop-1-en-2-yl)-5H-1,2,3-oxathiazole 2,2-dioxide (3e) 
Following the general procedure, 3e (1.05 g, 4.41 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 1:1) as a 
white solid, starting from α-hydroxy ketone 2e (1.18 g, 6.69 
mmol) and sulfamoyl chloride (1.55 g, 13.39 mmol) in dry DMA 
(17 mL), and then p-toluenesulfonic acid (127 mg, 0.67 mmol) using toluene (17 
mL) as solvent. 
Yield: 66%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.52-7.41 (m, 5H, Carom-H), 7.20 
(app d, J = 1.2 Hz, 1H, Carom-CH), 5.48 (s, 2H, OCH2), 2.34 (d, J = 1.2 Hz, 3H, 
CH3C). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 177.2 (CN), 143.6 (Carom-CH), 
134.1 (Carom-C), 130.3, 130.3 (Carom-H), 129.0 (CH3C), 128.9 (Carom-H), 74.1 
(OCH2), 14.8 (CH3C). 
IR (ATR) cm-1: 1618 (C=C st), 1563 (C=N st), 1359 (SO2 st as), 1196 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 142-144. 
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MS (EI) m/z (relative abundance): 237 (4), 207 (1), 172 (4), 157 (100), 143 
(33), 130 (11), 115 (76), 102 (4), 91 (20), 77 (10), 63 (9), 51 (10). 
HRMS: Calculated for [C11H12NO3S]+: 238.0538 [M+H]+; found: 238.0542. 
Procedure for the synthesis of 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxide 
3b. 
4-(Cyclopent-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide (3b) 
To a mixture of CH3CN/H2O (100:20 mL), trifluoroacetic acid 
(3.06 mL, 40.00 mmol) and 1-(cyclopent-1-en-1-yl)ethanone 1b 
(2.38 mL, 20.00 mmol) were added. Then 
[bis(trifluoroacetoxy)iodo]benzene (17.73 g, 40.00 mmol) was 
added and the reaction was stirred under reflux during 5 hours and then allowed to 
reach room temperature. The solvent was removed under vacuum and H2O (100 
mL) was added. The mixture was extracted with CH2Cl2 (3 × 200 mL) and the 
combined organic layers were washed with a solution of saturated aqueous 
NaHCO3 (3 × 200 mL). The organic phase was dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure obtaining the corresponding α-
hydroxy ketone 2b, which was employed in the following step without further 
purification. To a solution of α-hydroxy ketone 2b in dry DMA (50 mL) under 
inert atmosphere, sulfamoyl chloride (4.62 g, 40.00 mmol) was added portionwise. 
After stirring at room temperature for 2 hours, the reaction mixture was diluted 
with EtOAc (200 mL) and washed with brine (3 × 200 mL). The resulting organic 
layer was dried over anhydrous Na2SO4, filtered and the solvent was removed 
under reduced pressure. Then p-toluenesulfonic acid (380 mg, 2.00 mmol) and 
toluene (50 mL) were added, and the reaction was stirred under reflux for 1 hour 
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with a Dean-Stark receiver. The mixture was diluted with EtOAc (200 mL) and 
washed with a solution of saturated aqueous NaHCO3 (3 × 200 mL). The resulting 
organic layer was dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo. After purification by flash column chromatography (FC) (hexanes/EtOAc 
gradient from 6:4 to 1:1) the cyclic sulfamidate imine 3b (258 mg, 1.38 mmol) 
was isolated as a brown solid. 
Yield: 7%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.94-6.86 (m, 1H, CH2CH), 5.30 (s, 
2H, OCH2), 2.81-2.65 (m, 4H, CH2CH+CH2CCH), 2.12-2.00 (m, 2H, 
CH2CH2CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.9 (CN), 150.8 (CH2CH), 135.9 
(CH2CCH), 74.3 (OCH2), 35.0 (CH2CCH), 31.4 (CH2CH), 22.4 (CH2CH2CH2). 
IR (ATR) cm-1: 1612 (C=C st), 1565 (C=N st), 1347 (SO2 st as), 1178 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 134-136. 
MS (EI) m/z (relative abundance): 187 (33), 159 (1), 122 (2), 106 (13), 93 
(79), 80 (12), 66 (100), 53 (7). 
HRMS: Calculated for [C7H10NO3S]+: 188.0381 [M+H]+; found: 188.0383. 
2.3. Synthesis of decalines 6a-i. 
General procedure: 
The α,β-unsaturated aldehyde 4 (1.50 or 2.00 mmol) was added to a solution 
of (S)-diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (0.20 mmol, 20 
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mol%), DABCO (0.20 mmol, 20 mol%) and the 4-(cyclohex-1-en-1-yl)-5H-1,2,3-
oxathiazole 2,2-dioxide 3a (1.00 mmol) in dry CHCl3 (2 mL) under inert 
atmosphere. The reaction mixture was stirred at the indicated temperature in each 
case, following its evolution by 1H-NMR. After consumption of the starting 
material, the product was isolated directly by flash column chromatography (FC) 
with the indicated eluent, obtaining the decalines 6a-i. The racemic standards for 
HPLC separation conditions were prepared under the same reaction conditions, 
using in these cases a 1:1 ratio of (R)- and (S)-diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether (0.20 mmol, 20 mol%) as catalyst at room 
temperature. 
(3aS,4R,5S,5aR,9aR)-4-Methyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6a) 
Following the general procedure, 6a (27 mg, 0.099 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow solid after 48 hours at -30 ºC, starting from 4-(cyclohex-
1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 mg, 0.150 
mmol) and (E)-crotonaldehyde 4a (19 μL, 0.225 mmol) in the 
presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 66%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 22.19 min, τminor = 35.53 min. 
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[]D20: +1.2 (c = 0.69, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.49 (d, J = 4.2 Hz, 1H, C-5CHO), 
4.81 (d, J = 10.6 Hz, 1H, H-3a), 2.39-2.28 (m, 1H, H-9a), 2.25-2.17 (m, 3H, H-
4+H-5+H-9a), 1.97-1.87 (m, 1H, H-8a), 1.86-1.76 (m, 3H, H-5a+H-6a+H-7a), 1.68-
1.54 (m, 1H, H-9b), 1.36-1.22 (m, 3H, H-6b+H-7b+H-8b), 1.19 (d, J = 6.0 Hz, 3H, 
C-4CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 185.5 (C-9b), 
89.9 (C-3a), 58.5 (C-5), 44.5 (C-9a), 43.6 (C-5a), 40.7 (C-4), 31.3 (C-6), 26.2 (C-
9), 25.0 (C-7), 24.4 (C-8), 17.0 (C-4CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1630 (C=N st), 1368 (SO2 st as), 1194 (SO2 
st sym). 
M.p. (n-hexane/i-PrOH) (ºC): 137-139. 
MS (EI) m/z (relative abundance): 271 (5), 243 (12), 227 (46), 214 (3), 201 
(25), 192 (15), 178 (58), 162 (31), 150 (29), 134 (9), 122 (16), 108 (36), 91 (19), 
81 (49), 71 (100), 55 (37). 
HRMS: Calculated for [C12H18NO4S]+: 272.0957 [M+H]+; found: 272.0946. 
(3aS,4R,5S,5aR,9aR)-4-Ethyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6b) 
Following the general procedure, 6b (28 mg, 0.099 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 60 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-pent-2-enal 4b (29 μL, 0.300 mmol) in 
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the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 66%. 
dr: >20:1. 
ee: 95%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 17.93 min, τminor = 25.57 min. 
[]D20: +1.9 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.47 (d, J = 4.5 Hz, 1H, C-5CHO), 
5.01 (d, J = 10.7 Hz, 1H, H-3a), 2.40-2.16 (m, 4H, H-9a+H-4+H-5+H-9a), 1.96-
1.87 (m, 1H, H-8a), 1.83-1.76 (m, 3H, H-5a+H-6a+H-7a), 1.74-1.66 (m, 1H, H-9b), 
1.62-1.49 (m, 2H, C-4CH2), 1.35-1.21 (m, 3H, H-6b+H-7b+H-8b), 0.97 (t, J = 7.5 
Hz, 3H, C-4CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 186.2 (C-9b), 
87.2 (C-3a), 55.6 (C-5), 45.6 (C-9a), 44.4 (C-5a), 43.4 (C-4), 31.4 (C-6), 26.3 (C-
9), 25.0 (C-7), 24.4 (C-8), 23.1 (C-4CH2), 8.7 (C-4CH2CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1631 (C=N st), 1369 (SO2 st as), 1194 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 285 (6), 256 (11), 241 (24), 228 (16), 
216 (5), 205 (78), 192 (93), 176 (100), 164 (36), 148 (27), 136 (35), 125 (34), 108 
(55), 95 (40), 81 (97), 67 (69), 55 (63). 
HRMS: Calculated for [C13H20NO4S]+: 286.1113 [M+H]+; found: 286.1116. 
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(3aS,4R,5S,5aR,9aR)-4-Propyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6c) 
Following the general procedure, 6c (32 mg, 0.107 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 60 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-hex-2-enal 4c (35 μL, 0.300 mmol) in 
the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 71%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 30.01 min, τminor = 42.72 min. 
[]D20: +2.8 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.47 (d, J = 4.4 Hz, 1H, C-5CHO), 
4.97 (d, J = 10.4 Hz, 1H, H-3a), 2.37-2.24 (m, 3H, H-9a+H-4+H-5), 2.22-2.15 (m, 
1H, H-9a), 1.96-1.88 (m, 1H, H-8a), 1.86-1.75 (m, 3H, H-5a+H-6a+H-7a), 1.61-
1.22 (m, 8H, H-9b+H-6b+H-7b+H-8b+C-4(CH2)2), 0.91 (t, J = 7.0 Hz, 3H, C-
4(CH2)2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 185.9 (C-9b), 
88.1 (C-3a), 56.6 (C-5), 44.8 (C-9a), 44.4 (C-5a), 43.5 (C-4), 33.3 (C-4(CH2)2), 
31.4 (C-6), 26.3 (C-9), 25.0 (C-7), 24.4 (C-8), 18.3 (C-4(CH2)2), 14.1 (C-
4(CH2)2CH3). 
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IR (ATR) cm-1: 1725 (C=O st), 1631 (C=N st), 1369 (SO2 st as), 1194 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 299 (5), 270 (11), 255 (16), 235 (13), 
219 (76), 206 (45), 190 (100), 176 (24), 164 (37), 150 (30), 136 (25), 125 (32), 
108 (45), 95 (47), 81 (67), 67 (58), 55 (64). 
HRMS: Calculated for [C14H22NO4S]+: 300.1270 [M+H]+; found: 300.1258. 
(3aS,4R,5S,5aR,9aR)-4-Butyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6d) 
Following the general procedure, 6d (32 mg, 0.101 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 72 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-hept-2-enal 4d (39 μL, 0.300 mmol) 
in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 67%. 
dr: >20:1. 
ee: 95%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 27.02 min, τminor = 36.08 min. 
[]D20: +2.3 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.47 (d, J = 4.4 Hz, 1H, C-5CHO), 
4.99 (d, J = 10.5 Hz, 1H, H-3a), 2.38-2.24 (m, 3H, H-9a+H-4+H-5), 2.21-2.16 (m, 
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1H, H-9a), 1.91-1.88 (m, 1H, H-8a), 1.85-1.76 (m, 3H, H-5a+H-6a+H-7a), 1.65-
1.24 (m, 10H, H-9b+H-6b+H-7b+H-8b+C-4(CH2)3), 0.88 (t, J = 7.0 Hz, 3H, C-
4(CH2)3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.5 (C-5CHO), 186.1 (C-9b), 
88.0 (C-3a), 56.4 (C-5), 44.8 (C-9a), 44.4 (C-5a), 43.5 (C-4), 31.4 (C-6), 30.6 (C-
4(CH2)3), 26.8 (C-4(CH2)3), 26.3 (C-9), 25.0 (C-7), 24.4 (C-8), 22.7 (C-4(CH2)3), 
13.8 (C-4(CH2)3CH3). 
IR (ATR) cm-1: 1724 (C=O st), 1632 (C=N st), 1371 (SO2 st as), 1195 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 313 (3), 233 (45), 220 (28), 204 (100), 
190 (16), 176 (15), 164 (25), 148 (17), 125 (23), 109 (22), 95 (29), 81 (43), 67 
(39), 55 (45). 
HRMS: Calculated for [C15H24NO4S]+: 314.1426 [M+H]+; found: 314.1420. 
(3aS,4R,5S,5aR,9aR)-4-Isobutyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6e) 
Following the general procedure, 6e (30 mg, 0.097 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 60 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-5-methylhex-2-enal 4e (34 mg, 0.300 
mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
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Yield: 65%. 
dr: >20:1. 
ee: 97%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 26.32 min, τminor = 32.17 min. 
[]D20: +5.3 (c = 0.69, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.46 (d, J = 4.4 Hz, 1H, C-5CHO), 
4.89 (d, J = 10.1 Hz, 1H, H-3a), 2.35-2.16 (m, 4H, H-9a+H-4+H-5+H-9a), 1.94-
1.89 (m, 1H, H-8a), 1.84-1.75 (m, 3H, H-5a+H-6a+H-7a), 1.63-1.22 (m, 7H, H-
9b+H-6b+H-7b+H-8b+C-4CH2+CH(CH3)2), 0.91-0.87 (m, 6H, CH(CH3)2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 185.4 (C-9b), 
90.0 (C-3a), 58.4 (C-5), 44.4 (C-9a), 43.3 (C-5a), 43.0 (C-4), 42.9 (C-4CH2), 31.4 
(C-6), 26.3 (C-9), 25.6 (CH(CH3)2), 25.0 (C-7), 24.4 (C-8), 23.3, 21.9 
(CH(CH3)2). 
IR (ATR) cm-1: 1725 (C=O st), 1632 (C=N st), 1368 (SO2 st as), 1194 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 233 (82), 204 (46), 176 (61), 162 (11), 
146 (95), 120 (100), 106 (40), 91 (32), 77 (30), 64 (19). 
HRMS: Calculated for [C15H24NO4S]+: 314.1426 [M+H]+; found: 314.1421. 
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(3aS,4R,5S,5aR,9aR)-4-Pentyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6f) 
Following the general procedure, 6f (30 mg, 0.092 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 9:1 to 
8:2) as a yellow oil after 72 hours at room temperature, 
starting from 4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3a (30 mg, 0.150 mmol) and (E)-oct-2-enal 4f 
(45 μL, 0.300 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 61%. 
dr: >20:1. 
ee: 95%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 25.69 min, τminor = 34.01 min. 
[]D20: +3.4 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.47 (d, J = 4.4 Hz, 1H, C-5CHO), 
4.99 (d, J = 10.4 Hz, 1H, H-3a), 2.38-2.24 (m, 3H, H-9a+H-4+H-5), 2.22-2.16 (m, 
1H, H-9a), 1.93-1.88 (m, 1H, H-8a), 1.85-1.74 (m, 3H, H-5a+H-6a+H-7a), 1.66-
1.22 (m, 12H, H-9b+H-6b+H-7b+H-8b+C-4(CH2)4), 0.87 (t, J = 6.9 Hz, 3H, C-
4(CH2)4CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 186.0 (C-9b), 
88.0 (C-3a), 56.4 (C-5), 44.9 (C-9a), 44.4 (C-5a), 43.5 (C-4), 31.7 (C-4(CH2)4), 
31.4 (C-6), 30.8 (C-4(CH2)4), 26.3 (C-9), 25.0 (C-7), 24.4 (C-8), 24.3, 22.3 (C-
4(CH2)4), 13.9 (C-4(CH2)4CH3). 
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IR (ATR) cm-1: 1724 (C=O st), 1632 (C=N st), 1372 (SO2 st as), 1195 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 327 (6), 281 (38), 234 (89), 207 (100), 
164 (33), 136 (49), 108 (34), 81 (68), 55 (90). 
HRMS: Calculated for [C16H26NO4S]+: 328.1583 [M+H]+; found: 328.1585. 
(3aS,4R,5S,5aR,9aR)-4-Hexyl-4,5,5a,6,7,8,9,9a-octahydro-3aH-naphtho[1,2-
d][1,2,3]oxathiazole-5-carbaldehyde 2,2-dioxide (6g) 
Following the general procedure, 6g (29 mg, 0.085 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 9:1 to 
8:2) as a yellow oil after 72 hours at room temperature, 
starting from 4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3a (30 mg, 0.150 mmol) and (E)-non-2-enal 4g 
(50 μL, 0.300 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 57%. 
dr: >20:1. 
ee: 95%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 26.36 min, τminor = 34.75 min. 
[]D20: +2.3 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.47 (d, J = 4.3 Hz, 1H, C-5CHO), 
4.99 (d, J = 10.4 Hz, 1H, H-3a), 2.39-2.23 (m, 3H, H-9a+H-4+H-5), 2.21-2.14 (m, 
1H, H-9a), 1.95-1.87 (m, 1H, H-8a), 1.84-1.75 (m, 3H, H-5a+H-6a+H-7a), 1.66-
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1.20 (m, 14H, H-9b+H-6b+H-7b+H-8b+C-4(CH2)5), 0.87 (t, J = 6.4 Hz, 3H, C-
4(CH2)5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.4 (C-5CHO), 186.0 (C-9b), 
88.0 (C-3a), 56.4 (C-5), 44.9 (C-9a), 44.4 (C-5a), 43.5 (C-4), 31.5 (C-4(CH2)5), 
31.4 (C-6), 30.9, 29.2 (C-4(CH2)5), 26.3 (C-9), 25.0 (C-7), 24.7 (C-4(CH2)5), 24.4 
(C-8), 22.5 (C-4(CH2)5), 14.0 (C-4(CH2)5CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1632 (C=N st), 1371 (SO2 st as), 1197 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 341 (2), 281 (12), 261 (54), 232 (5), 207 
(28), 146 (13), 96 (20), 79 (18), 55 (24). 
HRMS: Calculated for [C17H28NO4S]+: 342.1739 [M+H]+; found: 342.1725. 
(3aS,3bR,7S,7aS,7bR,11aR)-Benzyl 7-hydroxy-4,5,7,7a,7b,8,9,10,11,11a-
decahydro-3aH-benzo[h][1,2,3]oxathiazolo[5,4-f]isoquinoline-6(3bH)-
carboxylate 2,2-dioxide (6h) 
Following the general procedure, 6h (38 mg, 0.092 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 6:4) as a 
yellow oil after 48 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-benzyl (5-oxopent-3-en-1-
yl)carbamate 4h (70 μL, 0.300 mmol) in the presence of DABCO (3 mg, 0.030 
mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 61%. 
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dr: >20:1. 
ee: 94%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 33.52 min, τminor = 63.03 
min. 
[]D20: +7.1 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.40-7.32 (m, 5H, Carom-H), 5.98-
5.92 (m, 1H, H-7), 5.15 (s, 2H, OCH2), 4.73 (d, J = 10.8 Hz, 1H, H-3a), 4.05-3.97 
(m, 1H, H-5a), 3.23-3.17 (m, 1H, H-5b), 2.46 (bs, 1H, OH), 2.26-2.11 (m, 5H, H-
3b+H-11a+H-11a+H-8a+H-4a), 1.92-1.83 (m, 2H, H-9a+H-10a), 1.72-1.59 (m, 2H, 
H-7b+H-11b), 1.48-1.40 (m, 2H, H-7a, H-4b), 1.32-1.24 (m, 2H, H-9b+H-10b), 
1.18-1.10 (m, 1H, H-8b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 186.1 (C-11b), 156.1 (NCO), 136.0 
(Carom-C), 128.7, 128.4, 128.0 (Carom-H), 89.9 (C-3a), 73.6 (C-7), 67.7 (OCH2), 
45.2 (C-7a), 45.1 (C-11a), 44.3 (C-7b), 41.7 (C-3b), 37.5 (C-5), 29.8 (C-4), 29.4 
(C-8), 26.2 (C-11), 25.1, 24.7 (C-9+C-10). 
IR (ATR) cm-1: 3408 (O-H st), 1682 (C=O st), 1629 (C=N st), 1369 (SO2 st 
as), 1197 (SO2 st sym). 
MS (EI) m/z (relative abundance): 207 (13), 218 (4), 147 (18), 129 (100), 
112 (24), 83 (17), 70 (31), 57 (38). 
HRMS: Calculated for [C21H26N2O6SNa]+: 457.1409 [M+Na]+; found: 
457.1410. 
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(3aS,4S,5S,5aR,9aR,9bR)-5-(Hydroxymethyl)-4-phenyldecahydro-1H-
naphtho[1,2-d][1,2,3]oxathiazole 2,2-dioxide (6i) 
Following the general procedure, 6i (15 mg, 0.045 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 6:4 to 1:1) as a 
white solid after 48 hours at room temperature, starting from 4-
(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3a (30 
mg, 0.150 mmol) and (E)-cinnamaldehyde 4i (28 μL, 0.225 
mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent, followed by reduction with NaBH4 (7 mg, 0.180 
mmol) in MeOH (2 mL) at 0 ºC during 15 minutes and quenched with a solution 
of saturated aqueous NH4Cl (1.5 mL). The mixture was extracted with CH2Cl2 (3 
× 5 mL) and the combined organic layers were dried with anhydrous Na2SO4, 
filtered and the solvent was removed under reduced pressure. 
Yield: 30%. 
dr: >20:1. 
ee: 97%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 26.01 min, τminor = 17.56 min. 
[]D20: -92.5 (c = 0.44, MeOH). 
1H-NMR (, ppm) (MeOD, 300 MHz): 7.35-7.23 (m, 5H, Carom-H), 4.92-
4.88 (m, 1H, H-3a), 4.10-4.04 (m, 1H, H-9b), 3.62 (dd, J = 11.2, 2.3 Hz, 1H, 
CHaHbOH), 3.40-3.29 (m, 1H, H-4), 3.05 (dd, J = 11.2, 2.0 Hz, 1H, CHaHbOH), 
2.19-2.10 (m, 1H, H-6a), 1.87-1.66 (m, 5H, H-7a+H-8a+H-9a+H-5a+H-9a), 1.44-
1.29 (m, 4H, H-5+H-9b+H-7b+H-8b), 1.00-0.86 (m, 1H, H-6b). 
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13C-NMR (, ppm) (MeOD, 125.7 MHz): 142.0 (Carom-C), 130.2, 129.7, 
128.1 (Carom-H), 92.0 (C-3a), 61.9 (C-9b), 58.7 (CH2OH), 47.9 (C-5), 47.2 (C-4), 
43.2 (C-9a), 35.8 (C-5a), 31.8 (C-9), 31.1 (C-6), 27.6, 27.3 (C-7+C-8). 
IR (ATR) cm-1: 3551 (O-H st), 1339 (SO2 st as), 1185 (SO2 st sym). 
M.p. (hexanes/EtOAc) (ºC): 177-179. 
MS (EI) m/z (relative abundance): 281 (38), 239 (13), 207 (100), 179 (13), 
148 (60), 117 (24), 91 (44), 64 (26). 
HRMS: Calculated for [C17H24NO4S]+: 338.1426 [M+H]+; found: 338.1431. 
2.4. Synthesis of cyclohexanes 7a-s. 
General procedure: 
The α,β-unsaturated aldehyde 4 (1.50 or 2.00 mmol) was added to a solution 
of (S)-diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (0.20 mmol, 20 
mol%), DABCO (0.20 mmol, 20 mol%) and the corresponding 4-alkenyl-5H-
1,2,3-oxathiazole 2,2-dioxide 3c-e (1.00 mmol) in dry CHCl3 (2 mL) under inert 
atmosphere. The reaction mixture was stirred at -30 ºC, following its evolution by 
1H-NMR. After consumption of the starting material, in the indicated cases, it was 
necessary to leave the reaction at room temperature during four hours in order to 
improve the diastereoselectivity of the process. Finally, the product was isolated 
directly by flash column chromatography (FC) with the indicated eluent, obtaining 
the cycloadducts 7a-s. The racemic standards for HPLC separation conditions 
were prepared under the same reaction conditions, using in these cases a 1:1 ratio 
of (R)- and (S)-diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether (0.20 mmol, 20 
mol%) as catalyst at room temperature. 
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(4R,5R,6S,7S,7aS)-4,5-Dimethyl-7-phenyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7a) 
Following the general procedure, 7a (30 mg, 0.099 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow solid after 60 hours, starting from (E)-4-(1-methylprop-1-
en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c (26 mg, 0.150 mmol) 
and (E)-cinnamaldehyde 4i (28 μL, 0.225 mmol) in the presence of 
DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 66%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 50.49 min, τminor = 39.03 
min. 
[]D20: -50.3 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.34 (d, J = 3.8 Hz, 1H, C-6CHO), 
7.40-7.20 (m, 5H, Carom-H), 5.28 (d, J = 11.5 Hz, 1H, H-7a), 3.23 (app t, J = 11.7 
Hz, 1H, H-7), 2.95-2.82 (m, 1H, H-6), 2.60 (dq, J = 12.6, 6.3 Hz, 1H, H-4), 2.08-
1.93 (m, 1H, H-5), 1.43 (d, J = 6.3 Hz, 3H, C-4CH3), 1.18 (d, J = 6.5 Hz, 3H, C-
5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.7 (C-6CHO), 186.2 (C-3a), 
135.0 (Carom-C), 129.5, 128.8, 127.8 (Carom-H), 89.1 (C-7a), 57.9 (C-6), 51.5 (C-7), 
41.7 (C-4), 40.2 (C-5), 17.6 (C-5CH3), 13.0 (C-4CH3). 
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IR (ATR) cm-1: 1727 (C=O st), 1631 (C=N st), 1369 (SO2 st as), 1198 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 142-144 (Decomposed). 
MS (EI) m/z (relative abundance): 307 (7), 278 (21), 198 (100), 182 (31), 
145 (13), 131 (64), 117 (15), 104 (31), 91 (58), 77 (32), 64 (11), 51 (12). 
HRMS: Calculated for [C15H18NO4S]+: 308.0957 [M+H]+; found: 308.0954. 
(4R,5R,6S,7S,7aS)-4,5-Dimethyl-7-(p-tolyl)-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7b) 
Following the general procedure, 7b (28 mg, 0.088 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 6:4) 
as a yellow oil after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
(26 mg, 0.150 mmol) and (E)-4-methylcinnamaldehyde 4j (33 
mg, 0.225 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. After full conversion, the reaction was stirred at room 
temperature during four hours to achieve only one diastereoisomer. 
Yield: 59%. 
dr: >20:1. 
ee: >99%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 20.88 min, τminor = -. 
[]D20: -71.8 (c = 1.03, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 9.34 (d, J = 3.9 Hz, 1H, C-6CHO), 
7.17 (d, J = 8.2 Hz, 2H, Carom-H), 7.11 (d, J = 8.2 Hz, 2H, Carom-H), 5.25 (d, J = 
11.3 Hz, 1H, H-7a), 3.20 (app t, J = 11.7 Hz, 1H, H-7), 2.91-2.79 (m, 1H, H-6), 
2.59 (dq, J = 12.6, 6.3 Hz, 1H, H-4), 2.33 (s, 3H, Carom-CH3), 2.06-1.92 (m, 1H, H-
5), 1.43 (d, J = 6.3 Hz, 3H, C-4CH3), 1.18 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.7 (C-6CHO), 186.1 (C-3a), 
138.8, 132.0 (Carom-C), 130.2, 127.6 (Carom-H), 89.2 (C-7a), 58.0 (C-6), 51.2 (C-7), 
41.7 (C-4), 40.1 (C-5), 21.1 (Carom-CH3), 17.7 (C-5CH3), 13.0 (C-4CH3). 
IR (ATR) cm-1: 1727 (C=O st), 1626 (C=N st), 1368 (SO2 st as), 1198 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 321 (12), 292 (16), 212 (100), 196 (33), 
145 (39), 128 (17), 115 (30), 91 (27), 77 (11). 
HRMS: Calculated for [C16H20NO4S]+: 322.1113 [M+H]+; found: 322.1115. 
(4R,5R,6S,7S,7aS)-7-(4-Methoxyphenyl)-4,5-dimethyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7c) 
Following the general procedure, 7c (33 mg, 0.098 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as a yellow oil after 48 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3c (26 mg, 0.150 mmol) and (E)-4-
methoxycinnamaldehyde 4l (37 mg, 0.225 mmol) in the presence of DABCO (3 
mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 
0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
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Yield: 65%. 
dr: >20:1. 
ee: >99%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 21.73 min, τminor = -. 
[]D20: -60.5 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.33 (d, J = 3.9 Hz, 1H, C-6CHO), 
7.14 (d, J = 8.6 Hz, 2H, Carom-H), 6.88 (d, J = 8.6 Hz, 2H, Carom-H), 5.22 (d, J = 
11.3 Hz, 1H, H-7a), 3.78 (s, 3H, OCH3), 3.19 (app t, J = 11.7 Hz, 1H, H-7), 2.90-
2.78 (m, 1H, H-6), 2.58 (dq, J = 12.6, 6.3 Hz, 1H, H-4), 2.07-1.89 (m, 1H, H-5), 
1.42 (d, J = 6.3 Hz, 3H, C-4CH3), 1.17 (d, J = 6.4 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.8 (C-6CHO), 186.2 (C-3a), 
159.8 (Carom-C), 128.9 (Carom-H), 126.9 (Carom-C), 114.8 (Carom-H), 89.3 (C-7a), 
58.1 (C-6), 55.3 (OCH3), 50.8 (C-7), 41.7 (C-4), 40.1 (C-5), 17.6 (C-5CH3), 13.0 
(C-4CH3). 
IR (ATR) cm-1: 1726 (C=O st), 1625 (C=N st), 1368 (SO2 st as), 1197 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 337 (32), 281 (15), 256 (17), 228 (93), 
207 (40), 160 (56), 134 (100), 108 (57), 91 (28), 64 (28). 
HRMS: Calculated for [C16H20NO5S]+: 338.1062 [M+H]+; found: 338.1053. 
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(4R,5R,6S,7S,7aS)-7-(4-Acetoxy-3-methoxyphenyl)-4,5-dimethyl-5,6,7,7a-
tetrahydro-4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7d) 
Following the general procedure, 7d (43 mg, 0.108 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as a yellow oil after 48 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3c (26 mg, 0.150 mmol) and (E)-4-acetoxy-3-
methoxycinnamaldehyde 4m (52 mg, 0.225 mmol) in the presence of DABCO (3 
mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 
0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 72%. 
dr: >20:1. 
ee: >99%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 85.52 min, τminor = -. 
[]D20: -46.1 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.36 (d, J = 3.7 Hz, 1H, C-6CHO), 
7.02 (d, J = 8.1 Hz, 1H, Carom-H), 6.85-6.76 (m, 2H, Carom-H), 5.23 (d, J = 11.2 Hz, 
1H, H-7a), 3.81 (s, 3H, OCH3), 3.20 (app t, J = 11.7 Hz, 1H, H-7), 2.95-2.86 (m, 
1H, H-6), 2.59 (dq, J = 12.6, 6.4 Hz, 1H, H-4), 2.30 (s, 3H, OCOCH3), 2.04-1.89 
(m, 1H, H-5), 1.41 (d, J = 6.4 Hz, 3H, C-4CH3), 1.17 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.6 (C-6CHO), 185.9 (C-3a), 
168.7 (OCOCH3), 151.7, 140.0, 133.8 (Carom-C), 123.7, 119.4, 112.3 (Carom-H), 
88.9 (C-7a), 57.6 (C-6), 56.1 (OCH3), 51.3 (C-7), 41.7 (C-4), 40.3 (C-5), 20.7 
(OCOCH3), 17.6 (C-5CH3), 13.0 (C-4CH3). 
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IR (ATR) cm-1: 1762 (OC=O st), 1727 (C=O st), 1629 (C=N st), 1367 (SO2 
st as), 1196 (SO2 st sym). 
MS (EI) m/z (relative abundance): 281 (46), 253 (10), 207 (100), 177 (12), 
129 (59), 96 (17), 64 (33). 
HRMS: Calculated for [C18H22NO7S]+: 396.1117 [M+H]+; found: 396.1126. 
(4R,5R,6S,7S,7aS)-7-(3,5-Dimethoxyphenyl)-4,5-dimethyl-5,6,7,7a-tetrahydro-
4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7e) 
Following the general procedure, 7e (39 mg, 0.106 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as a yellow oil after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3c (26 mg, 0.150 mmol) and (E)-3,5-
dimethoxycinnamaldehyde9 4n (43 mg, 0.225 mmol) in 
the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 71%. 
dr: >20:1. 
ee: 99%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 56.28 min, τminor = 42.95 
min. 
                                                 
9 Barcelos, R. C.; Pastre, J. C.; Caixeta, V.; Vendramini-Costa, D. B.; de Carvalho, J. E.; Pilli, R. A. 
Bioorg. Med. Chem. 2012, 20, 3635. 
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[]D20: -38.8 (c = 0.90, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.38 (d, J = 3.6 Hz, 1H, C-6CHO), 
6.39 (t, J = 2.2 Hz, 1H, Carom-H), 6.35 (d, J = 2.2 Hz, 2H, Carom-H), 5.27 (d, J = 
11.3 Hz, 1H, H-7a), 3.77 (s, 6H, 2 × OCH3), 3.13 (app t, J = 11.7 Hz, 1H, H-7), 
2.90-2.77 (m, 1H, H-6), 2.57 (dq, J = 12.6, 6.4 Hz, 1H, H-4), 2.03-1.91 (m, 1H, H-
5), 1.42 (d, J = 6.4 Hz, 3H, C-4CH3), 1.18 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.5 (C-6CHO), 186.0 (C-3a), 
161.5, 137.3 (Carom-C), 105.9, 100.1 (Carom-H), 88.8 (C-7a), 57.8 (C-6), 55.4 
(OCH3), 51.8 (C-7), 41.7 (C-4), 40.2 (C-5), 17.6 (C-5CH3), 13.0 (C-4CH3). 
IR (ATR) cm-1: 1726 (C=O st), 1629 (C=N st), 1367 (SO2 st as), 1197 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 348 (5), 277 (23), 217 (13), 191 (15), 
164 (100), 113 (21), 71 (33). 
HRMS: Calculated for [C17H22NO6S]+: 368.1168 [M+H]+; found: 368.1167. 
(4R,5R,6S,7S,7aS)-7-(4-Chlorophenyl)-4,5-dimethyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7f) 
Following the general procedure, 7f (44 mg, 0.130 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as a yellow solid after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
(35 mg, 0.200 mmol) and (E)-4-chlorocinnamaldehyde 4o 
(52 mg, 0.300 mmol) in the presence of DABCO (4 mg, 0.040 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (14 mg, 0.040 mmol) and using dry 
CHCl3 (0.4 mL) as solvent. 
Experimental 283 
 
Yield: 65%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 16.28 min, τminor = 18.19 
min. 
[]D20: -55.9 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.36 (d, J = 3.9 Hz, 1H, C-6CHO), 
7.38-7.31 (m, 2H, Carom-H), 7.20-7.14 (m, 2H, Carom-H), 5.22 (d, J = 11.3 Hz, 1H, 
H-7a), 3.23 (app t, J = 11.7 Hz, 1H, H-7), 2.94-2.79 (m, 1H, H-6), 2.60 (dq, J = 
12.7, 6.4 Hz, 1H, H-4), 2.07-1.91 (m, 1H, H-5), 1.42 (d, J = 6.4 Hz, 3H, C-4CH3), 
1.19 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.4 (C-6CHO), 185.9 (C-3a), 
134.8, 133.6 (Carom-C), 129.7, 129.1 (Carom-H), 88.8 (C-7a), 57.8 (C-6), 50.8 (C-7), 
41.7 (C-4), 40.3 (C-5), 17.6 (C-5CH3), 12.9 (C-4CH3). 
IR (ATR) cm-1: 1728 (C=O st), 1626 (C=N st), 1360 (SO2 st as), 1202 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 188-190 (Decomposed). 
MS (EI) m/z (relative abundance): 258 (53), 207 (100), 180 (16), 147 (31), 
119 (17), 79 (19), 50 (31). 
HRMS: Calculated for [C15H17NO4SCl]+: 342.0567 [M+H]+; found: 
342.0553. 
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(4R,5R,6S,7S,7aS)-7-(4-Bromophenyl)-4,5-dimethyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7g) 
Following the general procedure, 7g (39 mg, 0.100 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as an orange solid after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
(26 mg, 0.150 mmol) and (E)-4-bromocinnamaldehyde 4p 
(49 mg, 0.225 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 67%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 29.41 min, τminor = 22.99 min. 
[]D20: -62.3 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.35 (d, J = 3.8 Hz, 1H, C-6CHO), 
7.50 (d, J = 8.5 Hz, 2H, Carom-H), 7.11 (d, J = 8.5 Hz, 2H, Carom-H), 5.23 (d, J = 
11.3 Hz, 1H, H-7a), 3.21 (app t, J = 11.7 Hz, 1H, H-7), 2.93-2.81 (m, 1H, H-6), 
2.60 (dq, J = 12.6, 6.4 Hz, 1H, H-4), 2.06-1.92 (m, 1H, H-5), 1.42 (d, J = 6.4 Hz, 
3H, C-4CH3), 1.19 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.4 (C-6CHO), 185.9 (C-3a), 
134.1 (Carom-C), 132.6, 129.5 (Carom-H), 122.9 (Carom-C), 88.7 (C-7a), 57.7 (C-6), 
50.8 (C-7), 41.7 (C-4), 40.3 (C-5), 17.6 (C-5CH3), 13.0 (C-4CH3). 
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IR (ATR) cm-1: 1726 (C=O st), 1630 (C=N st), 1369 (SO2 st as), 1198 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 110-112. 
MS (EI) m/z (relative abundance): 305 (53), 281 (36), 207 (89), 180 (29), 
147 (59), 119 (3), 84 (100), 51 (41). 
HRMS: Calculated for [C15H17NO4SBr]+: 386.0062 [M+H]+; found: 
386.0072. 
(4R,5R,6S,7S,7aS)-4,5-Dimethyl-7-(4-nitrophenyl)-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7h) 
Following the general procedure, 7h (39 mg, 0.110 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 6:4 to 
1:1) as a yellow oil after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3c (26 mg, 0.150 mmol) and (E)-4-nitrocinnamaldehyde 4r 
(41 mg, 0.225 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. After full conversion, the reaction was stirred at room 
temperature during four hours to achieve only one diastereoisomer. 
Yield: 73%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 41.51 min, τminor = 49.45 
min. 
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[]D20: -54.8 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.42 (d, J = 3.7 Hz, 1H, C-6CHO), 
8.22 (d, J = 8.7 Hz, 2H, Carom-H), 7.44 (d, J = 8.7 Hz, 2H, Carom-H), 5.28 (d, J = 
11.3 Hz, 1H, H-7a), 3.40 (app t, J = 11.7 Hz, 1H, H-7), 3.02-2.93 (m, 1H, H-6), 
2.67 (dq, J = 12.7, 6.4 Hz, 1H, H-4), 2.10-1.97 (m, 1H, H-5), 1.45 (d, J = 6.4 Hz, 
3H, C-4CH3), 1.24 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 198.9 (C-6CHO), 185.5 (C-3a), 
148.0, 142.4 (Carom-C), 129.0, 124.6 (Carom-H), 88.1 (C-7a), 57.5 (C-6), 50.8 (C-7), 
41.8 (C-4), 40.6 (C-5), 17.6 (C-5CH3), 12.9 (C-4CH3). 
IR (ATR) cm-1: 1726 (C=O st), 1629 (C=N st), 1521 (NO2 st as), 1372 (SO2 
st as), 1347 (NO2 st sym), 1199 (SO2 st sym). 
MS (EI) m/z (relative abundance): 281 (34), 245 (40), 207 (100), 170 (41), 
142 (69), 115 (57), 91 (25), 64 (33). 
HRMS: Calculated for [C15H17N2O6S]+: 353.0807 [M+H]+; found: 
353.0815. 
(4R,5R,6S,7S,7aS)-7-(4-Cyanophenyl)-4,5-dimethyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7i) 
Following the general procedure, 7i (37 mg, 0.110 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 6:4 to 
1:1) as a yellow oil after 48 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
(26 mg, 0.150 mmol) and (E)-4-cyanocinnamaldehyde10 4s 
                                                 
10 Battistuzzi, G.; Cacchi, S.; Fabrizi, G. Org. Lett. 2003, 5, 777. 
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(35 mg, 0.225 mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 73%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 35.29 min, τminor = 44.40 
min. 
[]D20: -59.9 (c = 0.83, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.39 (d, J = 3.7 Hz, 1H, C-6CHO), 
7.67 (d, J = 8.3 Hz, 2H, Carom-H), 7.37 (d, J = 8.3 Hz, 2H, Carom-H), 5.24 (d, J = 
11.3 Hz, 1H, H-7a), 3.32 (app t, J = 11.7 Hz, 1H, H-7), 2.98-2.86 (m, 1H, H-6), 
2.64 (dq, J = 12.6, 6.4 Hz, 1H, H-4), 2.08-1.95 (m, 1H, H-5), 1.44 (d, J = 6.4 Hz, 
3H, C-4CH3), 1.23 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 198.9 (C-6CHO), 185.5 (C-3a), 
140.5 (Carom-C), 133.1, 128.8 (Carom-H), 118.0 (Carom-CN), 112.9 (Carom-C), 88.2 
(C-7a), 57.4 (C-6), 51.1 (C-7), 41.7 (C-4), 40.5 (C-5), 17.6 (C-5CH3), 12.9 (C-
4CH3). 
IR (ATR) cm-1: 2229 (C≡N st), 1725 (C=O st), 1627 (C=N st), 1372 (SO2 st 
as), 1198 (SO2 st sym). 
MS (EI) m/z (relative abundance): 281 (10), 253 (31), 225 (32), 197 (62), 
180 (14), 154 (100), 116 (31), 77 (19), 51 (15). 
HRMS: Calculated for [C16H17N2O4S]+: 333.0909 [M+H]+; found: 
333.0917. 
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(4R,5R,6S,7S,7aS)-4,5-Dimethyl-7-(4-(trifluoromethyl)phenyl)-5,6,7,7a-
tetrahydro-4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7j) 
Following the general procedure, 7j (38 mg, 0.101 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 7:3 to 
6:4) as a yellow oil after 60 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
(26 mg, 0.150 mmol) and (E)-4-
(trifluoromethyl)cinnamaldehyde9 4t (45 mg, 0.225 mmol) in the presence of 
DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 67%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 27.65 min, τminor = 22.09 
min. 
[]D20: -33.4 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.39 (d, J = 3.7 Hz, 1H, C-6CHO), 
7.64 (d, J = 8.0 Hz, 2H, Carom-H), 7.38 (d, J = 8.0 Hz, 2H, Carom-H), 5.26 (d, J = 
11.3 Hz, 1H, H-7a), 3.33 (app t, J = 11.7 Hz, 1H, H-7), 3.01-2.87 (m, 1H, H-6), 
2.70-2.56 (m, 1H, H-4), 2.09-1.95 (m, 1H, H-5), 1.44 (d, J = 6.3 Hz, 3H, C-4CH3), 
1.22 (d, J = 6.4 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.1 (C-6CHO), 185.6 (C-3a), 
139.2 (Carom-C), 131.1 (q, 2JCF = 32.9 Hz, Carom-CF3), 128.4 (Carom-H), 126.4 (q, 
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3JCF = 3.5 Hz, Carom-H), 123.7 (q, 1JCF = 272.1 Hz, CF3), 88.5 (C-7a), 57.6 (C-6), 
51.0 (C-7), 41.8 (C-4), 40.5 (C-5), 17.6 (C-5CH3), 12.9 (C-4CH3). 
IR (ATR) cm-1: 1727 (C=O st), 1622 (C=N st), 1369 (SO2 st as), 1199 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 266 (14), 239 (11), 215 (36), 199 (38), 
172 (18), 155 (32), 127 (10), 113 (52), 100 (50), 85 (14), 71 (100), 58 (23). 
HRMS: Calculated for [C16H17NO4SF3]+: 376.0830 [M+H]+; found: 
376.0829. 
(4R,5R,6S,7R,7aS)-4,5,7-Trimethyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7k) 
Following the general procedure, 7k (13 mg, 0.054 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 48 hours, starting from (E)-4-(1-methylprop-1-en-1-
yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c (26 mg, 0.150 mmol) and 
(E)-crotonaldehyde 4a (19 μL, 0.225 mmol) in the presence of 
DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 36%. 
dr: >20:1. 
ee: 91%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 18.02 min, τminor = 20.46 min. 
[]D20: -19.5 (c = 0.67, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 9.48 (d, J = 4.1 Hz, 1H, C-6CHO), 
4.82 (d, J = 10.8 Hz, 1H, H-7a), 2.45 (dq, J = 12.7, 6.4 Hz, 1H, H-4), 2.23-2.13 
(m, 2H, H-6+H-7), 1.94-1.85 (m, 1H, H-5), 1.40 (d, J = 6.4 Hz, 3H, C-4CH3), 
1.19 (d, J = 6.0 Hz, 3H, C-7CH3), 1.14 (d, J = 6.5 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 200.2 (C-6CHO), 186.4 (C-3a), 
89.8 (C-7a), 59.3 (C-6), 41.5 (C-4), 40.1 (C-5), 39.7 (C-7), 17.7 (C-5CH3), 16.9 
(C-7CH3), 13.0 (C-4CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1629 (C=N st), 1367 (SO2 st as), 1196 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 217 (22), 202 (32), 188 (13), 175 (16), 
152 (86), 136 (51), 124 (28), 110 (25), 96 (23), 69 (100), 55 (68). 
HRMS: Calculated for [C10H16NO4S]+: 246.0800 [M+H]+; found: 246.0789. 
(4R,5R,6S,7S,7aS)-5-Ethyl-4-methyl-7-phenyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7l) 
Following the general procedure, 7l (28 mg, 0.086 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow solid after 60 hours, starting from (E)-4-(1-methylbut-1-
en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3d (28 mg, 0.150 
mmol) and (E)-cinnamaldehyde 4i (28 μL, 0.225 mmol) in the 
presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 57%. 
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dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 51.80 min, τminor = 60.44 
min. 
[]D20: -64.1 (c = 0.44, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.34 (d, J = 4.1 Hz, 1H, C-6CHO), 
7.40-7.21 (m, 5H, Carom-H), 5.23 (d, J = 11.1 Hz, 1H, H-7a), 3.25 (app t, J = 11.5 
Hz, 1H, H-7), 3.12-3.03 (m, 1H, H-6), 2.81 (dq, J = 12.5, 6.4 Hz, 1H, H-4), 2.14-
2.05 (m, 1H, H-5), 1.82-1.71 (m, 1H, C-5CHaHb), 1.61-1.51 (m, 1H, C-5CHaHb), 
1.40 (d, J = 6.4 Hz, 3H, C-4CH3), 0.97 (t, J = 7.5 Hz, 3H, C-5CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.3 (C-6CHO), 186.8 (C-3a), 
135.1 (Carom-C), 129.5, 128.9, 127.8 (Carom-H), 88.9 (C-7a), 53.9 (C-6), 51.7 (C-7), 
44.9 (C-5), 37.8 (C-4), 21.4 (C-5CH2), 12.6 (C-4CH3), 7.2 (C-5CH2CH3). 
IR (ATR) cm-1: 1726 (C=O st), 1626 (C=N st), 1368 (SO2 st as), 1196 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 167-169. 
MS (EI) m/z (relative abundance): 238 (24), 207 (28), 147 (19), 129 (10), 
112 (23), 83 (20), 57 (38). 
HRMS: Calculated for [C16H20NO4S]+: 322.1113 [M+H]+; found: 322.1123. 
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(4R,5R,6S,7S,7aS)-5-Ethyl-7-(4-methoxyphenyl)-4-methyl-5,6,7,7a-
tetrahydro-4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7m) 
Following the general procedure, 7m (35 mg, 0.099 
mmol) was isolated by FC (hexanes/EtOAc gradient 
from 7:3 to 6:4) as a yellow solid after 60 hours, 
starting from (E)-4-(1-methylbut-1-en-1-yl)-5H-1,2,3-
oxathiazole 2,2-dioxide 3d (28 mg, 0.150 mmol) and 
(E)-4-methoxycinnamaldehyde 4l (37 mg, 0.225 mmol) in the presence of 
DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 66%. 
dr: 10:1. 
ee: 99%. Determined by HPLC using a Chiralcel OZ-3 column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 30.50 min, τminor = 23.85 min. 
[]D20: -68.6 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.32 (d, J = 4.1 Hz, 1H, C-6CHO), 
7.14 (d, J = 8.6 Hz, 2H, Carom-H), 6.88 (d, J = 8.6 Hz, 2H, Carom-H), 5.19 (d, J = 
11.1 Hz, 1H, H-7a), 3.78 (s, 3H, OCH3), 3.20 (app t, J = 11.5 Hz, 1H, H-7), 3.08-
2.99 (m, 1H, H-6), 2.84-2.74 (m, 1H, H-4), 2.10-2.00 (m, 1H, H-5), 1.80-1.70 (m, 
1H, C-5CHaHb), 1.58-1.48 (m, 1H, C-5CHaHb), 1.38 (d, J = 6.3 Hz, 3H, C-4CH3), 
0.95 (t, J = 7.5 Hz, 3H, C-5CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.6 (C-6CHO), 187.0 (C-3a), 
159.8 (Carom-C), 128.9 (Carom-H), 127.0 (Carom-C), 114.8 (Carom-H), 89.2 (C-7a), 
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55.3 (OCH3), 54.1 (C-6), 51.0 (C-7), 44.7 (C-5), 37.8 (C-4), 21.4 (C-5CH2), 12.6 
(C-4CH3), 7.2 (C-5CH2CH3). 
IR (ATR) cm-1: 1726 (C=O st), 1626 (C=N st), 1370 (SO2 st as), 1197 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 68-70. 
MS (EI) m/z (relative abundance): 244 (12), 215 (100), 187 (12), 175 (26), 
134 (28), 121 (25), 91 (13), 77 (8). 
HRMS: Calculated for [C17H22NO5S]+: 352.1219 [M+H]+; found: 352.1236. 
(4R,5R,6S,7S,7aS)-7-(3,5-Dimethoxyphenyl)-5-ethyl-4-methyl-5,6,7,7a-
tetrahydro-4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7n) 
Following the general procedure, 7n (35 mg, 0.092 
mmol) was isolated by FC (hexanes/EtOAc gradient 
from 7:3 to 6:4) as a yellow oil after 60 hours, starting 
from (E)-4-(1-methylbut-1-en-1-yl)-5H-1,2,3-
oxathiazole 2,2-dioxide 3d (28 mg, 0.150 mmol) and 
(E)-3,5-dimethoxycinnamaldehyde 4n (43 mg, 0.225 
mmol) in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 61%. 
dr: 8:1. 
ee: 99%. Determined by HPLC using a Chiralcel OZ-3 column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 17.84 min, τminor = 32.09 min. 
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[]D20: -34.4 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.37 (d, J = 3.8 Hz, 1H, C-6CHO), 
6.40-6.34 (m, 3H, Carom-H), 5.26 (d, J = 11.0 Hz, 1H, H-7a), 3.77 (s, 6H, 2 × 
OCH3), 3.20-3.07 (m, 1H, H-7), 3.07-2.97 (m, 1H, H-6), 2.85-2.75 (m, 1H, H-4), 
2.08-1.99 (m, 1H, H-5), 1.76-1.68 (m, 1H, C-5CHaHb), 1.59-1.49 (m, 1H, C-
5CHaHb), 1.38 (d, J = 6.3 Hz, 3H, C-4CH3), 0.95 (t, J = 7.5 Hz, 3H, C-5CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 199.4 (C-6CHO), 187.0 (C-3a), 
161.5, 137.5 (Carom-C), 106.0, 100.0 (Carom-H), 88.8 (C-7a), 55.4 (OCH3), 53.8 (C-
6), 51.9 (C-7), 44.9 (C-5), 37.8 (C-4), 21.3 (C-5CH2), 12.6 (C-4CH3), 7.2 (C-
5CH2CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1627 (C=N st), 1368 (SO2 st as), 1196 (SO2 
st sym). 
MS (EI) m/z (relative abundance): 348 (8), 263 (29), 231 (12), 189 (27), 
164 (100), 113 (33), 91 (9), 77 (6). 
HRMS: Calculated for [C18H24NO6S]+: 382.1324 [M+H]+; found: 382.1323. 
(4R,5R,6S,7S,7aS)-7-(4-Bromophenyl)-5-ethyl-4-methyl-5,6,7,7a-tetrahydro-
4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7o) 
Following the general procedure, 7o (37 mg, 0.093 mmol) 
was isolated as a mixture of diastereoisomers by FC 
(hexanes/EtOAc gradient from 7:3 to 6:4) as a yellow oil 
after 60 hours, starting from (E)-4-(1-methylbut-1-en-1-
yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3d (28 mg, 0.150 
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mmol) and (E)-4-bromocinnamaldehyde 4p (49 mg, 0.225 mmol) in the presence 
of DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl 
ether 5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 62%. 
dr: 8:1. 
ee: 97%. Determined by HPLC using a Chiralcel OZ-3 column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 21.40 min, τminor = 14.66 min. 
[]D20: -53.5 (c = 1.07, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (*denotes minor diastereoisomer 
signals): 9.34 (d, J = 4.1 Hz, 1H, C-6CHO), 7.49 (d, J = 8.4 Hz, 2H, Carom-H), 7.11 
(d, J = 8.4 Hz, 2H, Carom-H), 5.37* (d, J = 11.1 Hz, 1H, H-7a), 5.18 (d, J = 11.2 
Hz, 1H, H-7a), 3.49-3.36* (m, 1H, H-7), 3.23 (app t, J = 11.5 Hz, 1H, H-7), 3.10-
2.98 (m, 1H, H-6), 2.81 (dq, J = 12.5, 6.3 Hz, 1H, H-4), 2.26-2.16* (m, 1H, H-5), 
2.13-2.01 (m, 1H, H-5), 1.84-1.70 (m, 1H, C-5CHaHb), 1.58-1.48 (m, 1H, C-
5CHaHb), 1.38 (d, J = 6.3 Hz, 3H, C-4CH3), 1.31* (d, J = 7.3 Hz, 3H, C-4CH3), 
1.12* (t, J = 7.4 Hz, 3H, C-5CH2CH3), 0.96 (t, J = 7.5 Hz, 3H, C-5CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor diastereoisomer 
signals): 199.6*, 199.1 (C-6CHO), 195.6*, 186.8 (C-3a), 134.3*, 134.2 (Carom-C), 
132.6, 132.3*, 130.5*, 129.5 (Carom-H), 122.9, 122.3* (Carom-C), 88.7, 86.6* (C-
7a), 53.7, 52.8* (C-6), 51.0, 48.4* (C-7), 45.3*, 44.9 (C-5), 37.8, 35.4* (C-4), 
23.1*, 21.4 (C-5CH2), 12.6, 11.2* (C-4CH3), 10.9*, 7.2 (C-5CH2CH3). 
IR (ATR) cm-1: 1724 (C=O st), 1626 (C=N st), 1371 (SO2 st as), 1198 (SO2 
st sym). 
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MS (EI) m/z (relative abundance): 293 (57), 265 (54), 251 (14), 186 (29), 
171 (56), 157 (100), 143 (32), 129 (71), 115 (57), 102 (31), 77 (22), 63 (16). 
HRMS: Calculated for [C16H19NO4SBr]+: 400.0218 [M+H]+; found: 
400.0234. 
(4R,5R,6S,7S,7aS)-5-Ethyl-4-methyl-7-(4-nitrophenyl)-5,6,7,7a-tetrahydro-
4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7p) 
Following the general procedure, 7p (27 mg, 0.075 
mmol) was isolated as a mixture of diastereoisomers by 
FC (hexanes/EtOAc gradient from 6:4 to 1:1) as a 
yellow solid after 60 hours, starting from (E)-4-(1-
methylbut-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3d (28 mg, 0.150 mmol) and (E)-4-nitrocinnamaldehyde 4r (41 mg, 0.225 mmol) 
in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 50%. 
dr: 13:1. 
ee: 94%. Determined by HPLC using a Chiralpak OZ-3 column [n-hexane/i-
PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 61.50 min, τminor = 41.73 min. 
[]D20: -59.4 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (*denotes minor diastereoisomer 
signals): 9.43* (d, J = 3.8 Hz, 1H, C-6CHO), 9.40 (d, J = 3.9 Hz, 1H, C-6CHO), 
8.22 (d, J = 8.7 Hz, 2H, Carom-H), 7.44 (d, J = 8.7 Hz, 2H, Carom-H), 5.43* (d, J = 
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11.2 Hz, 1H, H-7a), 5.25 (d, J = 11.2 Hz, 1H, H-7a), 3.41 (app t, J = 11.5 Hz, 1H, 
H-7), 3.20-3.11 (m, 1H, H-6), 2.87 (dq, J = 12.5, 6.3 Hz, 1H, H-4), 2.16-2.06 (m, 
1H, H-5), 1.86-1.75 (m, 1H, C-5CHaHb), 1.63-1.51 (m, 1H, C-5CHaHb), 1.40 (d, J 
= 6.3 Hz, 3H, C-4CH3), 1.00 (t, J = 7.5 Hz, 3H, C-5CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 198.7 (C-6CHO), 186.3 (C-3a), 
148.0, 142.5 (Carom-C), 129.1, 124.5 (Carom-H), 88.1 (C-7a), 53.6 (C-6), 51.0 (C-7), 
45.3 (C-5), 37.9 (C-4), 21.4 (C-5CH2), 12.5 (C-4CH3), 7.2 (C-5CH2CH3). 
IR (ATR) cm-1: 1725 (C=O st), 1627 (C=N st), 1520 (NO2 st as), 1373 (SO2 
st as), 1348 (NO2 st sym), 1199 (SO2 st sym). 
M.p. (hexanes/EtOAc) (ºC): 91-93. 
MS (EI) m/z (relative abundance): 281 (9), 207 (29), 147 (21), 129 (100), 
112 (25), 71 (24), 57 (42). 
HRMS: Calculated for [C16H18N2O6SNa]+: 389.0783 [M+Na]+; found: 
389.0787. 
(4R,5R,6S,7S,7aS)-4-Methyl-5,7-diphenyl-5,6,7,7a-tetrahydro-4H-
benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7q) 
Following the general procedure, 7q (22 mg, 0.060 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 7:3 to 1:1) as a 
yellow solid after 84 hours, starting from (E)-4-(1-phenylprop-1-
en-2-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3e (48 mg, 0.200 
mmol) and (E)-cinnamaldehyde 4i (50 μL, 0.400 mmol) in the 
presence of DABCO (4 mg, 0.040 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (14 mg, 0.040 mmol) and using dry 
CHCl3 (0.4 mL) as solvent. 
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Yield: 30%. 
dr: >20:1. 
ee: 99%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 18.20 min, τminor = 21.02 
min. 
[]D20: -3.3 (c = 1.00, acetone). 
1H-NMR (, ppm) (CD3COCD3, 300 MHz): 9.25 (d, J = 3.9 Hz, 1H, C-
6CHO), 7.49-7.29 (m, 10H, Carom-H), 6.04 (d, J = 11.3 Hz, 1H, H-7a), 4.00-3.87 
(m, 1H, H-6), 3.72-3.49 (m, 2H, H-4+H-7), 3.35 (app t, J = 11.5 Hz, 1H, H-5), 
1.10 (d, J = 6.4 Hz, 3H, C-4CH3). 
13C-NMR (, ppm) (CD3COCD3, 75.5 MHz): 200.5 (C-6CHO), 188.6 (C-
3a), 139.8, 137.8 (Carom-C), 130.0, 129.9, 129.2, 129.2, 129.1, 128.8 (Carom-H), 
90.7 (C-7a), 58.1 (C-6), 53.0 (C-5), 52.5 (C-7), 41.9 (C-4), 13.5 (C-4CH3). 
IR (ATR) cm-1: 1713 (C=O st), 1626 (C=N st), 1370 (SO2 st as), 1200 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 189-191 (Decomposed). 
MS (EI) m/z (relative abundance): 286 (100), 243 (22), 207 (82), 180 (31), 
127 (11), 103 (5), 78 (14), 50 (36). 
HRMS: Calculated for [C20H20NO4S]+: 370.1113 [M+H]+; found: 370.1110. 
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(4R,5R,6S,7S,7aS)-7-(4-Bromophenyl)-4-methyl-5-phenyl-5,6,7,7a-
tetrahydro-4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7r) 
Following the general procedure, 7r (23 mg, 0.052 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 6:4 to 
1:1) as a yellow solid after 60 hours, starting from (E)-4-
(1-phenylprop-1-en-2-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3e (48 mg, 0.200 mmol) and (E)-4-bromocinnamaldehyde 
4p (87 mg, 0.400 mmol) in the presence of DABCO (4 mg, 0.040 mmol), 
diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (14 mg, 0.040 mmol) and 
using dry CHCl3 (0.4 mL) as solvent. 
Yield: 26%. 
dr: >20:1. 
ee: >99%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 17.72 min, τminor = -. 
[]D20: -13.4 (c = 1.00, acetone). 
1H-NMR (, ppm) (CD3COCD3, 300 MHz): 9.24 (d, J = 3.8 Hz, 1H, C-
6CHO), 7.60-7.30 (m, 9H, Carom-H), 6.02 (d, J = 11.2 Hz, 1H, H-7a), 4.02-3.91 (m, 
1H, H-6), 3.70-3.53 (m, 2H, H-4+H-7), 3.33 (app t, J = 11.5 Hz, 1H, H-5), 1.09 
(d, J = 6.4 Hz, 3H, C-4CH3). 
13C-NMR (, ppm) (CD3COCD3, 75.5 MHz): 200.5 (C-6CHO), 188.3 (C-
3a), 139.7, 137.4 (Carom-C), 132.9, 131.3, 130.1, 130.1, 128.9 (Carom-H), 122.6 
(Carom-C), 90.4 (C-7a), 57.8 (C-6), 53.0 (C-5), 51.8 (C-7), 41.9 (C-4), 13.4 (C-
4CH3). 
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IR (ATR) cm-1: 1710 (C=O st), 1626 (C=N st), 1367 (SO2 st as), 1198 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 184-186 (Decomposed). 
MS (EI) m/z (relative abundance): 281 (37), 236 (5), 207 (100), 157 (39), 
115 (42), 77 (24), 58 (37). 
HRMS: Calculated for [C20H17NO4SBr]¯: 446.0062 [M-H]¯; found: 
446.0090. 
(4R,5R,6S,7S,7aS)-4-Methyl-7-(4-nitrophenyl)-5-phenyl-5,6,7,7a-tetrahydro-
4H-benzo[d][1,2,3]oxathiazole-6-carbaldehyde 2,2-dioxide (7s) 
Following the general procedure, 7s (29 mg, 0.070 
mmol) was isolated by FC (hexanes/EtOAc gradient 
from 7:3 to 1:1) as a yellow solid after 60 hours, starting 
from (E)-4-(1-phenylprop-1-en-2-yl)-5H-1,2,3-
oxathiazole 2,2-dioxide 3e (48 mg, 0.200 mmol) and (E)-
4-nitrocinnamaldehyde 4r (72 mg, 0.400 mmol) in the presence of DABCO (4 mg, 
0.040 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (14 mg, 0.040 
mmol) and using dry CHCl3 (0.4 mL) as solvent. 
Yield: 35%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 26.61 min, τminor = 62.43 
min. 
[]D20: -30.8 (c = 1.00, acetone). 
Experimental 301 
 
1H-NMR (, ppm) (CD3COCD3, 300 MHz): 9.26 (d, J = 3.5 Hz, 1H, C-
6CHO), 8.26 (d, J = 8.8 Hz, 2H, Carom-H), 7.80 (d, J = 8.8 Hz, 2H, Carom-H), 7.55-
7.32 (m, 5H, Carom-H), 6.12 (d, J = 11.2 Hz, 1H, H-7a), 4.19-4.07 (m, 1H, H-6), 
3.80 (app t, J = 11.5 Hz 1H, H-7), 3.75-3.63 (m, 1H, H-4), 3.38 (app t, J = 11.6 
Hz, 1H, H-5), 1.12 (d, J = 6.4 Hz, 3H, C-4CH3). 
13C-NMR (, ppm) (CD3COCD3, 75.5 MHz): 200.4 (C-6CHO), 188.1 (C-
3a), 148.7, 145.4, 139.5 (Carom-C), 130.6, 130.1, 129.1, 129.0, 124.8 (Carom-H), 
90.0 (C-7a), 57.5 (C-6), 53.0 (C-5), 51.8 (C-7), 42.0 (C-4), 13.3 (C-4CH3). 
IR (ATR) cm-1: 1710 (C=O st), 1627 (C=N st), 1519 (NO2 st as), 1370 (SO2 
st as), 1349 (NO2 st sym), 1200 (SO2 st sym). 
M.p. (hexanes/EtOAc) (ºC): 229-231 (Decomposed). 
MS (EI) m/z (relative abundance): 281 (18), 207 (54), 154 (51), 115 (9), 77 
(100), 50 (34). 
HRMS: Calculated for [C20H17N2O6S]¯: 413.0807 [M-H]¯; found: 413.0835. 
2.5. Synthesis of cyclic sulfamidate 9. 
(3aS,4R,5S,5aR,9aR,9bR)-5-(Hydroxymethyl)-4-methyldecahydro-1H-
naphtho[1,2-d][1,2,3]oxathiazole 2,2-dioxide (9) 
NaBH4 (5 mg, 0.119 mmol) was added to a solution of the 
cycloadduct 6a (27 mg, 0.099 mmol) in MeOH (1 mL) at 0 ºC. 
The mixture was stirred at 0 ºC for 10 minutes, then a solution of 
saturated aqueous NH4Cl (1 mL) was added to quench the 
reaction and it was stirred for another 5 minutes. The mixture 
was extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were dried 
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with anhydrous Na2SO4, filtered and the solvent was removed under reduced 
pressure. After purification by flash column chromatography (FC) 
(hexanes/EtOAc gradient from 6:4 to 1:1) the cyclic sulfamidate 9 (27 mg, 0.099 
mmol) was isolated as a white solid. 
Yield: >99%. 
dr: >20:1. 
ee: 92%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 20.14 min, τminor = 22.86 
min. 
[]D20: -66.8 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 5.27 (d, J = 9.0 Hz, 1H, NH), 4.35 
(dd, J = 10.4, 5.0 Hz, 1H, H-3a), 4.06-4.00 (m, 1H, H-9b), 3.88-3.72 (m, 2H, 
CH2OH), 2.28-2.07 (m, 3H, OH+H-4+H-6a), 1.83-1.72 (m, 3H, H-7a+H-8a+H-9a), 
1.59-1.41 (m, 2H, H-9a+H-5a), 1.32-1.20 (m, 3H, H-7b+H-8b+H-9b), 1.12 (d, J = 
6.4 Hz, 3H, C-4CH3), 0.87-0.73 (m, 2H, H-5+H-6b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 91.8 (C-3a), 60.2 (C-9b), 57.7 
(CH2OH), 47.1 (C-5), 41.9 (C-9a), 34.0 (C-5a), 32.9 (C-4), 30.4 (C-9), 29.8 (C-6), 
26.1, 25.8 (C-7+C-8), 15.2 (C-4CH3). 
IR (ATR) cm-1: 3547 (O-H st), 3261 (N-H st), 1342 (SO2 st as), 1184 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 155-157. 
MS (EI) m/z (relative abundance): 245 (24), 190 (14), 163 (20), 148 (100), 
133 (14), 119 (19), 105 (40), 91 (27), 70 (36), 55 (22). 
HRMS: Calculated for [C12H22NO4S]+: 276.1270 [M+H]+; found: 276.1272. 
Experimental 303 
 
2.6. Synthesis of β-amino alcohol 10. 
(1R,2S,3R,4S,4aR,8aR)-1-Amino-4-(hydroxymethyl)-3-
methyldecahydronaphthalen-2-ol (10) 
To a suspension of LiAlH4 (52 mg, 1.380 mmol) in dry THF (5 
mL) a solution of the sulfamidate 9 (127 mg, 0.460 mmol) in 
dry THF (10 mL) was added dropwise at 0 ºC under inert 
atmosphere. The reaction mixture was stirred under reflux for 1 
hour, and HCl 1 M (1 mL) was added at room temperature. Then, the reaction was 
stirred under reflux for 1 hour more and cooled down to room temperature. The 
mixture was washed with CH2Cl2 (3 × 10 mL). The aqueous layer was basified 
with NaOH 1 M and then was extracted with CH2Cl2 (4 × 5 mL). The combined 
organic layers were dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure, obtaining the β-amino alcohol 10 (55 mg, 0.258 mmol) as a 
white solid, without further purification. 
Yield: 56%. 
[]D20: -37.1 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 3.83-3.71 (m, 2H, CH2OH), 3.12 
(dd, J = 10.6, 4.1 Hz, 1H, H-2), 2.86-2.80 (m, 1H, H-1), 2.36 (bs, 3H, NH2+OH), 
2.12-1.99 (m, 1H, H-5a), 1.83-1.68 (m, 2H, H-6a+H-7a), 1.66-1.46 (m, 2H, H-
3+H-8a), 1.40-1.14 (m, 6H, H-4a+H-8a+H-8b+H-6b+H-7b+OH), 1.07 (d, J = 6.3 
Hz, 3H, C-3CH3), 0.86-0.66 (m, 2H, H-5b+H-4). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 76.1 (C-2), 58.6 (CH2OH), 56.0 
(C-1), 49.4 (C-4), 44.8 (C-8a), 33.3 (C-4a), 33.3 (C-3), 30.6 (C-5), 30.3 (C-8), 
26.3, 26.2 (C-6+C-7), 15.5 (C-3CH3). 
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IR (ATR) cm-1: 3356 (O-H st). 
M.p. (CH2Cl2) (ºC): 102-104. 
MS (EI) m/z (relative abundance): 207 (94), 129 (100), 84 (23), 57 (52). 
HRMS: Calculated for [C12H24NO2]+: 214.1807 [M+H]+; found: 214.1810. 
2.7. Synthesis of bicyclic compounds 11a-i. 
General procedure: 
To a solution of the corresponding Michael/Michael cycloadduct 7 (1.00 
mmol) in DCE (2 mL), benzhydrylamine was added (1.00 mmol). The reaction 
was stirred at 75 ºC until it was completed. A solution of HCl 1 M (5.00 mmol) 
was added at 75 ºC, and the reaction was stirred during 20 minutes. Then, the 
reaction mixture was extracted with CH2Cl2 (3 x 10 mL). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The obtained crude product was charged onto silica gel and subjected to 
flash chromatography (FC) with the indicated eluent, obtaining the desired 
bicycles 11a-i. The racemic compounds for HPLC separation conditions were 
prepared under the same reaction conditions, using in these cases the racemic 
Michael/Michael cycloadduct (±)-7. 
(1S,2R,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (cis-11a) 
Following the general procedure, cis-11a (24 mg, 0.105 mmol) 
was isolated by FC (n-hexane/EtOAc gradient from 9:1 to 7:3) as 
a yellow oil after 17 hours, starting from cycloadduct 7a (46 mg, 
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0.150 mmol) and benzhydrylamine (28 mg, 0.150 mmol) using DCE (0.3 mL) as 
solvent. 
Yield: 70%. 
dr: 6.3:1. 
ee: 99%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 14.73 min, τminor = 21.14 
min. 
[]D20: +76.7 (c = 0.56, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.04 (s, 1H, CHO), 7.35-7.23 (m, 
5H, Carom-H), 3.38 (d, J = 4.2 Hz, 1H, H-6), 3.13 (d, J = 4.2 Hz, 1H, H-5), 3.10-
2.97 (m, 1H, H-2), 2.74-2.60 (m, 1H, H-3), 1.09 (d, J = 7.0 Hz, 3H, C-2CH3), 1.01 
(d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.3 (C-4), 197.9 (CHO), 132.6 
(Carom-C), 128.8, 128.8, 127.8 (Carom-H), 49.3 (C-1), 41.1 (C-3), 37.8 (C-6), 36.5 
(C-5), 34.6 (C-2), 13.2 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1703 (C=O st). 
MS (EI) m/z (relative abundance): 228 (16), 213 (1), 200 (11), 185 (16), 
171 (31), 157 (27), 143 (100), 129 (94), 115 (56), 103 (9), 91 (33), 77 (24), 65 
(12), 51 (12). 
HRMS: Calculated for [C15H17O2]+: 229.1229 [M+H]+; found: 229.1231. 
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(1S,2R,3R,5S,6R)-2,3-Dimethyl-4-oxo-6-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (trans-11a) 
Following the general procedure, trans-11a (3 mg, 0.015 mmol) 
was isolated by FC (n-hexane/EtOAc gradient from 9:1 to 7:3) as 
a yellow oil after 17 hours, starting from cycloadduct 7a (46 mg, 
0.150 mmol) and benzhydrylamine (28 mg, 0.150 mmol) using 
DCE (0.3 mL) as solvent. 
Yield: 10%. 
dr: 1:6.3. 
[]D20: +113.9 (c = 0.27, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.23 (s, 1H, CHO), 7.35-7.20 (m, 
5H, Carom-H), 3.24 (d, J = 4.9 Hz, 1H, H-5), 2.92 (d, J = 4.9 Hz, 1H, H-6), 2.58-
2.46 (m, 1H, H-2), 2.15-2.02 (m, 1H, H-3), 1.46 (d, J = 7.0 Hz, 3H, C-2CH3), 1.26 
(d, J = 7.7 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 211.7 (C-4), 197.0 (CHO), 132.1 
(Carom-C), 128.8, 128.7, 127.8 (Carom-H), 53.6 (C-3), 49.0 (C-1), 41.2 (C-2), 40.2 
(C-5), 39.2 (C-6), 19.7 (C-2CH3), 17.5 (C-3CH3). 
IR (ATR) cm-1: 1730 (C=O st), 1705 (C=O st). 
MS (EI) m/z (relative abundance): 228 (20), 213 (2), 200 (12), 185 (18), 
171 (34), 157 (27), 143 (100), 129 (97), 115 (64), 103 (10), 91 (41), 77 (28), 65 
(15), 51 (15). 
HRMS: Calculated for [C15H17O2]+: 229.1229 [M+H]+; found: 229.1230. 
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(1S,2R,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-(p-tolyl)bicyclo[3.1.0]hexane-1-
carbaldehyde (11b) 
Following the general procedure, 11b (15 mg, 0.064 
mmol) was isolated by FC (n-hexane/EtOAc gradient from 
9:1 to 7:3) as a yellow oil after 17 hours, starting from 
cycloadduct 7b (27 mg, 0.083 mmol) and benzhydrylamine 
(16 mg, 0.083 mmol) using DCE (0.16 mL) as solvent. 
Yield: 77%. 
dr: 6.7:1. 
[]D20: +76.7 (c = 0.44, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.03 (s, 1H, CHO), 7.15-7.08 (m, 
4H, Carom-H), 3.34 (d, J = 4.2 Hz, 1H, H-6), 3.10 (d, J = 4.2 Hz, 1H, H-5), 3.08-
2.96 (m, 1H, H-2), 2.71-2.59 (m, 1H, H-3), 2.31 (s, 3H, Carom-CH3), 1.08 (d, J = 
7.0 Hz, 3H, C-2CH3), 1.00 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.4 (C-4), 198.1 (CHO), 137.6 
(Carom-C), 129.5 (Carom-H), 129.4 (Carom-C), 128.7 (Carom-H), 49.3 (C-1), 41.1 (C-
3), 37.6 (C-6), 36.7 (C-5), 34.6 (C-2), 21.0 (Carom-CH3), 13.2 (C-2CH3), 8.5 (C-
3CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1703 (C=O st). 
MS (EI) m/z (relative abundance): 242 (23), 227 (4), 213 (9), 199 (14), 186 
(25), 171 (51), 157 (100), 143 (78), 128 (49), 115 (41), 105 (31), 91 (22), 77 (23), 
65 (13), 51 (10). 
HRMS: Calculated for [C16H19O2]+: 243.1385 [M+H]+; found: 243.1381. 
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(1S,2R,3S,5S,6R)-6-(4-Acetoxy-3-methoxyphenyl)-2,3-dimethyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (11c) 
Following the general procedure, 11c (10 mg, 0.033 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 8:2 to 6:4) as a yellow oil after 17 hours, starting 
from cycloadduct 7d (18 mg, 0.047 mmol) and 
benzhydrylamine (9 mg, 0.047 mmol) using DCE (0.1 mL) as solvent. 
Yield: 71%. 
dr: 6.7:1. 
[]D20: +48.1 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.05 (s, 1H, CHO), 6.99-6.94 (m, 
1H, Carom-H), 6.85-6.80 (m, 2H, Carom-H), 3.81 (s, 3H, OCH3), 3.35 (d, J = 4.1 Hz, 
1H, H-6), 3.10-2.97 (m, 2H, H-5+H-2), 2.71-2.56 (m, 1H, H-3), 2.29 (s, 3H, 
OCOCH3), 1.09 (d, J = 7.0 Hz, 3H, C-2CH3), 1.00 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.1 (C-4), 197.7 (CHO), 168.8 
(OCOCH3), 151.3, 139.3, 131.4 (Carom-C), 123.1, 121.0, 113.0 (Carom-H), 56.0 
(OCH3), 49.2 (C-1), 41.1 (C-3), 37.4 (C-6), 36.8 (C-5), 34.5 (C-2), 20.6 
(OCOCH3), 13.2 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1764 (OC=O st), 1731 (C=O st), 1703 (C=O st). 
MS (EI) m/z (relative abundance): 316 (5), 274 (100), 257 (4), 245 (18), 
231 (9), 218 (40), 203 (40), 189 (57), 175 (41), 157 (22), 137 (29), 115 (27), 103 
(9), 91 (19), 77 (23), 55 (14). 
HRMS: Calculated for [C18H21O5]+: 317.1389 [M+H]+; found: 317.1397. 
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(1S,2R,3S,5S,6R)-6-(4-Chlorophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (11d) 
Following the general procedure, 11d (20 mg, 0.077 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 9:1 to 7:3) as a yellow oil after 17 hours, starting 
from cycloadduct 7f (36 mg, 0.108 mmol) and 
benzhydrylamine (20 mg, 0.108 mmol) using DCE (0.22 mL) as solvent. 
Yield: 71%. 
dr: 6.1:1. 
[]D20: +75.4 (c = 0.66, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.12 (s, 1H, CHO), 7.29 (d, J = 8.4 
Hz, 2H, Carom-H), 7.17 (d, J = 8.4 Hz, 2H, Carom-H), 3.31 (d, J = 4.2 Hz, 1H, H-6), 
3.12-2.99 (m, 2H, H-5+H-2), 2.71-2.59 (m, 1H, H-3), 1.09 (d, J = 7.0 Hz, 3H, C-
2CH3), 1.01 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.0 (C-4), 197.3 (CHO), 133.8, 
131.1 (Carom-C), 130.2, 129.0 (Carom-H), 49.4 (C-1), 41.1 (C-3), 37.2 (C-6), 36.5 
(C-5), 34.6 (C-2), 13.4 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1700 (C=O st). 
MS (EI) m/z (relative abundance): 262 (29), 245 (1), 234 (11), 219 (19), 
206 (51), 191 (21), 177 (65), 163 (22), 153 (21), 143 (100), 128 (61), 115 (59), 
101 (20), 89 (23), 77 (20), 63 (20), 51 (16). 
HRMS: Calculated for [C15H14O2Cl]¯: 261.0682 [M-H]¯; found: 261.0679. 
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(1S,2R,3S,5S,6R)-6-(4-Bromophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (11e) 
Following the general procedure, 11e (17 mg, 0.055 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 9:1 to 7:3) as a yellow solid after 17 hours, starting 
from cycloadduct 7g (29 mg, 0.076 mmol) and 
benzhydrylamine (14 mg, 0.076 mmol) using DCE (0.16 mL) as solvent. 
Yield: 72%. 
dr: 5.9:1. 
[]D20: +68.0 (c = 0.49, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.13 (s, 1H, CHO), 7.44 (d, J = 8.4 
Hz, 2H, Carom-H), 7.11 (d, J = 8.4 Hz, 2H, Carom-H), 3.28 (d, J = 4.1 Hz, 1H, H-6), 
3.13-2.99 (m, 2H, H-5+H-2), 2.73-2.59 (m, 1H, H-3), 1.09 (d, J = 7.0 Hz, 3H, C-
2CH3), 1.01 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.9 (C-4), 197.2 (CHO), 131.9 
(Carom-H), 131.6 (Carom-C), 130.5 (Carom-H), 121.8 (Carom-C), 49.4 (C-1), 41.1 (C-
3), 37.2 (C-6), 36.4 (C-5), 34.6 (C-2), 13.4 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1704 (C=O st). 
M.p. (hexanes/EtOAc) (ºC): 102-104. 
MS (EI) m/z (relative abundance): 306 (14), 280 (5), 263 (8), 250 (27), 235 
(8), 223 (8), 209 (3), 195 (8), 183 (6), 171 (47), 155 (20), 142 (100), 128 (69), 115 
(51), 102 (21), 81 (19), 63 (17), 51 (13). 
HRMS: Calculated for [C15H14O2Br]¯: 305.0177 [M-H]¯; found: 305.0171. 
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(1S,2R,3S,5S,6R)-2,3-Dimethyl-6-(4-nitrophenyl)-4-oxobicyclo[3.1.0]hexane-1-
carbaldehyde (11f) 
Following the general procedure, 11f (14 mg, 0.051 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 8:2 to 6:4) as a yellow oil after 36 hours, starting 
from cycloadduct 7h (35 mg, 0.100 mmol) and 
benzhydrylamine (19 mg, 0.100 mmol) using DCE (0.2 mL) as solvent. 
Yield: 51%. 
dr: 6.3:1. 
[]D20: +55.4 (c = 0.40, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.30 (s, 1H, CHO), 8.18 (d, J = 8.7 
Hz, 2H, Carom-H), 7.40 (d, J = 8.7 Hz, 2H, Carom-H), 3.36 (d, J = 4.4 Hz, 1H, H-6), 
3.20-3.07 (m, 2H, H-5+H-2), 2.76-2.64 (m, 1H, H-3), 1.12 (d, J = 7.0 Hz, 3H, C-
2CH3), 1.04 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.3 (C-4), 196.2 (CHO), 147.3, 
140.2 (Carom-C), 129.8, 123.9 (Carom-H), 50.1 (C-1), 41.1 (C-3), 37.3 (C-6), 36.5 
(C-5), 34.6 (C-2), 13.6 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1733 (C=O st), 1703 (C=O st), 1519 (NO2 st as), 1345 (NO2 
st sym). 
MS (EI) m/z (relative abundance): 273 (16), 257 (2), 245 (30), 230 (27), 
217 (42), 200 (52), 188 (13), 170 (37), 155 (23), 142 (100), 128 (77), 115 (77), 
102 (25), 89 (23), 77 (26), 63 (24), 51 (16). 
HRMS: Calculated for [C15H14NO4]¯: 272.0923 [M-H]¯; found: 272.0923. 
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(1S,2R,3S,5S,6R)-6-(4-Cyanophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (11g) 
Following the general procedure, 11g (15 mg, 0.058 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 9:1 to 7:3) as a yellow oil after 36 hours, starting 
from cycloadduct 7i (33 mg, 0.100 mmol) and 
benzhydrylamine (19 mg, 0.100 mmol) using DCE (0.2 mL) as solvent. 
Yield: 58%. 
dr: 6.3:1. 
[]D20: +92.8 (c = 0.64, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.25 (s, 1H, CHO), 7.61 (d, J = 8.4 
Hz, 2H, Carom-H), 7.34 (d, J = 8.4 Hz, 2H, Carom-H), 3.33 (d, J = 4.4 Hz, 1H, H-6), 
3.17-3.04 (m, 2H, H-5+H-2), 2.75-2.61 (m, 1H, H-3), 1.10 (d, J = 7.0 Hz, 3H, C-
2CH3), 1.02 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.4 (C-4), 196.4 (CHO), 138.2 
(Carom-C), 132.4, 129.6 (Carom-H), 118.2 (Carom-CN), 111.7 (Carom-C), 50.0 (C-1), 
41.1 (C-3), 37.5 (C-6), 36.3 (C-5), 34.6 (C-2), 13.5 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 2227 (C≡N st), 1732 (C=O st), 1704 (C=O st). 
MS (EI) m/z (relative abundance): 253 (17), 234 (1), 225 (22), 210 (29), 
197 (51), 182 (27), 168 (84), 154 (100), 140 (54), 127 (23), 116 (35), 101 (12), 89 
(14), 77 (18), 63 (13), 53 (14). 
HRMS: Calculated for [C16H16NO2]+: 254.1181 [M+H]+; found: 254.1197. 
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(1S,2R,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-(4-
(trifluoromethyl)phenyl)bicyclo[3.1.0]hexane-1-carbaldehyde (11h) 
Following the general procedure, 11h (22 mg, 0.075 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 9:1 to 7:3) as a yellow oil after 17 hours, starting 
from cycloadduct 7j (38 mg, 0.100 mmol) and 
benzhydrylamine (19 mg, 0.100 mmol) using DCE (0.2 mL) as solvent. 
Yield: 75%. 
dr: 6.3:1. 
[]D20: +54.1 (c = 0.58, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.17 (s, 1H, CHO), 7.58 (d, J = 8.2 
Hz, 2H, Carom-H), 7.36 (d, J = 8.2 Hz, 2H, Carom-H), 3.36 (d, J = 4.2 Hz, 1H, H-6), 
3.16-3.04 (m, 2H, H-5+H-2), 2.75-2.61 (m, 1H, H-3), 1.10 (d, J = 7.0 Hz, 3H, C-
2CH3), 1.02 (d, J = 7.0 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.7 (C-4), 196.8 (CHO), 136.8 
(Carom-C), 130.0 (q, 2JCF = 32.8 Hz, Carom-CF3), 129.3 (Carom-H), 125.7 (q, 3JCF = 
3.7 Hz, Carom-H), 123.8 (q, 1JCF = 272.3 Hz, CF3), 49.6 (C-1), 41.1 (C-3), 37.3 (C-
6), 36.4 (C-5), 34.6 (C-2), 13.4 (C-2CH3), 8.5 (C-3CH3). 
IR (ATR) cm-1: 1733 (C=O st), 1705 (C=O st). 
MS (EI) m/z (relative abundance): 296 (22), 277 (9), 268 (34), 253 (40), 
240 (54), 225 (33), 211 (83), 191 (72), 177 (56), 159 (48), 143 (100), 128 (48), 
115 (50), 95 (19), 81 (35), 69 (14), 55 (28). 
HRMS: Calculated for [C16H14O2F3]¯: 295.0946 [M-H]¯; found: 295.0935. 
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(1R,2S,3S,5S,6R)-3-Methyl-6-(4-nitrophenyl)-4-oxo-2-
phenylbicyclo[3.1.0]hexane-1-carbaldehyde (11i) 
Following the general procedure, 11i (25 mg, 0.076 
mmol) was isolated by FC (n-hexane/EtOAc gradient 
from 8:2 to 6:4) as a yellow oil after 36 hours, starting 
from cycloadduct 7s (55 mg, 0.133 mmol) and 
benzhydrylamine (25 mg, 0.133 mmol) using DCE (0.26 mL) as solvent. 
Yield: 57%. 
dr: 3:1. 
[]D20: +121.5 (c = 0.82, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.23 (s, 1H, CHO), 8.18 (d, J = 8.7 
Hz, 2H, Carom-H), 7.43 (d, J = 8.7 Hz, 2H, Carom-H), 7.36-7.25 (m, 3H, Carom-H), 
7.18-6.90 (m, 2H, Carom-H), 4.22 (d, J = 8.4 Hz, 1H, H-2), 3.44 (d, J = 4.7 Hz, 1H, 
H-6), 3.37 (d, J = 4.7 Hz, 1H, H-5), 3.04-2.91 (m, 1H, H-3), 0.69 (d, J = 7.0 Hz, 
3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.8 (C-4), 195.6 (CHO), 147.3, 
140.0, 137.9 (Carom-C), 130.0, 130.0, 129.3, 127.9, 123.7 (Carom-H), 49.8 (C-1), 
46.9 (C-2), 42.3 (C-3), 38.4 (C-5), 37.8 (C-6), 9.8 (C-3CH3). 
IR (ATR) cm-1: 1733 (C=O st), 1708 (C=O st), 1519 (NO2 st as), 1345 (NO2 
st sym). 
MS (EI) m/z (relative abundance): 335 (16), 307 (7), 279 (34), 250 (37), 
204 (100), 141 (21), 115 (99), 91 (65), 51 (22). 
HRMS: Calculated for [C20H16NO4]¯: 334.1079 [M-H]¯; found: 334.1077. 
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2.8. Synthesis of bicyclic compounds 8a-s. 
General procedure: 
The α,β-unsaturated aldehyde 4 (1.50 mmol) was added to a solution of 
diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (0.20 mmol, 20 mol%), 
DABCO (3.00 mmol) and the corresponding 4-alkenyl-5H-1,2,3-oxathiazole 2,2-
dioxide 3c-e (1.00 mmol) in DCE (2 mL). The reaction was stirred at 75 ºC until it 
was completed. A saturated solution of NH4Cl (10 mL) was added and the 
aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The obtained crude product was charged onto silica gel and subjected to 
flash chromatography (FC) with the indicated eluent, obtaining the desired 
bicycles 8a-s. The racemic compounds for HPLC separation conditions were 
prepared under the same reaction conditions, using in these cases a 1:1 ratio of 
(R)- and (S)-diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether (0.20 mmol, 20 
mol%) as catalyst. 
(1S,2S,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (8a) 
Following the general procedure, 8a (18 mg, 0.079 mmol) was 
isolated by FC (hexanes/EtOAc gradient 9:1 to 8:2) as a yellow 
oil after 12 hours, starting from (E)-4-(1-methylprop-1-en-1-yl)-
5H-1,2,3-oxathiazole 2,2-dioxide 3c (26 mg, 0.150 mmol) and 
(E)-cinnamaldehyde 4i (28 μL, 0.225 mmol) in the presence of DABCO (50 mg, 
0.450 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using DCE (0.3 mL) as solvent. 
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Yield: 53%. 
dr: >20:1. 
ee: 94%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 13.43 min, τminor = 25.74 
min. 
[]D20: +34.4 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.85 (s, 1H, CHO), 7.40-7.27 (m, 
5H, Carom-H), 3.29 (d, J = 4.4 Hz, 1H, H-6), 3.11 (d, J = 4.4 Hz, 1H, H-5), 2.59 
(dq, J = 9.7, 6.5 Hz, 1H, H-2), 1.89 (dq, J = 9.7, 6.9 Hz, 1H, H-3), 1.33 (d, J = 6.5 
Hz, 3H, C-2CH3), 1.10 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.7 (C-4), 197.4 (CHO), 132.2 
(Carom-C), 129.0, 128.9, 128.0 (Carom-H), 49.1 (C-1), 45.1 (C-3), 39.6 (C-5), 36.5 
(C-2), 35.2 (C-6), 16.2 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1697 (C=O st). 
MS (EI) m/z (relative abundance): 228 (18), 207 (67), 171 (35), 143 (82), 
129 (100), 115 (56), 91 (48), 77 (40), 51 (15). 
HRMS: Calculated for [C15H15O2]¯: 227.1072 [M-H]¯; found: 227.1080. 
(1S,2S,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-(p-tolyl)bicyclo[3.1.0]hexane-1-
carbaldehyde (8b) 
Following the general procedure, 8b (20 mg, 0.082 mmol) 
was isolated by FC (hexanes/EtOAc gradient 9:1 to 7:3) as 
a yellow oil after 12 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c 
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(26 mg, 0.150 mmol) and (E)-4-methylcinnamaldehyde 4j (33 mg, 0.225 mmol) in 
the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 55%. 
dr: >20:1. 
ee: 93%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 12.13 min, τminor = 20.12 
min. 
[]D20: +27.7 (c = 0.50, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.85 (s, 1H, CHO), 7.24-7.13 (m, 
4H, Carom-H), 3.25 (d, J = 4.3 Hz, 1H, H-6), 3.08 (d, J = 4.3 Hz, 1H, H-5), 2.57 
(dq, J = 9.7, 6.5 Hz, 1H, H-2), 2.34 (s, 3H, Carom-CH3), 1.87 (dq, J = 9.7, 6.9 Hz, 
1H, H-3), 1.31 (d, J = 6.5 Hz, 3H, C-2CH3), 1.09 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.9 (C-4), 197.7 (CHO), 137.8 
(Carom-C), 129.7 (Carom-H), 129.1 (Carom-C), 128.8 (Carom-H), 49.1 (C-1), 45.1 (C-
3), 39.7 (C-5), 36.5 (C-2), 35.0 (C-6), 21.1 (Carom-CH3), 16.2 (C-2CH3), 12.2 (C-
3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 242 (26), 207 (19), 186 (26), 171 (50), 
157 (100), 143 (78), 128 (48), 115 (35), 105 (28), 91 (24), 77 (21), 51 (8). 
HRMS: Calculated for [C16H17O2]¯: 241.1229 [M-H]¯; found: 241.1226. 
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(1S,2S,3S,5S,6R)-6-(2-Methoxyphenyl)-2,3-dimethyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8c) 
Following the general procedure, 8c (15 mg, 0.058 mmol) 
was isolated by FC (hexanes/EtOAc gradient 8:2 to 7:3) as a 
yellow oil after 12 hours, starting from (E)-4-(1-methylprop-
1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c (26 mg, 0.150 
mmol) and (E)-2-methoxycinnamaldehyde 4k (37 mg, 0.225 mmol) in the 
presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 39%. 
dr: >20:1. 
ee: 90%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 18.10 min, τminor = 40.71 
min. 
[]D20: -24.7 (c = 0.49, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.64 (s, 1H, CHO), 7.34-7.27 (m, 
2H, Carom-H), 6.99-6.91 (m, 1H, Carom-H), 6.88-6.83 (m, 1H, Carom-H), 3.82 (s, 3H, 
OCH3), 3.13 (d, J = 4.5 Hz, 1H, H-6), 2.99 (d, J = 4.5 Hz, 1H, H-5), 2.60 (dq, J = 
9.7, 6.5 Hz, 1H, H-2), 1.91 (dq, J = 9.7, 6.9 Hz, 1H, H-3), 1.33 (d, J = 6.5 Hz, 3H, 
C-2CH3), 1.10 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.4 (C-4), 197.7 (CHO), 158.2 
(Carom-C), 129.5, 129.4 (Carom-H), 121.1 (Carom-C), 120.7, 110.2 (Carom-H), 55.3 
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(OCH3), 48.1 (C-1), 45.1 (C-3), 39.7 (C-5), 36.6 (C-2), 31.2 (C-6), 15.5 (C-
2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1719 (C=O st), 1694 (C=O st). 
MS (EI) m/z (relative abundance): 258 (89), 241 (7), 230 (10), 215 (19), 
202 (92), 185 (100), 173 (60), 159 (75), 144 (35), 128 (47), 115 (76), 102 (17), 91 
(74), 77 (41), 65 (18), 51 (16). 
HRMS: Calculated for [C16H17O3]¯: 257.1178 [M-H]¯; found: 257.1190. 
(1S,2S,3S,5S,6R)-6-(4-Methoxyphenyl)-2,3-dimethyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8d) 
Following the general procedure, 8d (17 mg, 0.065 
mmol) was isolated by FC (hexanes/EtOAc gradient 
8:2 to 7:3) as a yellow oil after 12 hours, starting from 
(E)-4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3c (26 mg, 0.150 mmol) and (E)-4-methoxycinnamaldehyde 4l (37 mg, 
0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 43%. 
dr: >20:1. 
ee: 94%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 22.05 min, τminor = 37.60 
min. 
[]D20: +30.8 (c = 0.50, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 8.86 (s, 1H, CHO), 7.21 (d, J = 8.7 
Hz, 2H, Carom-H), 6.88 (d, J = 8.7 Hz, 2H, Carom-H), 3.80 (s, 3H, OCH3), 3.23 (d, J 
= 4.4 Hz, 1H, H-6), 3.05 (d, J = 4.4 Hz, 1H, H-5), 2.56 (dq, J = 9.7, 6.5 Hz, 1H, 
H-2), 1.86 (dq, J = 9.7, 6.9 Hz, 1H, H-3), 1.31 (d, J = 6.5 Hz, 3H, C-2CH3), 1.09 
(d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.9 (C-4), 197.8 (CHO), 159.2 
(Carom-C), 130.0 (Carom-H), 124.0 (Carom-C), 114.4 (Carom-H), 55.3 (OCH3), 49.2 (C-
1), 45.2 (C-3), 40.0 (C-5), 36.5 (C-2), 34.7 (C-6), 16.2 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 258 (82), 241 (3), 229 (17), 215 (14), 
202 (96), 187 (55), 173 (84), 159 (59), 145 (34), 135 (22), 121 (100), 102 (24), 91 
(26), 77 (37), 65 (14), 51 (14). 
HRMS: Calculated for [C16H17O3]¯: 257.1178 [M-H]¯; found: 257.1188. 
(1S,2S,3S,5S,6R)-6-(4-Acetoxy-3-methoxyphenyl)-2,3-dimethyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8e) 
Following the general procedure, 8e (24 mg, 0.076 
mmol) was isolated by FC (hexanes/EtOAc gradient 8:2 
to 6:4) as a yellow solid after 12 hours, starting from 
(E)-4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3c (26 mg, 0.150 mmol) and (E)-4-acetoxy-3-methoxycinnamaldehyde 
4m (52 mg, 0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), 
diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and 
using DCE (0.3 mL) as solvent. 
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Yield: 51%. 
dr: >20:1. 
ee: 94%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 27.99 min, τminor = 47.73 
min. 
[]D20: +18.3 (c = 0.89, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.90 (s, 1H, CHO), 7.03-6.98 (m, 
1H, Carom-H), 6.90-6.83 (m, 2H, Carom-H), 3.83 (s, 3H, OCH3), 3.25 (d, J = 4.4 Hz, 
1H, H-6), 3.05 (d, J = 4.4 Hz, 1H, H-5), 2.58 (dq, J = 9.7, 6.5 Hz, 1H, H-2), 2.30 
(s, 3H, OCOCH3), 1.87 (dq, J = 9.7, 6.9 Hz, 1H, H-3), 1.32 (d, J = 6.5 Hz, 3H, C-
2CH3), 1.09 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.6 (C-4), 197.2 (CHO), 168.8 
(OCOCH3), 151.5, 139.5, 131.1 (Carom-C), 123.3, 121.2, 113.0 (Carom-H), 56.0 
(OCH3), 49.1 (C-1), 45.1 (C-3), 39.8 (C-5), 36.5 (C-2), 35.0 (C-6), 20.6 
(OCOCH3), 16.2 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1763 (OC=O st), 1731 (C=O st), 1697 (C=O st). 
M.p. (hexanes/EtOAc) (ºC): 99-101. 
MS (EI) m/z (relative abundance): 288 (29), 274 (3), 256 (100), 241 (66), 
227 (6), 213 (11), 201 (33), 185 (5), 169 (9), 152 (21), 139 (7), 115 (16), 102 (4), 
89 (3), 77 (6), 55 (4). 
HRMS: Calculated for [C18H19O5]¯: 315.1233 [M-H]¯; found: 315.1259. 
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(1S,2S,3S,5S,6R)-6-(3,5-Dimethoxyphenyl)-2,3-dimethyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8f) 
Following the general procedure, 8f (18 mg, 0.063 
mmol) was isolated by FC (hexanes/EtOAc gradient 8:2 
to 6:4) as a yellow oil after 12 hours, starting from (E)-
4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3c (26 mg, 0.150 mmol) and (E)-3,5-dimethoxycinnamaldehyde 4n (43 
mg, 0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 42%. 
dr: >20:1. 
ee: 92%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 25.08 min, τminor = 30.14 
min. 
[]D20: +6.7 (c = 0.74, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.86 (s, 1H, CHO), 6.43 (d, J = 2.1 
Hz, 2H, Carom-H), 6.38 (t, J = 2.1 Hz, 1H, Carom-H), 3.78 (s, 6H, 2 × OCH3), 3.22 
(d, J = 4.4 Hz, 1H, H-6), 3.06 (d, J = 4.4 Hz, 1H, H-5), 2.57 (dq, J = 9.6, 6.5 Hz, 
1H, H-2), 1.85 (dq, J = 9.6, 6.9 Hz, 1H, H-3), 1.31 (d, J = 6.5 Hz, 3H, C-2CH3), 
1.09 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.7 (C-4), 197.4 (CHO), 161.3, 
134.4 (Carom-C), 107.1, 99.6 (Carom-H), 55.4 (OCH3), 49.0 (C-1), 45.1 (C-3), 39.6 
(C-5), 36.4 (C-2), 35.2 (C-6), 16.2 (C-2CH3), 12.2 (C-3CH3). 
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IR (ATR) cm-1: 1731 (C=O st), 1697 (C=O st). 
MS (EI) m/z (relative abundance): 288 (24), 271 (20), 260 (5), 245 (8), 231 
(14), 215 (61), 203 (37), 189 (100), 174 (18), 158 (15), 145 (11), 128 (17), 115 
(23), 102 (8), 91 (15), 77 (15), 63 (7), 51 (6). 
HRMS: Calculated for [C17H19O4]¯: 287.1283 [M-H]¯; found: 287.1275. 
(1S,2S,3S,5S,6R)-6-(4-Chlorophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (8g) 
Following the general procedure, 8g (21 mg, 0.078 mmol) 
was isolated by FC (hexanes/EtOAc gradient 9:1 to 7:3) 
as a yellow oil after 12 hours, starting from (E)-4-(1-
methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3c (26 mg, 0.150 mmol) and (E)-4-chlorocinnamaldehyde 4o (39 mg, 0.225 mmol) 
in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 52%. 
dr: >20:1. 
ee: 92%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 15.47 min, τminor = 25.23 
min. 
[]D20: +29.7 (c = 0.85, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.85 (s, 1H, CHO), 7.37-7.30 (m, 
2H, Carom-H), 7.27-7.21 (m, 2H, Carom-H), 3.22 (d, J = 4.4 Hz, 1H, H-6), 3.06 (d, J 
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= 4.4 Hz, 1H, H-5), 2.58 (dq, J = 9.6, 6.5 Hz, 1H, H-2), 1.87 (dq, J = 9.6, 6.9 Hz, 
1H, H-3), 1.32 (d, J = 6.5 Hz, 3H, C-2CH3), 1.09 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.4 (C-4), 196.9 (CHO), 134.0, 
130.8 (Carom-C), 130.3, 129.3 (Carom-H), 49.1 (C-1), 45.1 (C-3), 39.6 (C-5), 36.5 
(C-2), 34.4 (C-6), 16.3 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 262 (41), 234 (11), 207 (71), 177 (80), 
143 (100), 115 (57), 81 (40), 77 (28), 53 (18). 
HRMS: Calculated for [C15H14O2Cl]¯: 261.0682 [M-H]¯; found: 261.0686. 
(1S,2S,3S,5S,6R)-6-(4-Bromophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (8h) 
Following the general procedure, 8h (21 mg, 0.069 
mmol) was isolated by FC (hexanes/EtOAc gradient 9:1 
to 7:3) as a yellow oil after 12 hours, starting from (E)-4-
(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3c (26 mg, 0.150 mmol) and (E)-4-bromocinnamaldehyde 4p (49 mg, 
0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 46%. 
dr: >20:1. 
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ee: 90%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 17.41 min, τminor = 26.38 
min. 
[]D20: +28.3 (c = 0.65, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.86 (s, 1H, CHO), 7.50 (d, J = 8.4 
Hz, 2H, Carom-H), 7.18 (d, J = 8.4 Hz, 2H, Carom-H), 3.20 (d, J = 4.5 Hz, 1H, H-6), 
3.06 (d, J = 4.5 Hz, 1H, H-5), 2.58 (dq, J = 9.6, 6.5 Hz, 1H, H-2), 1.87 (dq, J = 
9.6, 6.9 Hz, 1H, H-3), 1.32 (d, J = 6.5 Hz, 3H, C-2CH3), 1.10 (d, J = 6.9 Hz, 3H, 
C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.3 (C-4), 196.8 (CHO), 132.2 
(Carom-H), 131.4 (Carom-C), 130.6 (Carom-H), 122.0 (Carom-C), 49.0 (C-1), 45.1 (C-
3), 39.5 (C-5), 36.5 (C-2), 34.5 (C-6), 16.2 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 306 (16), 278 (5), 265 (9), 250 (32), 235 
(10), 221 (9), 209 (4), 193 (8), 171 (50), 155 (21), 142 (100), 128 (70), 115 (50), 
102 (21), 77 (16), 63 (15), 51 (11). 
HRMS: Calculated for [C15H14O2Br]¯: 305.0177 [M-H]¯; found: 305.0172. 
(1S,2S,3S,5S,6R)-2,3-Dimethyl-6-(2-nitrophenyl)-4-oxobicyclo[3.1.0]hexane-1-
carbaldehyde (8i) 
Following the general procedure, 8i (19 mg, 0.070 mmol) 
was isolated by FC (hexanes/EtOAc gradient 8:2 to 6:4) as a 
yellow oil after 12 hours, starting from (E)-4-(1-methylprop-
1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 3c (26 mg, 0.150 
mmol) and (E)-2-nitrocinnamaldehyde 4q (41 mg, 0.225 mmol) in the presence of 
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DABCO (50 mg, 0.450 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using DCE (0.3 mL) as solvent. 
Yield: 47%. 
dr: >20:1. 
ee: 92%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 25.73 min, τminor = 68.40 
min. 
[]D20: -66.8 (c = 0.54, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.91 (s, 1H, CHO), 8.00 (dd, J = 8.0, 
1.0 Hz, 1H, Carom-H), 7.70-7.61 (m, 1H, Carom-H), 7.60-7.48 (m, 2H, Carom-H), 3.57 
(d, J = 4.6 Hz, 1H, H-6), 3.04 (d, J = 4.6 Hz, 1H, H-5), 2.61 (dq, J = 9.9, 6.6 Hz, 
1H, H-2), 1.97 (dq, J = 9.9, 6.9 Hz, 1H, H-3), 1.39 (d, J = 6.6 Hz, 3H, C-2CH3), 
1.12 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.2 (C-4), 195.6 (CHO), 150.1 
(Carom-C), 133.5, 131.5, 129.3 (Carom-H), 127.8 (Carom-C), 125.1 (Carom-H), 48.9 (C-
1), 45.2 (C-3), 39.7 (C-5), 37.4 (C-2), 32.8 (C-6), 15.7 (C-2CH3), 12.1 (C-3CH3). 
IR (ATR) cm-1: 1733 (C=O st), 1703 (C=O st), 1525 (NO2 st as), 1348 (NO2 
st sym). 
MS (EI) m/z (relative abundance): 244 (10), 228 (10), 210 (12), 200 (19), 
182 (29), 169 (46), 156 (23), 144 (25), 135 (100), 115 (60), 102 (25), 91 (70), 79 
(57), 63 (26), 51 (27). 
HRMS: Calculated for [C15H16NO4]+: 274.1079 [M+H]+; found: 274.1077. 
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(1S,2S,3S,5S,6R)-2,3-Dimethyl-6-(4-nitrophenyl)-4-oxobicyclo[3.1.0]hexane-1-
carbaldehyde (8j) 
Following the general procedure, 8j (13 mg, 0.048 
mmol) was isolated by FC (hexanes/EtOAc gradient 8:2 
to 6:4) as a yellow oil after 12 hours, starting from (E)-
4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3c (26 mg, 0.150 mmol) and (E)-4-nitrocinnamaldehyde 4r (41 mg, 0.225 
mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 32%. 
dr: >20:1. 
ee: 86%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 24.55 min, τminor = 28.64 
min. 
[]D20: +32.9 (c = 0.57, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.90 (s, 1H, CHO), 8.24 (d, J = 8.7 
Hz, 2H, Carom-H), 7.49 (d, J = 8.7 Hz, 2H, Carom-H), 3.28 (d, J = 4.6 Hz, 1H, H-6), 
3.15 (d, J = 4.6 Hz, 1H, H-5), 2.62 (dq, J = 9.6, 6.5 Hz, 1H, H-2), 1.91 (dq, J = 
9.6, 6.9 Hz, 1H, H-3), 1.36 (d, J = 6.5 Hz, 3H, C-2CH3), 1.12 (d, J = 6.9 Hz, 3H, 
C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 208.6 (C-4), 195.8 (CHO), 147.6, 
139.9 (Carom-C), 129.9, 124.2 (Carom-H), 49.4 (C-1), 45.1 (C-3), 39.5 (C-5), 36.7 
(C-2), 34.4 (C-6), 16.3 (C-2CH3), 12.2 (C-3CH3). 
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IR (ATR) cm-1: 1733 (C=O st), 1699 (C=O st), 1519 (NO2 st as), 1344 (NO2 
st sym). 
MS (EI) m/z (relative abundance): 273 (25), 257 (2), 245 (33), 230 (30), 
217 (45), 200 (55), 188 (14), 170 (36), 155 (21), 142 (100), 128 (73), 115 (68), 
102 (24), 89 (20), 77 (23), 63 (19), 51 (15). 
HRMS: Calculated for [C15H14NO4]¯: 272.0923 [M-H]¯; found: 272.0927. 
(1S,2S,3S,5S,6R)-6-(4-Cyanophenyl)-2,3-dimethyl-4-oxobicyclo[3.1.0]hexane-
1-carbaldehyde (8k) 
Following the general procedure, 8k (16 mg, 0.062 
mmol) was isolated by FC (hexanes/EtOAc gradient 8:2 
to 6:4) as a yellow oil after 12 hours, starting from (E)-
4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3c (26 mg, 0.150 mmol) and (E)-4-cyanocinnamaldehyde 4s (35 mg, 0.225 
mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 41%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 28.72 min, τminor = 64.64 
min. 
[]D20: +43.0 (c = 0.53, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 8.87 (s, 1H, CHO), 7.67 (d, J = 8.3 
Hz, 2H, Carom-H), 7.43 (d, J = 8.3 Hz, 2H, Carom-H), 3.25 (d, J = 4.5 Hz, 1H, H-6), 
3.11 (d, J = 4.5 Hz, 1H, H-5), 2.61 (dq, J = 9.5, 6.5 Hz, 1H, H-2), 1.89 (dq, J = 
9.5, 6.9 Hz, 1H, H-3), 1.34 (d, J = 6.5 Hz, 3H, C-2CH3), 1.11 (d, J = 6.9 Hz, 3H, 
C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 208.8 (C-4), 196.0 (CHO), 137.9 
(Carom-C), 132.8, 129.7 (Carom-H), 118.1 (Carom-CN), 112.1 (Carom-C), 49.3 (C-1), 
45.1 (C-3), 39.3 (C-5), 36.7 (C-2), 34.6 (C-6), 16.3 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 2228 (C≡N st), 1732 (C=O st), 1701 (C=O st). 
MS (EI) m/z (relative abundance): 253 (25), 238 (8), 225 (26), 210 (32), 
197 (59), 182 (29), 168 (89), 154 (100), 140 (52), 127 (23), 116 (32), 101 (11), 91 
(4), 81 (15), 63 (11), 53 (11). 
HRMS: Calculated for [C16H14NO2]¯: 252.1025 [M-H]¯; found: 252.1030. 
(1S,2S,3S,5S,6R)-2,3-Dimethyl-4-oxo-6-(4-
(trifluoromethyl)phenyl)bicyclo[3.1.0]hexane-1-carbaldehyde (8l) 
Following the general procedure, 8l (24 mg, 0.081 
mmol) was isolated by FC (hexanes/EtOAc gradient 9:1 
to 7:3) as a yellow oil after 12 hours, starting from (E)-
4-(1-methylprop-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3c (26 mg, 0.150 mmol) and (E)-4-(trifluoromethyl)cinnamaldehyde 4t 
(45 mg, 0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-
2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
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Yield: 54%. 
dr: >20:1. 
ee: 90%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 10.32 min, τminor = 17.87 
min. 
[]D20: +16.2 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.85 (s, 1H, CHO), 7.63 (d, J = 8.2 
Hz, 2H, Carom-H), 7.44 (d, J = 8.2 Hz, 2H, Carom-H), 3.28 (d, J = 4.5 Hz, 1H, H-6), 
3.13 (d, J = 4.5 Hz, 1H, H-5), 2.61 (dq, J = 9.5, 6.5 Hz, 1H, H-2), 1.90 (dq, J = 
9.5, 6.9 Hz, 1H, H-3), 1.34 (d, J = 6.5 Hz, 3H, C-2CH3), 1.11 (d, J = 6.9 Hz, 3H, 
C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.1 (C-4), 196.4 (CHO), 136.5 
(Carom-C), 130.4 (q, 2JCF = 32.8 Hz, Carom-CF3), 129.4 (Carom-H), 126.0 (q, 3JCF = 
3.7 Hz, Carom-H), 123.8 (q, 1JCF = 272.3 Hz, CF3), 49.1 (C-1), 45.1 (C-3), 39.3 (C-
5), 36.6 (C-2), 34.5 (C-6), 16.3 (C-2CH3), 12.2 (C-3CH3). 
IR (ATR) cm-1: 1734 (C=O st), 1699 (C=O st). 
MS (EI) m/z (relative abundance): 296 (38), 268 (43), 240 (65), 211 (97), 
171 (54), 143 (100), 115 (49), 81 (34), 53 (22). 
HRMS: Calculated for [C16H14O2F3]¯: 295.0946 [M-H]¯; found: 295.0942. 
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(1S,2S,3S,5S,6R)-2-Ethyl-3-methyl-4-oxo-6-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (8m) 
Following the general procedure, 8m (16 mg, 0.065 mmol) was 
isolated by FC (hexanes/EtOAc gradient 9:1 to 7:3) as a yellow 
oil after 12 hours, starting from (E)-4-(1-methylbut-1-en-1-yl)-
5H-1,2,3-oxathiazole 2,2-dioxide 3d (28 mg, 0.150 mmol) and 
(E)-cinnamaldehyde 4i (28 μL, 0.225 mmol) in the presence of DABCO (50 mg, 
0.450 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using DCE (0.3 mL) as solvent. 
Yield: 43%. 
dr: >20:1. 
ee: 91%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 13.74 min, τminor = 27.37 
min. 
[]D20: -10.0 (c = 0.92, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.85 (s, 1H, CHO), 7.40-7.28 (m, 
5H, Carom-H), 3.30 (d, J = 4.5 Hz, 1H, H-6), 3.06 (d, J = 4.5 Hz, 1H, H-5), 2.65-
2.53 (m, 1H, H-2), 2.04-1.90 (m, 1H, H-3), 1.81-1.69 (m, 2H, CH2CH3), 1.19-1.08 
(m, 6H, C-3CH3+CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.0 (C-4), 197.0 (CHO), 132.3 
(Carom-C), 129.0, 128.9, 128.0 (Carom-H), 48.5 (C-1), 44.6 (C-3), 42.4 (C-2), 39.7 
(C-5), 35.1 (C-6), 26.0 (CH2CH3), 14.1 (C-3CH3), 12.5 (CH2CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1698 (C=O st). 
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MS (EI) m/z (relative abundance): 242 (25), 213 (14), 199 (7), 185 (67), 
171 (47), 157 (44), 141 (30), 129 (100), 105 (13), 91 (50), 77 (28), 67 (12), 51 
(11). 
HRMS: Calculated for [C16H17O2]¯: 241.1229 [M-H]¯; found: 241.1225. 
(1S,2S,3S,5S,6R)-2-Ethyl-6-(4-methoxyphenyl)-3-methyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8n) 
Following the general procedure, 8n (17 mg, 0.062 
mmol) was isolated by FC (hexanes/EtOAc gradient 
8:2 to 6:4) as a yellow oil after 12 hours, starting from 
(E)-4-(1-methylbut-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3d (28 mg, 0.150 mmol) and (E)-4-methoxycinnamaldehyde 4l (37 
mg, 0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 41%. 
dr: >20:1. 
ee: 90%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (97:3)]; flow rate 1.0 mL/min; τmajor = 23.13 min, τminor = 21.83 
min. 
[]D20: +10.7 (c = 0.96, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.87 (s, 1H, CHO), 7.21 (d, J = 8.6 
Hz, 2H, Carom-H), 6.88 (d, J = 8.6 Hz, 2H, Carom-H), 3.80 (s, 3H, OCH3), 3.24 (d, J 
= 4.5 Hz, 1H, H-6), 3.00 (d, J = 4.5 Hz, 1H, H-5), 2.62-2.50 (m, 1H, H-2), 2.01-
Experimental 333 
 
1.88 (m, 1H, H-3), 1.80-1.67 (m, 2H, CH2CH3), 1.16-1.06 (m, 6H, C-
3CH3+CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 210.2 (C-4), 197.3 (CHO), 159.2 
(Carom-C), 130.0 (Carom-H), 124.0 (Carom-C), 114.4 (Carom-H), 55.3 (OCH3), 48.6 (C-
1), 44.6 (C-3), 42.4 (C-2), 40.0 (C-5), 34.6 (C-6), 26.0 (CH2CH3), 14.2 (C-3CH3), 
12.5 (CH2CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1699 (C=O st). 
MS (EI) m/z (relative abundance): 272 (50), 255 (4), 243 (19), 229 (3), 216 
(42), 199 (46), 187 (36), 174 (16), 159 (27), 145 (24), 135 (18), 121 (100), 108 
(17), 91 (19), 77 (28), 65 (9), 55 (10). 
HRMS: Calculated for [C17H19O3]¯: 271.1334 [M-H]¯; found: 271.1328. 
(1S,2S,3S,5S,6R)-6-(4-Bromophenyl)-2-ethyl-3-methyl-4-
oxobicyclo[3.1.0]hexane-1-carbaldehyde (8o) 
Following the general procedure, 8o (14 mg, 0.045 
mmol) was isolated by FC (hexanes/EtOAc gradient 9:1 
to 7:3) as a yellow oil after 12 hours, starting from (E)-
4-(1-methylbut-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3d (28 mg, 0.150 mmol) and (E)-4-bromocinnamaldehyde 4p (49 mg, 
0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 30%. 
dr: >20:1. 
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ee: 86%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 18.25 min, τminor = 26.86 
min. 
[]D20: +15.8 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.87 (s, 1H, CHO), 7.50 (d, J = 8.4 
Hz, 2H, Carom-H), 7.18 (d, J = 8.4 Hz, 2H, Carom-H), 3.20 (d, J = 4.6 Hz, 1H, H-6), 
3.01 (d, J = 4.6 Hz, 1H, H-5), 2.63-2.41 (m, 1H, H-2), 2.02-1.89 (m, 1H, H-3), 
1.80-1.67 (m, 2H, CH2CH3), 1.17-1.07 (m, 6H, C-3CH3+CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 209.6 (C-4), 196.5 (CHO), 132.2 
(Carom-H), 131.4 (Carom-C), 130.5 (Carom-H), 122.0 (Carom-C), 48.4 (C-1), 44.6 (C-
3), 42.5 (C-2), 39.6 (C-5), 34.4 (C-6), 26.0 (CH2CH3), 14.2 (C-3CH3), 12.5 
(CH2CH3). 
IR (ATR) cm-1: 1731 (C=O st), 1701 (C=O st). 
MS (EI) m/z (relative abundance): 320 (30), 292 (8), 277 (5), 264 (55), 249 
(25), 235 (21), 222 (8), 209 (7), 185 (58), 169 (51), 156 (74), 141 (100), 128 
(100), 115 (90), 95 (50), 77 (33), 67 (36), 55 (20). 
HRMS: Calculated for [C16H16O2Br]¯: 319.0334 [M-H]¯; found: 319.0335. 
(1R,2R,3S,5S,6R)-3-methyl-4-oxo-2,6-diphenylbicyclo[3.1.0]hexane-1-
carbaldehyde (8p) 
Following the general procedure, 8p (21 mg, 0.073 mmol) was 
isolated by FC (hexanes/EtOAc gradient 9:1 to 8:2) as a yellow 
oil after 12 hours, starting from (E)-4-(1-phenylprop-1-en-2-yl)-
5H-1,2,3-oxathiazole 2,2-dioxide 3e (36 mg, 0.150 mmol) and 
(E)-cinnamaldehyde 4i (28 μL, 0.225 mmol) in the presence of DABCO (50 mg, 
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0.450 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using DCE (0.3 mL) as solvent. 
Yield: 49%. 
dr: >20:1. 
ee: 93%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 14.61 min, τminor = 29.31 
min. 
[]D20: +25.7 (c = 0.83, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.89 (s, 1H, CHO), 7.55-7.50 (m, 
2H, Carom-H), 7.46-7.39 (m, 2H, Carom-H), 7.37-7.23 (m, 6H, Carom-H), 3.81 (d, J = 
10.1 Hz, 1H, H-2), 3.68 (d, J = 4.5 Hz, 1H, H-6), 3.16 (d, J = 4.5 Hz, 1H, H-5), 
2.58 (dq, J = 10.1, 6.9 Hz, 1H, H-3), 1.20 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 208.4 (C-4), 196.4 (CHO), 139.7, 
131.9 (Carom-C), 129.0, 128.9, 128.8, 128.1, 127.5, 127.5 (Carom-H), 48.7 (C-1), 
46.4 (C-2), 44.2 (C-3), 38.7 (C-5), 36.0 (C-6), 13.0 (C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1699 (C=O st). 
MS (EI) m/z (relative abundance): 290 (17), 273 (1), 262 (4), 247 (4), 234 
(14), 215 (9), 205 (100), 191 (10), 171 (14), 156 (6), 144 (11), 128 (25), 115 (40), 
103 (8), 91 (40), 77 (15), 65 (6), 51 (6). 
HRMS: Calculated for [C20H17O2]¯: 289.1229 [M-H]¯; found: 289.1236. 
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(1R,2R,3S,5S,6R)-6-(4-Acetoxy-3-methoxyphenyl)-3-methyl-4-oxo-2-
phenylbicyclo[3.1.0]hexane-1-carbaldehyde (8q) 
Following the general procedure, 8q (29 mg, 0.077 
mmol) was isolated by FC (hexanes/EtOAc gradient 7:3 
to 1:1) as a yellow oil after 12 hours, starting from (E)-
4-(1-phenylprop-1-en-2-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3e (36 mg, 0.150 mmol) and (E)-4-acetoxy-3-methoxycinnamaldehyde 4m 
(52 mg, 0.225 mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-
2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 51%. 
dr: >20:1. 
ee: 90%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 26.85 min, τminor = 38.87 
min. 
[]D20: +19.1 (c = 0.81, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.95 (s, 1H, CHO), 7.53-7.46 (m, 
2H, Carom-H), 7.45-7.29 (m, 3H, Carom-H), 7.01-6.95 (m, 1H, Carom-H), 6.84-6.78 
(m, 2H, Carom-H), 3.86-3.76 (m, 4H, H-2+OCH3), 3.63 (d, J = 4.5 Hz, 1H, H-6), 
3.10 (d, J = 4.5 Hz, 1H, H-5), 2.57 (dq, J = 10.0, 6.9 Hz, 1H, H-3), 2.30 (s, 3H, 
OCOCH3), 1.20 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 208.3 (C-4), 196.2 (CHO), 168.8 
(OCOCH3), 151.5, 139.6, 139.6, 130.7 (Carom-C), 128.9, 127.5, 127.5, 123.3, 
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121.0, 112.8 (Carom-H), 55.9 (OCH3), 48.8 (C-1), 46.3 (C-2), 44.2 (C-3), 38.9 (C-
5), 35.8 (C-6), 20.6 (OCOCH3), 13.0 (C-3CH3). 
IR (ATR) cm-1: 1764 (OC=O st), 1732 (C=O st), 1699 (C=O st). 
MS (EI) m/z (relative abundance): 378 (5), 336 (100), 308 (4), 280 (33), 
251 (53), 235 (5), 218 (54), 190 (41), 165 (15), 137 (32), 115 (32), 91 (31), 77 
(18), 51 (7). 
HRMS: Calculated for [C23H21O5]¯: 377.1389 [M-H]¯; found: 377.1392. 
(1R,2R,3S,5S,6R)-6-(4-Bromophenyl)-3-methyl-4-oxo-2-
phenylbicyclo[3.1.0]hexane-1-carbaldehyde (8r) 
Following the general procedure, 8r (23 mg, 0.063 mmol) 
was isolated by FC (hexanes/EtOAc gradient 9:1 to 7:3) 
as a yellow oil after 12 hours, starting from (E)-4-(1-
phenylprop-1-en-2-yl)-5H-1,2,3-oxathiazole 2,2-dioxide 
3e (36 mg, 0.150 mmol) and (E)-4-bromocinnamaldehyde 4p (49 mg, 0.225 mmol) 
in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 42%. 
dr: >20:1. 
ee: 75%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 21.69 min, τminor = 47.16 
min. 
[]D20: +34.2 (c = 1.00, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 8.89 (s, 1H, CHO), 7.52-7.37 (m, 
7H, Carom-H), 7.11 (d, J = 8.3 Hz, 2H, Carom-H), 3.80 (d, J = 10.2 Hz, 1H, H-2), 
3.58 (d, J = 4.5 Hz, 1H, H-6), 3.10 (d, J = 4.5 Hz, 1H, H-5), 2.57 (dq, J = 10.2, 6.9 
Hz, 1H, H-3), 1.20 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 208.0 (C-4), 195.8 (CHO), 139.5 
(Carom-C), 132.2 (Carom-H), 131.0 (Carom-C), 130.4, 128.9, 127.6, 127.4 (Carom-H), 
122.2 (Carom-C), 48.7 (C-1), 46.4 (C-2), 44.1 (C-3), 38.6 (C-5), 35.3 (C-6), 13.0 
(C-3CH3). 
IR (ATR) cm-1: 1732 (C=O st), 1700 (C=O st). 
MS (EI) m/z (relative abundance): 368 (14), 342 (3), 327 (2), 312 (13), 285 
(8), 271 (2), 250 (4), 231 (5), 215 (18), 204 (100), 189 (8), 171 (29), 143 (10), 128 
(28), 115 (47), 102 (20), 91 (30), 77 (19), 63 (10), 51 (9). 
HRMS: Calculated for [C20H16O2Br]¯: 367.0334 [M-H]¯; found: 367.0340. 
(1R,2R,3S,5S,6R)-3-Methyl-6-(4-nitrophenyl)-4-oxo-2-
phenylbicyclo[3.1.0]hexane-1-carbaldehyde (8s) 
Following the general procedure, 8s (23 mg, 0.069 
mmol) was isolated by FC (hexanes/EtOAc gradient 8:2 
to 6:4) as a yellow oil after 12 hours, starting from (E)-
4-(1-phenylprop-1-en-2-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3e (36 mg, 0.150 mmol) and (E)-4-nitrocinnamaldehyde 4r (41 mg, 0.225 
mmol) in the presence of DABCO (50 mg, 0.450 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
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Yield: 46%. 
dr: >20:1. 
ee: 76%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (90:10)]; flow rate 0.8 mL/min; τmajor = 40.91 min, τminor = 37.61 
min. 
[]D20: +47.7 (c = 0.81, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.94 (s, 1H, CHO), 8.20 (d, J = 8.7 
Hz, 2H, Carom-H), 7.53-7.36 (m, 7H, Carom-H), 3.84 (d, J = 10.1 Hz, 1H, H-2), 3.65 
(d, J = 4.7 Hz, 1H, H-6), 3.20 (d, J = 4.7 Hz, 1H, H-5), 2.63 (dq, J = 10.1, 6.9 Hz, 
1H, H-3), 1.22 (d, J = 6.9 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 207.4 (C-4), 195.0 (CHO), 147.6, 
139.5, 139.1 (Carom-C), 129.7, 129.1, 127.8, 127.4, 124.2 (Carom-H), 49.0 (C-1), 
46.7 (C-2), 44.0 (C-3), 38.6 (C-5), 35.2 (C-6), 13.0 (C-3CH3). 
IR (ATR) cm-1: 1734 (C=O st), 1700 (C=O st), 1519 (NO2 st as), 1345 (NO2 
st sym). 
MS (EI) m/z (relative abundance): 335 (16), 318 (15), 292 (9), 279 (34), 
262 (6), 250 (41), 234 (13), 215 (25), 204 (100), 189 (29), 171 (15), 142 (15), 128 
(42), 115 (99), 102 (28), 91 (57), 77 (31), 63 (16), 51 (18). 
HRMS: Calculated for [C20H16NO4]¯: 334.1079 [M-H]¯; found: 334.1079. 
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2.9. Synthesis of tricyclic compounds 12a-c. 
General procedure: 
The α,β-unsaturated aldehyde 4 (1.00 mmol) was added to a solution of 
diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (0.20 mmol, 20 mol%), 
DABCO (5.00 mmol) and 4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3a (1.50 mmol) in DCE (2 mL). The reaction was stirred at 75 ºC until it 
was completed. A saturated solution of NH4Cl (10 mL) was added and the 
aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The obtained crude product was charged onto silica gel and subjected to 
flash chromatography (FC) with the indicated eluent, obtaining the desired 
tricycles 12a-c. The racemic compounds for HPLC separation conditions were 
prepared under the same reaction conditions, using in these cases a 1:1 ratio of 
(R)- and (S)-diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether (0.20 mmol, 20 
mol%) as catalyst. 
(1R,1aS,1bS,5aS,6aS)-6-oxo-1-phenyldecahydrocyclopropa[a]indene-1a-
carbaldehyde (12a) 
Following the general procedure, 12a (18 mg, 0.069 mmol) 
was isolated by FC (hexanes/EtOAc gradient 9:1 to 7:3) as a 
yellow oil after 12 hours, starting from 4-(cyclohex-1-en-1-yl)-
5H-1,2,3-oxathiazole 2,2-dioxide 3a (45 mg, 0.225 mmol) and 
(E)-cinnamaldehyde 4i (19 μL, 0.150 mmol) in the presence of DABCO (84 mg, 
0.750 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using DCE (0.3 mL) as solvent. 
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Yield: 46%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (90:10)]; flow rate 1.0 mL/min; τmajor = 19.87 min, τminor = 41.63 
min. 
[]D20: +49.7 (c = 0.69, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.87 (s, 1H, CHO), 7.42-7.23 (m, 
5H, Carom-H), 3.60 (d, J = 4.3 Hz, 1H, H-1), 2.91 (d, J = 4.3 Hz, 1H, H-6a), 2.43-
2.30 (m, 1H, H-1b), 2.29-2.21 (m, 1H, H-2a), 2.09-2.01 (m, 1H, H-5a), 1.93-1.80 
(m, 3H, H-5a+H-3a+H-4a), 1.45-1.33 (m, 2H, H-2b+H-3b), 1.27-1.18 (m, 2H, H-
5b+H-4b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 207.5 (C-6), 197.8 (CHO), 132.5 
(Carom-C), 129.0, 128.9, 128.0 (Carom-H), 47.5 (C-5a), 47.0 (C-1a), 41.5 (C-1b), 
37.6 (C-6a), 36.8 (C-1), 29.2 (C-2), 25.9, 25.8 (C-3+C-4), 24.7 (C-5). 
IR (ATR) cm-1: 1731 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 254 (39), 237 (3), 226 (19), 207 (10), 
197 (23), 183 (27), 165 (23), 155 (35), 141 (51), 129 (85), 115 (95), 103 (21), 91 
(100), 77 (48), 65 (21), 55 (21). 
HRMS: Calculated for [C17H19O2]+: 255.1385 [M+H]+; found: 255.1387. 
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(1R,1aS,1bS,5aS,6aS)-1-(4-Methoxyphenyl)-6-
oxodecahydrocyclopropa[a]indene-1a-carbaldehyde (12b) 
Following the general procedure, 12b (14 mg, 0.051 
mmol) was isolated by FC (hexanes/EtOAc gradient 
9:1 to 7:3) as a yellow oil after 12 hours, starting 
from 4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 
2,2-dioxide 3a (45 mg, 0.225 mmol) and (E)-4-methoxycinnamaldehyde 4l (25 
mg, 0.150 mmol) in the presence of DABCO (84 mg, 0.750 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 34%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 18.36 min, τminor = 42.20 
min. 
[]D20: +74.0 (c = 0.75, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.88 (s, 1H, CHO), 7.20 (d, J = 8.7 
Hz, 2H, Carom-H), 6.88 (d, J = 8.7 Hz, 2H, Carom-H), 3.80 (s, 3H, OCH3), 3.55 (d, J 
= 4.2 Hz, 1H, H-1), 2.85 (d, J = 4.2 Hz, 1H, H-6a), 2.41-2.29 (m, 1H, H-1b), 2.29-
2.19 (m, 1H, H-2a), 2.08-2.00 (m, 1H, H-5a), 1.93-1.77 (m, 3H, H-5a+H-3a+H-4a), 
1.45-1.32 (m, 2H, H-2b+H-3b), 1.27-1.17 (m, 2H, H-5b+H-4b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 207.7 (C-6), 198.1 (CHO), 159.2 
(Carom-C), 130.0 (Carom-H), 124.4 (Carom-C), 114.4 (Carom-H), 55.3 (OCH3), 47.6 (C-
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5a), 47.1 (C-1a), 41.5 (C-1b), 38.0 (C-6a), 36.4 (C-1), 29.2 (C-2), 25.9, 25.8 (C-
3+C-4), 24.8 (C-5). 
IR (ATR) cm-1: 1728 (C=O st), 1695 (C=O st). 
MS (EI) m/z (relative abundance): 284 (40), 267 (4), 255 (35), 239 (5), 227 
(10), 213 (8), 199 (6), 187 (12), 171 (21), 159 (22), 145 (22), 135 (14), 121 (100), 
107 (15), 91 (25), 77 (23), 55 (11). 
HRMS: Calculated for [C18H21O3]+: 285.1491 [M+H]+; found: 285.1494. 
(1R,1aS,1bS,5aS,6aS)-1-(4-Bromophenyl)-6-
oxodecahydrocyclopropa[a]indene-1a-carbaldehyde (12c) 
Following the general procedure, 12c (19 mg, 0.057 
mmol) was isolated by FC (hexanes/EtOAc gradient 
9:1 to 7:3) as a yellow oil after 12 hours, starting from 
4-(cyclohex-1-en-1-yl)-5H-1,2,3-oxathiazole 2,2-
dioxide 3a (45 mg, 0.225 mmol) and (E)-4-bromocinnamaldehyde 4p (32 mg, 
0.150 mmol) in the presence of DABCO (84 mg, 0.750 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using DCE 
(0.3 mL) as solvent. 
Yield: 38%. 
dr: >20:1. 
ee: 96%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 17.70 min, τminor = 47.53 
min. 
[]D20: +54.8 (c = 0.66, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 8.87 (s, 1H, CHO), 7.49 (d, J = 8.4 
Hz, 2H, Carom-H), 7.17 (d, J = 8.4 Hz, 2H, Carom-H), 3.52 (d, J = 4.3 Hz, 1H, H-1), 
2.85 (d, J = 4.3 Hz, 1H, H-6a), 2.42-2.29 (m, 1H, H-1b), 2.29-2.21 (m, 1H, H-2a), 
2.11-2.01 (m, 1H, H-5a), 1.95-1.79 (m, 3H, H-5a+H-3a+H-4a), 1.44-1.31 (m, 2H, 
H-2b+H-3b), 1.27-1.17 (m, 2H, H-5b+H-4b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 207.0 (C-6), 197.2 (CHO), 132.2 
(Carom-H), 131.7 (Carom-C), 130.6 (Carom-H), 122.0 (Carom-C), 47.5 (C-5a), 46.9 (C-
1a), 41.5 (C-1b), 37.4 (C-6a), 36.0 (C-1), 29.2 (C-2), 25.8, 25.8 (C-3+C-4), 24.7 
(C-5). 
IR (ATR) cm-1: 1732 (C=O st), 1697 (C=O st). 
MS (EI) m/z (relative abundance): 332 (48), 315 (5), 303 (17), 289 (7), 275 
(22), 263 (13), 249 (12), 235 (18), 222 (30), 207 (25), 195 (27), 182 (27), 169 
(63), 153 (60), 141 (73), 128 (97), 115 (100), 102 (44), 77 (50), 55 (39). 
HRMS: Calculated for [C17H16O2Br]¯: 331.0334 [M-H]¯; found: 331.0321. 
2.10. Synthesis of α-hydroxy ketone 14. 
(E)-1-Hydroxy-4-phenylbut-3-en-2-one (14) 
To a mixture of CH3CN/H2O (75:15 mL), trifluoroacetic acid 
(2.30 mL, 30.00 mmol) and (E)-4-phenylbut-3-en-2-one 13 (2.19 
g, 15.00 mmol) were added. Then 
[bis(trifluoroacetoxy)iodo]benzene (13.30 g, 30.00 mmol) was added and the 
reaction was stirred under reflux during 4 hours and then allowed to reach room 
temperature. The solvent was removed under vacuum and H2O (75 mL) was 
added. The mixture was extracted with CH2Cl2 (3 × 150 mL) and the combined 
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organic layers were washed with a solution of saturated aqueous NaHCO3 (3 × 
150 mL). The organic phase was dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. After purification by flash column 
chromatography (FC) (hexanes/EtOAc gradient from 7:3 to 1:1) the α-hydroxy 
ketone 14 (825 mg, 5.09 mmol) was isolated as a yellow oil. 
Yield: 34%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.66 (d, J = 16.3 Hz, 1H, Carom-CH), 
7.58-7.53 (m, 2H, Carom-H), 7.43-7.37 (m, 3H, Carom-H), 6.75 (d, J = 16.3 Hz, 1H, 
CHCO), 4.53 (d, J = 3.3 Hz, 2H, CH2OH), 3.43 (s, 1H, OH). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 198.1 (CO), 144.1 (Carom-CH), 
133.9 (Carom-C), 131.1, 129.1, 128.5 (Carom-H), 121.4 (CHCO), 67.1 (CH2OH). 
IR (ATR) cm-1: 3447 (O-H st), 1668 (C=O st). 
MS (EI) m/z (relative abundance): 162 (1), 131 (100), 103 (65), 77 (42), 51 
(21). 
HRMS: Calculated for [C10H11O2]+: 163.0759 [M+H]+; found: 163.0760. 
2.11. Synthesis of 4-alkenyl-5H-1,2,3-oxathiazole 2,2-dioxide 15. 
(E)-4-Styryl-5H-1,2,3-oxathiazole 2,2-dioxide (15) 
To a solution of α-hydroxy ketone 14 (751 mg, 4.63 mmol) in dry 
DMA (12 mL) under inert atmosphere, sulfamoyl chloride (1.07 
g, 9.26 mmol) was added portionwise. After stirring at room 
temperature for 2 hours, the reaction mixture was diluted with 
EtOAc (45 mL) and washed with brine (3 × 45 mL). The resulting organic layer 
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was dried over anhydrous Na2SO4, filtered and the solvent was removed under 
reduced pressure. Then p-toluenesulfonic acid (88 mg, 0.46 mmol) and toluene (12 
mL) were added, and the reaction was stirred under reflux for 1 hour with a Dean-
Stark receiver. The mixture was diluted with EtOAc (45 mL) and washed with a 
solution of saturated aqueous NaHCO3 (3 × 45 mL). The resulting organic layer 
was dried over anhydrous Na2SO4, filtered and concentrated in vacuo. After 
purification by flash column chromatography (FC) (hexanes/EtOAc gradient from 
7:3 to 4:6) the sulfamidate imine 15 (586 mg, 2.62 mmol) was isolated as a brown 
solid. 
Yield: 57%. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.62-7.44 (m, 6H, Carom-H+Carom-
CH), 7.02 (d, J = 16.6 Hz, 1H, CHCN), 5.39 (s, 2H, OCH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 174.2 (CN), 148.2 (Carom-CH), 
133.1 (Carom-C), 132.4, 129.4, 128.8 (Carom-H), 116.6 (CHCN), 74.1 (OCH2). 
IR (ATR) cm-1: 1625 (C=C st), 1557 (C=N st), 1358 (SO2 st as), 1187 (SO2 
st sym). 
M.p. (hexanes/EtOAc) (ºC): 172-174. 
MS (EI) m/z (relative abundance): 207 (30), 158 (13), 130 (76), 102 (37), 
77 (38), 64 (100), 51 (26). 
HRMS: Calculated for [C10H10NO3S]+: 224.0381 [M+H]+; found: 224.0386. 
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2.12. Synthesis of bicyclic compounds 16a-c. 
General procedure: 
The α,β-unsaturated aldehyde 4 (1.50 mmol) was added to a solution of 
diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (0.20 mmol, 20 mol%), 
DABCO (0.20 mmol, 20 mol%) and (E)-4-styryl-5H-1,2,3-oxathiazole 2,2-dioxide 
15 (1.00 mmol) in dry CHC l3 (2 mL) under inert atmosphere. The reaction was 
stirred at room temperature until it was completed. The obtained crude product 
was charged onto silica gel and subjected to flash chromatography (FC) with the 
indicated eluent, obtaining the desired bicycles 16a-c. The racemic compounds for 
HPLC separation conditions were prepared under the same reaction conditions, 
using in these cases a 1:1 ratio of (R)- and (S)-diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether (0.20 mmol, 20 mol%) as catalyst. 
(1S,2R,5S,6R)-4-oxo-2,6-diphenylbicyclo[3.1.0]hexane-1-carbaldehyde (16a) 
Following the general procedure, 16a (20 mg, 0.072 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9:1 to 7:3) as a 
yellow oil after 48 hours, starting from (E)-4-styryl-5H-1,2,3-
oxathiazole 2,2-dioxide 15 (33 mg, 0.150 mmol) and (E)-
cinnamaldehyde 4i (28 μL, 0.225 mmol) in the presence of DABCO (3 mg, 0.030 
mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 
mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 48%. 
dr: >20:1. 
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ee: 99%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (80:20)]; flow rate 1.0 mL/min; τmajor = 35.97 min, τminor = 47.30 
min. 
[]D20: +113.3 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.99 (s, 1H, CHO), 7.45-7.24 (m, 
10H, Carom-H), 4.44 (app t, J = 10.0 Hz, 1H, H-2), 3.44 (d, J = 4.7 Hz, 1H, H-6), 
3.21 (d, J = 4.7 Hz, 1H, H-5), 2.87 (dd, J = 18.6, 9.9 Hz, 1H, H-3a), 2.58 (dd, J = 
18.6, 10.0 Hz, 1H, H-3b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 206.8 (C-4), 196.5 (CHO), 140.1, 
131.6 (Carom-C), 129.1, 128.8, 128.6, 128.1, 127.3, 127.2 (Carom-H), 50.1 (C-1), 
40.4 (C-3), 40.1 (C-5), 37.4 (C-2), 35.1 (C-6). 
IR (ATR) cm-1: 1734 (C=O st), 1698 (C=O st). 
MS (EI) m/z (relative abundance): 276 (11), 258 (2), 247 (3), 234 (12), 215 
(10), 205 (100), 191 (12), 178 (9), 157 (15), 144 (23), 128 (29), 115 (51), 103 
(13), 91 (47), 77 (23), 65 (9), 51 (11). 
HRMS: Calculated for [C19H15O2]¯: 275.1072 [M-H]¯; found: 275.1071. 
(1S,2R,5S,6R)-6-(2-methoxyphenyl)-4-oxo-2-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (16b) 
Following the general procedure, 16b (21 mg, 0.069 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 8:2 to 6:4) 
as a yellow oil after 24 hours, starting from (E)-4-styryl-5H-
1,2,3-oxathiazole 2,2-dioxide 15 (33 mg, 0.150 mmol) and 
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(E)-2-methoxycinnamaldehyde 4k (37 mg, 0.225 mmol) in the presence of 
DABCO (3 mg, 0.030 mmol), diphenyl-2-pyrrolidinemethanoltrimethylsilyl ether 
5a (10 mg, 0.030 mmol) and using dry CHCl3 (0.3 mL) as solvent. 
Yield: 46%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 10.73 min, τminor = 12.04 
min. 
[]D20: +40.7 (c = 0.66, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.74 (s, 1H, CHO), 7.59-7.48 (m, 
2H, Carom-H), 7.42-7.33 (m, 2H, Carom-H), 7.32-7.26 (m, 3H, Carom-H), 7.01-6.90 
(m, 1H, Carom-H), 6.83-6.74 (m, 1H, Carom-H), 4.44 (app t, J = 10.0 Hz, 1H, H-2), 
3.52 (s, 3H, OCH3), 3.43 (d, J = 4.6 Hz, 1H, H-6), 3.04 (d, J = 4.6 Hz, 1H, H-5), 
2.78 (dd, J = 18.5, 9.8 Hz, 1H, H-3a), 2.65 (dd, J = 18.5, 10.3 Hz, 1H, H-3b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 207.3 (C-4), 196.7 (CHO), 158.2, 
139.6 (Carom-C), 129.7, 129.5, 128.2, 128.0, 127.0, 120.6 (Carom-H), 120.4 (Carom-
C), 110.3 (Carom-H), 54.7 (OCH3), 49.2 (C-1), 40.2 (C-3), 40.1 (C-5), 37.9 (C-2), 
31.0 (C-6). 
IR (ATR) cm-1: 1732 (C=O st), 1702 (C=O st). 
MS (EI) m/z (relative abundance): 306 (83), 289 (8), 277 (6), 264 (20), 247 
(8), 235 (100), 220 (37), 202 (61), 187 (31), 174 (33), 159 (24), 145 (20), 128 
(38), 115 (82), 103 (28), 91 (96), 77 (52), 65 (20), 51 (25). 
HRMS: Calculated for [C20H17O3]¯: 305.1178 [M-H]¯; found: 305.1175. 
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(1S,2R,5S,6R)-6-(4-methoxyphenyl)-4-oxo-2-phenylbicyclo[3.1.0]hexane-1-
carbaldehyde (16c) 
Following the general procedure, 16c (19 mg, 0.062 
mmol) was isolated by FC (hexanes/EtOAc gradient 
from 8:2 to 6:4) as a yellow oil after 24 hours, starting 
from (E)-4-styryl-5H-1,2,3-oxathiazole 2,2-dioxide 15 
(33 mg, 0.150 mmol) and (E)-4-methoxycinnamaldehyde 4l (37 mg, 0.225 mmol) 
in the presence of DABCO (3 mg, 0.030 mmol), diphenyl-2-
pyrrolidinemethanoltrimethylsilyl ether 5a (10 mg, 0.030 mmol) and using dry 
CHCl3 (0.3 mL) as solvent. 
Yield: 41%. 
dr: >20:1. 
ee: 98%. Determined by HPLC using a Chiralpak AD-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 13.40 min, τminor = 11.95 
min. 
[]D20: +45.5 (c = 0.27, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 9.00 (s, 1H, CHO), 7.41-7.28 (m, 
5H, Carom-H), 7.18 (d, J = 8.6 Hz, 2H, Carom-H), 6.87 (d, J = 8.6 Hz, 2H, Carom-H), 
4.42 (app t, J = 10.0 Hz, 1H, H-2), 3.80 (s, 3H, OCH3), 3.39 (d, J = 4.6 Hz, 1H, H-
6), 3.15 (d, J = 4.6 Hz, 1H, H-5), 2.86 (dd, J = 18.6, 9.9 Hz, 1H, H-3a), 2.56 (dd, J 
= 18.6, 10.1 Hz, 1H, H-3b). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 206.9 (C-4), 196.8 (CHO), 159.3, 
140.2 (Carom-C), 129.7, 128.8, 127.3, 127.1 (Carom-H), 123.4 (Carom-C), 114.5 
(Carom-H), 55.3 (OCH3), 50.2 (C-1), 40.5 (C-3), 40.5 (C-5), 37.3 (C-2), 34.7 (C-6). 
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IR (ATR) cm-1: 1737 (C=O st), 1699 (C=O st). 
MS (EI) m/z (relative abundance): 306 (75), 289 (6), 277 (25), 264 (21), 
247 (10), 235 (100), 220 (31), 202 (62), 189 (23), 174 (46), 159 (22), 145 (55), 
135 (13), 121 (94), 102 (30), 91 (44), 77 (48), 63 (16), 51 (20). 
HRMS: Calculated for [C20H17O3]¯: 305.1178 [M-H]¯; found: 305.1176. 
2.13. Synthesis of diols 17a and 17p. 
General procedure: 
NaBH4 (2.00 mmol) was added to a solution of the cyclopropane 8 (1.00 
mmol) in MeOH (10 mL) at 0 ºC. The mixture was stirred at 0 ºC for 30 minutes, 
then a solution of saturated aqueous NH4Cl (1 mL) was added to quench the 
reaction and it was stirred for another 5 minutes. The mixture was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried with anhydrous 
Na2SO4, filtered and the solvent was removed under reduced pressure. The 
obtained crude product was charged onto silica gel and subjected to flash 
chromatography (FC) with the indicated eluent, obtaining the desired diols 17a 
and 17p. 
(1S,2R,3S,4S,5S,6R)-5-(Hydroxymethyl)-3,4-dimethyl-6-
phenylbicyclo[3.1.0]hexan-2-ol (17a) 
Following the general procedure, 17a (17 mg, 0.072 mmol) was 
isolated by FC (n-hexane/EtOAc gradient from 1:1 to 3:7) as a 
yellow oil, starting from cyclopropane 8a (17 mg, 0.075 mmol) 
and NaBH4 (6 mg, 0.150 mmol) in MeOH (700 μL) at 0 ºC. 
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Yield: 96%. 
dr: >20:1. 
[]D20: -52.3 (c = 0.69, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.32-7.14 (m, 5H, Carom-H), 4.05 
(dd, J = 7.2, 4.9 Hz, 1H, H-2), 3.60 (d, J = 12.1 Hz, 1H, CHaHbOH), 3.27 (d, J = 
12.1 Hz, 1H, CHaHbOH), 2.46 (d, J = 4.0 Hz, 1H, H-6), 2.11 (app t, J = 4.4 Hz, 
1H, H-1), 2.01-1.86 (m, 1H, H-4), 1.45 (s, 2H, 2 × OH), 1.13 (d, J = 6.5 Hz, 3H, 
C-4CH3), 1.11-1.02 (m, 4H, H-3+C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 137.6 (Carom-C), 128.6, 128.3, 
126.2 (Carom-H), 80.0 (C-2), 62.6 (CH2OH), 45.2 (C-3), 42.1 (C-4), 40.4 (C-5), 
31.8 (C-1), 24.7 (C-6), 16.0 (C-3CH3), 15.0 (C-4CH3). 
IR (ATR) cm-1: 3328 (O-H st). 
MS (EI) m/z (relative abundance): 232 (1), 214 (14), 196 (32), 181 (46), 
169 (49), 158 (35), 143 (56), 129 (73), 115 (58), 105 (24), 91 (100), 77 (41), 65 
(17), 51 (19). 
HRMS: Calculated for [C15H20O2Na]+: 255.1361 [M+Na]+; found: 
255.1362. 
(1S,2R,3S,4R,5R,6R)-5-(Hydroxymethyl)-3-methyl-4,6-
diphenylbicyclo[3.1.0]hexan-2-ol (17p) 
Following the general procedure, 17p (12 mg, 0.041 mmol) was 
isolated by FC (n-hexane/EtOAc gradient from 1:1 to 3:7) as a 
yellow solid, starting from cyclopropane 8p (14 mg, 0.048 mmol) 
and NaBH4 (4 mg, 0.095 mmol) in MeOH (500 μL) at 0 ºC. 
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Yield: 85%. 
dr: >20:1. 
ee: 92%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (85:15)]; flow rate 1.0 mL/min; τmajor = 23.27 min, τminor = 11.71 
min. 
[]D20: +4.8 (c = 0.68, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.47-7.16 (m, 10H, Carom-H), 4.20 
(dd, J = 8.1, 4.8 Hz, 1H, H-2), 3.51 (d, J = 12.0 Hz, 1H, CHaHbOH), 3.18 (d, J = 
12.0 Hz, 1H, CHaHbOH), 3.10 (d, J = 10.8 Hz, 1H, H-4), 3.05 (d, J = 3.7 Hz, 1H, 
H-6), 2.19 (app t, J = 4.4 Hz, 1H, H-1), 1.89-1.52 (m, 3H, H-3+2 × OH), 1.06 (d, 
J = 6.5 Hz, 3H, C-3CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 141.0, 137.1 (Carom-C), 128.8, 
128.7, 128.3, 127.9, 127.0, 126.4 (Carom-H), 79.6 (C-2), 61.9 (CH2OH), 52.4 (C-4), 
44.1 (C-3), 39.9 (C-5), 30.0 (C-1), 25.5 (C-6), 15.8 (C-3CH3). 
IR (ATR) cm-1: 3304 (O-H st). 
M.p. (hexanes/EtOAc) (ºC): 148-150. 
MS (EI) m/z (relative abundance): 276 (8), 258 (35), 246 (39), 228 (19), 
215 (29), 205 (21), 191 (14), 178 (17), 165 (50), 155 (33), 144 (32), 129 (83), 115 
(72), 105 (23), 91 (100), 77 (37), 65 (14), 51 (19). 
HRMS: Calculated for [C20H22O2Na]+: 317.1518 [M+Na]+; found: 
317.1512. 
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2.14. Synthesis of diol 18. 
(1S,2S,3S,4R,5S,6R)-5-(Hydroxymethyl)-3,4-dimethyl-6-
phenylbicyclo[3.1.0]hexan-2-ol (18) 
L-Selectride 1 M in THF (122 μL, 0.122 mmol) was added to a 
solution of the cyclopropane 11a (11 mg, 0.049 mmol) in dry 
THF (0.5 mL) at -78 ºC under inert atmosphere. The mixture was 
stirred at -78 ºC for 2.5 hours, then a solution of saturated 
aqueous NH4Cl (1 mL) was added at -78 ºC to quench the reaction and it was 
stirred for another 5 minutes at room temperature. The mixture was extracted with 
AcOEt (3 × 5 mL). The combined organic layers were dried with anhydrous 
Na2SO4, filtered and the solvent was removed under reduced pressure. After 
purification by flash column chromatography (FC) (hexanes/EtOAc gradient from 
6:4 to 1:1) the diol 18 (11 mg, 0.046 mmol) was isolated as a yellow oil. 
Yield: 93%. 
dr: >20:1. 
[]D20: -20.3 (c = 0.62, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.33-7.18 (m, 5H, Carom-H), 4.14 
(app d, J = 4.6 Hz, 1H, H-2), 3.91 (d, J = 12.1 Hz, 1H, CHaHbOH), 3.30 (d, J = 
12.1 Hz, 1H, CHaHbOH), 2.42-2.28 (m, 1H, H-4), 2.21 (d, J = 3.9 Hz, 1H, H-6), 
2.10-1.96 (m, 2H, H-1+H-3), 1.56 (s, 2H, 2 × OH), 1.13 (d, J = 7.4 Hz, 3H, C-
4CH3), 1.03 (d, J = 7.2 Hz, 3H, C-3CH3). 
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13C-NMR (, ppm) (CDCl3, 75.5 MHz): 137.8 (Carom-C), 128.5, 128.4, 
126.2 (Carom-H), 76.7 (C-2), 60.4 (CH2OH), 43.0 (C-5), 38.6, 38.4 (C-3+C-4), 
33.6 (C-1), 29.5 (C-6), 14.4 (C-4CH3), 9.6 (C-3CH3). 
IR (ATR) cm-1: 3368 (O-H st). 
MS (EI) m/z (relative abundance): 214 (12), 196 (28), 181 (38), 169 (26), 
158 (49), 143 (99), 129 (81), 115 (61), 105 (25), 91 (100), 77 (45), 65 (17), 51 
(21). 
HRMS: Calculated for [C15H20O2Na]+: 255.1361 [M+Na]+; found: 
255.1369. 
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3. ORGANOCATALYTIC APPROACH TO CHIRAL PROLINE 
DERIVATIVES 
3.1. Synthesis of pyrrolidines 22a-r. 
General procedure for the Michael addition/imine formation step: 
The aminomalonate11 20 (0.56 mmol) was added to a solution of 9-epi-9-
amino-9-deoxycinchonidine12 21a (0.08 mmol, 20 mol%), the corresponding acid 
(0.16 mmol, 40 mol%), and α,β-unsaturated ketone 19 (0.40 mmol) in the 
indicated solvent (2 mL). The reaction was stirred at room temperature, following 
its evolution by 1H-NMR. After consumption of the starting material, the solvent 
was removed obtaining the corresponding cyclic imine, which was reduced 
without further purification as follows. The racemic compounds for HPLC 
separation conditions were prepared under the same conditions, using in these 
cases benzhydrylamine (0.08 mmol, 20 mol%) instead of catalyst 21a, followed by 
the reduction of the resulting imine. 
General procedure for the reduction step: 
NaBH3CN (0.80 mmol) was added to a solution of the crude cyclic imine in 
dry EtOH (15 mL) under inert atmosphere. The mixture was stirred at room 
temperature for 2 hours, HCl (1 M) was added till reaching an acidic pH and it 
was stirred for another 10 minutes. The solvent was removed under reduced 
                                                 
11 The aminomalonate 20 was obtained from the commercially available ammonium salt (1.00 mmol) 
after dissolving in a solution of NaHCO3 (1.00 mmol) in water (1 mL) and extracting with CH2Cl2 
(3 x 2 mL). The combined organic extracts were dried over NaSO4, filtered and concentrated under 
vacuum, obtaining the corresponding amine. 
12 Oliva, C. G.; Silva, A. M. S.; Resende, D. I. S. P.; Paz, F. A. A.; Cavaleiro, J. A. S. Eur. J. Org. 
Chem. 2010, 3449. 
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pressure and a saturated solution of NaCl (10 mL) was added, followed by the 
addition of NaOH (4 M) till a basic pH was observed, and the mixture was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried with 
anhydrous Na2SO4, filtered and the solvent was removed under reduced pressure. 
The pyrrolidines 22a-r were obtained following this procedure, and purified by 
flash column chromatography (FC) with the indicated eluent. 
(3S,5S)-Diethyl 5-methyl-3-phenylpyrrolidine-2,2-dicarboxylate (22a) 
Following the general procedure, 22a (110 mg, 0.36 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 42 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-phenylbut-3-en-2-one 19a (59 
mg, 0.40 mmol) in the presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-
epi-9-amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) 
as solvent, followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 
mmol) and EtOH as solvent (15 mL). 
Yield: 89%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 10.28 min, τminor = 9.42 min. 
[]D20: -20.8 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.46-7.03 (m, 5H, Carom-H), 4.41-
4.25 (m, 2H, H-3+CH3CHaHb), 4.14 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.78 
(dq, J = 10.6, 7.1 Hz, 1H, CH3CHcHd), 3.42 (dq, J = 10.6, 7.1 Hz, 1H, 
CH3CHcHd), 3.32-3.17 (m, 1H, H-5), 2.79 (bs, 1H, NH), 2.29 (ddd, J = 12.3, 7.0, 
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5.4 Hz, 1H, H-4a), 1.82-1.67 (m, 1H, H-4b), 1.35 (d, J = 6.1 Hz, 3H, C-5CH3), 1.24 
(t, J = 7.1 Hz, 3H, CH3CH2), 0.72 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.3, 170.3 (CO2Et), 140.1 (Carom-
C), 128.6, 128.0, 126.9 (Carom-H), 77.9 (C-2), 61.8, 61.5 (CH3CH2), 53.6 (C-5), 
50.9 (C-3), 41.6 (C-4), 19.9 (C-5CH3), 14.0, 13.3 (CH3CH2). 
IR (ATR) cm-1: 1723 (C=O st). 
MS (EI) m/z (relative abundance): 232 (M+ - CO2Et, 100), 204 (8), 186 (2), 
170 (1), 159 (11), 144 (9), 127 (11), 116 (43), 103 (3), 91 (8), 77 (3), 65 (1), 55 
(4), 44 (1), 29 (6). 
HRMS: Calculated for [C17H24NO4]+: 306.1705 [M+H]+; found: 306.1706. 
(3S,5S)-Diethyl 5-methyl-3-(p-tolyl)pyrrolidine-2,2-dicarboxylate (22b) 
Following the general procedure, 22b (89 mg, 0.28 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 41 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(p-tolyl)but-
3-en-2-one 19b (64 mg, 0.40 mmol) in the presence of 
methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 
21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, followed by the 
reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) and EtOH as 
solvent (15 mL). 
Yield: 70%. 
dr: >20:1. 
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ee: 90%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 14.02 min, τminor = 12.50 min. 
[]D20: -26.8 (c = 1.03, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.15 (d, J = 8.1 Hz, 2H, Carom-H), 
7.00 (d, J = 8.1 Hz, 2H, Carom-H), 4.35-4.17 (m, 2H, H-3+CH3CHaHb), 4.09 (dq, J 
= 10.8, 7.1 Hz, 1H, CH3CHaHb), 3.74 (dq, J = 10.6, 7.1 Hz, 1H, CH3CHcHd), 3.41 
(dq, J = 10.6, 7.1 Hz, 1H, CH3CHcHd), 3.27-3.11 (m, 1H, H-5), 2.74 (bs, 1H, NH), 
2.29-2.14 (m, 4H, H-4a+Carom-CH3), 1.75-1.60 (m, 1H, H-4b), 1.29 (d, J = 6.1 Hz, 
3H, C-5CH3), 1.19 (t, J = 7.1 Hz, 3H, CH3CH2), 0.70 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.2, 170.4 (CO2Et), 136.8, 136.3 
(Carom-C), 128.6, 128.4 (Carom-H), 77.8 (C-2), 61.6, 61.3 (CH3CH2), 53.5 (C-5), 
50.5 (C-3), 41.6 (C-4), 20.9 (Carom-CH3), 19.9 (C-5CH3), 13.9, 13.2 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 246 (M+ - CO2Et, 100), 218 (4), 201 (6), 
184 (1), 173 (13), 155 (13), 145 (5), 130 (38), 115 (55), 103 (4), 91 (5), 77 (3), 65 
(1), 55 (4), 45 (1), 29 (5). 
HRMS: Calculated for [C18H26NO4]+: 320.1862 [M+H]+; found: 320.1862. 
(3S,5S)-Diethyl 3-(2-methoxyphenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22c) 
Following the general procedure, 22c (90 mg, 0.27 mmol) was 
isolated by FC (hexanes/EtOAc 8:2) as a colourless oil after 119 
hours, starting from diethyl 2-aminomalonate 20a (98 mg, 0.56 
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mmol) and (E)-4-(2-methoxyphenyl)but-3-en-2-one13 19c (71 mg, 0.40 mmol) in 
the presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 67%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 4.90 min, τminor = 7.39 min. 
[]D20: +1.0 (c = 1.03, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.24 (dd, J = 7.6, 1.7 Hz, 1H, Carom-
H), 7.14 (ddd, J = 8.2, 7.6, 1.7 Hz, 1H, Carom-H), 6.87-6.81 (m, 1H, Carom-H), 6.78 
(dd, J = 8.2, 1.1 Hz, 1H, Carom-H), 4.72 (dd, J = 9.8, 8.0 Hz, 1H, H-3), 4.30 (dq, J 
= 10.7, 7.1 Hz, 1H, CH3CHaHb), 4.14 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.86-
3.71 (m, 4H, OCH3+CH3CHcHd), 3.48 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 
3.30-3.13 (m, 1H, H-5), 2.86 (bs, 1H, NH), 2.29 (ddd, J = 12.3, 8.0, 5.9 Hz, 1H, 
H-4a), 1.76-1.62 (m, 1H, H-4b), 1.31 (d, J = 6.2 Hz, 3H, C-5CH3), 1.23 (t, J = 7.1 
Hz, 3H, CH3CH2), 0.75 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.1, 169.8 (CO2Et), 157.7, 129.8 
(Carom-C), 129.1, 127.8, 120.4, 110.3 (Carom-H), 77.6 (C-2), 61.7, 61.1 (CH3CH2), 
55.3 (OCH3), 53.5 (C-5), 44.4 (C-3), 41.3 (C-4), 19.9 (C-5CH3), 14.0, 13.4 
(CH3CH2). 
IR (ATR) cm-1: 1731 (C=O st). 
                                                 
13 McConville, M.; Saidi, O.; Blacker, J.; Xiao, J. J. Org. Chem. 2009, 74, 2692. 
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MS (EI) m/z (relative abundance): 262 (M+ - CO2Et, 100), 234 (1), 216 
(32), 201 (30), 186 (5), 174 (5), 155 (11), 146 (13), 127 (14), 117 (5), 107 (3), 91 
(9), 77 (4), 65 (1), 55 (4), 44 (1), 29 (4). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1800. 
(3S,5S)-Diethyl 3-(3-methoxyphenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22d) 
Following the general procedure, 22d (104 mg, 0.31 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 68 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(3-
methoxyphenyl)but-3-en-2-one14 19d (71 mg, 0.40 mmol) in the 
presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 77%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 4.96 min, τminor = 6.91 min. 
[]D20: -26.8 (c = 0.98, CH2Cl2). 
                                                 
14 Feng, X.-W.; Li, C.; Wang, N.; Li, K.; Zhang, W.-W.; Wang, Z.; Yu, X.-Q. Green Chem. 2009, 
11, 1933. 
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1H-NMR (, ppm) (CDCl3, 300 MHz): 7.30-7.21 (m, 1H, Carom-H), 7.15 
(ddd, J = 8.1, 7.5, 1.7 Hz, 1H, Carom-H), 6.90-6.75 (m, 2H, Carom-H), 4.73 (dd, J = 
9.8, 8.0 Hz, 1H, H-3), 4.31 (dq, J = 10.8, 7.1 Hz, 1H, CH3CHaHb), 4.15 (dq, J = 
10.8, 7.1 Hz, 1H, CH3CHaHb), 3.86-3.72 (m, 4H, OCH3+CH3CHcHd), 3.49 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHcHd), 3.31-3.14 (m, 1H, H-5), 2.87 (bs, 1H, NH), 2.30 
(ddd, J = 12.3, 8.0, 5.9 Hz, 1H, H-4a), 1.78-1.62 (m, 1H, H-4b), 1.32 (d, J = 6.2 
Hz, 3H, C-5CH3), 1.24 (t, J = 7.1 Hz, 3H, CH3CH2), 0.76 (t, J = 7.1 Hz, 3H, 
CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 169.6, 168.7 (CO2Et), 157.7, 140.1 
(Carom-C), 127.3, 119.2, 112.6, 111.0 (Carom-H), 76.2 (C-2), 60.2, 59.9 (CH3CH2), 
53.5 (OCH3), 51.9 (C-5), 49.3 (C-3), 40.1 (C-4), 18.3 (C-5CH3), 12.4, 11.7 
(CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 262 (M+ - CO2Et, 100), 234 (4), 216 (2), 
201 (3), 188 (8), 174 (6), 161 (5), 146 (30), 127 (9), 117 (6), 103 (2), 91 (5), 77 
(3), 65 (1), 55 (3), 41 (1), 29 (4). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1794. 
(3S,5S)-Diethyl 3-(4-methoxyphenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22e) 
Following the general procedure, 22e (106 mg, 0.32 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) 
as a colourless oil after 41 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(4-
methoxyphenyl)but-3-en-2-one 19e (71 mg, 0.40 mmol) in the 
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presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 79%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 5.14 min, τminor = 7.47 min. 
[]D20: -28.6 (c = 0.99, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.19 (d, J = 8.7 Hz, 2H, Carom-H), 
6.74 (d, J = 8.7 Hz, 2H, Carom-H), 4.36-4.16 (m, 2H, H-3+CH3CHaHb), 4.09 (dq, J 
= 10.8, 7.1 Hz, 1H, CH3CHaHb), 3.83-3.68 (m, 4H, OCH3+CH3CHcHd), 3.43 (dq, J 
= 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.25-3.11 (m, 1H, H-5), 2.67 (bs, 1H, NH), 2.21 
(ddd, J = 12.3, 7.0, 5.4 Hz, 1H, H-4a), 1.74-1.59 (m, 1H, H-4b), 1.29 (d, J = 6.1 
Hz, 3H, C-5CH3), 1.19 (t, J = 7.1 Hz, 3H, CH3CH2), 0.74 (t, J = 7.1 Hz, 3H, 
CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.3, 170.4 (CO2Et), 158.6, 131.9 
(Carom-C), 129.5, 113.3 (Carom-H), 77.7 (C-2), 61.7, 61.4 (CH3CH2), 55.2 (OCH3), 
53.4 (C-5), 50.1 (C-3), 41.6 (C-4), 19.9 (C-5CH3), 13.9, 13.4 (CH3CH2). 
IR (ATR) cm-1: 1722 (C=O st). 
MS (EI) m/z (relative abundance): 262 (M+ - CO2Et, 100), 234 (1), 216 (1), 
201 (10), 189 (15), 174 (9), 155 (17), 146 (23), 127 (19), 115 (3), 103 (2), 91 (5), 
77 (3), 65 (1), 55 (5), 42 (1), 19 (4). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1797. 
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(3S,5S)-Diethyl 3-(2,6-dimethoxyphenyl)-5-methylpyrrolidine-2,2-
dicarboxylate (22f) 
Following the general procedure, 22f (92 mg, 0.25 mmol) was 
isolated by FC (hexanes/EtOAc 1:1) as a colourless oil after 97 
hours, starting from diethyl 2-aminomalonate 20a (98 mg, 0.56 
mmol) and (E)-4-(2,6-dimethoxyphenyl)but-3-en-2-one15 19f 
(82 mg, 0.40 mmol) in the presence of methanesulfonic acid (15 mg, 0.16 mmol), 
9-epi-9-amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 
mL) as solvent, followed by the reduction using sodium cyanoborohydride (50 mg, 
0.80 mmol) and EtOH as solvent (15 mL). 
Yield: 63%. 
dr: >20:1. 
ee: 77%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 6.36 min, τminor = 5.27 min. 
[]D20: -20.8 (c = 0.99, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.07 (t, J = 8.3 Hz, 1H, Carom-H), 
6.46 (d, J = 8.3 Hz, 2H, Carom-H), 5.12 (app t, J = 9.0 Hz, 1H, H-3), 4.29 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHaHb), 4.11 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.83-
3.70 (m, 7H, 2 × OCH3+CH3CHcHd), 3.59 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 
3.24-3.07 (m, 1H, H-5), 2.93 (bs, 1H, NH), 2.17 (ddd, J = 12.0, 9.0, 6.7 Hz, 1H, 
H-4a), 1.94-1.80 (m, 1H, H-4b), 1.30 (d, J = 6.2 Hz, 3H, C-5CH3), 1.21 (t, J = 7.1 
Hz, 3H, CH3CH2), 0.74 (t, J = 7.1 Hz, 3H, CH3CH2). 
                                                 
15 Ballerini, E.; Minuti, L.; Piermatti, O. J. Org. Chem. 2010, 75, 4251. 
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13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.1, 169.1 (CO2Et), 158.6 (Carom-
C), 127.6 (Carom-H), 118.7 (Carom-C), 104.1 (Carom-H), 78.7 (C-2), 61.8, 60.8 
(CH3CH2), 56.0 (OCH3), 54.7 (C-5), 40.5 (C-3), 40.3 (C-4), 19.5 (C-5CH3), 14.0, 
13.4 (CH3CH2). 
IR (ATR) cm-1: 1731 (C=O st). 
MS (EI) m/z (relative abundance): 292 (M+ - CO2Et, 100), 264 (11), 246 
(13), 231 (23), 215 (7), 201 (5), 191 (3), 176 (10), 155 (10), 146 (4), 127 (11), 102 
(2), 91 (4), 77 (2), 55 (3), 41 (1), 29 (3). 
HRMS: Calculated for [C19H28NO6]+: 366.1917 [M+H]+; found: 366.1901. 
(3S,5S)-Diethyl 3-(3,5-dimethoxyphenyl)-5-methylpyrrolidine-2,2-
dicarboxylate (22g) 
Following the general procedure, 22g (98 mg, 0.27 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 8:2 to 
7:3) as a colourless oil after 29 hours, starting from diethyl 
2-aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(3,5-
dimethoxyphenyl)but-3-en-2-one16 19g (82 mg, 0.40 mmol) 
in the presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 67%. 
dr: >20:1. 
                                                 
16 Zumbansen, K.; Döhring, A.; List, B. Adv. Synth. Catal. 2010, 352, 1135. 
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ee: 87%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 5.91 min, τminor = 8.39 min. 
[]D20: -27.4 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 6.47 (d, J = 2.3 Hz, 2H, Carom-H), 
6.29 (t, J = 2.3 Hz, 1H, Carom-H), 4.32 (dq, J = 10.8, 7.1 Hz, 1H, CH3CHaHb), 4.22 
(dd, J = 11.2, 7.0 Hz, 1H, H-3), 4.12 (dq, J = 10.8, 7.1 Hz, 1H, CH3CHaHb), 3.88-
3.72 (m, 7H, 2 × OCH3+CH3CHcHd), 3.54 (dq, J = 10.6, 7.1 Hz, 1H, CH3CHcHd), 
3.29-3.13 (m, 1H, H-5), 2.68 (bs, 1H, NH), 2.25 (ddd, J = 12.3, 7.0, 5.3 Hz, 1H, 
H-4a), 1.76-1.59 (m, 1H, H-4b), 1.32 (d, J = 6.1 Hz, 3H, C-5CH3), 1.23 (t, J = 7.1 
Hz, 3H, CH3CH2), 0.79 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.2, 170.4 (CO2Et), 160.4, 142.5 
(Carom-C), 106.6, 99.2 (Carom-H), 77.7 (C-2), 61.8, 61.5 (CH3CH2), 55.3 (OCH3), 
53.6 (C-5), 51.1 (C-3), 41.7 (C-4), 19.9 (C-5CH3), 14.0, 13.4 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 292 (M+ - CO2Et, 100), 246 (2), 218 (6), 
204 (3), 191 (4), 176 (17), 155 (5), 127 (5), 109 (2), 91 (2), 77 (1), 55 (2), 41 (1), 
29 (3). 
HRMS: Calculated for [C19H28NO6]+: 366.1917 [M+H]+; found: 366.1903. 
(3S,5S)-Diethyl 3-(2-fluorophenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22h) 
Following the general procedure, 22h (100 mg, 0.31 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 42 hours, starting from diethyl 2-
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aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(2-fluorophenyl)but-3-en-2-
one17 19h (66 mg, 0.40 mmol) in the presence of methanesulfonic acid (15 mg, 
0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) and 
using THF (2 mL) as solvent, followed by the reduction using sodium 
cyanoborohydride (50 mg, 0.80 mmol) and EtOH as solvent (15 mL). 
Yield: 78%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 15.79 min, τminor = 13.19 min. 
[]D20: -31.6 (c = 1.03, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.32 (dt, J = 7.6, 1.6 Hz, 1H, Carom-
H), 7.22-7.09 (m, 1H, Carom-H), 7.09-6.89 (m, 2H, Carom-H), 4.62 (dd, J = 9.6, 7.9 
Hz, 1H, H-3), 4.30 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 4.14 (dq, J = 10.7, 7.1 
Hz, 1H, CH3CHaHb), 3.82 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.54 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHcHd), 3.32-3.15 (m, 1H, H-5), 2.84 (bs, 1H, NH), 2.35 
(ddd, J = 12.8, 7.9, 6.0 Hz, 1H, H-4a), 1.76-1.54 (m, 1H, H-4b), 1.33 (d, J = 6.1 
Hz, 3H, C-5CH3), 1.23 (t, J = 7.1 Hz, 3H, CH3CH2), 0.80 (t, J = 7.1 Hz, 3H, 
CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 170.7, 169.6 (CO2Et), 161.1 (d, 
1JCF = 247.1 Hz, Carom-F), 129.8 (d, 3JCF = 4.1 Hz, Carom-H), 128.3 (d, 3JCF = 8.4 Hz, 
Carom-H), 128.1 (d, 2JCF = 13.9 Hz, Carom-C), 123.8 (d, 4JCF = 3.5 Hz, Carom-H), 
115.0 (d, 2JCF = 23.1 Hz, Carom-H), 77.6 (C-2), 61.9, 61.4 (CH3CH2), 53.3 (C-5), 
43.0 (C-3), 41.7 (C-4), 19.9 (C-5CH3), 14.0, 13.3 (CH3CH2). 
                                                 
17 Lin, Y.-M.; Li, Z.; Casarotto, V.; Ehrmantraut, J.; Nguyen, A. N. Tetrahedron Lett. 2007, 48, 
5531. 
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IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 250 (M+ - CO2Et, 100), 222 (11), 201 
(2), 190 (1), 176 (15), 162 (6), 149 (11), 134 (43), 109 (8), 96 (1), 81 (1), 68 (1), 
55 (3), 29 (5). 
HRMS: Calculated for [C17H23NO4F]+: 324.1611 [M+H]+; found: 324.1601. 
(3S,5S)-Diethyl 3-(4-fluorophenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22i) 
Following the general procedure, 22i (95 mg, 0.29 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 26 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(4-
fluorophenyl)but-3-en-2-one13 19i (66 mg, 0.40 mmol) in the 
presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 74%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (99:1)]; flow rate 1.0 mL/min; τmajor = 14.52 min, τminor = 13.65 min. 
[]D20: -26.7 (c = 0.99, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.35-7.23 (m, 2H, Carom-H), 7.00-
6.86 (m, 2H, Carom-H), 4.41-4.21 (m, 2H, H-3+CH3CHaHb), 4.14 (dq, J = 10.7, 7.1 
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Hz, 1H, CH3CHaHb), 3.81 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.48 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHcHd), 3.31-3.15 (m, 1H, H-5), 2.76 (bs, 1H, NH), 2.27 
(ddd, J = 12.3, 7.0, 5.4 Hz, 1H, H-4a), 1.77-1.54 (m, 1H, H-4b), 1.33 (d, J = 6.1 
Hz, 3H, C-5CH3), 1.23 (t, J = 7.1 Hz, 3H, CH3CH2), 0.78 (t, J = 7.1 Hz, 3H, 
CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.1, 170.2 (CO2Et), 161.9 (d, 
1JCF = 245.4 Hz, Carom-F), 135.8 (d, 4JCF = 3.2 Hz, Carom-C), 130.1 (d, 3JCF = 7.9 Hz, 
Carom-H), 114.7 (d, 2JCF = 21.1 Hz, Carom-H), 77.7 (C-2), 61.8, 61.5 (CH3CH2), 53.4 
(C-5), 50.0 (C-3), 41.7 (C-4), 19.9 (C-5CH3), 13.9, 13.4 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 250 (M+ - CO2Et, 100), 222 (7), 201 (3), 
188 (1), 177 (12), 155 (8), 134 (21), 127 (11), 109 (9), 88 (1), 55 (5), 44 (1), 29 
(5). 
HRMS: Calculated for [C17H23NO4F]+: 324.1611 [M+H]+; found: 324.1599. 
(3S,5S)-Diethyl 3-(4-chlorophenyl)-5-methylpyrrolidine-2,2-dicarboxylate 
(22j) 
Following the general procedure, 22j (104 mg, 0.31 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 27 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(4-
chlorophenyl)but-3-en-2-one 19j (72 mg, 0.40 mmol) in the 
presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
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followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 78%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 13.42 min, τminor = 12.14 min. 
[]D20: -34.0 (c = 0.99, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.27-7.10 (m, 4H, Carom-H), 4.35-
4.16 (m, 2H, H-3+CH3CHaHb), 4.09 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.77 
(dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.46 (dq, J = 10.7, 7.1 Hz, 1H, 
CH3CHcHd), 3.27-3.12 (m, 1H, H-5), 2.73 (bs, 1H, NH), 2.23 (ddd, J = 12.3, 7.0, 
5.4 Hz, 1H, H-4a), 1.72-1.55 (m, 1H, H-4b), 1.29 (d, J = 6.1 Hz, 3H, C-5CH3), 1.19 
(t, J = 7.1 Hz, 3H, CH3CH2), 0.74 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.0, 170.1 (CO2Et), 138.6, 132.6 
(Carom-C), 129.9, 128.0 (Carom-H), 77.6 (C-2), 61.8, 61.5 (CH3CH2), 53.4 (C-5), 
50.1 (C-3), 41.4 (C-4), 19.9 (C-5CH3), 14.0, 13.3 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 266 (M+ - CO2Et, 100), 238 (5), 220 (1), 
193 (8), 178 (5), 165 (3), 150 (27), 138 (1), 127 (11), 115 (6), 103 (2), 89 (4), 78 
(1), 55 (4), 29 (5). 
HRMS: Calculated for [C17H23NO4Cl]+: 340.1316 [M+H]+; found: 
340.1313. 
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(3S,5S)-Diethyl 5-methyl-3-(4-(trifluoromethyl)phenyl)pyrrolidine-2,2-
dicarboxylate (22k) 
Following the general procedure, 22k (79 mg, 0.21 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 23 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(4-
(trifluoromethyl)phenyl)but-3-en-2-one16 19k (86 mg, 0.40 
mmol) in the presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-
amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as 
solvent, followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 
mmol) and EtOH as solvent (15 mL). 
Yield: 53%. 
dr: >20:1. 
ee: 87%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 5.58 min, τminor = 6.97 min. 
[]D20: -23.4 (c = 1.03, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.64-7.36 (m, 4H, Carom-H), 4.40-
4.26 (m, 2H, H-3+CH3CHaHb), 4.14 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.77 
(dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.45 (dq, J = 10.7, 7.1 Hz, 1H, 
CH3CHcHd), 3.34-3.19 (m, 1H, H-5), 2.82 (bs, 1H, NH), 2.30 (ddd, J = 12.4, 7.1, 
5.4 Hz, 1H, H-4a), 1.79-1.65 (m, 1H, H-4b), 1.34 (d, J = 6.1 Hz, 3H, C-5CH3), 1.23 
(t, J = 7.1 Hz, 3H, CH3CH2), 0.70 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.0, 170.0 (CO2Et), 144.4 (Carom-
C), 129.3 (q, 2JCF = 32.5 Hz, Carom-CF3), 129.0 (Carom-H), 124.8 (q, 3JCF = 3.7 Hz, 
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Carom-H), 124.2 (q, 1JCF = 271.8 Hz, CF3), 77.7 (C-2), 62.0, 61.6 (CH3CH2), 53.5 
(C-5), 50.4 (C-3), 41.3 (C-4), 19.9 (C-5CH3), 13.9, 13.2 (CH3CH2). 
IR (ATR) cm-1: 1727 (C=O st). 
MS (EI) m/z (relative abundance): 300 (M+ - CO2Et, 100), 272 (13), 254 
(1), 240 (1), 226 (14), 199 (15), 184 (35), 159 (5), 127 (6), 103 (1), 89 (1), 55 (4), 
29 (5). 
HRMS: Calculated for [C18H23NO4F3]+: 374.1579 [M+H]+; found: 
374.1569. 
(3S,5S)-Diethyl 5-methyl-3-(4-nitrophenyl)pyrrolidine-2,2-dicarboxylate (22l) 
Following the general procedure, 22l (98 mg, 0.28 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 20 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(4-
nitrophenyl)but-3-en-2-one16 19l (77 mg, 0.40 mmol) in the 
presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 70%. 
dr: >20:1. 
ee: 86%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 15.16 min, τminor = 19.05 
min. 
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[]D20: -29.5 (c = 0.98, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.14-8.07 (m, 2H, Carom-H), 7.54-
7.48 (m, 2H, Carom-H), 4.39-4.26 (m, 2H, H-3+CH3CHaHb), 4.16 (dq, J = 10.7, 7.1 
Hz, 1H, CH3CHaHb), 3.82 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.49 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHcHd), 3.35-3.21 (m, 1H, H-5), 2.81 (bs, 1H, NH), 2.35 
(ddd, J = 12.6, 7.2, 5.5 Hz, 1H, H-4a), 1.77-1.63 (m, 1H, H-4b), 1.34 (d, J = 6.1 
Hz, 3H, C-5CH3), 1.24 (t, J = 7.1 Hz, 3H, CH3CH2), 0.76 (t, J = 7.1 Hz, 3H, 
CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 170.8, 169.6 (CO2Et), 148.3, 146.9 
(Carom-C), 129.5, 128.1 (Carom-H), 77.7 (C-2), 62.1, 61.7 (CH3CH2), 53.4 (C-5), 
50.2 (C-3), 41.4 (C-4), 20.0 (C-5CH3), 14.0, 13.5 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st), 1522 (NO2 st as), 1343 (NO2 st sym). 
MS (EI) m/z (relative abundance): 277 (M+ - CO2Et, 100), 261 (1), 249 (8), 
231 (3), 203 (6), 189 (2), 172 (1), 157 (11), 142 (5), 130 (5), 115 (8), 103 (2), 89 
(3), 77 (2), 55 (2), 41 (1), 29 (4). 
HRMS: Calculated for [C17H23N2O6]+: 351.1556 [M+H]+; found: 351.1542. 
(3R,5S)-Diethyl 3-(furan-2-yl)-5-methylpyrrolidine-2,2-dicarboxylate (22m) 
Following the general procedure, 22m (94 mg, 0.32 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
colourless oil after 120 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(furan-2-
yl)but-3-en-2-one 19m (54 mg, 0.40 mmol) in the presence of trifluoroacetic acid 
(18 mg, 0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) 
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and using CHCl3 (2 mL) as solvent, followed by the reduction using sodium 
cyanoborohydride (50 mg, 0.80 mmol) and EtOH as solvent (15 mL). 
Yield: 80%. 
dr: >20:1. 
ee: 86%. Determined by HPLC using a Chiralcel OZ-3 column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 8.99 min, τminor = 11.09 min. 
[]D20: -26.4 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.29 (dd, J = 1.9, 0.7 Hz, 1H, Carom-
H), 6.25 (dd, J = 3.2, 1.9 Hz, 1H, Carom-H), 6.14 (d, J = 3.2 Hz, 1H, Carom-H), 4.41-
4.28 (m, 2H, H-3+CH3CHaHb), 4.13 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.99 
(dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.71 (dq, J = 10.7, 7.1 Hz, 1H, 
CH3CHcHd), 3.29-3.16 (m, 1H, H-5), 2.80 (bs, 1H, NH), 2.24 (ddd, J = 12.3, 7.0, 
5.4 Hz, 1H, H-4a), 1.78-1.69 (m, 1H, H-4b), 1.32 (d, J = 6.2 Hz, 3H, C-5CH3), 1.24 
(t, J = 7.1 Hz, 3H, CH3CH2), 0.99 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 170.7, 170.3 (CO2Et), 153.2 (Carom-
C), 141.5, 110.2, 107.1 (Carom-H), 76.6 (C-2), 62.0, 61.9 (CH3CH2), 53.8 (C-5), 
45.1 (C-3), 39.8 (C-4), 19.9 (C-5CH3), 13.9, 13.6 (CH3CH2). 
IR (ATR) cm-1: 1727 (C=O st). 
MS (EI) m/z (relative abundance): 222 (M+ - CO2Et, 100), 201 (7), 176 (3), 
149 (20), 127 (24), 106 (25), 91 (3), 79 (6), 67 (1), 55 (8), 41 (1), 29 (6). 
HRMS: Calculated for [C15H22NO5]+: 296.1498 [M+H]+; found: 296.1498. 
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(3R,5S)-Diethyl 5-methyl-3-(thiophen-2-yl)pyrrolidine-2,2-dicarboxylate 
(22n) 
Following the general procedure, 22n (101 mg, 0.32 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 120 hours, starting from diethyl 2-
aminomalonate 20a (98 mg, 0.56 mmol) and (E)-4-(thiophen-2-
yl)but-3-en-2-one 19n (62 mg, 0.40 mmol) in the presence of trifluoroacetic acid 
(18 mg, 0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 21a (23 mg, 0.08 mmol) 
and using CHCl3 (2 mL) as solvent, followed by the reduction using sodium 
cyanoborohydride (50 mg, 0.80 mmol) and EtOH as solvent (15 mL). 
Yield: 81%. 
dr: >20:1. 
ee: 87%. Determined by HPLC using a Chiralcel OZ-3 column [n-hexane/i-
PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 8.11 min, τminor = 10.00 min. 
[]D20: -22.4 (c = 0.97, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.13 (dd, J = 5.0, 1.2 Hz, 1H, Carom-
H), 6.97-6.88 (m, 2H, Carom-H), 4.51 (dd, J = 11.4, 6.7 Hz, 1H, H-3), 4.35 (dq, J = 
10.7, 7.1 Hz, 1H, CH3CHaHb), 4.17 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 3.89 
(dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.62 (dq, J = 10.7, 7.1 Hz, 1H, 
CH3CHcHd), 3.36-3.18 (m, 1H, H-5), 2.56 (bs, 1H, NH), 2.38 (ddd, J = 12.1, 6.7, 
5.4 Hz, 1H, H-4a), 1.84-1.71 (m, 1H, H-4b), 1.34 (d, J = 6.2 Hz, 3H, C-5CH3), 1.26 
(t, J = 7.1 Hz, 3H, CH3CH2), 0.88 (t, J = 7.1 Hz, 3H, CH3CH2). 
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13C-NMR (, ppm) (CDCl3, 75.5 MHz): 168.9, 168.2 (CO2Et), 140.5 (Carom-
C), 124.3, 123.5, 121.9 (Carom-H), 75.4 (C-2), 59.8, 59.7 (CH3CH2), 51.4 (C-5), 
44.3 (C-3), 40.3 (C-4), 17.9 (C-5CH3), 11.9, 11.4 (CH3CH2). 
IR (ATR) cm-1: 1724 (C=O st). 
MS (EI) m/z (relative abundance): 238 (M+ - CO2Et, 100), 201 (8), 190 (1), 
176 (1), 165 (18), 155 (20), 137 (4), 127 (24), 110 (4), 97 (7), 82 (3), 68 (2), 55 
(8), 45 (4), 29 (6). 
HRMS: Calculated for [C15H22NO4S]+: 312.1270 [M+H]+; found: 312.1269. 
(3S,5S)-Diethyl 5-ethyl-3-(4-methoxyphenyl)pyrrolidine-2,2-dicarboxylate 
(22o) 
Following the general procedure, 22o (92 mg, 0.26 mmol) 
was isolated by FC (hexanes/EtOAc 8:2) as a colourless oil 
after 168 hours, starting from diethyl 2-aminomalonate 20a 
(98 mg, 0.56 mmol) and (E)-1-(4-methoxyphenyl)pent-1-en-
3-one 19o (76 mg, 0.40 mmol) in the presence of 
methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 
21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, followed by the 
reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) and EtOH as 
solvent (15 mL). 
Yield: 65%. 
dr: >20:1. 
ee: 89%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 4.66 min, τminor = 6.86 min. 
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[]D20: -24.1 (c = 1.02, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.28-7.20 (m, 2H, Carom-H), 6.81-
6.74 (m, 2H, Carom-H), 4.31 (dq, J = 10.8, 7.1 Hz, 1H, CH3CHaHbO), 4.23-4.08 (m, 
2H, H-3+CH3CHaHbO), 3.86-3.73 (m, 4H, OCH3+CH3CHcHdO), 3.50 (dq, J = 
10.7, 7.2 Hz, 1H, CH3CHcHdO), 3.08-2.98 (m, 1H, H-5), 2.75 (bs, 1H, NH), 2.28 
(ddd, J = 12.6, 7.3, 5.6 Hz, 1H, H-4a), 1.87-1.72 (m, 1H, C-5CHaHb), 1.70-1.66 
(m, 1H, H-4b), 1.64-1.48 (m, 1H, C-5CHaHb), 1.23 (t, J = 7.1 Hz, 3H, CH3CH2O), 
0.97 (t, J = 7.5 Hz, 3H, C-5CH2CH3), 0.78 (t, J = 7.1 Hz, 3H, CH3CH2O). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.4, 170.4 (CO2Et), 158.6, 132.3 
(Carom-C), 129.6, 113.3 (Carom-H), 77.4 (C-2), 61.7, 61.4 (CH3CH2O), 59.5 
(OCH3), 55.3 (C-5), 49.4 (C-3), 39.3 (C-4), 28.2 (C-5CH2), 14.0, 13.4 
(CH3CH2O), 11.4 (C-5CH2CH3). 
IR (ATR) cm-1: 1722 (C=O st). 
MS (EI) m/z (relative abundance): 276 (M+ - CO2Et, 100), 246 (1), 230 (1), 
216 (1), 203 (7), 186 (2), 169 (16), 141 (13), 121 (3), 104 (1), 91 (3), 69 (3), 54 
(1), 29 (4). 
HRMS: Calculated for [C19H28NO5]+: 350.1967 [M+H]+; found: 350.1948. 
(3S)-Diethyl 3,5-diphenyl-3,4-dihydro-2H-pyrrole-2,2-dicarboxylate (22p) 
Following the general procedure, 22p (34 mg, 0.09 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 8:2 to 7:3) as a 
yellow oil after 192 hours, starting from diethyl 2-
aminomalonate 20a (74 mg, 0.42 mmol) and (E)-1,3-diphenylprop-2-en-1-one 19p 
(62 mg, 0.30 mmol) in the presence of methanesulfonic acid (12 mg, 0.12 mmol), 
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9-epi-9-amino-9-deoxycinchonidine 21a (18 mg, 0.06 mmol) and using THF (1.5 
mL) as solvent. 
Yield: 31%. 
ee: 58%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (97:3)]; flow rate 1.0 mL/min; τmajor = 33.56 min, τminor = 24.49 min. 
1H-NMR (, ppm) (CDCl3, 300 MHz): 8.02-7.96 (m, 2H, Carom-H), 7.52-
7.40 (m, 3H, Carom-H), 7.27-7.17 (m, 5H, Carom-H), 4.54 (dd, J = 9.0, 5.6 Hz, 1H, 
H-3), 4.40 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHaHb), 4.21 (dq, J = 10.7, 7.1 Hz, 1H, 
CH3CHaHb), 3.81 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHcHd), 3.71-3.54 (m, 2H, 
CH3CHcHd+H-4a), 3.40 (dd, J = 17.4, 5.6 Hz, 1H, H-4b), 1.30 (t, J = 7.1 Hz, 3H, 
CH3CH2), 0.84 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 177.6 (C-5), 168.9, 167.5 (CO2Et), 
139.5, 133.1 (Carom-C), 131.5, 128.4, 128.3, 128.2, 128.1, 127.2 (Carom-H), 91.5 (C-
2), 62.1, 61.1 (CH3CH2), 48.3 (C-3), 43.6 (C-4), 13.9, 13.4 (CH3CH2). 
IR (ATR) cm-1: 1729 (C=O st). 
MS (EI) m/z (relative abundance): 365 (1), 292 (M+ - CO2Et, 100), 246 
(12), 233 (15), 219 (37), 191 (11), 187 (90), 165 (4), 140 (4), 115 (24), 105 (62), 
91 (7), 77 (17), 65 (2). 
HRMS: Calculated for [C22H24NO4]+: 366.1705 [M+H]+; found: 306.1701. 
(3S,5S)-Dimethyl 5-methyl-3-phenylpyrrolidine-2,2-dicarboxylate (22q) 
Following the general procedure, 22q (101 mg, 0.37 mmol) 
was isolated by FC (hexanes/EtOAc 8:2) as a colourless oil 
after 41 hours, starting from dimethyl 2-aminomalonate 20b 
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(82 mg, 0.56 mmol) and (E)-4-phenylbut-3-en-2-one 19a (59 mg, 0.40 mmol) in 
the presence of methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-
deoxycinchonidine 21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, 
followed by the reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) 
and EtOH as solvent (15 mL). 
Yield: 91%. 
dr: >20:1. 
ee: 90%. Determined by HPLC using a Chiralpak IA column [n-hexane/i-
PrOH (98:2)]; flow rate 1.0 mL/min; τmajor = 11.86 min, τminor = 10.17 min. 
[]D20: -28.0 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.33-7.07 (m, 5H, Carom-H), 4.30 
(dd, J = 11.3, 7.1 Hz, 1H, H-3), 3.75 (s, 3H, CH3O), 3.30-3.17 (m, 1H, H-5), 3.12 
(s, 3H, CH3O), 2.80 (bs, 1H, NH), 2.35-2.21 (m, 1H, H-4a), 1.80-1.69 (m, 1H, H-
4b), 1.34 (d, J = 6.1 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.8, 170.7 (CO2Me), 139.7 
(Carom-C), 128.4, 128.1, 127.0 (Carom-H), 78.1 (C-2), 53.9 (C-5), 53.1, 52.3 
(CH3O), 51.3 (C-3), 41.5 (C-4), 19.8 (C-5CH3). 
IR (ATR) cm-1: 1727 (C=O st). 
MS (EI) m/z (relative abundance): 218 (M+ - CO2Me, 100), 184 (2), 173 (6), 
158 (11), 141 (18), 131 (9), 116 (47), 103 (3), 91 (8), 77 (4), 68 (3), 59 (4), 42 (3), 
28 (2). 
HRMS: Calculated for [C15H20NO4]+: 278.1392 [M+H]+; found: 278.1380. 
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(3S,5S)-Dimethyl 3-(2,6-dimethoxyphenyl)-5-methylpyrrolidine-2,2-
dicarboxylate (22r) 
Following the general procedure, 22r (91 mg, 0.27 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 6:4 to 4:6) as a 
white solid after 72 hours, starting from dimethyl 2-
aminomalonate 20b (98 mg, 0.56 mmol) and (E)-4-(2,6-
dimethoxyphenyl)but-3-en-2-one 19f (82 mg, 0.40 mmol) in the presence of 
methanesulfonic acid (15 mg, 0.16 mmol), 9-epi-9-amino-9-deoxycinchonidine 
21a (23 mg, 0.08 mmol) and using THF (2 mL) as solvent, followed by the 
reduction using sodium cyanoborohydride (50 mg, 0.80 mmol) and EtOH as 
solvent (15 mL). 
Yield: 67%. 
dr: >20:1. 
ee: 80%. Determined by HPLC using a Chiralpak AS-H column [n-
hexane/i-PrOH (95:5)]; flow rate 1.0 mL/min; τmajor = 7.71 min, τminor = 6.47 min. 
[]D20: -17.5 (c = 0.66, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.11 (t, J = 8.3 Hz, 1H, Carom-H), 
6.50 (d, J = 8.3 Hz, 2H, Carom-H), 5.18-5.12 (m, 1H, H-3), 3.78 (s, 6H, 2 × Carom-
OCH3), 3.76 (s, 3H, CO2CH3), 3.25-3.14 (m, 4H, CO2CH3+H-5), 2.18 (ddd, J = 
12.0, 9.1, 6.6 Hz, 1H, H-4a), 1.93 (ddd, J = 12.0, 10.4, 9.1 Hz, 1H, H-4b), 1.33 (d, 
J = 6.2 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 171.6, 169.7 (CO2Me), 158.5 
(Carom-C), 127.7 (Carom-H), 118.2 (Carom-C), 104.1 (Carom-H), 78.7 (C-2), 55.6 
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(Carom-OCH3), 54.8 (C-5), 53.2, 51.8 (CO2CH3), 40.9 (C-3), 40.0 (C-4), 19.5 (C-
5CH3). 
IR (ATR) cm-1: 1727 (C=O st). 
M.p. (hexanes/EtOAc) (ºC): 118-120. 
MS (EI) m/z (relative abundance): 278 (M+ - CO2Me, 100), 246 (11), 231 
(22), 216 (8), 204 (3), 191 (4), 176 (11), 161 (3), 141 (25), 113 (20), 91 (16), 77 
(3), 59 (3), 42 (2), 28 (1). 
HRMS: Calculated for [C17H24NO6]+: 338.1604 [M+H]+; found: 338.1595. 
3.2. Synthesis of prolines 23a-o and 23q-r. 
General procedure: 
MeLi (1.00 mmol) was added dropwise to a solution of the corresponding 
pyrrolidine 22 (1.00 mmol) in dry THF (10 mL) at -78 ºC under inert atmosphere. 
The reaction was stirred during 1 hour at -78 ºC and then the reaction was 
quenched with the dropwise addition of water (1 mL) at -78 ºC. The reaction 
mixture was warmed to room temperature, subsequently brine (10 mL) was added 
and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
obtained crude product was charged onto silica gel and subjected to flash column 
chromatography (FC) yielding the desired product 23. 
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(2R,3S,5S)-Diethyl 5-methyl-3-phenylpyrrolidine-1,2-dicarboxylate (23a) 
Following the general procedure, 23a (44 mg, 0.14 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22a (52 mg, 0.17 
mmol) and methyllithium (0.12 mL of a 1.46 M solution in 
diethyl ether, 0.17 mmol), using dry THF (1.7 mL) as solvent. 
Yield: 84%. 
dr: 7:1. 
[]D20: -51.2 (c = 0.44, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.36-7.23 (m, 5H, Carom-H), 4.51* (d, J = 6.2 Hz, 1H, H-2), 4.43 
(d, J = 6.6 Hz, 1H, H-2), 4.25-4.03 (m, 5H, C-2CO2CH2CH3+NCO2CH2CH3+H-
5), 3.48-3.31 (m, 1H, H-3), 2.66-2.43 (m, 1H, H-4a), 1.90-1.74 (m, 1H, H-4b), 
1.40-1.14 (m, 9H, C-2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.6, 172.2* (C-2CO2Et), 155.4*, 154.5 (NCO2Et), 140.7, 140.6* (Carom-C), 
128.7, 127.1, 127.1 (Carom-H), 66.7, 66.4* (C-2), 61.4*, 61.0, 60.9 (C-
2CO2CH2CH3+NCO2CH2CH3), 55.1, 54.2* (C-5), 47.9, 47.1* (C-3), 41.7*, 41.4 
(C-4), 21.5*, 20.3 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1708 (NC=O st). 
MS (EI) m/z (relative abundance): 305 (1), 260 (1), 232 (M+ - CO2Et, 100), 
216 (2), 204 (10), 188 (12), 172 (1), 160 (29), 144 (4), 129 (7), 117 (16), 104 (3), 
91 (9), 77 (2), 55 (2). 
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HRMS: Calculated for [C17H24NO4]+: 306.1705 [M+H]+; found: 306.1699. 
(2R,3S,5S)-Diethyl 5-methyl-3-(p-tolyl)pyrrolidine-1,2-dicarboxylate (23b) 
Following the general procedure, 23b (26 mg, 0.08 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22b (32 mg, 0.10 
mmol) and methyllithium (0.07 mL of a 1.48 M solution in 
diethyl ether, 0.10 mmol), using dry THF (1.0 mL) as solvent. 
Yield: 80%. 
dr: 10:1. 
[]D20: -63.2 (c = 0.61, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.19-7.09 (m, 4H, Carom-H), 4.47* (d, J = 6.7 Hz, 1H, H-2), 4.40 
(d, J = 6.9 Hz, 1H, H-2), 4.26-4.00 (m, 5H, C-2CO2CH2CH3+NCO2CH2CH3+H-
5), 3.41-3.30 (m, 1H, H-3), 2.63-2.42 (m, 1H, H-4a), 2.33 (s, 3H, Carom-CH3), 1.90-
1.69 (m, 1H, H-4b), 1.42-1.13 (m, 9H, C-2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.6, 172.3* (C-2CO2Et), 155.4*, 154.5 (NCO2Et), 137.6, 137.5*, 136.8, 136.7* 
(Carom-C), 129.3, 127.0 (Carom-H), 66.8, 66.5* (C-2), 61.3*, 61.0, 60.9 (C-
2CO2CH2CH3+NCO2CH2CH3), 55.1, 54.2* (C-5), 47.6, 46.7* (C-3), 41.8*, 41.5 
(C-4), 21.5* (C-5CH3), 21.0 (Carom-CH3), 20.3 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* 
(C-2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1743 (C=O st), 1710 (NC=O st). 
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MS (EI) m/z (relative abundance): 319 (2), 246 (M+ - CO2Et, 100), 230 (4), 
218 (11), 202 (12), 186 (1), 174 (29), 158 (5), 145 (5), 131 (20), 117 (7), 105 (6), 
91 (7), 77 (2), 55 (2). 
HRMS: Calculated for [C18H26NO4]+: 320.1862 [M+H]+; found: 320.1852. 
(2R,3S,5S)-Diethyl 3-(2-methoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23c) 
Following the general procedure, 23c (30 mg, 0.09 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22c (38 mg, 0.12 
mmol) and methyllithium (0.08 mL of a 1.40 M solution in 
diethyl ether, 0.12 mmol), using dry THF (1.2 mL) as solvent. 
Yield: 78%. 
dr: >20:1. 
[]D20: -54.0 (c = 1.20, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.29-7.19 (m, 2H, Carom-H), 6.95-6.90 (m, 1H, Carom-H), 6.86 (d, 
J = 8.1 Hz, 1H, Carom-H), 4.63* (d, J = 5.4 Hz, 1H, H-2), 4.51 (d, J = 5.9 Hz, 1H, 
H-2), 4.27-4.01 (m, 5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.82 (s, 3H, 
OCH3), 3.77-3.65 (m, 1H, H-3), 2.62-2.41 (m, 1H, H-4a), 1.86-1.72 (m, 1H, H-4b), 
1.35-1.14 (m, 9H, C-2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.8, 172.5* (C-2CO2Et), 157.0 (Carom-C), 155.6*, 154.7 (NCO2Et), 129.3*, 
129.1 (Carom-C), 128.1, 128.0*, 127.1, 120.5, 120.4*, 110.5, 110.4* (Carom-H), 
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65.2, 65.0* (C-2), 61.3*, 60.9, 60.8 (C-2CO2CH2CH3+NCO2CH2CH3), 55.2 
(OCH3), 55.0, 54.1* (C-5), 41.8, 41.1* (C-3), 39.7*, 39.3 (C-4), 21.7*, 20.6 (C-
5CH3), 14.6*, 14.5, 14.2, 14.1* (C-2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1743 (C=O st), 1705 (NC=O st). 
MS (EI) m/z (relative abundance): 335 (7), 289 (4), 262 (M+ - CO2Et, 100), 
246 (3), 233 (5), 218 (8), 203 (1), 190 (34), 174 (5), 161 (5), 147 (11), 131 (8), 
115 (5), 91 (14), 77 (3), 55 (2). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1808. 
(2R,3S,5S)-Diethyl 3-(3-methoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23d) 
Following the general procedure, 23d (14 mg, 0.04 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22d (18 mg, 0.05 
mmol) and methyllithium (0.04 mL of a 1.53 M solution in 
diethyl ether, 0.05 mmol), using dry THF (0.5 mL) as solvent. 
Yield: 77%. 
dr: >20:1. 
[]D20: -47.5 (c = 0.99, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.28-7.20 (m, 1H, Carom-H), 6.85 (d, J = 7.7 Hz, 1H, Carom-H), 
6.82-6.75 (m, 2H, Carom-H), 4.49* (d, J = 6.6 Hz, 1H, H-2), 4.43 (d, J = 6.8 Hz, 
1H, H-2), 4.26-4.01 (m, 5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.80 (s, 3H, 
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OCH3), 3.41-3.32 (m, 1H, H-3), 2.62-2.47 (m, 1H, H-4a), 1.90-1.71 (m, 1H, H-4b), 
1.45-1.11 (m, 9H, C-2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.6, 172.2* (C-2CO2Et), 159.8 (Carom-C), 155.4*, 154.5 (NCO2Et), 142.4, 
142.3* (Carom-C), 129.6, 119.4, 113.3, 113.2*, 112.1 (Carom-H), 66.6, 66.4* (C-2), 
61.4*, 61.1, 61.0, 60.9* (C-2CO2CH2CH3+NCO2CH2CH3), 55.2 (OCH3), 55.0, 
54.2* (C-5), 47.8, 47.0* (C-3), 41.7*, 41.3 (C-4), 21.5*, 20.4 (C-5CH3), 14.6*, 
14.5, 14.2, 14.1* (C-2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1705 (NC=O st). 
MS (EI) m/z (relative abundance): 335 (1), 262 (M+ - CO2Et, 100), 246 (4), 
234 (5), 218 (7), 206 (2), 190 (18), 174 (2), 162 (3), 147 (6), 134 (3), 121 (3), 103 
(1), 91 (4), 78 (1), 65 (1). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1798. 
(2R,3S,5S)-Diethyl 3-(4-methoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23e) 
Following the general procedure, 23e (52 mg, 0.16 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) 
as a colourless oil, starting from pyrrolidine 22e (71 mg, 0.21 
mmol) and methyllithium (0.16 mL of a 1.35 M solution in 
diethyl ether, 0.21 mmol), using dry THF (2.1 mL) as solvent. 
Yield: 73%. 
dr: 6:1. 
[]D20: -57.4 (c = 1.04, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.17 (d, J = 8.6 Hz, 2H, Carom-H), 6.86 (d, J = 8.6 Hz, 2H, Carom-
H), 4.43* (d, J = 6.8 Hz, 1H, H-2), 4.35 (d, J = 6.9 Hz, 1H, H-2), 4.26-4.01 (m, 
5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.79 (s, 3H, OCH3), 3.39-3.29 (m, 1H, 
H-3), 2.60-2.41 (m, 1H, H-4a), 1.87-1.69 (m, 1H, H-4b), 1.43-1.13 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.6, 172.2* (C-2CO2Et), 158.7 (Carom-C), 155.4*, 154.4 (NCO2Et), 132.5, 
132.4* (Carom-C), 128.1, 114.0 (Carom-H), 67.0, 66.7* (C-2), 61.3*, 61.0, 60.9 (C-
2CO2CH2CH3+NCO2CH2CH3), 55.3 (OCH3), 55.0, 54.1* (C-5), 47.2, 46.4* (C-3), 
41.9*, 41.6 (C-4), 21.5*, 20.3 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1705 (NC=O st). 
MS (EI) m/z (relative abundance): 335 (5), 262 (M+ - CO2Et, 100), 246 (2), 
233 (9), 218 (6), 206 (5), 190 (17), 174 (3), 161 (5), 147 (15), 134 (5), 116 (9), 
103 (2), 91 (7), 77 (2), 55 (2). 
HRMS: Calculated for [C18H26NO5]+: 336.1811 [M+H]+; found: 336.1795. 
(2R,3S,5S)-Diethyl 3-(2,6-dimethoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23f) 
Following the general procedure, 23f (32 mg, 0.09 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22f (44 mg, 0.12 
mmol) and methyllithium (0.09 mL of a 1.31 M solution in 
diethyl ether, 0.12 mmol), using dry THF (1.2 mL) as solvent. 
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Yield: 73%. 
dr: 3:1. 
[]D20: +54.6 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.16 (t, J = 8.3 Hz, 1H, Carom-H), 6.50 (d, J = 8.3 Hz, 2H, Carom-
H), 4.62* (d, J = 8.5 Hz, 1H, H-2), 4.48 (d, J = 8.6 Hz, 1H, H-2), 4.29-3.78 (m, 
6H, C-2CO2CH2CH3+NCO2CH2CH3+H-5+H-3), 3.75 (s, 6H, 2 × OCH3), 2.96-
2.72 (m, 1H, H-4a), 2.21-1.96 (m, 1H, H-4b), 1.55-1.50 (m, 3H, C-5CH3), 1.29* (t, 
J = 7.1 Hz, 3H, CO2CH2CH3), 1.19 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 0.98 (t, J = 
7.1 Hz, 3H, CO2CH2CH3), 0.91* (t, J = 7.1 Hz, 3H, CO2CH2CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
171.4*, 171.3 (C-2CO2Et), 159.6 (Carom-C), 155.6*, 154.7 (NCO2Et), 128.3, 
128.2* (Carom-H), 112.7*, 112.6 (Carom-C), 103.8 (Carom-H), 62.8*, 62.5 (C-2), 
61.0*, 60.8, 60.2 (C-2CO2CH2CH3+NCO2CH2CH3), 55.4 (OCH3), 54.5, 54.0* (C-
5), 38.0, 37.8* (C-3), 35.8*, 35.1 (C-4), 21.2*, 20.1 (C-5CH3), 14.6, 13.8, 13.7* 
(C-2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1744 (C=O st), 1698 (NC=O st). 
MS (EI) m/z (relative abundance): 292 (M+ - CO2Et, 100), 263 (1), 246 (1), 
220 (11), 204 (2), 191 (2), 177 (3), 161 (4), 147 (3), 132 (1), 121 (3), 103 (1), 91 
(5), 79 (1), 68 (1), 56 (1). 
HRMS: Calculated for [C19H28NO6]+: 366.1917 [M+H]+; found: 366.1907. 
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(2R,3S,5S)-Diethyl 3-(3,5-dimethoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23g) 
Following the general procedure, 23g (52 mg, 0.14 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 
to 7:3) as a colourless oil, starting from pyrrolidine 22g (61 
mg, 0.17 mmol) and methyllithium (0.11 mL of a 1.48 M 
solution in diethyl ether, 0.17 mmol), using dry THF (1.7 
mL) as solvent. 
Yield: 84%. 
dr: 10:1. 
[]D20: -47.7 (c = 0.65, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.5:1, *denotes minor 
rotamer signals): 6.42 (d, J = 2.0 Hz, 2H, Carom-H), 6.35 (t, J = 2.0 Hz, 1H, Carom-
H), 4.47* (d, J = 6.7 Hz, 1H, H-2), 4.41 (d, J = 6.6 Hz, 1H, H-2), 4.27-3.99 (m, 
5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.78 (s, 6H, 2 × OCH3), 3.40-3.25 (m, 
1H, H-3), 2.63-2.42 (m, 1H, H-4a), 1.89-1.69 (m, 1H, H-4b), 1.46-1.12 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.6, 172.2* (C-2CO2Et), 161.0 (Carom-C), 155.4*, 154.5 (NCO2Et), 143.2, 
143.0* (Carom-C), 105.4, 98.8*, 98.7 (Carom-H), 66.5, 66.4* (C-2), 61.4*, 61.1, 
61.0, 60.9* (C-2CO2CH2CH3+NCO2CH2CH3), 55.3 (OCH3), 55.0, 54.1* (C-5), 
48.0, 47.2* (C-3), 41.6*, 41.2 (C-4), 21.5*, 20.4 (C-5CH3), 14.6*, 14.4, 14.2, 
14.1* (C-2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1703 (NC=O st). 
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MS (EI) m/z (relative abundance): 365 (8), 319 (2), 292 (M+ - CO2Et, 100), 
264 (2), 248 (5), 220 (11), 203 (2), 177 (4), 161 (2), 145 (1), 119 (1), 91 (1), 77 
(1), 55 (1). 
HRMS: Calculated for [C19H28NO6]+: 366.1917 [M+H]+; found: 366.1934. 
(2R,3S,5S)-Diethyl 3-(2-fluorophenyl)-5-methylpyrrolidine-1,2-dicarboxylate 
(23h) 
Following the general procedure, 23h (50 mg, 0.15 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22h (59 mg, 0.18 
mmol) and methyllithium (0.13 mL of a 1.40 M solution in 
diethyl ether, 0.18 mmol), using dry THF (1.8 mL) as solvent. 
Yield: 85%. 
dr: 17:1. 
[]D20: -46.8 (c = 1.36, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.34-7.29 (m, 1H, Carom-H), 7.26-7.19 (m, 1H, Carom-H), 7.14-
7.09 (m, 1H, Carom-H), 7.07-6.98 (m, 1H, Carom-H), 4.59* (d, J = 6.0 Hz, 1H, H-2), 
4.47 (d, J = 6.4 Hz, 1H, H-2), 4.29-4.01 (m, 5H, C-
2CO2CH2CH3+NCO2CH2CH3+H-5), 3.68-3.60 (m, 1H, H-3), 2.66-2.44 (m, 1H, 
H-4a), 1.91-1.74 (m, 1H, H-4b), 1.41-1.12 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.3, 171.9* (C-2CO2Et), 160.8 (d, 1JCF = 246.2 Hz, Carom-F), 155.5*, 154.5 
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(NCO2Et), 128.8 (d, 3JCF = 8.2 Hz, Carom-H), 128.7* (d, 3JCF = 8.3 Hz, Carom-H), 
127.9 (d, 3JCF = 3.6 Hz, Carom-H), 127.8 (d, 2JCF = 26.7 Hz, Carom-C), 124.3 (d, 4JCF 
= 3.4 Hz, Carom-H), 115.6 (d, 2JCF = 22.2 Hz, Carom-H), 115.5* (d, 2JCF = 22.2 Hz, 
Carom-H), 65.4, 65.1* (C-2), 61.4*, 61.2, 61.1, 61.0* (C-
2CO2CH2CH3+NCO2CH2CH3), 55.0, 54.0* (C-5), 41.2, 40.4* (C-3), 40.2*, 39.8 
(C-4), 21.5*, 20.4 (C-5CH3), 14.6*, 14.5, 14.1, 14.0* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1746 (C=O st), 1709 (NC=O st). 
MS (EI) m/z (relative abundance): 323 (4), 250 (M+ - CO2Et, 100), 234 (1), 
222 (10), 206 (17), 190 (1), 178 (42), 162 (5), 150 (4), 135 (14), 122 (3), 109 (11), 
96 (1), 83 (1), 56 (1). 
HRMS: Calculated for [C17H23NO4F]+: 324.1611 [M+H]+; found: 324.1603. 
(2R,3S,5S)-Diethyl 3-(4-fluorophenyl)-5-methylpyrrolidine-1,2-dicarboxylate 
(23i) 
Following the general procedure, 23i (41 mg, 0.13 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22i (58 mg, 0.18 
mmol) and methyllithium (0.13 mL of a 1.35 M solution in 
diethyl ether, 0.18 mmol), using dry THF (1.8 mL) as solvent. 
Yield: 71%. 
dr: 6:1. 
[]D20: -47.9 (c = 1.01, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.25-7.19 (m, 2H, Carom-H), 7.07-6.95 (m, 2H, Carom-H), 4.43* (d, 
J = 6.7 Hz, 1H, H-2), 4.36 (d, J = 6.9 Hz, 1H, H-2), 4.26-4.02 (m, 5H, C-
2CO2CH2CH3+NCO2CH2CH3+H-5), 3.41-3.31 (m, 1H, H-3), 2.60-2.46 (m, 1H, 
H-4a), 1.85-1.68 (m, 1H, H-4b), 1.43-1.11 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.4, 172.0* (C-2CO2Et), 161.9 (d, 1JCF = 245.6 Hz, Carom-F), 155.3*, 154.4 
(NCO2Et), 136.2 (Carom-C), 128.7 (d, 3JCF = 8.0 Hz, Carom-H), 115.5 (d, 2JCF = 21.4 
Hz, Carom-H), 66.9, 66.7* (C-2), 61.4*, 61.1, 61.0 (C-
2CO2CH2CH3+NCO2CH2CH3), 55.0, 54.1* (C-5), 47.2, 46.4* (C-3), 41.9*, 41.6 
(C-4), 21.4*, 20.3 (C-5CH3), 14.6*, 14.4, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1706 (NC=O st). 
MS (EI) m/z (relative abundance): 323 (1), 250 (M+ - CO2Et, 100), 234 (1), 
222 (6), 206 (9), 178 (29), 162 (4), 150 (4), 135 (19), 122 (3), 109 (12), 95 (1), 82 
(2), 68 (1), 55 (2). 
HRMS: Calculated for [C17H23NO4F]+: 324.1611 [M+H]+; found: 324.1593. 
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(2R,3S,5S)-Diethyl 3-(4-chlorophenyl)-5-methylpyrrolidine-1,2-dicarboxylate 
(23j) 
Following the general procedure, 23j (73 mg, 0.21 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22j (85 mg, 0.25 
mmol) and methyllithium (0.19 mL of a 1.31 M solution in 
diethyl ether, 0.25 mmol), using dry THF (2.5 mL) as solvent. 
Yield: 86%. 
dr: 7:1. 
[]D20: -78.5 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.30 (d, J = 8.4 Hz, 2H, Carom-H), 7.19 (d, J = 8.4 Hz, 2H, Carom-
H), 4.45* (d, J = 6.4 Hz, 1H, H-2), 4.38 (d, J = 6.8 Hz, 1H, H-2), 4.27-3.97 (m, 
5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.43-3.28 (m, 1H, H-3), 2.64-2.44 (m, 
1H, H-4a), 1.87-1.66 (m, 1H, H-4b), 1.45-1.11 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.3, 172.0* (C-2CO2Et), 155.3*, 154.4 (NCO2Et), 139.2, 139.1*, 132.9 (Carom-
C), 128.8, 128.5 (Carom-H), 66.6, 66.4* (C-2), 61.5*, 61.2, 61.1, 61.0* (C-
2CO2CH2CH3+NCO2CH2CH3), 55.0, 54.1* (C-5), 47.3, 46.4* (C-3), 41.7*, 41.4 
(C-4), 21.5*, 20.3 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1704 (NC=O st). 
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MS (EI) m/z (relative abundance): 339 (1), 266 (M+ - CO2Et, 100), 252 (1), 
238 (6), 222 (9), 194 (30), 181 (2), 166 (4), 151 (9), 129 (13), 115 (13), 101 (2), 
82 (4), 77 (2), 55 (4). 
HRMS: Calculated for [C17H23NO4Cl]+: 340.1316 [M+H]+; found: 
340.1302. 
(2R,3S,5S)-Diethyl 5-methyl-3-(4-(trifluoromethyl)phenyl)pyrrolidine-1,2-
dicarboxylate (23k) 
Following the general procedure, 23k (39 mg, 0.10 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22k (49 mg, 0.13 
mmol) and methyllithium (0.10 mL of a 1.31 M solution in 
diethyl ether, 0.13 mmol), using dry THF (1.3 mL) as solvent. 
Yield: 80%. 
dr: 5:1. 
[]D20: -55.1 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.59 (d, J = 8.1 Hz, 2H, Carom-H), 7.39 (d, J = 8.1 Hz, 2H, Carom-
H), 4.53* (d, J = 5.8 Hz, 1H, H-2), 4.45 (d, J = 6.4 Hz, 1H, H-2), 4.28-4.01 (m, 
5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.53-3.36 (m, 1H, H-3), 2.70-2.48 (m, 
1H, H-4a), 1.90-1.71 (m, 1H, H-4b), 1.44-1.13 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.2, 171.8* (C-2CO2Et), 155.4*, 154.4 (NCO2Et), 144.9 (Carom-C), 129.5 (q, 
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2JCF = 32.7 Hz, Carom-CF3), 127.6 (Carom-H), 125.6 (q, 3JCF = 3.6 Hz, Carom-H), 
124.0 (q, 1JCF = 272.0 Hz, CF3), 66.5, 66.2* (C-2), 61.5*, 61.2, 61.1, 61.0* (C-
2CO2CH2CH3+NCO2CH2CH3), 55.0, 54.1* (C-5), 47.5, 46.7* (C-3), 41.6*, 41.2 
(C-4), 21.5*, 20.4 (C-5CH3), 14.6*, 14.4, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1743 (C=O st), 1706 (NC=O st). 
MS (EI) m/z (relative abundance): 373 (1), 300 (M+ - CO2Et, 100), 286 (1), 
272 (4), 256 (12), 228 (28), 200 (2), 185 (4), 159 (3), 145 (1), 129 (4), 115 (1), 82 
(1), 55 (1). 
HRMS: Calculated for [C18H23NO4F3]+: 374.1579 [M+H]+; found: 
374.1565. 
(2R,3S,5S)-Diethyl 5-methyl-3-(4-nitrophenyl)pyrrolidine-1,2-dicarboxylate 
(23l) 
Following the general procedure, 23l (13 mg, 0.04 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) 
as a colourless oil, starting from pyrrolidine 22l (54 mg, 0.15 
mmol) and methyllithium (0.10 mL of a 1.53 M solution in 
diethyl ether, 0.15 mmol), using dry THF (1.5 mL) as solvent. 
Yield: 60%.18 
dr: 7:1. 
[]D20: -72.7 (c = 0.61, CH2Cl2). 
                                                 
18 Calculated yield over a conversion of 40%. 
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1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.1:1, *denotes minor 
rotamer signals): 8.20 (d, J = 8.6 Hz, 2H, Carom-H), 7.45 (d, J = 8.6 Hz, 2H, Carom-
H), 4.55* (d, J = 6.5 Hz, 1H, H-2), 4.47 (d, J = 6.3 Hz, 1H, H-2), 4.27-4.08 (m, 
5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.58-3.41 (m, 1H, H-3), 2.71-2.51 (m, 
1H, H-4a), 1.89-1.75 (m, 1H, H-4b), 1.40-1.19 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
171.9, 171.6* (C-2CO2Et), 155.4*, 154.3 (NCO2Et), 148.4, 147.1 (Carom-C), 128.1, 
124.0 (Carom-H), 66.3, 66.1* (C-2), 61.6*, 61.3, 61.3, 61.2* (C-
2CO2CH2CH3+NCO2CH2CH3), 55.0, 54.1* (C-5), 47.5, 46.6* (C-3), 41.6*, 41.2 
(C-4), 21.5*, 20.4 (C-5CH3), 14.6*, 14.5, 14.2, 14.2* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1705 (NC=O st), 1521 (NO2 st as), 1346 
(NO2 st sym). 
MS (EI) m/z (relative abundance): 277 (M+ - CO2Et, 100), 261 (2), 249 (4), 
233 (13), 205 (39), 187 (10), 177 (2), 159 (8), 143 (2), 129 (12), 115 (10), 103 (2), 
91 (4), 77 (2), 55 (2). 
HRMS: Calculated for [C17H23N2O6]+: 351.1556 [M+H]+; found: 351.1540. 
(2R,3R,5S)-Diethyl 3-(furan-2-yl)-5-methylpyrrolidine-1,2-dicarboxylate 
(23m) 
Following the general procedure, 23m (29 mg, 0.10 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22m (37 mg, 0.13 
mmol) and methyllithium (0.10 mL of a 1.31 M solution in 
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diethyl ether, 0.13 mmol), using dry THF (1.3 mL) as solvent. 
Yield: 78%. 
dr: 9:1. 
[]D20: -47.3 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.36-7.31 (m, 1H, Carom-H), 6.36-6.25 (m, 1H, Carom-H), 6.20-
6.12 (m, 1H, Carom-H), 4.60* (d, J = 4.4 Hz, 1H, H-2), 4.53 (d, J = 4.7 Hz, 1H, H-
2), 4.26-4.00 (m, 5H, C-2CO2CH2CH3+NCO2CH2CH3+H-5), 3.53-3.40 (m, 1H, H-
3), 2.60-2.40 (m, 1H, H-4a), 2.04-1.87 (m, 1H, H-4b), 1.32-1.12 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.2, 171.9* (C-2CO2Et), 155.4*, 154.4 (NCO2Et), 154.2*, 154.1 (Carom-C), 
141.8, 110.3, 105.7, 105.6* (Carom-H), 64.5 (C-2), 61.4*, 61.3, 61.2, 61.0* (C-
2CO2CH2CH3+NCO2CH2CH3), 54.6, 53.7* (C-5), 41.5, 40.6* (C-3), 37.3*, 36.9 
(C-4), 21.4*, 20.4 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1735 (C=O st), 1703 (NC=O st). 
MS (EI) m/z (relative abundance): 295 (16), 250 (1), 222 (M+ - CO2Et, 
100), 206 (4), 194 (9), 178 (12), 162 (1), 150 (32), 134 (4), 122 (7), 107 (12), 94 
(5), 79 (8), 68 (2), 55 (3). 
HRMS: Calculated for [C15H22NO5]+: 296.1498 [M+H]+; found: 296.1489. 
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(2R,3R,5S)-Diethyl 5-methyl-3-(thiophen-2-yl)pyrrolidine-1,2-dicarboxylate 
(23n) 
Following the general procedure, 23n (52 mg, 0.17 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) as 
a colourless oil, starting from pyrrolidine 22n (62 mg, 0.20 
mmol) and methyllithium (0.14 mL of a 1.48 M solution in 
diethyl ether, 0.20 mmol), using dry THF (2.0 mL) as solvent. 
Yield: 84%. 
dr: 13:1. 
[]D20: -51.1 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.22-7.16 (m, 1H, Carom-H), 6.96-6.90 (m, 2H, Carom-H), 4.50* (d, 
J = 6.1 Hz, 1H, H-2), 4.43 (d, J = 6.3 Hz, 1H, H-2), 4.26-3.99 (m, 5H, C-
2CO2CH2CH3+NCO2CH2CH3+H-5), 3.69-3.62 (m, 1H, H-3), 2.71-2.52 (m, 1H, 
H-4a), 1.98-1.79 (m, 1H, H-4b), 1.42-1.13 (m, 9H, C-
2CO2CH2CH3+NCO2CH2CH3+C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.1, 171.8* (C-2CO2Et), 155.2*, 154.3 (NCO2Et), 144.3 (Carom-C), 126.9, 124.3, 
124.2*, 124.0 (Carom-H), 67.3, 67.2* (C-2), 61.4*, 61.2, 61.1, 61.0* (C-
2CO2CH2CH3+NCO2CH2CH3), 54.9, 54.0* (C-5), 43.3, 42.6* (C-3), 42.1*, 41.7 
(C-4), 21.4*, 20.3 (C-5CH3), 14.6*, 14.5, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1705 (NC=O st). 
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MS (EI) m/z (relative abundance): 311 (6), 238 (M+ - CO2Et, 100), 222 (4), 
210 (5), 194 (5), 182 (1), 166 (15), 150 (3), 137 (3), 123 (12), 110 (3), 97 (7), 79 
(2), 65 (1), 53 (1). 
HRMS: Calculated for [C15H22NO4S]+: 312.1270 [M+H]+; found: 312.1255. 
(2R,3S,5S)-Diethyl 5-ethyl-3-(4-methoxyphenyl)pyrrolidine-1,2-dicarboxylate 
(23o) 
Following the general procedure, 23o (49 mg, 0.14 mmol) 
was isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 
7:3) as a colourless oil, starting from pyrrolidine 22o (55 
mg, 0.16 mmol) and methyllithium (0.10 mL of a 1.53 M 
solution in diethyl ether, 0.16 mmol), using dry THF (1.6 
mL) as solvent. The reaction was quenched with the dropwise addition of t-BuOH 
(0.06 mL, 0.63 mmol) in dry THF (1 mL) at -78 ºC. 
Yield: 89%. 
dr: 6:1. 
[]D20: -52.2 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.3:1, *denotes minor 
rotamer signals): 7.17 (d, J = 8.6 Hz, 2H, Carom-H), 6.86 (d, J = 8.6 Hz, 2H, Carom-
H), 4.38* (d, J = 7.1 Hz, 1H, H-2), 4.33 (d, J = 7.1 Hz, 1H, H-2), 4.26-4.02 (m, 
4H, C-2CO2CH2CH3+NCO2CH2CH3), 4.00-3.87 (m, 1H, H-5), 3.80 (s, 3H, 
OCH3), 3.42-3.26 (m, 1H, H-3), 2.54-2.37 (m, 1H, H-4a), 2.33-2.17 (m, 1H, C-
5CHaHb), 2.07-1.93* (m, 1H, C-5CHaHb), 1.93-1.74 (m, 1H, H-4b), 1.52-1.36 (m, 
1H, C-5CHaHb), 1.32-1.12 (m, 6H, CO2CH2CH3+C-5CH2CH3), 0.90-0.78 (m, 3H, 
CO2CH2CH3). 
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13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
172.5, 172.1* (C-2CO2Et), 158.7 (Carom-C), 155.3*, 154.4 (NCO2Et), 132.5, 
132.3* (Carom-C), 128.1, 114.0 (Carom-H), 67.1, 66.9* (C-2), 61.3*, 61.0, 60.9 (C-
2CO2CH2CH3+NCO2CH2CH3), 60.5, 59.6* (C-5), 55.3 (OCH3), 47.3, 46.5* (C-3), 
38.6*, 38.3 (C-4), 27.1*, 26.1 (C-5CH2), 14.6*, 14.4, 14.2, 14.1* (C-
2CO2CH2CH3+NCO2CH2CH3), 9.8, 9.6* (C-5CH2CH3). 
IR (ATR) cm-1: 1742 (C=O st), 1706 (NC=O st). 
MS (EI) m/z (relative abundance): 349 (3), 320 (4), 276 (M+ - CO2Et, 100), 
248 (7), 232 (3), 218 (1), 204 (11), 187 (1), 174 (11), 160 (2), 147 (13), 130 (12), 
115 (3), 91 (5), 77 (2), 58 (1). 
HRMS: Calculated for [C19H28NO5]+: 350.1967 [M+H]+; found: 350.1949. 
(2R,3S,5S)-Dimethyl 5-methyl-3-phenylpyrrolidine-1,2-dicarboxylate (23q) 
Following the general procedure, 23q (61 mg, 0.22 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) 
as a colourless oil, starting from pyrrolidine 22q (76 mg, 0.27 
mmol) and methyllithium (0.19 mL of a 1.48 M solution in 
diethyl ether, 0.27 mmol), using dry THF (2.7 mL) as solvent. 
Yield: 80%. 
dr: 10:1. 
[]D20: -58.9 (c = 1.19, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.2:1, *denotes minor 
rotamer signals): 7.37-7.19 (m, 5H, Carom-H), 4.54* (d, J = 6.4 Hz, 1H, H-2), 4.47 
(d, J = 6.4 Hz, 1H, H-2), 4.22-4.00 (m, 1H, H-5), 3.79-3.60 (m, 6H, C-
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2CO2CH3+NCO2CH3), 3.50-3.33 (m, 1H, H-3), 2.66-2.44 (m, 1H, H-4a), 1.93-1.75 
(m, 1H, H-4b), 1.37 (d, J = 6.0 Hz, 3H, C-5CH3), 1.26* (d, J = 6.1 Hz, 3H, C-
5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
173.0, 172.7* (C-2CO2Me), 155.8*, 154.8 (NCO2Me), 140.6, 140.4* (Carom-C), 
128.7, 127.2, 127.0 (Carom-H), 66.5, 66.4* (C-2), 55.2, 54.2* (C-5), 52.6, 52.2 (C-
2CO2CH3+NCO2CH3), 47.8, 47.0* (C-3), 41.7*, 41.3 (C-4), 21.4*, 20.3 (C-
5CH3). 
IR (ATR) cm-1: 1747 (C=O st), 1699 (NC=O st). 
MS (EI) m/z (relative abundance): 277 (1), 262 (1), 218 (M+ - CO2Me, 100), 
202 (10), 186 (3), 170 (1), 158 (5), 143 (18), 128 (8), 117 (27), 103 (4), 91 (15), 
77 (4), 59 (11). 
HRMS: Calculated for [C15H20NO4]+: 278.1392 [M+H]+; found: 278.1381. 
(2R,3S,5S)-Dimethyl 3-(2,6-dimethoxyphenyl)-5-methylpyrrolidine-1,2-
dicarboxylate (23r) 
Following the general procedure, 23r (10 mg, 0.03 mmol) was 
isolated by FC (hexanes/EtOAc gradient from 9.5:0.5 to 7:3) 
as a colourless oil, starting from pyrrolidine 22r (14 mg, 0.04 
mmol) and methyllithium (0.03 mL of a 1.53 M solution in 
diethyl ether, 0.04 mmol), using dry THF (0.4 mL) as solvent. 
Yield: 75%. 
dr: 3:1. 
[]D20: +60.7 (c = 0.99, CH2Cl2). 
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1H-NMR (, ppm) (CDCl3, 300 MHz) (rotamers ratio 1.4:1, *denotes minor 
rotamer signals): 7.17 (t, J = 8.3 Hz, 1H, Carom-H), 6.51 (d, J = 8.3 Hz, 2H, Carom-
H), 4.60* (d, J = 8.4 Hz, 1H, H-2), 4.48 (d, J = 8.5 Hz, 1H, H-2), 4.11-4.02 (m, 
1H, H-5), 4.01-3.84 (m, 1H, H-3), 3.80-3.63 (m, 9H, 2 × Carom-OCH3+CO2CH3), 
3.46 (s, 3H, CO2CH3), 2.92-2.70 (m, 1H, H-4a), 2.17-1.98 (m, 1H, H-4b), 1.55-
1.49 (m, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz) (*denotes minor rotamer signals): 
171.8 (C-2CO2Me), 159.5 (Carom-C), 156.0*, 155.1 (NCO2Me), 128.4 (Carom-H), 
112.5*, 112.4 (Carom-C), 103.8 (Carom-H), 62.8*, 62.4 (C-2), 55.5 (Carom-OCH3), 
54.7, 54.0* (C-5), 52.3*, 52.2, 51.3 (C-2CO2CH3+NCO2CH3), 38.0, 37.5* (C-3), 
35.7*, 34.9 (C-4), 21.2*, 20.1 (C-5CH3). 
IR (ATR) cm-1: 1746 (C=O st), 1698 (NC=O st). 
MS (EI) m/z (relative abundance): 337 (2), 305 (1), 278 (M+ - CO2Me, 100), 
262 (1), 246 (2), 219 (1), 204 (2), 188 (4), 175 (1), 161 (6), 147 (3), 134 (1), 121 
(4), 105 (1), 91 (6), 77 (2), 59 (6). 
HRMS: Calculated for [C17H24NO6]+: 338.1604 [M+H]+; found: 338.1596. 
3.3. Synthesis of prolines 24a and 24q. 
General procedure: 
Trimethylsilyl iodide (10.00 mmol) was added dropwise to a solution of 23 
(1.00 mmol) in dry CHCl3 (66.7 mL) under inert atmosphere. The reaction mixture 
was refluxed during 24 hours, then MeOH (37.3 mL) was added and the mixture 
was refluxed for 3 hours more. The reaction was allowed to reach room 
temperature and then the solvent was removed under reduced pressure. Et2O (5 
mL) and few drops of HCl conc. were added and the solution was stirred for 15 
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minutes at room temperature. The mixture was washed with Et2O (3 × 20 mL). 
The liquid phase was basified by the addition of aqueous NH3, and it was 
extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered and the solvent was removed in vacuo, yielding the 
desired product 24 without further purification. 
(2R,3S,5S)-Ethyl 5-methyl-3-phenylpyrrolidine-2-carboxylate (24a) 
Following the general procedure, 24a (36 mg, 0.15 mmol) was 
obtained as a colourless oil, starting from proline 23a (59 mg, 
0.19 mmol), trimethylsilyl iodide (0.27 mL, 1.9 mmol) and 
CHCl3 (10.0 mL), followed by the addition of MeOH (5.6 mL). 
Yield: 80%. 
[]D20: -60.5 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.33-7.16 (m, 5H, Carom-H), 4.26-
4.01 (m, 2H, CH3CH2), 3.84 (d, J = 7.4 Hz, 1H, H-2), 3.58-3.42 (m, 1H, H-5), 
3.42-3.28 (m, 1H, H-3), 2.47-2.25 (m, 2H, H-4a+NH), 1.67-1.56 (m, 1H, H-4b), 
1.25 (d, J = 6.1 Hz, 3H, C-5CH3), 1.19 (t, J = 7.1 Hz, 3H, CH3CH2). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 175.2 (CO2Et), 143.0 (Carom-C), 
128.5, 127.4, 126.6 (Carom-H), 67.2 (C-2), 60.9 (CH3CH2), 54.6 (C-5), 50.8 (C-3), 
44.0 (C-4), 21.2 (C-5CH3), 14.2 (CH3CH2). 
IR (ATR) cm-1: 1730 (C=O st). 
MS (EI) m/z (relative abundance): 161 (13), 160 (M+ - CO2Et, 100), 144 
(4), 129 (4), 117 (10), 100 (2), 91 (9), 83 (4), 73 (3), 63 (1), 55 (4). 
HRMS: Calculated for [C14H20NO2]+: 234.1494 [M+H]+; found: 234.1484. 
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The spectral data is in agreement with previous report.19 
(2R,3S,5S)-Methyl 5-methyl-3-phenylpyrrolidine-2-carboxylate (24q) 
Following the general procedure, 24q (33 mg, 0.15 mmol) was 
obtained as a colourless oil, starting from pyrrolidine 23q (61 
mg, 0.22 mmol), trimethylsilyl iodide (0.30 mL, 2.2 mmol) and 
CHCl3 (11.0 mL), followed by the addition of MeOH (6.4 mL). 
Yield: 70%. 
[]D20: -66.3 (c = 1.01, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 300 MHz): 7.38-7.21 (m, 5H, Carom-H), 3.88 (d, 
J = 7.3 Hz, 1H, H-2), 3.68 (s, 3H, CH3O), 3.55-3.44 (m, 1H, H-5), 3.43-3.35 (m, 
1H, H-3), 2.42 (bs, 1H, NH), 2.32 (ddd, J = 12.4, 7.4, 5.2 Hz, 1H, H-4a), 1.66-1.55 
(m, 1H, H-4b), 1.25 (d, J = 6.1 Hz, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 75.5 MHz): 175.8 (CO2Me), 143.0 (Carom-C), 
128.6, 127.3, 126.7 (Carom-H), 67.1 (C-2), 54.6 (C-5), 52.1 (CH3O), 50.6 (C-3), 
44.1 (C-4), 21.0 (C-5CH3). 
IR (ATR) cm-1: 1731 (C=O st). 
MS (EI) m/z (relative abundance): 204 (1), 183 (1), 160 (M+ - CO2Me, 100), 
144 (5), 128 (5), 115 (21), 103 (3), 91 (15), 83 (12), 72 (4), 65 (3), 55 (11). 
HRMS: Calculated for [C13H18NO2]+: 220.1338 [M+H]+; found: 220.1323. 
                                                 
19 Halland, N.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 8331. 
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4. TOTAL SYNTHESIS OF (+)-GREEK TOBACCO LACTONE 
4.1. Synthesis of adduct 31. 
((2R,3S)-3-Methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl)methanol (31) 
A mixture of 4 Å molecular sieves (4.5 g) and dry CH2Cl2 
(250 mL) under inert atmosphere, was cooled to -23 ºC. 
Then, titanium isopropoxide (9.5 mL, 32.4 mmol) and D-(-
)-diethyl tartrate (7.0 mL, 40.9 mmol) were added and stirred for 30 minutes. A 
solution of t-butyl hydrogen peroxide (5.5 M in decanes, 32.0 mL, 176.0 mmol) 
was added dropwise and stirred for 30 minutes. Nerol (28.5 mL, 162.0 mmol) was 
added dropwise over 50 minutes, and then stirred at -23 ºC for 3 hours. The 
reaction was quenched by the addition of H2O (185 mL) at 0 ºC and stirred for 5 
hours. After the addition of aqueous NaOH 7.5 M (37 mL), the solution was 
saturated with NaCl and filtered through Celite. The filtrate was extracted with 
CH2Cl2 (3 × 200 mL) and the combined organic layers were dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. After purification by flash column 
chromatography (FC) (n-hexane/EtOAc gradient from 3:1 to 2:1) the epoxide 31 
(20.9 g, 123.0 mmol) was isolated as a yellow oil. 
Yield: 76%. 
ee: 71%. Determined by chiral GC using a Supelco β-Dex 120 column; 
oven temp. 140 ºC isocratic; τmajor = 10.32 min, τminor = 9.52 min. 
[]D20: +13.1 (c = 1.00, CHCl3). 
1H-NMR (, ppm) (CDCl3, 500 MHz): 5.10-5.05 (m, 1H, C=CH), 3.79 
(ddd, J = 11.6, 6.9, 4.3 Hz, 1H, CHaHbOH), 3.66-3.61 (m, 1H, CHaHbOH), 2.95 
408 Chapter 5 
 
(dd, J = 6.9, 4.3 Hz, 1H, OCH), 2.26-2.22 (m, 1H, OH), 2.17-2.01 (m, 2H, 
C=CHCH2), 1.69-1.61 (m, 4H, CCH3+CCHaHb), 1.61-1.58 (m, 3H, CCH3), 1.46 
(ddd, J = 13.8, 9.9, 6.9 Hz, 1H, CCHaHb), 1.32 (s, 3H, OCCH3). 
13C-NMR (, ppm) (CDCl3, 125.7 MHz): 132.4 (C=CH), 123.2 (C=CH), 
64.3 (OCH), 61.5 (OCCH3), 61.2 (CH2OH), 33.1 (CCH2), 25.6 (CCH3), 24.1 
(C=CHCH2), 22.1 (CCH3), 17.6 (OCCH3). 
IR (ATR) cm-1: 3423 (O-H st). 
HRMS: Calculated for [C10H18O2Na]+: 193.1204 [M+Na]+; found: 
193.1218. 
The spectral data is in agreement with previous reports.20 
4.2. Synthesis of adduct 32. 
((2R,3S)-3-Methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl)methyl 4-
methylbenzenesulfonate (32) 
To a solution of p-toluenesulfonyl chloride (1.22 g, 6.38 
mmol) and DMAP (169 mg, 1.38 mmol) in dry CH2Cl2 (40 
mL) under inert atmosphere, a solution of the epoxide 31 
(773 mg, 4.54 mmol) in dry CH2Cl2 (8 mL) was added dropwise at room 
temperature. Then, Et3N (1.71 mL, 12.26 mmol) was added dropwise and stirred 
for 12 hours at room temperature. A solution of saturated aqueous NH4Cl (20 mL) 
was added and after separation of the layers, the aqueous phase was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried over anhydrous 
                                                 
20 a) Malkov, A. V.; Bourhani, Z.; Kočovský, P. Org. Biomol. Chem. 2005, 3, 3194; b) Banwell, M. 
G.; Bui, C. T.; Simpson, G. W. J. Chem. Soc., Perkin Trans. 1 1998, 791. 
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Na2SO4, filtered and concentrated under reduced pressure. After purification by 
flash column chromatography (FC) (n-hexane/EtOAc 8:1) the epoxide 32 (1.13 g, 
3.50 mmol) was isolated as a yellow oil. 
Yield: 77%. 
[]D20: +22.9 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 400 MHz): 7.79 (d, J = 8.2 Hz, 2H, Carom-H), 
7.34 (d, J = 8.2 Hz, 2H, Carom-H), 5.06-4.93 (m, 1H, C=CH), 4.16 (dd, J = 11.1, 
5.0 Hz, 1H, CHaHbOTs), 4.03 (dd, J = 11.1, 6.4 Hz, 1H, CHaHbOTs), 2.95 (dd, J = 
6.3, 5.0 Hz, 1H, OCH), 2.44 (s, 3H, Carom-CH3), 2.13-1.97 (m, 2H, C=CHCH2), 
1.66 (s, 3H, CCH3), 1.57 (s, 3H, CCH3), 1.50 (ddd, J = 14.1, 9.5, 5.9 Hz, 1H, 
CCHaHb), 1.40-1.32 (m, 1H, CCHaHb), 1.28 (s, 3H, OCCH3). 
13C-NMR (, ppm) (CDCl3, 100.7 MHz): 145.0, 132.5 (Carom-C), 132.4 
(C=CH), 129.8, 127.8 (Carom-H), 122.8 (C=CH), 68.4 (CH2OTs), 60.9 (OCCH3), 
59.9 (OCH), 32.8 (CCH2), 25.5 (CCH3), 23.8 (C=CHCH2), 21.6 (Carom-CH3), 21.5 
(CCH3), 17.4 (OCCH3). 
IR (ATR) cm-1: 1360 (SO2 st as), 1175 (SO2 st sym). 
HRMS: Calculated for [C17H24O4SNa]+: 347.1293 [M+Na]+; found: 
347.1308. 
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4.3. Synthesis of adduct 33. 
(2R,3R)-2,3-Dihydroxy-3,7-dimethyloct-6-en-1-yl 4-methylbenzenesulfonate 
(33) 
A solution of epoxide 32 (1.25 g, 3.86 mmol) in CH3CN 
(8.8 mL) and H2O (6.1 mL) was warmed up to 50 ºC. 
TsOH (44 mg, 0.23 mmol) was added and the reaction was 
stirred for 12 hours at 50 ºC. After cooling to room temperature, the mixture was 
extracted with Et2O (3 × 10 mL). The combined organic layers were washed with 
brine (30 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. 
After purification by flash column chromatography (FC) (n-hexane/EtOAc 
gradient from 1:1 to 2:3) the diol 33 (845 mg, 2.47 mmol) was isolated as a yellow 
oil. 
Yield: 64%. 
[]D20: +11.3 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 500 MHz): 7.80 (d, J = 8.2 Hz, 2H, Carom-H), 
7.35 (d, J = 8.2 Hz, 2H, Carom-H), 5.10-5.04 (m, 1H, C=CH), 4.22 (dd, J = 10.4, 
2.7 Hz, 1H, CHaHbOTs), 4.03 (dd, J = 10.4, 8.2 Hz, 1H, CHaHbOTs), 3.74-3.68 
(m, 1H, CHOH), 2.72 (d, J = 4.1 Hz, 1H, OH), 2.45 (s, 3H, Carom-CH3), 2.05-1.97 
(m, 2H, C=CHCH2), 1.67 (s, 3H, CCH3), 1.60-1.44 (m, 5H, CCH3+CCH2), 1.11 
(s, 3H, HOCCH3). 
13C-NMR (, ppm) (CDCl3, 125.7 MHz): 145.1, 132.6 (Carom-C), 132.2 
(C=CH), 130.0, 127.9 (Carom-H), 123.8 (C=CH), 74.1 (CHOH), 73.3 (HOCCH3), 
71.4 (CH2OTs), 38.8 (CCH2), 25.6 (CCH3), 22.1 (C=CHCH2), 22.0 (HOCCH3), 
21.6 (Carom-CH3), 17.6 (CCH3). 
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IR (ATR) cm-1: 3512 (O-H st), 1357 (SO2 st as), 1174 (SO2 st sym). 
HRMS: Calculated for [C17H26O5SNa]+: 365.1399 [M+Na]+; found: 
365.1415. 
4.4. Synthesis of adduct 28. 
(R)-6-Methyl-2-((R)-oxiran-2-yl)hept-5-en-2-ol (28) 
To a solution of diol 33 (550 mg, 1.61 mmol) in MeOH (6 
mL), K2CO3 (555 mg, 4.02 mmol) was added at -10 ºC and 
the reaction was stirred for 40 min at this temperature. After 
that the mixture was powered into a solution of 10% citric acid (8.5 mL) and 
extracted with Et2O (4 × 10 mL). The combined organic phases were washed with 
brine (30 mL) and dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. After purification by flash column chromatography (FC) (n-
hexane/EtOAc gradient from 4:1 to 1:1) the epoxide 28 (238 mg, 1.40 mmol) was 
isolated as a yellow oil. 
Yield: 87%. 
[]D20: -2.6 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 400 MHz): 5.13-5.05 (m, 1H, C=CH), 2.94 (dd, 
J = 4.0, 2.9 Hz, 1H, OCH), 2.74 (dd, J = 5.1, 2.9 Hz, 1H, OCHaHb), 2.66 (dd, J = 
5.1, 4.0 Hz, 1H, OCHaHb), 2.14-2.04 (m, 2H, C=CHCH2), 1.66 (s, 3H, CCH3), 
1.63-1.55 (m, 5H, CCH3+CCH2), 1.16 (s, 3H, HOCCH3). 
13C-NMR (, ppm) (CDCl3, 100.7 MHz): 131.8 (C=CH), 124.0 (C=CH), 
69.2 (HOCCH3), 57.6 (OCH), 43.2 (OCH2), 41.1 (CCH2), 25.6 (CCH3), 22.7 
(HOCCH3), 22.1 (C=CHCH2), 17.6 (CCH3). 
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IR (ATR) cm-1: 3448 (O-H st). 
HRMS: Calculated for [C10H18O2Na]+: 193.1204 [M+Na]+; found: 
193.1206. 
4.5. Synthesis of adduct 27. 
(3R,4R)-3,4-Dihydroxy-4,8-dimethylnon-7-enenitrile (27) 
To a solution of epoxide 28 (210 mg, 1.23 mmol) in dry 
toluene (10.5 mL) at 0 ºC, Et2AlCN (1 M in toluene, 1.36 
mL, 1.36 mmol) was added dropwise. The reaction was 
stirred at room temperature for 5 hours.Then, the mixture was diluted with EtOAc 
(10 mL) and cooled to 0 ºC, followed by the addition of NaF (135 mg, 3.21 mmol) 
and water (1 mL). The evolving gas is collected into a basic aqueous solution 
(NaOH 2 M). The resulting mixture was stirred at room temperature for 30 
minutes, filtered through a pad of Na2SO4 and evaporated to dryness. After 
purification by flash column chromatography (FC) (n-hexane/EtOAc gradient 
from 2:1 to 1:1) the nitrile 27 (175 mg, 0.89 mmol) was isolated as a yellow solid. 
Yield: 72%. 
[]D20: +13.0 (c = 1.00, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 400 MHz): 5.09-5.03 (m, 1H, C=CH), 3.79-3.72 
(m, 2H, CHOH+OH), 2.63 (bs, 1H, OH), 2.58-2.49 (m, 2H, CH2CN), 2.08-1.96 
(m, 2H, C=CHCH2), 1.65 (s, 3H, CCH3), 1.58 (s, 3H, CCH3), 1.54-1.46 (m, 2H, 
CCH2), 1.10 (s, 3H, HOCCH3). 
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13C-NMR (, ppm) (CDCl3, 100.7 MHz): 132.2 (C=CH), 123.7 (C=CH), 
119.0 (CN), 74.0 (HOCCH3), 72.4 (CHOH), 38.2 (CCH2), 25.6 (CCH3), 22.1 
(C=CHCH2), 21.4 (HOCCH3), 21.0 (CH2CN), 17.6 (CCH3). 
IR (ATR) cm-1: 3441 (O-H st), 2253 (C≡N st). 
M.p. (n-hexane/AcOEt) (ºC): 55-57. 
HRMS: Calculated for [C11H19NO2Na]+: 220.1313 [M+Na]+; found: 
220.1342. 
4.6. Synthesis of β-hydroxylactone 26. 
(4R,5R)-4-Hydroxy-5-methyl-5-(4-methylpent-3-en-1-yl)dihydrofuran-2(3H)-
one (26) 
To a solution of nitrile 27 (149 mg, 0.76 mmol) in EGME 
(750 μL), an aqueous solution of NaOH 2 M (2.0 mL) was 
added and the mixture was heated under reflux for 1.5 hours. 
Then, the solution was acidified with HCl 2 M to pH = 2 and stirred for 17 hours 
at room temperature. After extraction with Et2O (8 mL), the resulting aqueous 
phase was saturated with NaCl and further extracted with Et2O (3 × 8 mL). The 
combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography (FC) (n-
hexane/EtOAc gradient from 2:1 to 1:1) afforded the β-hydroxylactone 26 (119 
mg, 0.60 mmol) as a colourless oil and the elimination product 34 (4 mg, 0.02 
mmol) as a colourless oil. 
Yield: 79%. 
[]D20: +21.2 (c = 0.22, CHCl3). 
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1H-NMR (, ppm) (CDCl3, 700 MHz): 5.17-5.14 (m, 1H, C=CH), 4.19 (dd, 
J = 6.1, 2.1 Hz, 1H, CHOH), 2.94 (dd, J = 18.0, 6.1 Hz, 1H, O2CCHaHb), 2.51 (dd, 
J = 18.0, 2.1 Hz, 1H, O2CCHaHb), 2.25 (bs, 1H, OH), 2.18-2.06 (m, 2H, 
C=CHCH2), 1.85 (ddd, J = 14.1, 10.2, 5.4 Hz, 1H, CCHaHb), 1.79 (ddd, J = 14.1, 
10.4, 6.5 Hz, 1H, CCHaHb), 1.70 (s, 3H, CCH3), 1.63 (s, 3H, CCH3), 1.35 (s, 3H, 
OCCH3). 
13C-NMR (, ppm) (CDCl3, 100.7 MHz): 175.7 (CO), 132.6 (C=CH), 123.4 
(C=CH), 90.1 (OCCH3), 73.2 (CHOH), 38.4 (O2CCH2), 33.9 (CCH2), 25.5 
(CCH3), 22.9 (OCCH3), 22.3 (C=CHCH2), 17.6 (CCH3). 
IR (ATR) cm-1: 3428 (O-H st), 1749 (C=O st). 
HRMS: Calculated for [C11H18O3Na]+: 221.1154 [M+Na]+; found: 
221.1170. 
The spectral data is in agreement with previous report.21 
(R)-5-Methyl-5-(4-methylpent-3-en-1-yl)furan-2(5H)-one (34) 
Yield: 3%. 
1H-NMR (, ppm) (CDCl3, 700 MHz): 7.34 (d, J = 5.6 Hz, 
1H, O2CCH=CH), 6.00 (d, J = 5.6 Hz, 1H, O2CCH=CH), 
5.04-4.98 (m, 1H, C=CH), 2.03-1.96 (m, 1H, C=CHCHaHb), 1.94-1.87 (m, 1H, 
C=CHCHaHb), 1.85 (ddd, J = 14.0, 10.5, 5.4 Hz, 1H, CCHaHb), 1.72 (ddd, J = 
14.0, 10.7, 5.2 Hz, 1H, CCHaHb), 1.66 (s, 3H, CCH3), 1.56 (s, 3H, CCH3), 1.46 (s, 
3H, OCCH3). 
                                                 
21 Viturro, C. I.; Maier, M. S.; Stortz, C. A.; de la Fuente, J. R. Tetrahedron: Asymmetry 2001, 12, 
991. 
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13C-NMR (, ppm) (CDCl3, 176.2 MHz): 172.6 (CO), 160.2 (O2CCH=CH), 
132.7 (C=CH), 122.8 (C=CH), 120.4 (O2CCH=CH), 88.9 (OCCH3), 38.2 (CCH2), 
25.6 (CCH3), 24.0 (OCCH3), 22.4 (C=CHCH2), 17.7 (CCH3). 
IR (ATR) cm-1: 1752 (C=O st). 
HRMS: Calculated for [C11H16O2Na]+: 203.1048 [M+Na]+; found: 
203.0992. 
The spectral data is in agreement with previous report.22 
4.7. Synthesis of (+)-Greek tobacco lactone 25. 
(3aR,5R,7aR)-7a-Methyl-5-(prop-1-en-2-yl)hexahydro-2H-furo[3,2-b]pyran-
2-one (25) 
A mixture of β-hydroxylactone 26 (35 mg, 0.176 mmol) and 
palladium(II) trifluoroacetate (60 mg, 0.176 mmol) in dry 
DMSO (1.8 mL) under inert atmosphere, was stirred at 80 ºC 
using microwave irradiation during 8 hours. The reaction mixture was allowed to 
reach room temperature and then filtered over silica gel. The filtrate was 
concentrated under reduced pressure and purificated by flash column 
chromatography (FC) (n-hexane/EtOAc gradient from 4:1 to 1:1), obtaining the 
(+)-Greek tobacco lactone 25 (14 mg, 0.072 mmol) as a colourless oil. 
Yield: 41%. 
dr: 85:15. 
[]D20: +33.0 (c = 0.1, CH2Cl2). 
                                                 
22 Siitonen, J. H.; Pihko, P. M. Synlett 2014, 25, 1888. 
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1H-NMR (, ppm) (CDCl3, 700 MHz): 4.97-4.95 (m, 1H, CCHaHb), 4.86-
4.84 (m, 1H, CCHaHb), 4.08 (app d, J = 4.3 Hz, 1H, H-3a), 3.74-3.71 (m, 1H, H-
5), 2.88 (dd, J = 17.5, 4.3 Hz, 1H, H-3a), 2.54 (dd, J = 17.5, 0.6 Hz, 1H, H-3b), 
2.32-2.28 (m, 1H, H-7a), 1.73-1.67 (m, 5H, CCH3+H-7b+H-6a), 1.60-1.57 (m, 1H, 
H-6b), 1.31 (s, 3H, C-7aCH3). 
13C-NMR (, ppm) (CDCl3, 176.2 MHz): 175.7 (C-2), 144.8 (C-5C), 111.4 
(CCH2), 81.6 (C-7a), 78.6, 77.5 (C-3a+C-5), 38.2 (C-3), 32.3 (C-7), 25.2 (C-
7aCH3), 25.1 (C-6), 18.4 (CCH3). 
IR (ATR) cm-1: 1777 (C=O st). 
HRMS: Calculated for [C11H16O3Na]+: 219.0997 [M+Na]+; found: 
219.0997. 
The spectral data is in agreement with previous report.23 
4.8. Synthesis of cycloadduct 35. 
(3aS,8aS)-5,5,8a-Trimethylhexahydrofuro[3,2-b]oxepin-2(3H)-one (35) 
A mixture of β-hydroxylactone 26 (20.4 mg, 0.103 mmol), 
benzoquinone (22.3 mg, 0.206 mmol), White catalyst (5.2 mg, 
0.010 mmol) and silver trifluoromethanesulfonate (2.6 mg, 
0.010 mmol) in dry dioxane (0.3 mL) under inert atmosphere, was stirred at 80 ºC 
during 18 hours. The reaction was allowed to reach room temperature and then 
brine (5 mL) was added, followed by the extraction with EtOAc (3 × 5 mL). The 
combined organic layers were dried with anhydrous Na2SO4, filtered and the 
solvent was removed under reduced pressure. After purification by flash column 
                                                 
23 Clark, J. S.; Hayes, S. T.; Blake, A. J.; Gobbi, L. Tetrahedron Lett. 2007, 48, 2501. 
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chromatography (FC) (n-hexane/EtOAc gradient from 3:1 to 2:1) the cycloadduct 
35 (12.5 mg, 0.063 mmol) was obtained as a white solid. 
Yield: 61%. 
[]D20: -26.2 (c = 0.50, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 400 MHz): 4.01 (app d, J = 7.7 Hz, 1H, H-3a), 
2.96 (dd, J = 18.7, 7.7 Hz, 1H, H-3a), 2.45 (app d, J = 18.7 Hz, 1H, H-3b), 2.25-
2.14 (m, 1H, H-8a), 1.84-1.74 (m, 2H, H-8b+H-7a), 1.67-1.59 (m, 1H, H-6a), 1.51-
1.42 (m, 2H, H-7b+H-6b), 1.33 (d, J = 0.8 Hz, 3H, C-8aCH3), 1.22 (s, 3H, C-
5CH3), 1.13 (s, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 176.2 MHz): 175.0 (C-2), 90.7 (C-8a), 76.8 (C-
5), 73.3 (C-3a), 37.1 (C-3), 36.0 (C-6), 32.8 (C-8), 27.5 (C-5CH3), 26.7 (C-5CH3), 
23.0 (C-8aCH3), 18.4 (C-7). 
IR (ATR) cm-1: 1766 (C=O st). 
M.p. (CH2Cl2) (ºC): 79-81. 
HRMS: Calculated for [C11H18O3Na]+: 221.1154 [M+Na]+; found: 
221.1166. 
4.9. Synthesis of cycloadducts 36 and 37. 
General procedure for the synthesis of cycloadducts 36 and 37. 
To a mixture of the β-hydroxylactone 26 (26.6 mg, 0.134 mmol) and 
palladium trifluoroacetate (23.0 mg, 0.067 mmol), dry acetonitrile (0.5 mL) was 
added. The flask was evacuated and back-filled with O2 (3 × balloon), heated to 80 
ºC and allowed to stir under O2 (1 atm) during 90 minutes. The mixture was 
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allowed to reach room temperature and then filtered over silica gel. The filtrate 
was concentrated under reduced pressure and purificated by flash column 
chromatography (FC) (n-hexane/EtOAc gradient from 4:1 to 3:1), obtaining the 
cycloadduct 36 (12.8 mg, 0.065 mmol) and 37 (4.0 mg, 0.020 mmol) as a white 
solids in a 3.8:1 ratio. 
(3aS,8aS)-5,5,8a-Trimethyl-3,3a,8,8a-tetrahydrofuro[3,2-b]oxepin-2(3H)-one 
(36) 
Yield: 49%. 
[]D20: -52.2 (c = 0.50, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 700 MHz): 5.51 (ddd, J = 11.0, 
8.8, 5.4 Hz, 1H, H-7), 5.39-5.36 (m, 1H, H-6), 4.07 (app d, J = 7.0 Hz, 1H, H-3a), 
3.08-3.04 (m, 1H, H-8a), 2.91 (dd, J = 18.3, 7.1 Hz, 1H, H-3a), 2.47 (app d, J = 
18.3 Hz, 1H, H-3b), 2.16 (dd, J = 12.8, 8.8 Hz, 1H, H-8b), 1.33 (d, J = 1.0 Hz, 3H, 
C-8aCH3), 1.32 (s, 3H, C-5CH3), 1.24 (s, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 176.2 MHz): 175.2 (C-2), 138.0 (C-6), 121.3 
(C-7), 90.3 (C-8a), 79.2 (C-5), 73.7 (C-3a), 36.8 (C-3), 32.8 (C-8), 29.2 (C-
5CH3), 25.2 (C-5CH3), 23.4 (C-8aCH3). 
IR (ATR) cm-1: 1773 (C=O st). 
M.p. (CH2Cl2) (ºC): 87-89. 
HRMS: Calculated for [C11H16O3Na]+: 219.0997 [M+Na]+; found: 
219.1014. 
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(3aS,8aS)-5,5,8a-Trimethyl-3,3a,5,6-tetrahydrofuro[3,2-b]oxepin-2(8aH)-one 
(37) 
Yield: 15%. 
[]D20: -28.5 (c = 0.20, CH2Cl2). 
1H-NMR (, ppm) (CDCl3, 500 MHz): 5.80-5.76 (m, 1H, H-
8), 5.68 (ddd, J = 10.8, 8.6, 5.8 Hz, 1H, H-7), 4.17 (app d, J = 6.5 Hz, 1H, H-3a), 
2.96 (dd, J = 18.1, 6.5 Hz, 1H, H-3a), 2.48 (app d, J = 18.1 Hz, 1H, H-3b), 2.39-
2.33 (m, 1H, H-6a), 1.93 (ddd, J = 14.9, 8.6, 1.0 Hz, 1H, H-6b), 1.39 (s, 3H, C-
8aCH3), 1.21 (s, 3H, C-5CH3), 1.17 (s, 3H, C-5CH3). 
13C-NMR (, ppm) (CDCl3, 176.2 MHz): 174.5 (C-2), 132.4 (C-8), 123.6 
(C-7), 91.8 (C-8a), 76.2 (C-5), 72.7 (C-3a), 37.3 (C-3), 36.5 (C-6), 27.6 (C-
5CH3), 25.9 (C-5CH3), 24.7 (C-8aCH3). 
IR (ATR) cm-1: 1765 (C=O st). 
M.p. (CH2Cl2) (ºC): 83-85. 
HRMS: Calculated for [C11H16O3Na]+: 219.0997 [M+Na]+; found: 
219.1013. 
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Abbreviations, acronyms and symbols  
 
Ac Acetyl 
app d Apparent doublet 
app t Apparent triplet 
Ar Aryl 
ATR Attenuated total reflectance 
BAIB (Diacetoxyiodo)benzene 
Bn Benzyl 
Boc tert-Butoxycarbonyl 
BQ p-Benzoquinone 
bs Broad signal 
c Concentration (measured in g/100mL) 
Carom Aromatic carbon 
Cat Catalyst 
Cbz Benzyloxycarbonyl 
CI Chemical ionization 
Conv. Conversion 
COSY Correlation spectroscopy 
 Chemical shift 
d Doublet 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DBU 1,5-diazabycyclo[5.4.0]undec-5-ene 
DCE 1,2-dichloroethane 
dd Doublet of doublets 
424 Appendix 
 
ddd Doublet of doublets of doublets 
DEPT Distortionless Enhancement by Polarization Transfer 
DET Diethyl tartrate 
DFT Density functional theory 
(DHQD)2PHAL Hydroquinidine 1,4-phthalazinediyl diether 
DIPEA N,N-Diisopropylethylamine 
DIPT Diisopropyl tartrate 
DKR Dynamic kinetic resolution 
DMA N,N-Dimethylacetamide 
DMAP N,N-Dimethylaminopyridine 
DME 1,2-Dimethoxyethane 
DMF N,N-Dimethylformamide 
DMPU 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO Dimethylsulfoxide 
DPP Diphenylphosphoric acid 
dq Doublet of quartets 
dr Diastereomeric ratio 
E Electrophile 
ee Enantiomeric excess 
EGME 2-Methoxyethanol 
EI Electron ionization 
ent Enantiomer 
equiv. Equivalent 
ESI Electrospray ionization 
et al. Et alii (and others) 
eV Electron volt 
EWG Electron-withdrawing group 
FC Flash chromatography 
FGI Functional group interconversion 
FT Fourier transform 
GC Gas chromatography 
HMBC Heteronuclear multiple bond correlation 
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HOMO Highest occupied molecular orbital 
HPLC High performance liquid chromatography 
HRMS High resolution mass spectrometry 
HSQC Heteronuclear single-quantum correlation spectroscopy 
i.e. Id est (that is) 
IR Infrared 
J Coupling constant 
LiHDMS Lithium bis(trimethylsilyl)amide 
LUMO Lowest unoccupied molecular orbital 
m Multiplet 
M.p. Melting point 
m/z Mass-to-charge ratio 
M+ Molecular ion 
MBH Morita-Baylis-Hillman 
Mes Mesityl 
MS Mass spectrometry or Molecular sieves 
MW Microwave 
n.d. Not determined 
n.O.e. Nuclear Overhauser effect 
n.r. No reaction 
NMR Nuclear magnetic resonance  
NOESY Nuclear Overhauser effect correlation spectroscopy 
Ns p-Nitrobenzenesulfonyl 
Nu Nucleophile 
PCC Pyridinium chlorochromate 
phen Phenanthroline 
PIFA Bis-trifluoroacetoxy iodobenzene 
PMP p-Methoxyphenyl 
ppm Parts per million 
Pro Proline 
PTC Phase Transfer Catalysis 
Py Pyridine 
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q Quartet 
QDT Quinidine thiourea 
QNT Quinine thiourea 
QTOF Quadrupole-time of flight 
R Alkyl group or substituent 
r.t. Room temperature  
s Singlet 
SOMO Single Occupied Molecular Orbital 
t Triplet 
T Temperature 
TBAF Tetrabutylammonium fluoride 
TBDPS tert-Butyldiphenylsilyl 
TBHP Tert-Butyl hydroperoxide 
TBS/TBDMS tert-Butyldimethylsilyl 
TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
TES Triethylsilyl 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
TMP 2,2,6,6-Tetramethylpiperidine 
TMS Trimethysilyl 
major Retention time of the major enantiomer 
minor Retention time of the minor enantiomer 
Tr Trityl/triphenylmethyl 
Ts Tosyl 
UPLC Ultra performance liquid chromatography 
vs. Versus 
X Halogen or heteroatom 
& And 
 
 Resumen extendido  
 
En el presente trabajo de investigación se han desarrollado diversas 
metodologías basadas en reacciones en cascada iniciadas por adiciones de 
Michael, con el fin de obtener productos de interés de manera enantioenriquecida, 
empleando aminas quirales como elementos estereoinductores de la reacción, bajo 
activación via ion iminio. 
En concreto, las reacciones en cascada Michael/Michael, aplicando la 
organocatálisis como herramienta estereoinductora, permiten la síntesis de 
compuestos carbo- y heterocíclicos polisustituidos de manera enantiocontrolada. 
Esto está basado en el diseño adecuado de nuevos sustratos con diferentes 
funcionalidades capaces de participar en este tipo de reacciones. En ese sentido, y 
dada la experiencia de nuestro grupo en el campo de la organocatálisis asimétrica, 
nos propusimos como primer objetivo del presente trabajo el estudio de la 
versatilidad sintética de los 2,2-dióxidos de 4-alquenil-5H-1,2,3-oxatiazol como 
reactivos multifuncionales en procesos en cascada. 
Así, en primer lugar, se ha demostrado la aplicabilidad de este tipo de 
sustratos como dadores/aceptores de Michael en reacciones en cascada, junto a 
aldehídos α,β-insaturados, iniciadas por adición de Michael bajo activación via ion 
iminio, seguida de otra adición conjugada mediante catálisis via enamina, 
empleando una amina secundaria quiral como elemento estereoinductor de la 
reacción y una base como cocatalizador, obteniéndose compuestos cíclicos 
polisustituidos (Esquema 1). 
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Esquema 1 
Una vez demostrada la viabilidad de la reacción, y tras un proceso de 
optimización, se determinaron las mejores condiciones para llevar a cabo la 
reacción, las cuales dependían del tipo de sustrato inicial. De esta manera, se 
consiguió extender la metodología de manera eficaz al empleo de enales con 
diferentes sustituyentes en posición β, así como al empleo de varios 2,2-dióxidos 
de 4-alquenil-5H-1,2,3-oxatiazol, con sustituyentes de diferente naturaleza. Así, se 
obtuvo una serie de ciclohexanos y derivados de decalina con muy buenos 
rendimientos y con excelentes estereoselectividades (Esquema 2). 
 
Esquema 2 
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Además, se estudió la versatilidad de los cicloaductos obtenidos teniendo en 
cuenta la habilidad del sulfonato como grupo saliente. Por un lado, se demostró la 
obtención de la agrupación 1,2-amino alcohol, mediante transformación de uno de 
los cicloaductos como ejemplo representativo (Esquema 3).  
 
Esquema 3 
Por otro lado, se consiguieron preparar compuestos bicíclicos de mayor 
complejidad, con anillos de tres y cinco miembros fusionados, de manera eficaz 
mediante un proceso de sustitución nucleófila transanular, seguido de hidrólisis de 
la imina resultante, empleando una amina primaria aquiral como promotora de la 
reacción. (Esquema 4). 
 
Esquema 4 
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Teniendo en cuenta el tipo de reactividad observado, procedimos a llevar a 
cabo la síntesis de estos compuestos bicíclicos mediante un proceso en cascada 
Michael/Michael/SN2 transanular/hidrólisis de la imina, a partir de los 2,2-
dióxidos de 4-alquenil-5H-1,2,3-oxatiazol y enales. Tras un proceso de 
optimización se llegó a la conclusión general de que aumentando la temperatura y 
los equivalentes de base la reacción en cascada se veía favorecida, dándose, 
inesperadamente, la formación de otro diastereoisómero. De esta manera, se 
extendió la reacción, obteniéndose una gran variedad de compuestos bicíclicos y 
tricíclicos con rendimientos moderados y con un excelente estereocontrol 
(Esquema 5). Además, en varios casos se ha llevado a cabo la síntesis 
diastereoselectiva de los correspondientes dioles, mediante reducción de los dos 
grupos carbonilo presentes en el biciclo. 
 
Esquema 5 
Como segundo objetivo principal de la presente memoria, se ha desarrollado 
una metodología organocatalítica dirigida a la síntesis de derivados de prolina de 
manera estereocontrolada. Así, en primera instancia, se comenzó con la 
preparación de pirrolidinas quirales mediante una reacción en cascada 
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Michael/condensación intramolecular entre aminomalonatos y cetonas α,β-
insaturadas, seguida de la reducción diastereoselectiva de la imina resultante en 
one-pot. Para ello, se empleó una amina primaria quiral derivada de la cinchona 
como catalizador, y un ácido de Brønsted como cocatalizador, el cual resultó ser 
clave en el curso estereoquímico de la reacción. En las mejores condiciones, se 
evaluaron una serie de enonas β-arílicas y varios aminomalonatos, obteniéndose 
en todos los casos muy buenos resultados (Esquema 6). 
 
Esquema 6 
Con el fin de preparar las prolinas correspondientes, las pirrolidinas 
obtenidas se sometieron a un proceso de transposición C→N de acilo, promovido 
por base, obteniéndose los correspondientes carbamatos con muy buenos 
rendimientos y diastereoselectividades (Esquema 7). 
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Esquema 7 
Por último, tras desprotección mediante un sencillo procedimiento, se 
obtuvieron los esteres de prolina objetivo con buenos rendimientos (Esquema 8). 
 
Esquema 8 
Finalmente, se recoge el trabajo llevado a cabo en una estancia de tres 
meses realizada en el grupo del profesor M. Christmann en la Universidad libre de 
Berlín. En dicho periodo, se desarrolló la síntesis total de la (+)-Greek tobacco 
lactone, pudiéndose completar en un total de siete pasos con un rendimiento 
global del 7%, partiendo del producto natural nerol (Esquema 9). 
 
Esquema 9 
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Parte del trabajo recogido en la presente memoria ha dado lugar a las 
siguientes publicaciones: 
1. “4-Alkenyl-5H-1,2,3-oxathiazole 2,2-dioxides in Catalytic and 
Enantioselective [4+2] Cycloaddition through Iminium Activation. 
Straightforward Access to the trans-Decaline Framework and to Densely 
Functionalized Cyclohexanes”. 
Iker Riaño, Uxue Uria, Luisa Carrillo, Efraim Reyes, Jose L. Vicario. 
Org. Chem. Front. 2015, 2, 206. 
2. “Organocatalytic Enantio- and Diastereoselective Synthesis of 3,5-
Disubstituted Prolines”. 
Iker Riaño, Estibaliz Díaz, Uxue Uria, Efraim Reyes, Luisa Carrillo, Jose L. 
Vicario. 
Chem. Commun. 2016, 52, 2330. 
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